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Typhoid fever is a potentially-life threatening systemic disease caused by Salmonella Typhi, a human-
restricted bacterium, spread through the faecal-oral route. Following a sustained rise in observed 
incidence in Fiji from 2004, in 2013, I undertook a nationally-representative cross-sectional serological 
survey of 1,531 participants to determine infection by age, assess putative risk factors, and quantify 
social contact patterns.  These data were utilised in the development of a transmission dynamic model.   
The literature indicated that typhoid transmission models are relatively under-utilised, particularly in 
economic evaluation, with little to guide use of vaccination in place of or alongside water, sanitation 
and hygiene (WASH). The serosurvey found that iTaukei and non-iTaukei Fijians have similar risk of 
raised IgG antibodies to the Vi antigen expressed by S. Typhi. Seroprevalence increased with age, 
suggestive of endemic transmission or declining incidence. Unimproved sanitation may increase risk of 
seropositivity. Geospatial analysis suggested rainfall, proximity to major rivers and creeks, or flood-
prone areas were risk factors for acquisition of anti-Vi IgG antibodies. Social mixing was assortative by 
ethnicity and age when assessed by mealtime contacts and highest in school-age children. Increasing 
number of age-adjusted contacts increases the odds ratio for being seropositive, though substantial 
uncertainties remain around the specificity and sensitivity of serological thresholds as indicators of 
past typhoid infection.  
An age- and ethnicity-structured transmission dynamic model fitted the serology and case surveillance 
data well when including a substantially reduced force of infection for high-dose infection being passed 
to non-iTaukei Fijians, and high generation of asymptomatic non-infectious cases per new infectious 
case. Surveillance reporting of infectious cases was estimated as one in five infectious adult cases and 
one in twelve infectious child cases. The fit to the data suggested endemic rather than declining 
transmission, and there was better fit with age-ethnic assortative mixing than with ethnically-
assortative or homogeneous mixing. 
Vaccine scenarios suggested that of single dose routine programmes, school entry could be more 
effective than school leaver vaccination, reflecting age-contact transmission probabilities in the model. 
Modest reduction (10%) in per-case infectious transmission through effective WASH programmes 
offered substantial incidence reductions of around 25%, comparable to two-dose (school entry and 
exit) ViPS vaccination programmes. Potential benefits of conjugate vaccines were projected to be 
similar to more effective WASH programmes, with administration alongside other vaccines in the 
second year of life projected to offer approximately 50% incidence reduction, the most benefit of any 
single dose regimen; with the impact being greater if typhoid carrier daily infectious risk is lower than 
the daily infectiousness of acute typhoid fever cases. 
Seroepidemiological investigations of Salmonella enterica serovar Typhi infection  
and the potential role of vaccination in the control of typhoid fever in Fiji 
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1. Introduction 
 
1.1 Background 
This doctoral thesis describes my seroepidemiological investigations into typhoid in the 
Republic of Fiji, outlined in a series of linked scientific papers. This research follows an 
invitation from the Fiji Ministry of Health (MOH) to academic and public health partners to 
examine an apparent upturn in typhoid fever cases and to determine appropriate control 
strategies. It was conducted as a secondment from UK National Health Service specialty 
training in public health as a Medical Research Council doctoral scholarship in vaccine 
science. 
My investigations primarily comprised of a national serological survey with collection of 
demographic data, social contact data and putative epidemiological and environmental risk 
factors. These data have been utilised in the development of a transmission dynamic model.  
This seroepidemiological approach seeks to address some of the information gaps on typhoid 
infection that cannot be attained through routine clinical and laboratory surveillance.  
The overall aims of this research are (i) to strengthen epidemiological understanding of the 
transmission of Salmonella enterica Typhi, and (ii) to suggest potential evidence-based 
approaches to effective, sustained typhoid fever public health interventions in the Fijian 
archipelago. 
 
1.1.1 Typhoid fever  
Typhoid fever is caused by the gram-negative bacterium Salmonella enterica subspecies 
enterica serovar Typhi (S. Typhi). It is a faecal-orally transmitted systemic disease which is 
considered exclusive to humans and may present with prolonged fever, influenza-like-illness, 
headache, malaise, anorexia and abdominal symptoms.1 Complications are associated with 
delayed administration of effective antibiotics1 and can include encephalopathy, meningitis, 
myocarditis and intestinal perforation, with an estimated “case-fatality rate” (CFR, more 
strictly: proportion of clinical cases which are fatal) of 1% amongst the risk-adjusted 
estimated 12 million cases (95% confidence interval 10 to 15 million) arising annually in low 
and middle income countries.2,3  While treatable with antibiotics, increasing antimicrobial 
resistance is a worrying trend internationally.4 Notably, in November 2016, an extensively 
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drug resistant (XDR) strain emerged in an outbreak in Sindh, Pakistan with resistance to 
chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole, quinolones and third-
generation cephalosporins, including plasmid-mediated resistance.5 The potential for typhoid 
fever to return to CFRs of the pre-antibiotic era of approximately 15% is a significant 
concern.6 Vaccination against typhoid has often been given a secondary role to sanitary 
interventions, which many suggest is a missed opportunity for disease prevention. 4,7–9 
The use and nomenclature of both Salmonella Typhi and typhoid fever are subject to debate 
and evolution. The taxonomic history of the organism previously known as Salmonella 
typhosa10 and Salmonella typhi11 is not pertinent to this thesis; the use of “typhoid” and its 
derivatives is. Some authoritative typhoid papers use “typhoid fever” to refer to any systemic 
infection with Salmonella Typhi: 1,4 by definition this includes subclinical and asymptomatic 
infection as well as the disease. Others use a stricter definition of typhoid fever to refer to the 
clinical disease only.12 This thesis uses “typhoid fever” to refer to the clinical disease and the 
public health problem caused by Salmonella Typhi and “typhoid” to refer to any infection by 
Salmonella Typhi. 
 
1.1.1.2 Epidemiology and modes of transmission of Typhoid (fever) 
 
Disease Burden 
Typhoid incidence is considered high if >100 per 100,000 population, medium if 10 to 100 per 
100,000 and low if <10.13 In Western Europe and North America, typhoid fever has been 
largely eliminated or controlled, with water quality improvements and other public health 
reforms variously attributed to the disease’s decline.14–16  In these settings, most 
contemporary cases are travel-associated.17–19   
Recent typhoid fever research has predominantly been sited in South Asia, where the disease 
burden is considered the highest globally,2,4,13 with multiple epidemiological studies and 
vaccine trials in urban slums as the highest incidence settings.20–23  The incidence of typhoid 
fever in Africa, where enteric fever surveillance is sparse, is gradually being unmasked.24,25  In 
the Pacific islands, typhoid has been recognised as a long-standing health concern in Fiji, 
Samoa and Papua New Guinea, with a Pacific clade of S. Typhi identified through 
phylogenetic analysis of sequenced genomes.26–32 Recent global meta-regression estimates 
assign Oceanian states the highest typhoid incidence rates though it is unclear if predictor 
indices such as flood risk may over-estimate typhoid incidence in small-island populations.33  
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Modes of transmission 
A consideration in communicable disease control in any setting are the predominant modes 
of transmission. For interventions to be effective in interrupting transmission, they should 
typically be well matched to these. These can be serendipitous: addressing malodorous 
sewage as a source of miasmic airborne illness in London was erroneous in theoretical 
construct but the resultant sewage system effective in cutting faecal-oral diseases such as 
cholera.34 For typhoid control, whilst vaccination works by reducing susceptibility to infection, 
with additional indirect protection through reduction in case numbers, individual 
components of WASH (water quality, water supply, sanitation and hygiene; and specific 
elements within each) must align appropriately to transmission modes between portals of 
exit and entry.  
The F-diagram model of diarrhoeal disease transmission paths may be informative to typhoid 
transmission modes (figure 1.1, adapted).35 Public health engineers note that water quality 
interventions may have a lesser role than sanitation and hygiene for many faecal-oral 
diseases: better to prevent water contamination through effective sanitation (with avoidance 
of other contaminations) than to clean polluted water (personal communication: Val Curtis 
and Sandy Cairncross). Water access and water supply as facilitators of hygiene may take 
precedence over water quality as a policy intent.36  
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Figure 1.1. F-diagram 
Black arrows indicate potential transmission mechanisms; vertical grey bars denote potential 
transmission-blocking factors. 
 
Typhoid fever following consumption of food or water that has been contaminated by the 
faeces of a case or carrier may dominate contemporary discourse.37 However, as outlined in 
this subsection, a critical read of the historical and other more recent literature indicates a 
diversity of mechanisms of transmission, more consistent with the breadth of modes in the F-
diagram. This suggests epidemiological investigations should not be focused on these to the 
exclusion of all other modes. The predominant modes of transmission are also thought to 
vary with incidence, as will also be discussed in this subsection. 
Furthermore, an important concern for public health practitioners is to identify those at high 
risk of becoming cases and/or transmitting disease to others, if resources are insufficient for 
universal coverage of interventions, or if interventions are better deployed in a targeted 
manner. Whilst peak incidence is often cited as being under five years or in school-aged 
children,38,39 a transmission dynamic perspective notes that average age of infection falls as 
incidence and force of infection rise: such that typhoid is a disease of young childhood in high 
incidence settings, and with first infection most likely arise in older groups in settings with 
less intense transmission.13  
Case's 
Faeces
Fluid
Fields
Flies
Floors
Fomites
Fingers
Food
New 
case
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Typhoid fever is further described as being transmitted through “short cycle” and “long cycle” 
routes.40 The most recent background paper by the World Health Organization characterises 
these as “contamination of food and water in the immediate environment through 
inadequate hygiene and sanitation measures, either by shedding from temporary or chronic 
carriers” and “contamination of the broader environment, such as pollution of water supplies 
by sewage, inadequate treatment of piped water or use of raw human feces as a crop 
fertiliser.”39  Mathematical modellers of typhoid have used these groupings to reflect direct 
person-to-person and indirect transmission.40,41 
Under the wide-used Bradley classification of water-associated disease, typhoid fever is  the 
archetypal classical waterborne disease.42  Though influential over the last 40 years, this 
classification draws attention to a single mode of typhoid transmission only, omitting food 
and other typhoid transmission routes. Bradley himself reiterates the intent of this work as a 
functional classification to inform disease control in East Africa, and to shift debate, from 
industrial-nation focus on quality of piped water when considering interventions, toward 
other aspects of WASH.43 Colleagues of Bradley found an absence of impact on typhoid fever 
for piped-water interventions in Lesotho, southern Africa, suggesting ingestion of remotely-
contaminated water was not the principle route of transmission.44  
The historical literature on typhoid indicates a diversity of modes of communication for 
typhoid and their relative contributions in settings with different incident rates. The seminal 
1873 work on typhoid by William Budd, an English medical epidemiologist, sought to 
demonstrate typhoid fever as a communicable disease from intestinal discharges, when 
medical contemporaries did not consider it so.45 Budd noted that his country practice enable 
elucidation of such aetiologies, which were obscured to city practitioners, detailing in turn a 
range of incidents which demonstrated typhoid’s contagious properties and modes of 
transmission. A chain of transmission of typhoid fever spread through the villages served by 
Budd, from one case to the next, only associated with household contacts of cases, while no 
cases arose in what might be deemed control households without cases but with otherwise 
identical circumstances, including exposure to noxious aromas from pit latrines and other 
putative causes of the disease. This indicated that typhoid fever was transmitted person-to-
person, often affecting those who tended to the sick. Whether this is direct transmission or 
by fomites is not elucidated. Such transmission can be avoided by appropriate faecal and 
hand hygiene and infection control measures.46,47 
Budd also observes a latent period between infection and disease onset, and that an attack 
appeared to confer lifelong immunity. Alongside “propagation by contagion” Budd also notes 
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typhoid’s “quasi-miasmic” ability to “infect the ground… which has misled so many observers 
as to their true mode of spreading”. Budd documented an outbreak in Bristol associated with 
a contaminated well serving “houses of a good class” whose neighbours remained free of 
fever. An outbreak at a ball in Cowbridge in Wales was traced to a well with adjacent cesspit 
which had received “the bulk of the diarrhoeal discharges” of a typhoid fever patient where 
“percolation from one to the other was almost inevitable”. Amongst modes of 
communication, Budd notes contaminated hands and linen to transmit typhoid, describing a 
local case in a washerwoman contracting from bed clothes of two typhoid fever patients, and 
noting observations from the Fever Hospital in London that the washing profession was 
struggle to recruit due to the inevitability of succumbing to the disease. This is tempered by a 
reflection that the public increasingly appreciated the need to sterilise soiled products before 
sending for washing. Pawnbroker transmission through linen of the deceased is also 
reported, as is transmission from contact with the clothing of those nursing cases. 
In the United States of America (USA) the most well-known case of typhoid infection is that of 
Mary Mallon, a New York chef. Her fiery disbelief that she could have asymptomatic chronic 
faecal carriage of S. Typhi thereby causing a series of cases and deaths in households saw her 
continue to work against official advice and resulted in her incarceration for public 
protection. The investigation report by George Soper details associations in persons, time and 
place, demonstrating epidemiologically Mallon to be the source and foodborne transmission 
the mode of communication when householders and others suspected sanitation defects and 
contaminated water supplies.48 
Other studies from the USA demonstrate the important role for waterborne typhoid to 
contribute to the typhoid fever burden, where sewage systems have not protected the 
drinking water supply. Arguably, substantial contamination of piped drinking water is the 
most effective means for high incidence of typhoid fever to be attained, bringing large doses 
and so water borne transmission is typically associated with the highest incidences of typhoid 
fever. Sears found sewage leakage from a factory intro piped water to be responsible for a 
highly-localised outbreak.49 Sedgwick and McNutt’s paper on typhoid fever incidence in 
Massachusetts state and Hamberg, Germany, is informative.50 Sedgwick had intervened to 
introduce sewage filtration to the Merrimac river in an effort to cut typhoid fever mortality 
rates in Lowell and Lawrence, with rates dropping from 112 per 100,000 in each to 24 and 25 
per 100,000 respectively.51 Interestingly the temporal association of water filtration and the 
decline in illness is not always strong: the figures published in the paper suggest decline 
preceded the introduction of filtration but does not preclude public awareness of the hazards 
of piped water reducing the illness rates. Stronger evidence of the impact of water filtration 
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on US waterborne typhoid is provided by Johnson’s 1916 review, noting this to be greater in 
the north than the south, where other routes were considered to have a proportionally 
greater contribution.52 
Sedgwick also, with Winslow,51 coined the phrase “prosodemic transmission” to refer to 
faecal-oral typhoid transmission from person-to-person by direct or indirect means 
(regardless of the specific elements of the transmission chain), citing Budd’s study of the 
same in England. It is taken from the Greek, “pros” meaning “from” and “to” and “demos”, 
well known to epidemiologists as “the people”. Sedgwick and Winslow reserve “epidemic” as 
"that special case in which circumstances permit the transfer of infection to a large number 
of persons through the same medium, and at approximately the same time" equivalent to 
“point-source” epidemics in current usage. 
Importantly, Sedgwick and Winslow note that prosodemic mortality rates of typhoid in 
Massachusetts cities is of a range 13 to 25 per 100,000. Allowing a six to ten fold increase for 
clinical cases (Budd allows 9.5 recoveries per fatality45, Levine 6.676) gives an incidence rate in 
the range 78 to 250 per 100,000. This indicates that incidence rates classified today as very 
high can be attained without transmission through municipal piped water.  Furthermore, this 
suggests that towns in Massachusetts, USA had incidence 125 years ago that would be 
considered very high by current standards. 
The contribution of flies (e.g. housefly Musca domestica (Diptera: Muscidae)) to typhoid 
transmission is disputed. Typhoid infection requires relatively high inoculating doses of 
Salmonella Typhi (see table below) when compared to diseases such as shigellosis requiring 
just tens of Shigella spp. organisms.53 Experimental work has shown S. Typhi to persist for up 
to ten days on the surface or gut of houseflies;54 nevertheless, diseases with lower infecting 
doses that typhoid may be more amenable to transmission by the small feet and alimentary 
systems of flies travelling from exposed faeces to prepared food. Many have historically 
ascribed typhoid fever to fly-borne contamination of food, including Budd, and Walter Reed 
and colleagues assessing sanitary failings in US military bases55, with Rosenau et al attributing 
15% of cases in military bases to flies.56 
Typhoid may be contracted through eating contaminated crops. Wastewater is an acceptable 
fertiliser for human-consumed vegetables, within guidelines, with contamination by 
pathogens such as Escherichia Coli more likely at markets than in fields.57,58 Experimental 
assessment has found S. Typhi persistence in soil for months, and detection of viable 
organism in root and leaf vegetables one month after harvesting from growth in 
contaminated soil.54 In a major outbreak in Santiago, Chile in the late 1970s and early 1980s, 
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70% of cases were attributed to locally-grown vegetables, with important corroborating 
evidence from S. Typhi detection by Moore swabs in sewers that flowed to crop fields.59–61 
Interventions to improve wastewater quality alongside educational programmes and other 
interventions to reduce consumption of raw vegetables have been given credit for driving 
down incidence.59 
Data from Tokyo in the first half of the 20th century further demonstrated the importance of 
safe disposal of faecal matter, with an economically-driven interrupted time series natural 
experiment reported by Nagashima in 2004.62 Collection of night-soil had previously been 
undertaken for free due to the commercial value of human faeces as a fertilizer. When 
chemical fertilizers became popular, night soil collection declined, and typhoid became 
established in affluent areas of Tokyo until government intervention to provide a night-soil 
collection service.62 
More recent decades have seen a number of case-control studies and other epidemiological 
investigations into the transmission of typhoid. It should be noted that outbreak transmission 
and endemic or prosodemic transmission may not follow the same modes, with endemic 
transmission less likely to be investigated than if there is a perceived excess of cases, 
potentially biasing the literature towards transmission modes associated with epidemic 
disease. Similarly, transmission in high incidence settings may be more likely to be 
investigated than in lower incidence settings. These recent studies reveal a diversity of 
transmission mechanisms. 
Mermin and colleagues reported in 1999 on a multi-drug resistant typhoid outbreak in 
Tajikistan associated with drinking unboiled water following equipment failure at a water 
plant, with back-siphonage causing faecal contamination.63  In 2001, Olsen and colleagues 
reported on a restaurant outbreak on Nauru that was attributed to two food handlers with 
faecal carriage of S. Typhi. In a 2001 study in southern Vietnam, Luxemburger and colleagues 
found recent contact with a typhoid fever patient and low socioeconomic status were 
associated with disease in an adjusted logistic regression analysis with community controls.64 
Vollaard and colleagues examined typhoid fever in Jakarta in 2001-3 using case-control 
methods.65 Against community controls, they found adjusted risk factors to be “mostly 
related to the household” including recent cases in the household, absence of soap for 
handwashing, sharing food from the same plate and absence of toilet in the household. With 
control selection matched by geography but not age, the study also found typhoid fever cases 
to be younger than controls. Studying Kamalapur slum in Dhaka, Bangladesh, Ram et al’s 
2006 case control study identified on multivariable analysis drinking unboiled water at home 
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and consumption of foul-smelling water to be independently associated with illness, as was 
consumption of papaya, whilst latrine use was protective.21 Srikantiah’s 2007 study in 
Samarkand, Uzbekistan, found on adjusted logistic regression that risk factors were 
consumption of unboiled water outside the home, consumption of antimicrobials in the two 
weeks prior to disease onset and being a student. Routinely washing vegetables and drinking 
in tea houses were protective. Most houses in Samarkand draw household water from deep 
underground sources unlikely to harbour significant S. Typhi concentrations, in contrast to 
sources outside the home which are more likely to draw surface water and risk 
contamination. In Kathmandu, Nepal, low income and use of a household rather than 
community toilet were associated with typhoid fever in a 2013 adjusted case-control analysis 
by Karkey and colleagues.66 Molecular methods applied in Kathmandu have identified 
household transmission and detected S. Typhi in municipal water spouts used as a supply of 
drinking water.67 However, no bacterial culture and isolation was successfully done from any 
water sample: as polymerase chain reaction (PCR) can detect killed/dead bacteria as well as 
live organism, such findings do not conclusively support transmission through this mode. 
A WHO expert-elicitation exercise on foodborne transmission global burdens estimated that 
in Oceania, foodborne transmission accounted for median 49% (95% “uncertainly” 10 to 84%) 
of typhoid fever incidence, person-to-person transmission (not defined) 13% (0 to 51%) and 
water 33% (1% to 66%).68 Sustained transmission of typhoid in another Pacific island, Samoa, 
led to this being the setting for a ground-breaking transmission dynamic computational 
model developed by WHO in the 1970s, discussed further in the literature review 
chapter.30,69,70 
Asymptomatic gallbladder carriage is established in a small percentage of cases, more 
commonly in women, older patient and those with gallstones, leading to prolonged faecal 
shedding (less commonly urinary shedding, typically if tract damage exists, such as through 
schistosomiasis) over months or years.1 Gunn and colleagues divide carriage in three 
categories:  
 Convalescent: three weeks to three months post-infection (presumably “post-
ingestion” or “following the moment of infection” as carriage is a form of infection)  
 Temporary: three to twelve months 
 Chronic: more than one year.71 
Experimental work has shown that pathogenesis is dose-dependent: the probability of 
developing clinical disease increases and the time to onset decreases with higher ingested 
doses.72,73 This is consistent with the above epidemiological findings suggestive of 
28 
 
symptomatic infection from heavily sewage-contaminated water or crops, household 
transmission from acute cases, transmission from defective sanitation and contamination of 
fruit. The WHO notes that water consumption is more likely to deliver low inocula while 
foodborne inocula are usually high dose.74 
Ingested dose of S. 
Typhi 
Proportion of 
volunteers developing 
clinical disease  
Days to onset of 
clinical disease, 
geometric mean with 
95% CI 
109 0.95 
4.7  (4.1 to 5.4) 
108 0.89 
107 0.5 7.4 (4.9 to 11.2) 
105 0.28 9.3 (8.4 to 10.4) 
103 0 N/A 
Table 1.1. Ingested dose of S. Typhi, attack rates and incubation periods 
Source: Hornick et al 1970, Glynn et al 1995 72,73 
 
 
Diagnostics 
Current typhoid diagnostic tools are considered inadequate.75 The current gold standard test 
is blood culture, which has high specificity for typhoid but limited sensitivity, though this may 
be increased by larger blood draws with modern media and monitoring.76 Bone marrow 
culture is more sensitive but invasive and not commonly practiced.76 The outdated Widal test 
and modern rapid antibody test kits (often utilising Widal-based technology) are of limited 
clinical utility in differentiating typhoid from other febrile illnesses.77  The weakness of these 
diagnostic tools impairs surveillance efforts as well as tilting clinical management towards 
empirical treatment.75  
 
1.1.1.2 Immunobiology of Salmonella Typhi 
The pathogenic process from S. Typhi ingestion to clinical disease is complex.78–80 Bacteria 
passing through the low pH environment of the stomach into the small intestine arrive at the 
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lamina propria through M cells in Peyer’s patches or through trans-enterocyte passage in 
endocytic vacuoles. In the lamina propria of the susceptible host, macrophages engulf S. 
Typhi largely without killing them; these either remain in localised lymph tissue or drain into 
the mesenteric lymphatic system, from where S. Typhi can multiplying and enter the 
circulation.  This results in a primary bacteraemia, from where the bacteria can reach 
reticuloendothelial system organs and continue multiplication. A sustained second 
bacteraemia is associated with clinical disease, typically 8 – 14 days after ingestion.  
Salmonellas are classified based on the O (somatic) and H (flagellar) antigen under the 
Kauffman White scale: S. Typhi express d-flagellin (Hd), O9 and O12. Widal tests for typhoid 
using O and H antibody are strongly cross-reactive with other species and consequently of 
insufficient specificity for acute diagnosis or serological surveillance.81 Most Salmonella Typhi 
obtained from clinical samples also expresses the Vi capsular polysaccharide antigen, an 
abbreviation of “virulence”. Vi-expressing strains are more pathogenic than those which do 
not express it, such that disease caused by an S. Typhi strain lacking Vi is rare.72 Of bacterial 
species and serovars expressing Vi, only S. Typhi is recognised as a common pathogen in 
immunocompetent humans, in contrast to Citrobacter freundii and Salmonella enterica 
serovar Dublin.82 Urinalysis of Vi antigen by ELISA has been examined as a potential rapid 
diagnostic test for typhoid fever in a 2004 Egyptian-American study,83 however, equivalent 
sensitivity in examination of urine from other febrile patients suggests issues with the assay 
and limited validity.  
The utility of Vi antibody in diagnosis has been found to be limited in endemic settings due to 
slow onset in acute disease and high background prevalence.75,84 In a study in Vietnam, illness 
for two weeks or more was associated with a raised anti-Vi IgG response.85 Vi antibody 
detection has greater utility in population level studies in determining these background 
prevalences, where subclinical infection is likely to go untreated - one study in Kathmandu, 
Nepal, found higher prevalences in adults than children, suggestive of endemic transmission, 
or high historical rates of childhood infection and later decline.86 Another study using 
Kathmandu residual clinical samples from non-typhoid fever case patients found peak titres 
in young children and young adults and ELISA unit inter-quartile ranges in the region of 10 to 
100 EU across all ages, suggesting hospital attendees to have sustained high prior risk of S. 
Typhi exposure.66  
Very high anti-Vi titres have also been utilised in serological identification of chronic typhoid 
carriers such as in Chile, with a 75% sensitivity  (27 of 36 carriers; 95% CI: 57 to 87%) at 
threshold 1:160 and 92% specificity amongst 388 stool-culture negative women.87 Studies in 
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the USA, a low incidence setting, found Vi serology specific for carriage but insensitive (29 of 
38 total carriers; 76%, 95% CI: 59 to 88%) relative to stool culture.  
A 1986 expert meeting proposed wider use of serosurveillance to inform lifetime prevalence 
of symptomatic and asymptomatic infection using long-lived IgG Hd antibodies.88 At the time 
most Vi antigen preparations were insufficiently pure to offer adequate sensitivity or 
specificity, though more sensitive and specific Vi antibody tests were in development, in 
parallel with efforts to develop  a Vi-based vaccine.88 Serosurveillance for Hd IgG antibodies in 
Santiago, Chile, in 1978, had found 25% of 76 15-19 year olds to be seropositive at 1:40 titre, 
higher than the same age groups in other regions not affected by epidemic typhoid fever.89 
Age-based analysis in Santiago found less than 10% of 163 children under 15 years to have Hd 
seropositivity, rising to over 50% of 23 sampled 25-29 year olds. Older ages has 
seroprevalence around 40% from 36 samples. Interpretation of this may include endemic 
transmission with waning antibody in older age-groups, or recent outbreak with differential 
risk by age. 
Natural infection elicits both humoral and cell mediated immunity (CMI). Whilst cell-
mediated immunity is considered likely to be the major defence mechanism against typhoid, 
the fact that Vi is an effective vaccine indicates that anti-Vi has a role in protection during 
natural infection.90  
Correlates of immune protection are not clearly defined following infection or vaccination.91–
93 In highly endemic South African settings, a study by Klugman and colleagues 94 found that a 
Vi antibody titre correlating with protection was likely to lie within a range of 0.6 micrograms 
to 1.2 micrograms per millilitre.  From this they considered 1 microgram an arbitrary and 
conservative estimate of the level necessary for protection. More recently 1.4 to 2 
micrograms/ml has been suggested as a correlate.95 Standardisation of assays internationally 
is unfortunately incomplete.91  
Anti-Vi serology was reviewed by Robbins and Robbins in 1984, motivated by consideration of 
Vi as a vaccine candidate.96 They challenge some prior research (focused on carrier 
identification) that suggested no relationship between Vi antibodies, susceptibility or 
recovery, which held that the most typhoid fever patients do not produce antibodies within 
weeks of illness. Robbins and Robbins note instead that higher titres and higher proportions 
positive are observed later in the course of illness97 and suggesting impurity in Vi preparation 
used for assays rendered them invalid as unable to distinguish from background noise. 
Studies such as those by Landy and Lamb using purified Vi and passive haemagglutination in a 
highly endemic setting found seropositivity in current and recent cases but no response in 
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non-cases.98 A further issue identified with historical studies is the identification of protective 
effects driven by anti-Vi incomplete antibody – that which binds antigen but does not 
agglutinate.99 This could result in individuals who have been naturally infected being 
protected and yet have a serum antibody titre that cannot be identified on agglutination 
assays; such antibodies could be detectable by other means. 
There remains limited data on Vi antibody kinetics following natural infection. House et al 
found elevated Vi antibody response by ELISA optical density in Vietnamese patients who had 
been ill for at least two weeks.85 Lanata and colleagues found in Santiago raised titres in 
approximately half of acute cases,87 whilst women aged ≥25years with confirmed typhoid 
fever one to four years previously had GMT and titre distributions more comparable to the 
general population from whom they were drawn (the high community Hd seroprevalence by 
late adolescence in the same setting should be noted).89 Brodie’s study of antibodies 
following a typhoid outbreak in Aberdeen, UK, found a bimodal distribution of Vi antibody by 
agglutination assay in acute cases with only 20% seronegative. At 3 months, 70% had become 
seronegative, and at 6 months 40% were seronegative.100 Such findings may be consistent 
with an early IgM response and slower IgG response. 
 
Vi vaccinees’ antibody kinetics have been studied but are not readily interpretable in 
informing serological surveillance of natural infection. A small study by radioimmunoassay 
(RIA) in US volunteer vaccinees showed substantially raised titres three weeks after Vi-PS 
vaccination, with persistence at lower levels (but still above baseline) after three years.101 
Medium and long-term kinetic data is available from pilot participants in a vaccination trial in 
a typhoid-endemic area of South Africa Klugman and colleagues used ELISA optical density 
and RIA to examine serum pre- and post- vaccination, with these Vi assays considered more 
sensitive than the haemagluttination assays used previously for carrier detection.9,102 Both 
those in groups with and without pre-vaccination antibodies saw rise in titre at one month 
and wane at six and twelve months. At twelve months, titres had returned to comparable 
levels in those with baseline titres. For those without baseline titres, sustained response was 
observed by RIA and, for those receiving higher vaccine doses, by ELISA, though these were 
less than baseline titre in those with pre-vaccination antibodies. At three year follow-up, 
geometric mean titres were higher than those of controls.94 The 10 year follow-up of the 
South African vaccinees and controls appears to show that antibody had waned in 40 
vaccinees to 1.23 (range 0.21 to 2.30) microgram/ml geometric mean titre by RIA whilst 43 
control participants’ serology had reached GMT of 1.30 0.15 to 3.91) microgram/ml.102 Keddy 
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et al also report observing raised Vi in recent typhoid fever cases, including two control 
participant. Most notable for Vi seroepidemiology from the South African trial is that 40% of 
control participants at the age of nine had titres predicted to be protective, suggestive of 
natural infection. 
Work is ongoing for novel biomarkers of typhoid infection.103,104 Notably the recent 
characterisation of the typhoid toxin opens the future possibility of diagnostic methods, 
surveillance tools, therapeutics and vaccines based on the toxin and immune response to 
it.105  
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1.1.2 Setting 
Fiji is a populous Pacific island state and classified by the World Bank as an upper-middle 
income country.106  It is located approximately 2000km north of New Zealand in the Pacific 
Ocean. 
At the last census (2007) the total population of Fiji was 837,271, of whom 57% are iTaukei 
(see below), 37% Indo-Fijian, and 6% other ethnicities. Most of the population reside in the 
two main islands, Viti Levu, where the port capital Suva is found, and Vanua Levu in the 
north. The administrative divisions of the islands are shown in figure 1.1. 
 
Figure 1.2. Fiji administrative map.  
Source: Fiji Bureau of Statistics 107 
 
34 
 
 
 
1.1.2.1 Ethnicity in Fiji 
Ethnicity is an important consideration in the epidemiology of typhoid in Fiji, and the recent 
political and demographic history of Fiji are relevant in this regard. The language and 
terminology of ethnicity in Fiji is contested. In efforts to promote a singular national identity, 
on 30 June 2010 the government enacted a new law requiring all government agencies to 
replace “the word ‘Fijian’ or ‘indigenous’ or ‘indigenous Fijian’ with the word ‘iTaukei’ in all 
written laws, and all official documentation when referring to the original and native settlers 
of Fiji.”108  “Fijian” now denotes any citizen of the islands. This thesis uses the iTaukei word 
“iTaukei” to denote indigenous Melanesian Fijians (57% of the population), and “Indo-Fijian” 
to denote Fijians of Indian descent (38%). The term “Indo-Fijian” is widely used and 
understood by Fijians of all ethnicities including by influential Indo-Fijians such as the exiled 
academic Brij Lal.109 
Fiji’s multi-ethnic society is a product of its time as a British colony between 1874 and 1970. 
The period 1879 to 1916 saw the immigration of approximately 60,000 indentured labourers 
from India to work on sugar plantations.110 Many remained after their five-year contracts 
expired, with the Indian population also increasing due to the arrival to urban Fiji of smaller 
numbers of Gujarati free immigrants from 1900 as retailers or skilled professionals.111  The 
British Governor sought to protect indigenous traditions and rights, including barring the sale 
of Fijian land to non-iTaukei, leaving Indo-Fijians to lease land for property development and 
farming.112 Thus indigenous iTaukei Fijians spent much of the 20th century maintaining 
traditions and in subsistence farming, whilst Indo-Fijians sought to gain security and position 
through wealth creation.111  
By the 1980s Indo-Fijians had become the majority population and were making ever 
stronger calls for land and political rights. A coup in 1987 was led by an iTaukei military officer 
calling for iTaukei dominance of parliament and resulted in a period of racial unrest. Land 
leases were not renewed and Indo-Fijians were displaced from homes and farmland. 
Emigration of (skilled) Indo-Fijians has been a secular trend since this time.113 A period of 
political instability came to a head in 2000 when iTaukei businessman George Speight took 
hostages in parliament including Fiji’s first Indo-Fijian leader, Mahendra Chaudhry. A counter-
coup led by Commodore Josaia Voreqe (Frank) Bainimarama saw the installation of an 
interim military government. A coup was led by Bainimarama in 2006 to strengthen Indo-
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Fijian rights.114 In elections in September 2014 Bainimarama’s FijiFirst party became the 
largest party with Commodore Frank elected prime minister.115 
 
1.1.2.2 Population structure 
 
Regardless of political circumstance, iTaukei and Indo-Fijians live largely separate daily 
existences111 and experience different demographic forces, with birth and death rates higher 
in iTaukei than in Indo-Fijians, and rural residency more common amongst iTaukei Fijians.113 
Urban and rural population split is close to 50:50, with iTaukei Fijians comprising 64% of the 
rural population.113 Markers of material wealth are higher in Indo-Fijians.113 
Figure 1.2 shows the age structure of the iTaukei and Indo-Fijian populations. It is notable 
from a health, demographic and modelling perspective that the iTaukei Fijian population 
appears to have an "exponential" population curve indicative of a constant mortality rate, 
while the Indo-Fijian age structure is more "rectangular" and consistent with epidemiological 
transition.116  
 
Figure 1.3. Population pyramid of iTaukei Fijian and Indo -Fijians by age group.  
Data source: Census 2007. 
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1.1.2.3 WASH in Fiji 
WASH infrastructure and behaviours are important determinants of typhoid risk in Fiji. A 
1914 epidemiological report on dysentery (shigellosis) considered the reticulated water 
system in Suva to be “beyond reproach”.117 The most recent census (2008) indicated that 
both ethnic groups have similar access to safe water supply (metered, communal and roof-
tank) covering approximately 90% of households, up from 84% in 1996.113 
The Fiji Water Authority is responsible for the reticulated water system, with the 2007 SOPAC 
report noting surface water to be the primary source for most towns in Fiji, with groundwater 
use on smaller islands only. 
The United Nations note that due to an absence of primary legislation, “there is no clear 
ownership within any single government department when it comes to … regulating, 
managing, and delivering water resources and services.”118 
A recent systematic review of WASH in Pacific islands noted the importance of the cultural 
context in interventions, such as acceptability of household-level water harvesting schemes in 
iTaukei villages where community and communality are prized.119  
Census reported ownership of “modern” toilets (private or shared flush toilets, regardless of 
sewage connection) is higher amongst Indo-Fijians (83% vs 63% of iTaukei in 2007, up from 
54% and 35% respectively in 1996). In 2007, water seal toilets were used by 21% of iTaukei 
households and 3% of Indo-Fijian households, with pit latrines used by 14% and 14% of 
households respectively. 
Sewerage systems were described in a 2002 report, which found that even in highly densely 
populated Suva-Nausori, only one third of the population were connected to the mains 
sewage system, with 270,000 utilising septic tanks. 120 Overflow from undersized sewers, 
blockages and poorly maintained plants were considered to contribute significantly to faecal 
contamination of water.  
Socio-cultural aspects of hand hygiene have been examined in iTaukei Fijians by interview 
and focus group research.121 Confusion was found in some participants between diseases 
such as typhoid and lymphatic filariasis, with media focusing on diseases rather than common 
risk factors. Handwashing was viewed with ambivalence regarding health benefits, and more 
likely to occur in the context of bathing and washing rather than associated with meal 
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preparation or post-toileting. Intermittent water access and general water-scarcity in a peri-
urban settlement led to water being conserved for uses other than handwashing.  
 
1.1.3 Typhoid in Fiji 
Fiji has seen a sharp upturn in notified, blood-culture confirmed typhoid cases since 2004 
(figure 1.3), rising from low tens of cases to approximately 360 per annum (approximate 
crude annual incidence 43 per 100,000 population) with some provinces considered high 
incidence by international standards at over 100 case per 100,000.122–124  The Fijian enteric 
fever burden is almost exclusively due to typhoid, rather than paratyphoid fever, a clinical 
indistinguishable disease which has become more prevalent in Asia, where S. Paratyphi A is 
the most common causal organism.125,126  
 
Figure 1.4 Typhoid fever notified case incidence 1995 to 2014  
Data sources: Kumar et al (MOH data);122 Cleaned confirmed-case national surveillance 
database, Fiji Centre for Communicable Disease Control, Ministry of Health and Medical 
Services 
 
An Australian AID sponsored vaccination campaign was implemented in areas deemed at 
highest risk for typhoid following Cyclone Tomas in 2010, covering approximately 7% of the 
population, primarily Taveuni island and the southern coast of Vanua Levu, with smaller 
campaigns elsewhere. Achieving close to 100% coverage across all ages in some of these 
areas, the campaign was successful in reducing localised incidence, but appeared to have 
negligible effect on the overall typhoid epidemic.127 
Year 
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The overwhelming majority of reported cases are in iTaukei Fijians (94%), with a male excess 
(57%), a median age of 25 and an inter-quartile range of 15-36 years.128 See figure 1.4. 
Antimicrobial governance is considered relatively strong in Fiji, though stock shortages and 
empirical treatment are common, and antimicrobially-resistant typhoid fever is rare at 
present.123,129 A convenience sample survey of Fijian festival attenders found 41% reported 
antibiotic use in the previous month, including for colds, flu and other viral diseases which do 
not respond to antibiotics. Government health facilities were the main source of antibiotics, 
though almost 2% reported obtaining these from pharmacies without prescription.130 The 
understanding of a number of survey terms and validity of prevalences require further 
assessment through in-depth qualitative research.   
That the average age of infection appears to be in young adulthood suggests a lower annual 
force of infection compared with settings in the Indian subcontinent where disease is seen at 
high incidence rates earlier in childhood 38,86,131. Statistical and causal inference is limited, not 
least by surveillance biases, such as the potential for differential reporting in different age 
groups. Under-ascertainment in children is a distinct possibility, where empirical treatment 
may be more common than invasive diagnostic testing and the sensitivity of blood culture 
further reduced by reduced blood-volume draw.33,76 
 
Figure 1.5 Age- and ethnicity-specific incidence rates of laboratory confirmed 
typhoid in Fiji 2008-11  
(per 100,000 person years; 2007 census population; MOH data) 
 
Kumar and colleagues122 suggest possible causal mechanism for typhoid transmission in Fiji, 
noting association with the higher incidence of disease, including outbreaks, in the Northern 
Division and Suva peri-urban area. The proposed risk factors are poor sanitation, water 
supply and personal hygiene; slum settlements where sharing of toilets and water supply is 
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common; and the use of infected water in preparation of the herbal drink kava, which is 
consumed in groups with a communal bowl and cups. The sharing of farm tools is also 
asserted as increasing the rate of disease transmission, though no evidence is provided to 
implicate these particular fomites; public health officials have suggested poor sanitation 
facilities for seasonal sugar cane croppers was a driver of increased incidence in the Northern 
Division.132 Handwashing campaigns have been implemented but not resulted in any 
appreciable decline in disease.133 
 
1.1.4 International typhoid vaccination and control context 
Whilst this thesis is oriented toward the typhoid public health problem in Fiji, it is not 
independent of the international research and policy context. Multiple iterations of World 
Health Organization (WHO) typhoid position papers support consideration of typhoid 
vaccination in high risk population groups and for outbreak control.37,134,135  In practice, the 
cost of vaccines, limited duration of protection and inadequate immunogenicity in children 
under 2 have limited uptake by national authorities.23,136 At the time this thesis was 
submitted, international recommendations for programmatic typhoid vaccination, 
particularly with typhoid conjugate vaccines,  were being reviewed through the WHO 
Strategic Advisory Group of Experts on Immunization (SAGE),39 and through the GAVI 
Alliance, an international finance coordination body for vaccination programmes in countries 
with GNI up to USD 1,580 per capita (Fiji is not GAVI-eligible).137,138  
There are two internationally marketed typhoid vaccines: an injectable Vi-polysaccharide 
vaccine suitable from age 2 years and an oral three or four dose live Ty21a vaccine suitable 
from age five or six. Efficacy of each is modest, at around 50% over three years.139   Even with 
low efficacy vaccines, school-based programmes have shown success in controlling 
typhoid.140  
Much of the current typhoid control research effort is directed towards the development of 
Vi-conjugate vaccines which appear to offer greater efficacy, immunogenicity in the under-
twos and longer duration of protection. These use Vi antigen conjugated to an immunogenic 
protein such as recombinant exoprotein A of Pseudomonas aeruginosa (rEPA), the mutant 
diphtheria protein CRM197, tetanus toxoid (TT) or diphtheria toxoid (DT).141 Of these, Bharat 
Biotech’s single-dose typhoid-tetanus toxoid conjugate vaccine has gained licensure in 
India142 as has Bio-Med’s two-dose PedaTyph,143 and following submission of this thesis, 
Bharat’s product attained the WHO-prequalification status that will enable more widespread 
utilisation in low and middle income countries such as Fiji, consistent with the 2018 update to 
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the WHO position on typhoid vaccines.135 Oral typhoid vaccines that may offer greater 
efficacy or shorter regimens than Ty21a are also in development.141 
Policy-oriented research efforts including development of surveillance programmes for 
disease burden estimates,144,145 including serosurveillance;146 and vaccine trials undertaken or 
in-planning for typhoid Vi-conjugate vaccines.147  A notable recent development has been the 
revival in Oxford of the human challenge study model for vaccine efficacy testing. Originally 
undertaken in Maryland, USA, in volunteer prisoners, these controlled human challenge 
studies have also provided rich biological data as well as vaccine efficacy assessments.72,73,148–
152 
 
1.2 Research project and thesis 
To address typhoid in Fiji, an international expert meeting was convened by the MOH and 
Australian Aid in August 2012, approximately a month before the start of this doctoral 
project. The meeting’s aims were to make disease control recommendations and to identify 
the knowledge gaps that would merit addressing in order to assist control efforts.123  
This doctoral project took forward a meeting recommendation of a serological survey to 
inform age-specific incidence rates and to guide vaccination policy. Vaccination accordingly 
receives a specific focus alongside consideration of public health case management of cases 
and interventions to improve adequate access to sufficiently clean water, effective sanitation 
and handwashing with soap.  Findings from individual paper-format chapters have been 
shared with the Fijian Ministry of Health and Medical Services (MOHMS) during the 
development of each paper. The summarised thesis findings will have been presented to 
MOHMS in October 2017, alongside findings for other research groups undertaking case-
control and environmental analyses in accordance with the 2012 meeting.153,154 
 
1.2.1 Aims 
The overall aims of this research are (i) to strengthen epidemiological understanding of the 
transmission of typhoid fever, and (ii) to suggest potential evidence-based approaches to 
effective, sustained public health interventions in the Fijian archipelago. These overall aims 
were broken down into four sets of sub-aims, each corresponding with the appropriate 
chapter. 
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1.2.1.1 Serological study 
Aim: 
To determine the age-specific incidence and cumulative incidence of typhoid in Fiji in order to 
inform transmission modelling, testing the hypothesis that surveillance data under-ascertains 
childhood infection. 
Serological study hypotheses: 
a) That individuals with recent exposure to Salmonella Typhi, or vaccination 
with Vi polysaccharide vaccine, are likely to have higher Vi-antibody titres 
than uninfected controls (obtained from a non-typhoidal setting).  
b) That these titres will fall over time, and can be measured by re-testing 
individuals with previously high titres.  
 
With knowledge of the Vi-antibody titre kinetics, a number of further hypotheses can be 
investigated: 
c) That antibody responses suggest a higher proportion of children have had 
exposure to Salmonella Typhi than is suggested by surveillance data 
d) That antibody responses vary between age groups, indicating different 
historical and recent exposure to S. Typhi. 
e) That high antibody titres are associated with drinking water outside the 
home, the absence of improved sanitation, male sex, iTaukei ethnicity and 
rural residency, and that there will be interaction between two or more of 
these factors.   
 
 
Serology Study Objectives: 
1. Design appropriate sampling frames to identify a representative sample of Fijians 
resident in the two main islands, Viti Levu and Vanua Levu. 
2. Prospectively collect 1600 blood samples from this population sample for serological 
analysis. 
3. Gather risk factor data from the 1600 study participants. 
4. Validate a Vi antibody ELISA serology test against a passive haemagluttination test to 
the long-acting d-epitope of S. Typhi flagellin, using negative control blood from 
Europe and positive control blood from Fijian typhoid cases. 
42 
 
5. Statistically analyse the results of the serological survey to assess past exposure to 
typhoid in different age groups. 
6. Statistically assess different risk factors for typhoid serological titre differences, 
including between iTaukei Fijians and Indo-Fijians. 
7. Determine wane of typhoid vaccine antibody protection in a Fijian island (Taveuni) 
where mass vaccination was done in 2010 and antibody testing done in 2011, by 
testing serum sample from 300 volunteers in a repeat cross-sectional analysis.  
 
1.2.1.2 Social mixing study 
Aim: 
To determine social contact patterns in different age groups, and settings, as relevant to 
enteric infections and other person-to-person communicable diseases in Fiji, and as may be 
applicable in other Pacific island settings. 
Hypothesis 
a) That in urban and rural settings in Fiji, reported social contact will follow age-
based mixing patterns consistent with social mixing studies in Europe. 
Objectives: 
1. Develop and pilot a social mixing survey tool for enteric infection research, based on 
those used for POLYMOD and SMILI studies.155,156 
2. Complete social mixing surveys with serology study participants. 
3. Analyse social mixing data to developing context-specific contact matrices (e.g. 
participants in urban and rural settings or by iTaukei Fijian and Indo-Fijian ethnicity) 
suitable for modelling disease transmission. 
 
1.2.1.3 Transmission dynamic model 
Aim:  
To develop and validate an age-structured transmission dynamic model, using this to inform 
typhoid control by modelling likely impacts of vaccination programmes and interventions on 
sanitation, hygiene or water quality in Fiji. 
Hypotheses: 
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a) That spread of infection in children contributes substantially to disease in people 
aged 15 to 29. 
b) That vaccination of children of primary school age with annual vaccination of a 
school-year cohort would be predicted to reduce but not eliminate disease incidence 
in the whole population, and that this reduction would be greater if preceded with a 
multi-cohort campaign 
c) That improving sanitation would be predicted to control typhoid. 
 
 
Objectives: 
1. Collect routine surveillance data and other data sources for model data fitting. 
2. Using surveillance data, serological data, and social mixing data, develop and validate 
a transmission dynamic model in the R statistical environment. 
3. Model the likely impact of interventions with polysaccharide vaccines, Ty21a vaccines 
or Vi-conjugate vaccines on typhoid transmission and incidence, including 
programmes and campaigns administered to child cohorts. 
4. Model the likely impact of other interventions that may interrupt typhoid 
transmission, including sanitation improvements, hygiene campaigns and water 
quality improvements, alone and in combination with vaccination options. 
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1.2.2 Thesis structure 
This thesis is in the “by publication” format, comprising paper-format chapters in their 
published or peer-reviewed formats and a chapter detailing the ongoing development of a 
typhoid transmission dynamic model for Fiji. Each paper-format chapter is preceded by a 
short bridging section giving the rationale for the chapter, the role of the contributors, its 
place in the narrative of steps towards typhoid control in Fiji and details of other 
considerations that lie outside the scope of the published piece.  The nature of the thesis by 
publication necessitates some repetition in chapter introductory and methods sections, but 
these largely bring different angles to the problem, specific to the aims of each paper.  
 
The thesis chapters are as follow: 
1. Introduction. Describing the problem of typhoid in Fiji, and the context of the 
research. 
2. A review of typhoid fever transmission dynamic models and economic evaluations 
of vaccination. This literature review was published in 2015 in a Vaccine journal 
special edition coinciding with the 9th International Conference on Typhoid and 
Invasive Non-Typhoidal Salmonelloses.  
3. A cross-sectional seroepidemiological survey of typhoid fever in Fiji. This is the main 
paper of the thesis and is an analysis of my seroepidemiological fieldwork conducted 
in Fiji in 2013 and 2014, published in PLOS Neglected Tropical Diseases in 2017. This 
cross sectional study focuses on age-based patterns in unvaccinated areas of the 
Fijian mainland, but also includes findings from a Vi-polysaccharide vaccinated island 
and uses a cohort of convalescing cases to provide positive control data and insight 
into post-infection antibody waning.  
There is an extended bridging section prior to this paper which contains further 
details of the design, preparation and implementation of the serosurvey. 
4. Environmental factors drive the spatial distribution of Salmonella Typhi in Fiji: a Vi-
antigen seroprevalence study.   This is a geospatial analysis of environmental factors 
associated with seropositivity for typhoid Vi antibody. Analysis and writing were led 
by MSc student Rukie de Alwis, and the paper is under second round review at 
Emerging Infectious Diseases journal.  
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5. Social mixing in Fiji: who-eats-with-whom contact patterns and the implications of 
age and ethnic heterogeneity for disease dynamics in the Pacific Islands. A paper on 
social mixing in Fiji, which was under second round of review at PLOS ONE at the time 
of writing this introduction (September 2017). The seroepidemiological survey 
included questions on whom the participant ate with the previous day, by age and 
ethnicity, in order to determine mixing patterns of potential relevance to the 
transmission of typhoid and parameterisation of transmission models.  
6. Transmission dynamics of typhoid fever in Fiji: a modelling framework. A paper, in 
preparation for submission to Vaccine journal, of a deterministic transmission 
dynamic model of typhoid approximating the situation in Fiji, utilising national 
surveillance data, the serological findings and the social mixing data.  
7. Discussion. The thesis concludes with discussion of the findings and the merits and 
limitations of the approaches used in this thesis in investigating typhoid in Fiji. 
Alongside synthesising the country-specific consideration, it addresses the 
applications of these to wider understanding and control of typhoid fever and 
potential further research directions.  
 
 
1.2.3 Appendices and additional related research 
The appendices of the thesis comprise of both supplemental information and additional 
research papers related to the Fiji typhoid investigations.  
In this final section of the introduction I outline the main papers of the appendices and 
outline concurrent or ongoing research that is not included in the bound thesis, including 
those pieces of work directly linked to the doctoral work and other concurrent research that 
is noteworthy in the narrative of the doctorate but not directly contributing to it. 
 
Appendix paper A1: 
Informed consent form and survey  questionnaire. 
 
1.2.3.1 Additional research on typhoid 
I have peer-reviewed seven papers concerning typhoid or typhoid vaccination during the 
conduct of the thesis. One resulted in publication of an editorial.  
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Appendix paper A2: 
Evaluating Typhoid Vaccine Effectiveness in Travelers’ Vaccination. J Travel Med. 
2015;22:76-77. doi:10.1111/jtm.12185. An editorial arising from peer-reviewing a Broome-
method analysis of typhoid vaccine efficacy in returning travellers. 
 
I am included as a co-author in a series of poly-authored papers by Dr Vanessa Wong (Sanger 
Institute & University of Cambridge) and colleagues by dint of contributing to sharing of 
Salmonella Typhi DNA from Fiji and through the reference laboratories of the UK national 
communicable disease surveillance centre, for an international phylogenetic mapping 
collaboration.  
Non-enclosed papers: 
 Wong VK, Baker S, Pickard DJ, Parkhill J, et al. Phylogeographical analysis of the dominant 
multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental 
transmission events. Nat Genet. May 2015. doi:10.1038/ng.3281. 
Wong VK, Baker S, Connor TR, Pickard D, et al. An extended genotyping framework for 
Salmonella enterica serovar Typhi, the cause of human typhoid. Nat Commun. 
2016;7:12827. 
International Typhoid Consortium, Wong VK, Holt KE, Okoro C, et al. Molecular Surveillance 
Identifies Multiple Transmissions of Typhoid in West Africa. PLoS Negl Trop Dis. 
2016;10(9):e0004781. 
 
1.2.3.2 Additional Fiji-Pacific Research 
I have been engaged in collaborative projects stemming from the serological survey and 
other research activities, in part reflecting my ongoing role as a public health registrar.  
 
Leptospirosis  
The doctoral project also addressed leptospirosis, a waterborne bacterial disease transmitted 
through mammalian urine. I extended the serosurvey to run as a joint investigation into 
leptospirosis, strengthening the survey’s cost-utility. Typhoid, leptospirosis and dengue are 
described by local physicians as the “three plagues of Fiji”: flooding in 2012 led to 
leptospirosis outbreaks with 40 deaths amongst 576 reported cases (an observed case-
fatality risk of 7%).157 An expert-panel approach to leptospirosis was initiated by MOH and the 
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WHO shortly after the typhoid expert meeting, with synergies identified in serological 
information needs. Epidemiological risk factor collection was extended to include putative 
risk factors for leptospirosis, and additional survey clusters selected from high-risk areas. This 
has been led by Dr Colleen Lau of the Australian National University, and includes a fieldwork 
paper and the development of analytical methods at the interface of epidemiology and 
ecology. 
Appendix paper A2:  
Lau CL, Watson CH, Lowry JH, David MC et al. Human Leptospirosis Infection in Fiji: An Eco-
epidemiological Approach to Identifying Risk Factors and Environmental Drivers for 
Transmission. PLoS Negl Trop Dis. 2016;10(1):e0004405. 
 
Non-enclosed papers: 
Lau C, Mayfield H, Lowry JH, Watson CH et al. Unravelling Infectious Disease Eco-
epidemiology using Bayesian Networks and Scenario Analysis: A Case Study of Leptospirosis 
in Fiji. Environ Model Softw. 2017; 97: 271-286 
Lau C, Mayfield H, Lowry JH, Watson CH, Kama M and Nilles EJ. Using geographically-
weighted regression to understand spatial variation in the influence of environmental 
drivers of infectious disease transmission: A case study of human leptospirosis in Fiji. Under 
review at The Lancet Planetary Health 
 
Dengue 
The second additional disease investigated by this research programme came as a result of 
establishing the survey as a serum bank for other public health research for concerns such as 
dengue fever and other arthropod-borne viral diseases. The field survey concluded in the 
same month as an epidemic of dengue serotype 3 began in Central Division Fiji, and so a 
repeat visit to survey participants in 2015 enabled paired serology to be done pre- and post- 
epidemic to support understanding of epidemic dynamics and participant antibody dynamics 
against a backdrop of intermittent dengue outbreaks. This work is led by Dr Adam Kucharski 
of the London School of Hygiene & Tropical Medicine.  
Non-enclosed paper: 
Kucharski AJ, Watson CH, Kama M, Hue S, et al Dynamics of dengue transmission and control 
during a large outbreak in Fiji. In preparation. 
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Other Arboviral diseases 
Arboviral disease research has been twice-further extended using these serosurvey samples. 
Investigations into Ross River virus are being conducted by Dr Mike Kama, Fiji national advisor 
for communicable disease control, at the laboratories of Prof John Aaskov at the Queensland 
University of Technology, Australia and with Dr Van-Mai Cao-Lormeau of Institut Louis 
Malardé, French Polynesia.158 A third and likely final round of serum collection from the 
original survey participants in Central Division was completed in June 2017 by Alasdair 
Henderson, a doctoral candidate at the London School of Hygiene & Tropical Medicine. These 
investigations extended the Fiji dengue research programme and began Fijian serological 
investigation into an emergent infection in the Pacific islands, Zika.159,160 This was previously 
considered to have little public health importance beyond uncommon occurrence of Guillain-
Barré Syndrome but has now been associated with a major epidemic of microcephaly in 
South America, which saw the temporary declaration of a public health emergency of 
international concern.161–163  
 
Trachoma 
Field research on trachoma was being conducted by Colin Macleod at the time of my field 
investigations. Through advising on field operations and social science research methods, I 
was invited to be a co-author on a paper investigating the Fijian custom of eyelash-plucking, a 
major confounder in the surveillance of trichiasis and ocular Chlamydia trachomatis. 
Non-enclosed paper: 
Macleod C, Yalen C, Butcher R, et al. Eyelash Epilation in the Absence of Trichiasis: Results of 
a Population-Based Prevalence Survey in the Western Division of Fiji. PLoS Negl Trop Dis. 
2017;11(1):e0005277. doi:10.1371/journal.pntd.0005277. 
 
1.2.3.3 Concurrent Unrelated Research 
Ebola  
A further set of investigations in infectious disease epidemiology and vaccine science 
unrelated to typhoid but conducted during the timeline of the thesis warrants particular 
mention.  
The devastating and tragic outbreak of Ebola virus disease in West Africa from 2013 to 2016 
first closed off typhoid investigation using flagellin Hd immunoassays (intended to be run on a 
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10% survey serum subset for assay comparison), as the University of Maryland Center for 
Vaccine Development, the only institution running the assay, diverted all available resources 
to Ebola vaccine development at declaration of an international public health emergency in 
August 2014. Soon after this, I was seconded from the London School of Hygiene & Tropical 
Medicine to the WHO Ebola vaccine response based in Geneva.  
The principle output of my Geneva collaboration was the design and implementation of a 
novel cluster randomised trial (a ring vaccination trial entitled “Ebola: Ça Suffit!”). The trial 
had a fighting chance at demonstrating vaccine efficacy by utilising an appreciation of 
infectious disease dynamics and the epidemic operating environment to create a trial with 
could be feasibly implemented under demanding field conditions. Interim and final analysis 
demonstrated high efficacy for the VSV-ZEBOV vaccine (Merck) in Guinea.  
The second major piece of Ebola response research was to design and implement for the 
WHO (October 2015 to summer 2016) a VSV-ZEBOV vaccination cohort study in Guinean 
communities in which survivors resided. These communities were thought to be at risk of late 
transmission due to Ebolavirus persistence in semen and other body fluids. This study, “les 
proches des survivants” (those close to survivors), examines vaccine safety and 
immunogenicity in community members with baseline Ebola antibodies, asymptomatically 
acquired, relative to those without. Alongside leading the design and protocol writing of the 
vaccine cohort investigations, a substantial component of my work for “les proches des 
survivants” was to design, pilot and implement with field partners a comprehensive 
electronic data collection system compliant with Good Clinical Practice (GCP) trials standards.  
This used Android tablet computers running google.org’s OpenDataKit software and a system 
I designed of QR barcodes for recording participants, field staff and samples – this offers 
substantial potential for improving field deployment times for vaccine trials in future 
epidemics.  
An ongoing extension of the ring vaccination trial research has been to examine the dynamics 
of transmission in and around the trial, including reconstruction of epidemiological chains of 
transmission and comparison to putative molecular phylogenetic trees. This examines the 
epidemiological assumptions of the original trial and their applicability for future epidemic 
trial design. My Ebola research portfolio also includes contributions to modelled projections 
of epidemic scenarios for response planning and trial planning, appraisal of the risks of 
semen-mediated late transmission of Ebola virus, and contribution to vaccine deployment 
under GCP conditions to contain post-epidemic flare-ups. These papers and projects are 
listed below. 
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Non-enclosed papers: 
1. Ebola ça suffit ring vaccination trial consortium. The ring vaccination trial: a novel cluster 
randomised controlled trial design to evaluate vaccine efficacy and effectiveness during 
outbreaks, with special reference to Ebola. BMJ. 2015;351:H3740. doi:10.1136/bmj.h3740. 
2. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, et al. Efficacy and effectiveness of an 
rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the 
Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386(9996):857-866. 
doi:10.1016/S0140-6736(15)61117-5. 
3. Kieny MP, Longini IM, Henao-Restrepo AM, Watson CH, Egger M, Edmunds WJ. Changes in 
the primary outcome in Ebola vaccine trial: Authors’ reply. Lancet. 2016;387(10027):1509-
1510. doi:10.1016/S0140-6736(16)00686-3. 
4. Henao-Restrepo AM, Camacho A, Longini IM, Watson CH et al. Efficacy and effectiveness 
of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea 
ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. January 
2017. doi:10.1016/S0140-6736(16)32621-6. 
5. Eggo RM, Watson CH, Kucharski AJ, Camacho A, Funk S, Edmunds WJ. Duration of Ebola 
virus RNA persistence in semen of survivors: population-level estimates and projections. 
Eurosurveillance. 2015;20(48):pii=30083. doi:10.2807/1560-7917.ES.2015.20.48.30083. 
6. Kucharski AJ, Eggo RM, Watson CH, Camacho A, Funk S, Edmunds WJ. Effectiveness of Ring 
Vaccination as Control Strategy for Ebola Virus Disease. Emerg Infect Dis J. 2016;22(1). 
doi:10.3201/eid2201.151410. 
7. Camacho A, Eggo RM, Goeyvaerts N, et al. Real-time dynamic modelling for the design of 
a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone. Vaccine. 2016. 
doi:10.1016/j.vaccine.2016.12.019. 
8. Camacho A, Eggo RM, Funk S, Watson CH, Kucharski AJ, Edmunds WJ. Estimating the 
probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian 
modelling approach. BMJ Open. 2015;5(12). doi:10.1136/bmjopen-2015-009346. 
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Research in progress 
Gsell PS*, Camacho A*, Kucharski A*, Watson CH* et al Ring vaccination of adults and 
children with rVSV-ZEBOV under Expanded Access in response to an outbreak of Ebola virus 
disease in Guinea, 2016: an operational and vaccine safety report.  In press, Lancet 
Infectious Disease.             *contributed equally 
Eggo R*, Roberts A*, Watson C, Hue S, et al. Chains of Ebola transmission in Guinea and the 
ring vaccination trial: findings from epidemiology and phylodynamics. *contributed equally. 
In preparation. 
Watson CH, Camacho A, Gsell PS, Carroll M et al.  Vaccination des proches des survivants. An 
immunogenicity and safety cohort study in people connected to survivors of Ebola Virus 
Disease comparing those with and without baseline non-zero Ebola antibody titres. In 
preparation. 
Watson CH, Marks M, Abdourahamane D, Roberts C, Gsell PS et al. Design of a GCP-
compliant electronic data collection system for vaccine and clinical trials using Android 
tablets and OpenDataKit (ODK). In preparation. 
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Chapter 2. A review of typhoid fever transmission dynamic models and 
economic evaluations of vaccination. Watson CH, Edmunds WJ. Vaccine. 
2015. doi:10.1016/j.vaccine.2015.04.013. 
 
2.1 Bridging section 
This non-systematic review, completed in 2015, considers the role of published models in 
informing typhoid fever epidemiology and decisions around typhoid vaccine utilisation, 
including the economic appraisal of vaccination programmes. From the literature, data gaps 
that could support model estimates were identified. The Fiji fieldwork programme reflects 
efforts to close these gaps.  
As noted in the thesis introduction, my proposed overall aims included a sub-aim on 
economic evaluation aspect to the transmission dynamic modelling of Fiji, consistent with the 
approaches used in national immunisation technical advisory groups such as the UK’s Joint 
Committee on Vaccination and Immunisation. Cost-effectiveness analysis of possible Fiji 
typhoid vaccination programmes was curtailed on the grounds of feasibility within the 
timeframe of a PhD and with an eye to utility for in-country partners. This chapter offered a 
mechanism through which to engage with the health economic literature on typhoid 
vaccination. In terms of informing the formation of a model appropriate to the situation in 
Fiji, this literature review was a starting point for identifying relevant parameters and prior 
approaches to typhoid modelling. 
Whilst structured frameworks exist for reviews, systematic reviews and meta-analyses in a 
number of areas of health and medical research, including PRISMA and its extensions,1 the 
literature is thinner on methods specific to reviews of modelling. This chapter was informed 
by a review by Esther van Kleef on healthcare associated infection models,2 and by seminar 
notes by Richard White.3  
The review identified comparatively few transmission dynamic models of typhoid relative to 
similar burden infectious diseases, none using Bayesian methods, and found no economic 
analyses based on dynamic models, such as would meet current recommendations in 
accounting for indirect protection.4,5  
There have been developments in typhoid models and economic evaluation since the review 
was published. Of reviewed typhoid models, those by the Pitzer group at Yale are foremost in 
informing current typhoid vaccination and control policy discussions.6,7 The Pitzer group have 
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more recently published work on drivers of dynamics in Malawi8 and Nepal9 and on the cost-
effectiveness of typhoid conjugate vaccines.10 The latter, undertaken by Marina Antillón and 
colleagues ahead of updates to the WHO and GAVI position papers, used Bayesian parameter 
estimation (Hamiltonian Monte Carlo methods11) in a transmission dynamic model to 
produce typhoid vaccination economic evaluations in line with current recommended 
approaches to vaccine cost effectiveness analysis. This found 28%-43% of benefits were from 
indirect protection, which would not be captured in a static economic model.10 Vaccination 
versus improvements to WASH components remains an unanswered question in the 
economic evaluation of in typhoid control. 
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 There are relatively few dynamic models or economic analyses of typhoid 
vaccination. 
 The relative contribution of carriage to transmission is a key uncertainty. 
 Published economic analyses use static models that omit indirect protection of 
vaccines. 
 Nevertheless, vaccines appear highly cost-effective against WHO criteria in high-
incidence settings. 
 No economic model was found to compare vaccine and sanitation.   
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Abstract 
Despite a recommendation by the World Health Organization (WHO) that typhoid vaccines be 
considered for the control of endemic disease and outbreaks, programmatic use remains 
limited. Transmission models and economic evaluation may be informative in decision 
making about vaccine programme introductions and their role alongside other control 
measures. A literature search found few typhoid transmission models or economic 
evaluations relative to analyses of other infectious diseases of similar or lower health burden.   
Modelling suggests vaccines alone are unlikely to eliminate endemic disease in the short to 
medium term without measures to reduce transmission from asymptomatic carriage. The 
single identified data-fitted transmission model of typhoid vaccination suggests vaccines can 
reduce disease burden substantially when introduced programmatically but that indirect 
protection depends on the relative contribution of carriage to transmission in a given setting. 
This is an important source of epidemiological uncertainty, alongside the extent and nature of 
natural immunity. 
Economic evaluations suggest that typhoid vaccination can be cost-saving to health services if 
incidence is extremely high and cost-effective in other high-incidence situations, when 
compared to WHO norms. Targeting vaccination to the highest incidence age-groups is likely 
to improve cost-effectiveness substantially. Economic perspective and vaccine costs 
substantially affect estimates, with disease incidence, case-fatality rates, and vaccine efficacy 
over time also important determinants of cost-effectiveness and sources of uncertainty. 
Static economic models may under-estimate benefits of typhoid vaccination by omitting 
indirect protection. 
Typhoid fever transmission models currently require per-setting epidemiological 
parameterisation to inform their use in economic evaluation, which may limit their 
generalizability. We found no economic evaluation based on transmission dynamic modelling, 
and no economic evaluation of typhoid vaccination against interventions such as 
improvements in sanitation or hygiene.  
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2.2 Introduction 
Typhoid fever is an exclusively human enterically-transmitted systemic disease caused by 
infection with the bacterium Salmonella enterica enterica serovar Typhi. Although largely 
controlled in Europe and North America, typhoid remains endemic in many parts of the 
world, notably Asia, where it is an important cause of febrile illness in crowded, low-income 
settings.[1] A notable feature of typhoid is the carrier state – asymptomatically infected 
individuals who continue to shed S. Typhi in their stool or urine for many years, thereby 
sustaining transmission.[2] 
Despite a recommendation by the World Health Organization in 2008 that typhoid 
vaccination be considered for the control of endemic disease and outbreaks, programmatic 
use remains limited.[3]  
In the early twentieth-century, public health officials were debating the best methods of 
evaluating typhoid vaccine effectiveness, and whether vaccination was a distraction from 
improvements in sanitation and hygiene.[4] These remain contemporary policy issues for 
ministries of health and other health partners who may be considering programmatic anti-
typhoid vaccination as a counterpart to other anti-typhoid measures such as improvements 
to income distributions, sanitation, water supplies and hand washing with soap (post-
defecation and before the preparation of food in the home or sold in the street) as well as 
identification and management of carriage.[5–8] Transmission dynamic modelling and 
economic evaluation are two informative tools to support such decisions.[9,10] 
Where health budgets are limited, allocation of resources to activities which generate the 
best value for money maximises the population’s health (not withstanding other health 
programme criteria such as equity). To compare between and across health states, cost utility 
analysis (CUA) can be employed using a common metric of health, such as disability-adjusted 
life-year (DALY). The World Health Organization’s Choosing Interventions that are Cost–
Effective project (WHO-CHOICE) describes interventions as “cost-effective” if they add a DALY 
at a cost of less than three times Gross Domestic Product (GDP) per capita,  and “highly cost-
effective” if each DALY costs less than GDP per capita. These are arbitrary thresholds and 
meeting them does not necessarily lead to the intervention being adopted, as health 
decision-makers are often required to make choices between multiple interventions that fall 
below these thresholds. Furthermore, even highly cost-effective activities may be too 
expensive overall for a health service to provide within budget: a hypothetical drug adding a 
year of life and costing GDP per capita for each person treated would require the entire 
national economy to be spent giving the drug to every member of the population.[11]  
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By building on the germ theory of disease, and mass-action principles from the physical 
sciences,[12] mechanistic mathematical modelling enables extrapolation beyond observed 
data, and can be used to project the expected trends of disease in a population or the 
potential impact of control strategies such as vaccination. Through capturing indirect effects 
of immunization – the reduced incidence of disease in members of a population not 
themselves immunized, commonly described as “herd immunity” – these transmission 
dynamic models capture the impact of such interventions more completely than static 
economic models measuring only the direct effects in vaccinees.[13]  
In this review, typhoid transmission dynamic models and typhoid vaccine economic 
evaluations are examined for their potential contributions to informing disease control, 
identification of gaps in knowledge and indication of directions for further research. 
 
 
2.3 Methods 
PubMed was searched on 23 October 2014 without date restriction using the following 
terms: ("Typhoid Fever"[Mesh]) AND ("Nonlinear Dynamics"[Mesh] OR "Models, 
Theoretical"[Mesh] OR "Models, Statistical"[Mesh] OR "Computer Simulation"[Mesh] OR 
"Models, Economic"[Mesh] OR "Least-Squares Analysis"[Mesh] OR "Likelihood 
Functions"[Mesh] OR "Resource Allocation"[Mesh] OR "Cost-Benefit Analysis"[Mesh] ) AND 
(Humans[Mesh])  NOT "Mice"[Mesh]. 
Personal libraries were reviewed and reference lists in papers searched for modelling and 
economic studies that may not have been identified by the above search strategy. Results 
were restricted to those available in English. We obtained information about unpublished 
studies through the Coalition against Typhoid and International Vaccine Institute.  
Studies were included if they modelled typhoid transmission and/or analysed the cost-
effectiveness of vaccination in endemic settings. Endemic settings were identified using 
recent high-quality reviews.[14,15] We included cost of illness (COI) studies if they were 
linked to an analytical study, and willingness-to pay (WTP) studies if they included an 
economic evaluation or were linked to an analytical study. Studies were excluded if they used 
geographical or statistical modelling, including time-series analysis, without transmission 
dynamics, or if they addressed transmission or cost-effectiveness in non-endemic 
populations, such as international travellers. 
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Transmission models were assessed for their model structure, data sources, parameter 
estimates, use of fitting methods, sensitivity analysis and the contribution of their approach 
to epidemiological understanding of typhoid. Economic studies were evaluated by data 
sources, economic evaluation approach, perspective, comparator programmes, use of 
sensitivity analysis and capture of indirect effects of vaccination.  
  
70 
 
2.4 Results 
Seventy-nine titles were retrieved. Ten modelling papers were selected for review based on 
title or abstract.  One was discarded as a non-mechanistic time series study[16], one as it 
modelled outbreaks in a non-endemic setting[17], while two papers were of the same model 
and considered together.[18,19] These are summarised in tables 2.1 and 2.2.  
Table 2.1. Summary of typhoid transmission model types  
Characteristic Number of 
models (n=7) 
Reference 
 
Type of model 
 Compartmental  
o Deterministic 
o Stochastic 
 individual-based stochastic  
 
 
6  
0 
1  
 
 
[18–24] 
 
[25] 
Scope of model 
 Analytical/mathematical, 
o Without data 
o Uses data without fitting 
 Exploratory/epidemiological,  
o uses data without fitting 
o fitted to data 
  Policy-oriented/public health, 
o uses data without fitting 
o fitted to data 
 
 
1  
1 
 
1 
1 
 
2 
1 
 
 
[22] 
[23] 
 
[21] 
[25] 
 
[18–20] 
[24] 
Parameter-fitting method 
 Maximum likelihood estimation 
 Bayesian 
 
2 of 2 
0 
 
[24,25] 
 
Investigates vaccination 
 Compares with improved sanitation, 
hygiene or water supply 
 Include economic evaluation of vaccination 
4 
4 of 4 
 
2 of 4 
[18–21,24] 
[18–21,24] 
 
[18–20] 
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Table 2.2a. components and main findings of typhoid transmission models  
 First author 
and year 
Ref Model type Disease 
states 
Data source(s) Fitting process Interventions 
modelled 
Time horizon Sensitivity 
analysis 
Findings Comments 
 
1 Cvjetanović 
1971, 1978 
[18] 
[19] 
Compartmental 
deterministic 
with births = 
deaths, without 
age-structure 
N S Es Ea Is Ia Ct 
Cl Rt Rl 
Parameters 
estimated using 
literature and 
expert opinion. 
Considers an 
eidemiological 
scenario 
approximating 
Western Samoa. 
None Vaccination with 
whole-cell 
inactivated vaccines, 
VE 60%, 75% or 
90%, coverage 60, 
80 or 100%. 
  
As one-off or 5 
yearly campaigns. 
 
Sanitation 
60 years Epidemiological/ 
clinical 
parameters 
fixed. Effective 
contact rate 
(per capita per 
day) varied. 
For both low and high VE, single 
vaccination campaigns achieve 
temporary reduction in incidence 
rates before return to a rate 
determined by the force of 
infection, where force of infection 
is above an elimination threshold. 
Sustained reduction in force of 
infection reduces incidence. 
Multiple vaccination campaigns 
reduce incidence will campaigns 
are sustained. 
Multiple 
parameters are 
included 
without fitting. 
Outputs should 
be considered 
illustrative.  
2 Briscoe 1980 [22] Deterministic 
analytical SIS 
S I N/A N/A. Reviews 
Cvjetanović 
models. 
Analysis of role 
of force of 
infection and 
recovery on 
equilibrium 
prevalence. 
N/A N/A N/A Force of infection determines 
prevalence, and vice versa.  
Stochasticity may prevent disease 
eradication.  
Intended as an 
analytical 
model rather 
than 
epidemiological 
simulation. 
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 First author 
and year 
Ref Model type Disease 
states 
Data source(s) Fitting process Interventions 
modelled 
Time horizon Sensitivity 
analysis 
Findings Comments 
 
3 Bailey 1982 [23] Compartmental 
deterministic 
with births = 
deaths, without 
age-structure 
S E I C R [18] Rule-based 
simplification 
of Cvjetanović 
1971 
model[18] 
with direct 
mathematical 
solution of 
steady-state 
equations. 
N/A N/A N/A, suggests an 
approach to 
sensitivity 
analysis [26] 
For a steady-state model, structural 
simplification results in 
compartment population estimates 
consistent with the unsimplified 
model for a given effective contact 
rate. 
Reducing the 
number of 
compartments 
makes a model 
more suitable 
for validation 
with data. 
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 First author 
and year 
Ref Model type Disease 
states 
Data source(s) Fitting process Interventions 
modelled 
Time horizon Sensitivity 
analysis 
Findings Comments 
 
4 Cvjetanović 
1986 
[20] Age-structured 
compartmental 
deterministic 
SIRS. 
Birth and death 
rates from Chile 
N S I Ct Cl Rt Rl Demographic 
and typhoid 
surveillance data 
for Santiago and  
rest of Chile  
Effective 
contact rate 
per capita per 
unit day (age-
specific for 
acquisition) 
from linear 
interpolation 
of age-specific 
incidence. 
 
Visual 
goodness-of-
fit.  
Strong 
assumption 
that 20% of all 
cases are 
clinical. 
Vaccination with 
Ty21a, 95% VE at 
75% or 95% 
coverage of under 
25s with 5yrly 
revaccination. Food 
sanitation in schools 
reducing force of 
infection by 1/3 in 
ages 6 to 16y. 
Sanitation with 
annual 2% or 5% 
improvement in 
force of infection 
over 10 years. 
Interventions 
analysed 
over 25y 
after run-in 
to 
equilibrium. 
None Vaccination campaigns would 
reduce age-specific incidence and 
increase the age of peak incidence  
 
Vaccination would not eliminate 
disease over 25y but would result 
in year on year reduction in 
incidence if sustained. 
 
10y sanitation campaigns likely to 
reduce prevalence and continue to 
reduce prevalence after cessation.  
 
 
Somewhat 
simplified 
model 
structure, 
though now 
age structured. 
The model is 
not validated 
sufficiently 
against data, 
nor are outputs 
sufficiently 
clear to make 
strong policy 
conclusions. 
Age-based 
changes in 
incidence with 
vaccination are 
consistent with 
epidemic 
theory. 
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 First author 
and year 
Ref Model type Disease 
states 
Data source(s) Fitting process Interventions 
modelled 
Time horizon Sensitivity 
analysis 
Findings Comments 
 
5 González-
Guzmán 1989 
[21] Compartmental 
deterministic 
SIS structure 
with births and 
deaths 
S I V with 
environmental 
transmission 
Parameter 
estimates for 
Chile 
None, 
analytical 
model 
Reductions in 
combinations of:  
 carrier 
prevalence 
 indirect contact 
rate 
 direct contact 
rate 
 environmental 
life of the 
bacterium 
 bacterial count in 
the environment. 
Vaccination with 
Ty21a, coverage 
scaled for 
equivalence to VE 
74% or 95%. 
 
10y N/A Decline in incidence is not rapid, 
even with highly effective 
combined control measures.  
Reduction in chronic carriage most 
effective control procedure. 
Vaccination as a permanent 
programme would require a high 
proportion of the population to 
become immune to control typhoid 
within a meaningful timeframe.  
Author 
cautions 
against using 
the model to 
estimate the 
effect of a 
vaccination 
programme but 
that it indicates 
areas for 
further 
epidemiological 
parameter 
determination. 
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 First author 
and year 
Ref Model type Disease 
states 
Data source(s) Fitting process Interventions 
modelled 
Time horizon Sensitivity 
analysis 
Findings Comments 
 
6 Saul 2013 [25] Individual-
based 
stochastic, 
random-mixing. 
S E Is Ia Ct Cl Rt 
Rl, Rc, ;Rs; Vc Vs 
Surveillance 
data from 
Dhaka, 
Bangladesh, and 
Kolkata India. 
 
Migration, birth 
and death rates 
from Matlab, 
Bangladesh. 
Other 
parameter from 
literature and 
expert opinion. 
Maximum 
likelihood and 
visual 
inspection 
None 40y to 
equilibrium 
and 40y 
follow-up. 
20y for 
effects of 
carriage. 
Sensitivity 
analysis on 
refractory 
period from 
birth. 
Distinguishes between sterile 
immunity and clinical Immunity (in 
which individuals can be infected 
but not develop disease). Multiple 
infections needed to develop 
sterile immunity. 
Natural immunity is likely to be 
long-lasting but needs further field 
investigation. 
Carriage stabilizes dynamics, and is 
particularly important in lower 
incidence settings. 
 
Complex agent 
based model, 
limited 
availability of 
epidemiological 
data results in 
issues of 
parameter 
identifiability.  
Plausible 
combinations 
of parameters 
identified.  
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 First author 
and year 
Ref Model type Disease 
states 
Data source(s) Fitting process Interventions 
modelled 
Time horizon Sensitivity 
analysis 
Findings Comments 
 
7 Pitzer 2014 [24] Compartmental, 
age-structured 
deterministic 
S1 S2 I1 I2 R C W Surveillance 
case series, 
Vellore, Tamil 
Nadu, India 
Two-stage 
fitting with 
Latin 
hypercube 
sampling of 
starting 
parameters. 
Maximum 
likelihood 
estimation, 
simplex 
method.  
 
Vaccination with: 
Ty21a, (VE 48%, 
duration =natural 
immunity), 
Vi polysaccharide 
(VE 80%, 3y),  
Vi conjugate (VE 
95.6%, 19.2y). 
 
Vaccination of 
school age children 
as a campaign, 
routine vaccination 
of 6 year olds, or 
both together. 
 
Improvements in 
water and sanitation 
over 30y 
50y to quasi-
steady state 
and 25 y 
follow-up 
Multi-parameter 
sensitivity 
analysis in 
model fitting. 
Basic reproduction number is 
around 3 in Vellore and 7 in Dhaka. 
Natural immunity is likely to be 
long-lasting. 
Vaccination campaigns would not 
eliminate disease in Vellore but 
instead see disease rebound in 5 to 
10 y. 
A campaign plus routine 
immunization could result in a new 
lower incidence disease state. 
High baseline carriage rates reduce 
the indirect protection of vaccines 
– understanding carriage 
prevalence should be a disease 
control priority.  
In most circumstances modelled, 
improvements in hygiene & 
sanitation have more impact than 
vaccination. 
Best fitting 
parameter sets 
were highly 
sensitive to 
initial 
parameter 
selection. 
Identifies 
carrier 
transmissibility 
and relative 
contributions 
of short- and 
long- cycle as 
import 
epidemiological 
sources of 
uncertainty. 
VE = vaccine efficacy. Effective contact rate is the rate at which two individuals come into contact per unit time, with the nature of the contact being such that if 
one was infectious and the other susceptible, infection would be transmitted. 
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Table 2.2b. Disease states in typhoid models 
Abbeviation Disease state Comment 
N Newborn Susceptible in Cvjetanović’s model, refractory in Saul’s 
S 
S1 S2 
Susceptible; 
Fully and partially susceptible 
 
E;  
Es; Ea 
‘Exposed’;  
Symptomatic or  asymptomatic 
Infected but not (yet) infectious 
 
I; 
Is Ia 
I1 I2 
Infectious; 
Symptomatic or asymptomatic 
Primary or subclinical infection  
 
 
 
Primary infection of a fully susceptible individual or 
asymptomatic/ subclinical infection of a previously partially 
susceptible individual 
 
C;  
Ct; Cl 
Carrier;  
temporary; long-term 
 
R;  
Rt; Rl;  
Rc, ;Rs 
Removed/resistant/refractory/recovered;  
Temporary immunity; long-term immunity;  
Natural immunity to clinical disease; natural 
sterile immunity) 
Not able to be infected, immune. 
Clinical immunity is against disease but allows infection 
and onward transmission. 
Sterile immunity is against any infection. 
V 
Vc, ; Vs 
Vaccinated 
Vaccine-induced immunity to clinical 
disease; Vaccine-induced sterile immunity 
 
 
W ‘Water’ Long-cycle transmission from water or environmental 
contamination, contributed to by all infectious or carrier 
classes. 
 
 
A further, as yet unpublished, transmission model has been developed by the International 
Vaccine Institute (personal communication, Jin Kyung Park) and is not reviewed here.  
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Seven titles were identified as economic evaluation and obtained for full-text review (tables 
2.3 and 2.4) alongside two underpinning COI studies and one underpinning WTP study (table 
2.5).  
Table 2.3. Summary of typhoid vaccine economic evaluation types 
 
 
 
Characteristic Number of studies 
(n=7) 
 
Reference 
 
Based on field studies 5 [27–31] 
Perspective:   
 Public sector only 2 [27,32] 
 Private only 1 [29] 
 Societal (public and private)   
o Include intangible costs of 
pain, suffering and disability 
4 
3 
[28–31,33] 
[28,30] 
Analytical approach: 
(a study can include more than one 
approach) 
 Cost-benefit analysis component 
 Cost-effectiveness analysis component 
 Cost-utility analysis component 
 Willingness-to-pay component 
 Price-optimisation model 
 
 
4 
2 
2 
4 
1 
 
 
[29–32] 
[27,32] 
[30,33] 
[27–29] 
[27] 
Include indirect protection of vaccines 
 Include transmission dynamics 
1 
0 
[27] 
Evaluates improve sanitation, hygiene or 
water supply as an alternative to or adjunct 
to vaccination 
 
0  
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Table 2.4 Components and main findings of typhoid vaccine economic evaluations 
 First 
author, 
year, 
reference 
Analytical 
approach 
Economic 
perspec-
tive 
Setting Burden of 
disease 
Costs Vaccine 
intervent-
ion 
modelled 
Vaccine 
effective-
ness 
Time 
horizon 
Discount-
ing 
Disease 
dynamics 
Sensitivity 
analysis 
Data source(s) Findings 
1 Musgrove 
1992 
[32] 
CBA 
CEA 
 
 
Public 
sector 
 
 
PAHO 
SIREVA 
countries 
 
150 cases per 
year per 100k 
population. 
CFR1% 
Does not cost 
pain, suffering 
or death. 
Vaccine 
programs and 
clinical/ field 
trials or pilots. 
Mass 
vaccination;  
reducing 
number of 
doses over 
time. 
Estimated 
90% 
14 and 24 
years 
10%pa,  No Program 
administration 
costs, vaccine 
costs, delay 
between 
accrual of 
costs and 
benefits 
Expert opinion Describes incidence, 
treatment costs and 
vaccination costs at 
which a program 
would be cost-
neutral  
2 Shepard 
1995 
[33] 
CUA, cost 
per QALY. 
 
Public 
sector 
costs; 
societal 
benefit 
captured as 
QALYs  
Countries 
with 
middle, 
high or 
very high 
U5MR 
1.5 cases per 
person per 
lifetime. 
CFR 1.8% 
Morbidity is 
excluded from 
QALY 
estimates 
Marginal costs 
of additional 
vaccination 
within a 
childhood 
programme 
By birth 
cohort, two 
doses  
Anticipated 
80% over 
10y 
10 years 3%, costs 
and 
benefits 
No. Steady 
states pre-
and post- 
vaccine 
program 
start. 
Assumes 
disease most 
common in 
late 
childhood or 
early 
adulthood.  
1. Dose cost at 
USD50/ QALY. 
2. Vaccine 
development 
costs. 
 
Expert 
opinion; 
extrapolation 
of high 
incidence 
epidemiologic
al studies [34] 
Preliminary 
estimate of highly 
CE (<USD50 per 
QALY, 1992 price) if 
data assumptions 
are valid. 
Critical parameters 
are incidence, CFR, 
VE, vaccine costs 
3 Poulos 
2004 
[31] 
CBA Multi-
dimensional 
public 
sector and 
societal 
Kalkaji 
slum, New 
Delhi, 
India 
As per [35]. 
 Does not cost 
pain, suffering 
or death. 
As above. 
Public funded 
vaccine 
programme. 
Campaign 
with 80% 
coverage of:  
age 2-5, age 
6-19, or all-
age. 
70% for 3 
years 
3 years 10% No Incidence; 
Vaccine cost; 
Ratio of total 
economic 
benefit to 
measured COI 
Bahl 2004 [35] Immunization of 2-
5year olds is cost 
saving to the public 
sector in a high 
incidence setting. 
Sensitivity analysis 
and inclusion of 
private costs 
suggest vaccination 
of other ages may 
also be highly CE. 
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 First 
author, 
year, 
reference 
Analytical 
approach 
Economic 
perspec-
tive 
Setting Burden of 
disease 
Costs Vaccine 
intervent-
ion 
modelled 
Vaccine 
effective-
ness 
Time 
horizon 
Discount-
ing 
Disease 
dynamics 
Sensitivity 
analysis 
Data source(s) Findings 
4 Canh 2006 
[29] 
WTP, 
contingent 
valuation, 
CBA. 
Private Hue, 
Vietnam 
Raised 
incidence 
1995-9; 
associated 
with outbreak 
in 1996  
Benefits 
measured by 
WTP. 
Proposed USD 
0.67 
1.70 
3.30 
6.70 
13.30 
N/A Proposed: 
70%, 3y; 
70%, 20y; 
99%, 3y; 
99%, 20y 
N/A Inherent Typhoid 
perceived to 
be in decline 
by 67% of 
participants 
N/A Cross sectional 
survey in 2002 
of households 
with children  
Survey participants 
are more sensitive 
to price than to 
expected vaccine 
efficacy or duration 
of protection. 
Modest user fees 
could support a 
vaccination 
programme. 
5 Cook 2008 
[30] 
CUA Public 
sector and 
societal 
Kolkata, 
India; 
Karachi, 
Pakistan; 
North 
Jakarta, 
Indonesia; 
Hue, 
Vietnam 
Highest in the 
sites within 
Karachi and 
Kolkata, 
lowest in Hue. 
Reported 
incidence 
double to 
account for 
false negative 
blood 
cultures. 
DALY weight 
0.27, illness 
duration 7d 
CFR 1%. 
 
Private direct 
and indirect 
cost of illness 
obtained in 
interviews 
with 
confirmed 
cases, public 
costs obtained 
from health 
facilities. 
Public and 
private 
vaccination 
costs from 
literature and 
estimation. 
Campaigns: 
1. School 
children 5 
to 14y 
2. Children 
aged 2 to 
15y 
3. All 2y+ 
65%, 3y Over 
duration of 
vaccine 
3% No Single 
parameters 
and Monte 
Carlo across all 
parameters, 
triangular 
distribution. 
VE 55% to 
75%, duration 
2to4y,vaccine 
cost USD 0.40 
to 0.80 (2007 
prices), 
delivery cost 
variable. 
CFR 0.5% to 
3%, illness 
duration 4d to 
3w, DALY 
weight 0.08 to 
0.47. 
 
DOMI No programmes 
would be cost 
saving but (school-) 
child immunization 
would be very CE to 
health services or 
society in all but 
Hue, including 
under sensitivity 
analysis. 
Adult vaccination in 
Kolkata and 
N.Jakarta is less CE 
but still meet 
thresholds. 
Surveillance likely 
reduced illness costs 
through early 
diagnosis. 
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 First 
author, 
year, 
reference 
Analytical 
approach 
Economic 
perspec-
tive 
Setting Burden of 
disease 
Costs Vaccine 
intervent-
ion 
modelled 
Vaccine 
effective-
ness 
Time 
horizon 
Discount-
ing 
Disease 
dynamics 
Sensitivity 
analysis 
Data source(s) Findings 
6 Cook 2009 
[28] 
CBA total 
economic 
benefits vs 
costs 
 
1. Societal 
COI 
2. above + 
Value of 
statistical 
life (VSL) 
saved 
3. WTP 
(contingen
t 
valuation) 
+ public 
costs 
Societal 
 
Tiljala and 
Narkeldan
ga slums, 
Kolkata, 
India 
3.4 case per 
1000 2 to 4 y 
4.9 per 1000 
5to15y 
1.2 per 1000 
16y+ 
 
DALY weight 
0.27 
CFR 1%,  
Total marginal 
vaccine cost 
USD (2007) 
$1.11 
WTP as per 
[36]  
VSL from 
literature. 
Campaigns: 
1. School 
children 5 
to 14y 
2. Children 
aged 2 to 
15y 
3. All 2y+ 
65%, 3y 1 year cost, 
3 year 
benefits 
3% No As per  [30]. 
VSL varied by 
50%. 
Kolkata [37]  Economic 
perspective 1 is not 
cost neutral, but 
perspectives 2 and 3 
indicate benefits 
greater than cost 
across all campaign 
strategies. 
Sensitivity analyses 
suggest WTP and 
VSL models show 
net benefit for all 
campaign strategies 
across most 
parameter sets. 
  
7 Lauria 
2009 
[27] 
Optimizati
on model: 
different 
adult & 
child 
pricing, 
implicit 
CEA 
Public 
sector 
Hypothetic
al 
population 
3.5 annual 
cases per 
1000 children 
and 1per1000 
adults 
As per [38] Price-
dependent 
uptake 
70%, 3y 3y 8% Possible herd 
protection 
described in 
a sensitivity 
analysis, with 
variable adult 
and child 
transmissibili
ty. 
Monte Carlo 
simulation, 
allowing most 
parameters to 
vary. 
Five Asian 
countries[37] 
There is minimal 
advantage to 
different vaccination 
charges for children 
and adults under 
the static model. 
Herd protection 
greatly influences 
case numbers and 
value. 
CBA = cost-benefit analysis; CE = cost-effective(ness); CEA = cost-effectiveness analysis; CFR = case-fatality rate (proportion of cases that result in 
death); CUA = cost-utility analysis; COI = cost of illness; DALY = Disability adjusted life-year; DALY weight = a scale from 0 (perfect health) to 1 
(death). DOMI =Diseases of the most impoverished programme [39]; PAHO = Pan-American Health Organization; SIREVA = Sistema Regional de 
Vacunas (Regional Vaccine System); U5MR = under-five mortality rate; USD = United States Dollars; VE = vaccine effectiveness; WTP = willingness to 
pay 
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Table 2.5 Components and main findings of cost of illness studies and willingness to pay studies used in typhoid vaccine economic evaluations 
 First 
author, 
year, 
reference 
Analytical 
approach 
Economic 
perspec-
tive 
Setting Burden of 
disease 
Costs Vaccine 
interventio
n modelled 
Vaccine 
effective-
ness 
Time 
horizon 
Discount-
ing 
Disease 
dynamics 
Sensitivity 
analysis 
Data source(s) Findings 
1 Bahl 2004 
[35] 
Cost of 
Illness 
Multidimen
sional 
public 
sector and 
societal 
costs 
Kalkaji 
slum, New 
Delhi, 
India 
Culture 
confirmed 
incidence per 
year: 17 per 
1000 under 
5s; 
12 per 1000 5-
18y; 
1 per 1000 
>19y 
Public sector/ 
institutional 
and private 
costs, 
comprising 
direct 
medical, 
direct non-
medical and 
indirect costs; 
for 
hospitalized 
and non 
hospitalized 
N/A N/A One year 
surveillance 
N/A No.  
Decline in 
incidence 
rate with age 
is informative 
of an 
immunizing 
infection. 
With both 
most 
conservative 
and least 
conservative 
cost 
estimates, and 
with incidence 
both on 
confirmed and 
clinically 
suspected 
disease. 
Cohort study 
1995-6, 
weekly 
interviews and 
passive 
surveillance. 
Costs are high per 
episode regardless 
of age, both private 
and public/ 
institutional. 
Hospitalization and 
non-response to 
antimicrobials 
increase costs  
2 Poulos 
2011 
[38] 
COI Public and 
private 
(direct and 
indirect) 
Hechi, 
China; 
North 
Jakarta, 
Indonesia; 
Kolkata, 
India; 
Karachi, 
Pakistan; 
Hue, 
Vietnam. 
Highest in the 
sites within 
Karachi and 
Kolkata, 
lowest in 
Hechi and 
Hue. 
 
Measured by 
questionnaire, 
with estimates 
for nonmarket 
activities. 
Karachi costs 
from expert 
information. 
N/A N/A N/A 
Interviews 
at 7, 14 and 
90d from 
disease 
onset. 
N/A N/A N/A Interviews 
with cases or 
carers. 
Total episode costs 
range from USD 15 
to132. Private costs 
exceed public costs 
unless reimbursed. 
Hospitalization adds 
to costs 
substantially. 14 to 
49% of households 
borrowed money to 
pay for treatment. 
Costs of drug 
resistant infection 
are higher, but not 
significantly so. 
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 First 
author, 
year, 
reference 
Analytical 
approach 
Economic 
perspec-
tive 
Setting Burden of 
disease 
Costs Vaccine 
interventio
n modelled 
Vaccine 
effective-
ness 
Time 
horizon 
Discount-
ing 
Disease 
dynamics 
Sensitivity 
analysis 
Data source(s) Findings 
3 Whittingto
n 2009 
[36] 
WTP Private Tiljala 
slum and 
Beliaghata 
neighbour
hood, 
Kolkata, 
Inida 
2 case per 
1000 
population 
per year, peak 
incidence in 
older children 
and teenagers  
Proposed USD 
(2007)  
0.22 
0.56 
1.11 
11.11 
And sliding 
scale. 
Price-
dependent 
uptake 
70%, 3y N/A Inherent N/A N/A Cross sectional 
survey of 
households 
with children. 
9% would decline a 
vaccine, with a 
further 7% only 
accepting free 
vaccine. WTP is at 
least USD2. Vaccines 
for children were 
valued higher than 
those for adults. 
Time to think 
reduces willingness 
to purchase vaccine.  
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 A further COI study was identified but excluded as not linked to a published economic 
evaluation.[40]  
 
There was minimal overlap found between transmission modelling and economic evaluation. 
Of the transmission dynamic models, only those by the Cvjetanović group also had cost-
effectiveness components.[18–20] One economic study included quantitative consideration 
of indirect protection.[27]  
 
 
2.4.1 Transmission dynamic models 
The seven typhoid models identified range from two-state analytical tools to complex 
individual-based simulation or multi-state compartmental models (see table 1).  Only two 
models were formally fitted to data.[24,25]  
The structures of models (table 2a and 2b) are based on different assessments or 
representations of the natural history of typhoid fever, particularly in how immunity to S. 
Typhi is considered. González-Guzmán suggests that natural partial immunity is likely to arise 
but simplifies to a model with vaccine immunity only, noting that sufficiently high infectious 
doses can overcome immunity.[21] Pitzer uses population compartments to separately 
represent immunity against typhoid infection (‘sterile immunity’), and immunity against 
typhoid disease (‘clinical immunity’), allowing transition from the latter to either full 
susceptibility or to a subclinical infection that in turn restores full sterile immunity in the 
individual. This corresponds to immunity boosting repeated infection cycles without overt 
disease, particularly in adults after recovery from clinical disease in childhood, and allows 
bacterial shedding during subclinical infection to contribute to sustained transmission.[24] 
Saul similarly models both sterile and clinical immunity, with infection resulting in sterile 
immunity that wanes to clinical immunity (potentially after zero time) and then to 
susceptibility, and explores a range of hypothetical state-transition scenarios based on 
multiple infections, though he does not clearly resolve a most-likely scenario.[25]  Despite 
asymptomatic boosting being a long-standing hypothesis, or perhaps because of it, there is a 
paucity of data from microbiological, immunological or epidemiological studies to 
parameterise models or to validate assumptions.[41] 
While noting leaky immunity in those naturally infected (each individual has a reduced 
probability of further infection), González-Guzmán models Ty21a oral vaccine protection as 
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all-or-none, giving each vaccinee a probability of developing immunity or not. In this model, 
those who develop immunity following vaccination have 100% protection against typhoid, 
until vaccine wanes and they return to full susceptibility, an approach also applied by 
Cvjetanović.[18–21] Pitzer handles injected Vi vaccination the same, noting results were 
similar in a sensitivity analysis assuming leaky vaccine immunity. Pitzer represents oral Ty21a 
vaccination as akin to natural immunity, transitioning vaccinees to clinical immunity after full 
immunity wanes.[24] 
While vaccination programmes are predicted to reduce typhoid incidence, uncertainty 
around carriage prevalence, duration and contribution to the force of infection substantially 
affects vaccines’ projected impact.[21,24,25] In reviewing Cvjetanović’s 1978 model,[19] 
Anderson and May observe that the implicit assumption that the effective contact rate for 
carriers is equal to that of acute cases, combined with other fixed parameter estimates, gives 
carriers a contribution to transmission ten times that of other cases.[42] While illustrative of 
the potential contribution of carriage in sustaining disease, for policymaking it has been 
recommended that such assumptions should be tested against data.[43,44] An approach 
might be to conduct systematic, detailed investigation of incidence cases to identify potential 
sources, using suitable screening methods to look for carriers as well as acute cases, and 
combine this with population-level carriage surveys and water quality studies. While labour-
intensive, such investigations could be integrated into wider control efforts.[45] 
Chronic S. Typhi carriage can be treated with antibiotics and/or cholecystectomy for 
gallstone-associated infection, but there is no demonstrated role for vaccination in clearance 
of carriage.[46,47] Premised on this, Cvjetanović’s and Pitzer’s models demonstrate that 
where carriage contributes substantially to transmission in an endemic settings, vaccination is 
unlikely to result in elimination in the short-to-medium term.[18,24] Similarly, where carriage 
rates are high the indirect protective effects of vaccination are reduced, as the risk to the 
unvaccinated of acquiring disease from carriers is not diminished.[24,42]  The contribution of 
carriage, however, requires further epidemiological assessment, as does the role of short-
cycle and long-cycle (environmental) transmission.[21,24,25] 
If immunization of the susceptible population does not bring about typhoid elimination, then 
measures to reduce per case or per carrier infectivity, such as improved sanitation or hand 
washing with soap, might be considered instead of or in conjunction with vaccination.[48,49] 
The multi-compartment models suggest such a reduction in effective contact rates could lead 
to important reduction in prevalence.[21,23,24] This is consistent with Briscoe’s analytical 
model.[22] 
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Another feature of transmission dynamic studies is that the average age of infection increases 
as the force of infection decreases, for example, with the introduction of vaccine.[20] This is 
consistent with burden of disease studies which find earlier average age of infection in 
settings with higher disease incidence.[14,35] 
 
2.4.2 Economic evaluation 
Our literature search found seven papers evaluating typhoid vaccine cost effectiveness. The 
earliest two of which were based on values derived from expert opinion and are less 
informative to current policy considerations than the most recent five which were based on 
field studies, as outlined in tables 3 and 4. Two supporting COI studies and one supporting 
WTP study are outlined in table 5. These field-informed analyses share multiple common 
authorships with collaboration through the Diseases of the Most Impoverished (DOMI) 
programme. Of the seven economic evaluations, four included a cost-benefit analysis (CBA), 
two a cost-effectiveness analysis (CEA) and two a cost-utility analysis (CUA).  Four of these 
used a societal perspective [28,30,31,33]. Only one evaluation considers indirect protection 
quantitatively, but uses hypothetical values for herd immunity from different coverage levels 
rather than estimates from dynamical modelling.[27] No studies considered improvements in 
sanitation, hygiene or water supply as an alternative or adjunct to typhoid vaccination. 
In a one-year study of a very-high typhoid incidence area –  Kalkaji slum, Delhi – Bahl found 
average costs per episode of illness were high to both the health sector and families, 
excluding intangible costs such as pain, with hospitalization an important component of 
health service costs.[35] A CBA by Poulos on this data reported that a vaccination programme 
for children under five years of age would be cost-saving to the public sector. Analysis  from a 
societal perspective, incorporating private costs, indicated that vaccination in high incidence 
settings with modestly-priced vaccines could also have net benefits in other age groups.[31] 
Cook and colleagues conducted a CUA based on field data from multiple Asian sites,[30,38] 
and found that while typhoid vaccination using the Vi-polysaccharide across adults and 
children would be unlikely to be cost saving to the public sector, in high incidence settings it 
was likely such a programme would meet the standard for “very cost-effective” health 
interventions of less than per-capita gross domestic product (GDP) per DALY gained.  In these 
settings, targeting vaccination to the highest incidence age-groups improved cost-
effectiveness substantially. Through sensitivity analysis, the main determinants of cost-
effectiveness identified were vaccine cost, case-fatality rates (CFR), vaccine duration of 
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protection, (baseline) incidence and vaccine efficacy.  Cost-effectiveness was insensitive to 
vaccine coverage as no indirect protection was assumed.[30] 
WTP has also been used in economic evaluation of typhoid vaccines as an alternative 
approach to COI in valuing private or societal benefits. Such an approach is considered to 
demonstrate the value individuals place on the total benefit of the vaccine, though is 
confounded by ability to pay, and ability to value public sector activities foregone if vaccines 
are supplied through the state.[50] One study from Hue, Vietnam suggested that typhoid 
vaccination would pass a social cost-benefit test (total costs less than total societal benefit), 
based on demand estimates from a contingent valuation survey addressing hypothetical 
vaccine purchases for householders and their children.[29] Analysis by Cook of a similar WTP 
study done in Kolkata, India, by Whittington and colleagues, suggested that vaccination of 
children or all-ages would not pass a social cost-benefit test using COI , but costing benefits 
using WTP plus public costs would likely find that such programmes pass such a test. [28,36] 
WTP studies are also informative to vaccine uptake, with 9% of respondents in the Kolkata 
survey stating they would not accept a free vaccine, with data suggesting these individuals 
are more likely to be older, have lower income and never boil drinking water.[36] In the Hue 
survey, Canh suggests a number of issues affect validity of economic evaluation using WTP 
estimates, noting that householders were most sensitive to price, with proposed vaccine 
efficacy making no detectable difference to individual or household demand at a given 
price.[29]  
Observing that typhoid vaccines are equivalent to one-sixth of per-capita public sector health 
spending in India, Cook notes the potential for user fees in financing a state-administered 
programme.[28] Whittington’s Kolkata WTP survey suggested vaccine protection for children 
was given greater value than vaccinating adults.[36] Drawing on data from this study, a price 
optimisation model by Lauria of different vaccine prices for children and adults did not find a 
strong case for differential pricing, but in a non-dynamic sensitivity analysis of potential 
indirect protection scenarios found herd immunity to be a significant influence on incidence 
and cost-effectiveness.[27] 
 
2.5 Discussion 
This review found a relatively sparse literature on typhoid modelling and vaccine economic 
evaluations. Of seven transmission models found, only two were published in the last 25 
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years and use contemporary data-fitting methods. All five field-based economic evaluations 
we found shared multiple common authorships around the DOMI collaboration.   
Although the Global Burden of Disease is a much-criticised ranking, it provides some 
comparator infectious diseases, with measles and syphilis ranked close to typhoid and 
paratyphoid fever, and cholera attributed around one-third of the annual number of 
DALYs.[51] Repeating our (non-comprehensive) PubMed typhoid search strategy for these 
returned over six times as many measles papers, three times as many syphilis papers, and 
twice as many cholera papers. Typhoid fever transmission and economic evaluation appears 
relatively under-studied. Typhoid’s low profile-to-burden ratio has variously been attributed 
to ubiquity in developing countries, inadequate diagnostic tools, the absence of champions in 
health agencies, and affecting mostly the poor and the underclasses. [52] Effective antibiotics 
and previous non-availability of a long-acting infant vaccine have also been cited as reasons 
for the absence of internationally-funded typhoid vaccination programmes.[52] For budget-
constrained national health agencies, typhoid vaccination programmes may appear 
unattractive unless public sector cost saving can be demonstrated,  for example, if the 
incidence rate is very high.[31,35] 
Considering only a health services perspective – of treating typhoid and providing vaccine – 
omits private costs associated with the disease and therefore underestimates the societal 
impact of typhoid. Various approaches have been taken to address these costs and more 
completely capture the benefit of vaccination, from cost of illness studies for private 
expenses, estimates of health utility forgone due to illness, or by determining the extent to 
which people value vaccination in willingness-to-pay studies. While user fees and WTP are 
controversial,[10,50] economic evaluations that consider these have been consistent with 
typhoid economic analysis using more widely-accepted cost-utility analysis and private cost of 
illness. These CUAs suggest typhoid vaccine programmes are likely to be highly cost-effective 
(against international norms) where disease is highly endemic, particularly when targeted to 
the age-groups at highest risk of disease. The economic analyses, which do not include 
mechanistic components for transmission, emphasise as key drivers of cost-effectiveness the 
vaccine cost, case fatality rates, baseline incidence, vaccine efficacy and duration of 
protection.  
We did not find any economic evaluation comparing typhoid vaccination programmes against 
other potential means of typhoid control, such as measures to improve sanitation, hygiene or 
water supplies. It is still not possible to answer the century-old question of whether, in a 
given setting and within a limited budget, vaccination should be adopted over improved 
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sanitation and hygiene, or what combinations are optimal for control under what 
circumstances. Such analysis would need to be based on a transmission dynamic model, with 
extensive epidemiological surveillance for detailed burden of illness measurement, and 
comprehensive costing for CUA or CBA approaches that allow other diseases to be included in 
the evaluation. 
The only published data-fitted transmission model of typhoid vaccination suggests that while 
vaccination is effective in reducing disease incidence, if  other measures are not enacted to 
reduce the ongoing force of infection, particularly from asymptomatic carriage, short or 
medium-term vaccination campaigns are unlikely to result in elimination and would see 
disease rebound if vaccination stopped.[24] The authors of recent dynamic models 
emphasise our lack of understanding of certain aspects of the natural history of typhoid 
(particularly around acquisition of immunity, the role of carriers, and the contribution of 
short- and long-transmission cycles). [21,24,25] A model intended to examine what role the 
putative different forms of S. Typhi immunity have in determining typhoid incidence rates 
found an absence of suitable immuno-epidemiological data on which to fit parameters and 
make strong inferences, a challenge further compounded by the absence of age structure in 
the model.[25] 
Transmission dynamic modelling and a non-mechanistic economic analysis have shown that 
the level of indirect protection may have an important impact on vaccine effectiveness and 
cost-effectiveness respectively.[24,27] None of the economic models mechanistically 
consider disease dynamics and so cannot scientifically appraise the indirect effects of 
vaccination in cost-effectiveness calculations. Indeed, while a number of economic analyses 
readily acknowledged indirect effects as an important phenomenon, they specifically 
excluded them, citing the absence of evidence for Vi polysaccharide vaccine herd immunity 
pending the publication of cluster randomised controlled trials.[28,30,53,54] Early work by 
Cvjetanović is the only meeting point we found of mechanistic typhoid transmission 
modelling and economic analysis, but the complexity of this model and absence of fitting 
make it difficult to apply findings to contemporary disease control problems. [18,19] 
Using a static economic model premised only on direct protection in vaccinees may be a 
reasonable approximation in some situations, such as if vaccine-preventable new typhoid 
cases (symptomatic or otherwise) make a relatively small contribution to the force of 
infection compared with carriers and the unimmunised. Even in such circumstances, prior 
assessment with mechanistic modelling of field epidemiological data would be appropriate in 
estimating the relative contributions of each group to transmission. 
90 
 
While there seems limited inter-disciplinary dialogue between typhoid modellers and 
economists, a unifying concern is the importance of accurately determining age-based 
incidence rates, which can be highly variable within-country or between otherwise similar 
settings, and are central to estimates of vaccine impact and cost-effectiveness.  
Heterogeneity in disease rates, transmission mechanisms and health service provision may 
limit external validity of both typhoid modelling studies and economic evaluations. 
Accurate assessment of disease burden could be done with large, population-based studies to 
inform incidence, complications and case-fatality rates, using blood culture confirmation of 
cases, or altogether improved diagnostics.[30,55–57] It should be noted that even well-
conducted studies are unlikely to provide unbiased estimates, due to the positive health 
consequences of introducing disease surveillance. Bahl notes that active surveillance with 
early treatment gave rise to disease that is less severe, and less expensive, than disease 
detected through passive surveillance.[35] This is echoed in the DOMI disease burden study, 
which rather than the 1% case-fatality rate widely cited in literature, had a zero percent CFR 
amongst the 475 cases detected (which gives an upper 95% confidence interval of around 
0.63%).[30,37,58] 
Other field epidemiology and laboratory investigations could further inform typhoid 
transmission dynamics:[59] 
 Large, population-based, S. Typhi carriage studies, similar to those done in Chile in 
the early 1980s, [5] to determine prevalence in a range of endemic settings, 
potentially with serological surveys, [60]  alongside investigation of potential sources 
of infection amongst new cases.  
 Serological assay development and population-based serological surveys to 
determine past infection to S. Typhi, natural immunity and waning of this immunity. 
Seroprevalence could be linked to surveillance records to estimate the proportion of 
infections that are clinically apparent and notified to national authorities. 
 Epidemiological time series with consistent, transparent methodology and/or cross-
referencing between methods.[61] 
 Age-based social contact pattern surveys, which may inform short-cycle 
transmission.[62] 
For models to assess vaccination against other enteric fever control measures, findings could 
be incorporated from interventional field studies on the role of improvements to sanitation, 
hygiene and water supply in changing disease incidence and transmission. Ongoing scrutiny 
of vaccine efficacy and duration of vaccine protection may also be informative. Estimates of 
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efficacy of Ty21a vaccines in recent systematic reviews are less than in the data sources for 
early modelling, with the reviews focusing on individual RCTs rather than cluster field 
studies.[20,63–66] Estimates for Vi-polysaccharide effectiveness have also been modified 
downward.[31,64] Analysis of differences between cluster and individual randomised trials 
may be informative on indirect protection.  
This review has a number of limitations. In the absence of licensed human vaccines, the 
review does not cover paratyphoid fever or non-typhoidal salmonelloses. It covers only 
material in the English language, limited searches to a non-systematic enquiry of a single 
database and does not attempt to synthesis qualitatively or quantitatively any of the studies 
reviewed. Comparator studies have not been sought that consider investments in water, 
sanitation and hygiene as alternatives to typhoid vaccination.  
One possible feature observed in the course of this review is a less pessimistic assessment of 
disease burden, perhaps reflecting true decline, as well as a more sceptical perspective on 
vaccine efficacy estimates, with fewer inputs based on expert opinion alone. Any such trend 
towards assessment of vaccine costs and benefit firmly grounded in data is beneficial to 
equitable, scientifically-informed health-policy setting. 
It has been suggested that for a model to have sufficient complexity to enable robust cost-
effectiveness analysis, substantial data collection may be required.[67]  When data is in short 
supply, theoretically-informed modelling may still be a particularly appropriate tool to 
support decision-making.[68,69]  Transmission modelling using existing data explains 
patterns seen in average age of infection, demonstrates the importance of carriage, suggests 
optimal strategies for vaccination, and appraises the potential role of other interventions to 
reduce transmissibility.  
2.6 Conclusion 
Transmission dynamics have not yet been integrated into a comprehensive cost-utility 
analysis of typhoid vaccination and, as such, there is no economic evaluation that would meet 
contemporary gold standards.[9,70] Given the costs and time involved in further field study, 
constructive efforts could be made to integrate existing transmission modelling and cost-
effectiveness analyses, such as utilising the extensive collation of typhoid epidemiological and 
clinical parameters by Saul[25]  with the transparent, reproducible modelling approach of 
Pitzer,[24] and DOMI project economic data.[30,38] While such endeavours would not 
address the fundamental limitations on health service budget in endemic areas, an analysis of 
typhoid vaccination that enables economic comparison across health arenas could help bring 
into the public gaze the full potential of measures to control enteric fever, and improve the 
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prospects of protection from typhoid for people living with daily risks from a disease 
eliminated from most of the affluent world. 
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3.1 Serosurvey bridging section 
3.1.1 Introduction  
This section of the thesis describes the planning and operational background of the Fiji 
serology and social mixing survey which I conducted between September 2013 and January 
2014. The version of the serosurvey paper enclosed in this thesis is the last-but-one draft of 
the version published in PLOS Neglected Tropical Diseases,1 as cuts to methodological detail 
were made in condensing the final manuscript for the journal. Even in long-form, the paper 
omits details that are of relevance to describing the process leading to the implementation of 
the field research, and this bridging section is intended to complete those gaps. 
The subsections in this bridging section are in roughly chronological order. 
 
3.1.2 Preliminary planning 
Following the Fiji typhoid expert panel meeting recommendations in August 2012, the study 
was conceived and designed by me in autumn 2012 and early 2013, with input from 
colleagues and collaborators. Discussion and partnership with the Ministry of Health (MOH) 
and World Health Organization (WHO) Division of Pacific Technical Support was established 
through Australian Aid’s (AusAID) Fiji Health Sector Support Programme (FHSSP).  I visited Fiji 
between November and December 2012 to develop collaboration with local partners in 
drafting a research proposal and establishing the local mechanisms through which to take 
forward the proposals, such as ethical approval. 
The primary aim of the serosurvey was to determine antibody prevalence by age, with the 
study powered towards this. Secondary aims were to identify risk factors for raised antibody 
titres, based on a questionnaire interview. Also embedded in in the serological survey was a 
social contact survey from which to produce a mixing matrix that might weight risks of 
person-to-person transmission events. 
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3.1.3 Design 
I sought to conduct a nationally-representative study, and to include a study population that 
would reduce the selection biases that could limit internal and external validity and policy-
relevance. A national survey is preferable to convenience samples such as only sampling 
Suva, the capital, omitting large geographies; or using residual blood samples from hospitals 
which selects for the sick rather than the general population; or using blood donor residua 
which omit children entirely. 
A simple random survey with a whole-population sampling frame is desirable for simplifying 
statistical inference but logistically unfeasible and so a cluster design was utilised. UN 
handbooks on field sampling methods2,3 and the work of the late Steve Bennett4,5 and 
others6,7 were consulted on practical sampling methods for areas where details for structured 
sampling frames are incomplete, including Pacific islands.8 These supported the use of multi-
stage sampling based on available administrative data as described in the methods section of 
the paper. Analytical handling of clustering is also further described in the paper. As the 
survey was planned as a serum banking study, this further emphasised the importance of 
strong methods to support representativeness of the general population.  
The cluster size was set as 25 participants. This was based on the daily survey capability of a 
field team in prior serological research conducted by the US Centers for Disease Control and 
Prevention (CDC) and WHO on Fiji’s Taveuni island (Heather Scobie, Kashmira Date & Eric 
Nilles, unpublished work) a year after the cyclone Tomas vaccination campaign.9 One random 
participant was selected per household to reduces correlation. Age-stratified sampling was 
initially considered to ensure age-representativeness; however, with the random-selection 
approach, this was considered to on average have had balanced samples. Experience on 
Vanua Levu island (11 clusters) was that imbalanced clusters were readily feasible and so age-
stratified sampling was introduced for Viti Levu island where the majority of the survey was 
to take place. 
Taveuni samples would be collected as vaccinated comparators to the unvaccinated 
population. Mooted examination of waning post-vaccination antibody titres by repeat cross-
sectional analysis of Taveuni samples (2013 plus the 2011 CDC/WHO samples) was not taken 
forward.  
As noted in the introduction, a proposal was made by the WHO, who were funding the 
fieldwork costs, to extend the survey scope to encompass leptospirosis, following an expert 
meeting in Fiji in May 2013 on control of the zoonotic pathogen, and was a welcome 
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opportunity to increase the utility of the sero-survey.10 The leptospirosis serosurvey approach 
was to be risk-analytical rather than population-representative in primary intent. This would 
require additional cluster sites purposefully selected in the Western Division for their known 
leptospirosis outbreak history, as well as those randomly selected for the typhoid survey. 
Multiple residents would be sampled per household unit in these clusters to maximise 
serological comparisons. These additional clusters were done within available time and 
resource. They are not included in the typhoid analysis. 
 
3.1.4 Serological testing plan 
A plan was also developed for serological testing. After field collection, venous blood samples 
would be allowed to clot, centrifuged at the field site, in a local hospital or a local operating 
base, and pipetted into cryovials. These would be transported to the MOH reference 
laboratories at the Fiji Centre for Communicable Disease Control (FCCDC) at Mataika House, 
Suva for freezing at -80˚C. From there they could be shipped on dry ice to international 
partners. Proposed domestic testing for IgG anti-Vi as a carrier detection tool was not 
expected to become available (and did not) in the timeline of the project. Use of anti-Vi IgG 
testing has been proposed since the 1950s as an alternative to faecal testing for 
asymptomatic carriage detection, though successive studies show less than ideal sensitivity 
and specificity, which has limited operational uptake.11 An alternative role for anti-Vi IgG 
serology may be in detection of past infection in seroepidemiological surveillance.  
The use of anti-Vi ELISA was proposed at the AusAID/MOH meeting by Stephen Baker at the 
Oxford University Clinical Research Unit (OUCRU) Enteric Pathogen Laboratory in Ho Chi 
Minh, Vietnam. Previous serosurveillance in Nepal using anti Vi ELISA in 2006 and 2009-11 
using residual serum samples indicated the potential for this to be an informative approach in 
the Fijian context, particularly on age-based serology.12,13  OUCRU would be the principal 
laboratory partners for the investigations. These samples would be examined using 
pharmaceutical grade Vi donated by Novartis, Italy.  
Testing was planned with Myron Levine of the University of Maryland using agglutination 
assays for antibody to d-flagellin (Hd), or an ELISA for anti-Hd that was in development in 
Maryland but not completed in the timeline of this thesis. This assay comparison was 
proposed to be on a 10% subset of samples, due to the cost of the assays.  As mentioned in 
the thesis introduction, this aspect of the study was not taken forward due to Ebola response 
commitments on both sides of the Atlantic. 
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3.1.5 Geographical coverage 
The national survey was conducted in Central, Western and Northern Divisions, with sampling 
frames based on unvaccinated populations. This excluded the southern side of Vanua Levu 
island, and pockets in  
We excluded Eastern Division small island groups for operational feasibility. The Eastern 
population is small at 37,000 and there are few reported typhoid fever cases, though this 
could reflect reporting as readily as reflecting the limited infection-sustaining ability of a small 
island population. A feature of Fiji is the mobility of the population between urban and rural, 
including to the eastern islands, giving adequate opportunity for transmission events.  
The other excluded areas were those that had been vaccinated in the 2010 campaign which 
followed Cyclone Tomas. Lists were obtained from AusAID FHSSP of vaccinated areas and 
their coverage and these areas excluded from sample frames. 
 
3.1.6 Funding and financial management 
It was initially unclear where funding might be obtained from in order to conduct a 
serological survey. There was no further funding available from AusAID to take forward this 
recommendation from the AusAID-MOH expert meeting, nor from within the AusAID funded 
Fiji Health Sector Support Programme. My MRC budget was insufficient.  Funding was 
attained through Eric Nilles, team leader for WHO’s Pacific emerging infection surveillance 
and response team, with whom I worked to develop a detailed budget plan for submission to 
the WHO Western Pacific Regional Office for approval.  
The support of Stephen Baker at OUCRU Vietnam to undertake the anti-Vi serology at no cost 
greatly improved the feasibility of the project. Additional competitive funding from the 
Chadwick Trust for personal research costs was also sought and obtained.  
With the addition of the leptospirosis extension, the budget was distinctly tight; tighter still 
with an additional requirement of a preparatory visit to rural field sites by Kitione Rawalai, 
the MOH-appointed local study coordinator. One cost pressure was addressed when the 
University of Queensland, as host institute of Colleen Lau, lead for the leptospirosis study, 
was able to purchase two portable mains centrifuges for the survey, on provision these were 
returned to the institution to facilitate further Pacific fieldwork, which was done following the 
study. 
Financial management of the GBP 90,000 budget was one of the most challenging and time-
consuming aspects of the study; including large-scale cashflow management for staff and 
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research costs in a country where LSHTM had no research base. In particular, cash withdrawal 
limits and prohibitive international transfer fees would have made it impossible to pay for the 
field team from a foreign based account on the required weekly basis. This necessitated 
arrangement to be made with the School’s Chief Financial Officer for use of a personally-held 
bank account in Fiji as the operational account for staff costs from where cheque payments 
could be made. Attaining a bank account as a kaivalagi, “a person from the land of 
foreigners”, was also an informative exposure to navigating Fijian administrative pathways.  
LSHTM funds were duly transferred to the account and accountability maintained through 
the emailing of photographs of payment receipts and cheques to LSHTM departmental 
administration colleagues along with detailed records and bank statements.  
Field research costs such as vehicle hire, ferry tickets and accommodation continued to put 
through receipted, itemised claims forms, which totalled tens of thousands of pounds. With 
careful management, the study was completed within budget. 
 
3.1.7 Field team recruitment 
As per the costed operational plan and following the appointment of Kitione Rawalai in July 
2013 as local coordinator, we established two independently operational field teams under 
direction of each of us, with rotation of staff between the teams to share best practice and 
good morale. Each team comprised two field workers and a phlebotomist.  
Each team requiring a field worker able to represent the team effectively at iTaukei village 
sevusevu ceremonies, detailed below. Two such field workers were recruited, Ilai Koru, a 
former Navy environmental health officer, and Leone Vunileba, a census officer, who would 
also be able to drive one of the vehicles (to contain staff costs, I drove the other vehicle 
during research in Vanua Levu and Western Division). Ilai and Leone were joined by two very 
capable and experienced graduates of the Bachelors in Public Health programme at Fiji 
National University, Jeremaia Coriakula and Mere Taufa. The teams were completed by the 
recruitment of newly-qualified phlebotomists Sala Ratulevu and Ala Salesi, identified through 
the MOH blood service. Substitutes were found to cover periods of unavailability through 
local MOH facilities. Figure 3.1 is a photograph of the field team in an iTaukei village. 
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Figure 3.1 Field team outside a village hall  
 (L to R) Jeremaia Coriakula, Conall Watson, Sala Ratulevu, Mere Taufa, Kitione Rawalai, 
Leone Vunileba, Ala Salesi and Ilai Koru. 
 
3.1.8 Fieldwork plan 
After completing piloting in the Suva area in August 2013, our planned approach was to do 
the fieldwork as an anti-clockwise lap of Fiji.  We would sail to Taveuni island in the north east 
in September 2013 and completing sampling on the larger neighbouring island Vanua Levu 
before returning to Suva for rest and and re-stocking supplies.  
The second leg would be to completing an anticlockwise loop of Viti Levu, to cover the 
Western Division. The final section would be to complete fieldwork in Central Division by 
December, which could be managed as day trips in or from Suva. This frontloaded the 
demanding elements of fieldwork, with the understanding in the field team that the work 
would get progressively more straightforward, and avoid remote travel during the onset of 
the rainy season in December. 
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3.1.9 Ethical approval 
Ethics approval was sought in Fiji in December 2012 from the National Health Research 
Committee (NHRC) and the Fiji National Research Ethics Review Committee (FNRERC), both 
hosted by the Ministry of Health. Reviews from NHRC were received in April 2013 requesting 
substantially more information than was apparent from the ethic committee application 
forms.  I submitted a 40-page response document and fifteen supporting files in May 2013. 
Verbal approval from the NHRC was received following their meeting in July 2013. The 
committee had approved the scientific and technical aspects of the study and was passing the 
study to the FNRERC for further consideration due to the inclusion of human participants. 
Approval was received on 13 September 2013 from the FNRERC (reference 2013 03). We 
sailed to Taveuni that night.  
Ethics approval from the London School of Hygiene and Tropical Medicine was sought and 
received in 2013 prior to commencement of the study (LSHTM reference 6344).  
 
3.1.10 Equipment procurement 
An inventory of resources and equipment was drawn up based on the anticipated needs for 
the typhoid and leptospirosis components plus contingency. Questionnaires were printed by 
a local company. A manual centrifuge was brought from London for use in remote sites 
without power. Fiji is a regional centre of medicine and commerce in the Pacific islands and 
has a number of medical suppliers from whom phlebotomy equipment could be procured, as 
had been done for previous WHO studies. Other standard medical consumables such as 
gloves, swabs and alcohol gel were sourced through local pharmacies.  
Due to the Pacific geography and market demand, a number of items had to be specially 
ordered from other parts of the wholesale company in Australia and New Zealand with a 
lead-time of several weeks, and only just arrived in time. This include “gold-top” serum 
separator blood tubes that would be used to reduce red-cell contamination in transit and 
safety shielded needles used to reduce the risk of needlestick injuries. Unused equipment 
was donated to the MOH at the end of the study. For subsequent dengue fieldwork, 
equipment was procured in London and flown to Fiji. 
 
3.1.11 Training, questionnaire development and survey piloting  
We spent time in Suva and Central Division training on study processes and developing the 
proposed questionnaire (figure 3.2), including individual-level piloting and community-level 
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piloting. This included strategies for sensitive question areas including toilets, handwashing 
habits, income and social mixing by ethnicity, as necessitated by the socially conservative 
norms in Fiji. This led to modifications of the questionnaire such as dropping physical contact 
as a form of social contact. See thesis appendix A1 for the questionnaire. 
With further refinement, we would have shortened the survey length by removing the 
distinction in the leptospirosis question sets between small-scale farming/animal keeping for 
domestic use and equivalent questions on these being done as a source of income or 
employment. Whilst this was a distinction made in other Pacific island settings examined in 
prior leptospirosis research, many Fijian participants did not differentiate domestic and 
commercial farming.  
Study processes included methods of community level random selection to reduce selection 
bias, using random number selection grids, pen-spin methods adapted from EPI for villages 
and settlements, and equivalent methods for urban and road-side communities. 
 
Figure 3.2 Questionnaire development  
3.1.12 Risk management 
Standard operating procedures were put in place and training given on management of risks 
to patients and study staff, including needlestick injury management, and reporting 
mechanism for study participants to the field team and the MOH of any complaints or 
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adverse events. One member of field staff required an overnight hospital stay for an 
unspecified illness during the course of the research but was discharged without sequelae. 
No needlestick injuries occurred, and no complaints or adverse event reports were received 
from participants.  
 
3.1.13 Permissions and consent 
At the administrative level, we notified divisional medical officers of plans to work in their 
division, and were often able to enlist the assistance of zonal community nurses through 
subdivisional medical officers and the public health nursing system. Media outreach was 
done through divisional MOH to inform people of the survey and support local disease 
control efforts (figure 3.3). 
 
Figure 3.3. Public engagement through the Fiji  Times  
Fijian residential settings can be broadly divided into three: residential housing, informal 
settlements and traditional iTaukei villages. Before household could be approached in an 
iTaukei village, permission was required from a village official, usually through a sevusevu 
ceremony. At these, we explained the purpose of our visit and sought permission from 
headmen (akin to chief executives or mayors) or hereditary chiefs to conduct the study, 
handing over the traditional gift of a large wrapped bundle of dried yaqona roots, which are 
pounded to make the traditional kava drink, a putative sedative anxiolytic and local 
anaesthetic consumed socially and ritually from a wooden tanoa (figure 3.4).14 
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Figure 3.4. Preparation of kava from ground yaqona  
 Once village permission had been established, fieldwork was conducted in the village as it 
would be in other settings, with the community supportive of research endorsed by the 
village leadership enabling rapid progress. Community health workers and zonal nurses 
(figure 3.5) were frequently available in villages to support the study through personal 
connections, local knowledge and detailed, up-to-date village health censuses. 
 
Fig 3.5. Assistance from MOH zonal nursing staff  
 
Individual informed consent was obtained as described in the main paper, including the 
opportunity to decline questions or withdraw from any or all parts of the study. Individual 
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consent was not replaced by village-level permissions. During informed consent, potential 
participants were often surprised to hear that the blood would be sent to Vietnam for the 
typhoid immunity testing. We would explain that there was a lot of typhoid in Vietnam, so 
colleagues there were the international experts on the disease and its tests, which reassured 
participants. Leptospirosis immunity testing in Australia was readily accepted.  
 
3.1.14 Field implementation 
The cross-sectional field survey was implemented as described. Some of the more remote 
mountainous villages selected by the random sampling required 4x4 vehicles (figure 3.6) and 
overnight stays for access.   
 
Figure 3.6. Travel by 4-wheeled drive vehicle.  
The most remote sites required travel on horseback or by raft (figure 3.7).  
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Figure 3.7. Travel by horse and raft to remote field sites  
 
3.1.15 Patient cohort 
The patient cohort was identified as described in the main paper. Serum collection was 
initiated following return from the survey work in the Western Division and completed in 
2014 after the Central Division cross-sectional sampling was completed. Most of these visits 
were done by me with a phlebotomist after dropping off one team at a Central Division 
cluster survey site. We organised the teams so that the local study coordinator, a physician, 
was able to do the phlebotomy for one team, freeing up a phlebotomist for the patient visits.  
Recovering patients were contacted by phone or in person, and informed consent obtained 
as per the main study procedures. Follow-up appointments were arranged and patients 
visited at a location convenient for the patient, including at or near workplaces.  
3.1.16 Serum management 
The field team were initially responsible for serum processing during fieldwork on Taveuni 
and Vanua Levu. Samples were stored refrigerated at Tamavua Hospital, Taveuni, and sent to 
Mataika House with routine clinical samples. Vanua Levu samples were stored refrigerated at 
Labasa Hospital, Vanua Levu, and taken to FCCDC at Mataika House by the team when we 
returned to Viti Levu. With more favourable budget forecast outturn by the time the survey 
reached the Western Division, we were able to arrange the assistance of laboratory 
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colleagues at Lautoka Hospital to complete centrifugation and aliquotting/labelling of 
samples for Western Division. These were held at Lautoka Hospital and driven back to Suva 
on the final day of Western fieldwork. In Central Division, sample processing was done 
entirely at Mataika House. 
Samples were also labelled to match the study participant identified and divided into four 
alphabetically coded aliquots:  
A) Sent to Ho Chi Minh, Vietnam, for typhoid analysis; 
B) Sent to Queensland, Australia, for leptospirosis analysis; 
C) Held for d-flagellin analysis in Maryland, USA; and  
D) Reference serum bank sample held at Mataika House. 
Customs permissions were obtained for sample transport. Air shipping was arranged through 
a local company, with dry ice sufficient for the journey plus delays, and samples packaged in 
accordance with International Air Transport Association requirements for biological samples. 
Samples were received frozen, intact and on schedule in Vietnam and Australia.  
 
3.1.17 Serum analysis 
A first run of ELISAs was completed in June 2014. Examination of the titre results with the 
field data suggested the possibility of an operational issue with the ELISA.  A second run was 
completed in December 2014, as per the methods described in the paper, and are the results 
presented here.  
 
3.1.18 Data management 
Data was checked during fieldwork and feedback given to the teams as necessary. This 
included the modification to use age-stratified sampling on Viti Levu. Completed paper 
questionnaires were stored in opaque folders during fieldwork, and transported to Mataika 
House for data entry. Data entry team members were recruited through collaborating 
partners at FCCDC and WHO and are named in the acknowledgements section of the paper. 
Training was given and entry was done in EpiData with secure handling of patient identifiable 
data. Original paper records were stored securely at Mataika House following completion of 
data entry. Encrypted patient identifiable records are held on a secure server at LSHTM. Data 
analysis is of an anonymised dataset. Data cleaning was undertaken in 2014 and shared with 
Colleen Lau for the leptospirosis analysis.  
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3.1.19 Data analysis 
I analysed the serological data in the R statistical environment in 2015-16.15 For examination 
of possible seropositivity we discussed possible analytical approaches with Niel Hens at the 
University of Hasselt, Belgium pre- and post-fieldwork.16 On Niel’s advice, I examined the 
patient cohort serology data using a mixed model of antibody log titre wane with fixed rate 
towards candidate thresholds, examining best fit to determine the most likely threshold.17  
Additional to the primary age-based, ethnicity-stratified analysis, an epidemiological risk 
factor logistic regression model was developed.18–20 This was a secondary research aim, 
intended to provide supportive evidence of possible risks of previous Salmonella Typhi 
exposure. Examination of the dataset showed minimal clustering once data were stratified by 
age group and a risk factor analysis was undertaken without variance adjustment. After 
examination of a number of methods for cluster analysis in R,6,21–24 I repeated this analysis 
with allowance for clustering, using the RMS package.24 This required writing of a specific R 
function to convert RMS model output into the epidemiologically-framed results reported in 
the paper.  
 
3.1.20 Dissemination 
Preliminary serological findings were reported to MOHMS in January 2015, and results of the 
formal non-clustered analysis in September 2015. Final results were presented to the Pacific 
Islands session of the Tropical Medicine and Malaria Conference in Brisbane, Australia, in 
September 2016 and published in July 2017.  
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Abstract 
Fiji, an upper-middle income state in the Pacific Ocean, has experienced an increase in 
confirmed case notifications of typhoid fever, a bacterial disease caused by Salmonella 
enterica serovar Typhi (S. Typhi). To characterize the epidemiology of S. Typhi exposure in Fiji, 
we conducted a cross-sectional sero-epidemiological survey measuring IgG against the Vi 
antigen of S. Typhi to estimate the effect of age, ethnicity, and other variables on 
seroprevalence. Epidemiologically relevant cut-off titres were established using a mixed 
model analysis of data from recovering culture-confirmed typhoid fever cases. A total of 
1,787 participants were enrolled and their plasma assayed for anti-Vi IgG; 1,531 of these 
were resident in mainland areas that had not been previously vaccinated against S. Typhi 
(seropositivity 32.3% (95%CI 28.2 to 36.3%)), 256 were resident on Taveuni island, which had 
been previously vaccinated (seropositivity 71.5% (95%CI 62.1 to 80.9%)). The seroprevalence 
on the Fijian mainland is one to two orders of magnitude higher than expected from 
confirmed case surveillance incidence, suggesting substantial subclinical or otherwise 
unreported typhoid. We found no significant differences in seropositivity prevalences by 
ethnicity, which is in contrast to disease surveillance data in which the indigenous iTaukei 
Fijian population are disproportionately affected. Using multivariable logistic regression, 
seropositivity was associated with increased age (odds ratio 1.3 (95% CI 1.2 to 1.4) per 10 
years), the presence of a pit latrine (OR 1.6, 95%CI 1.1 to 2.3) as opposed to a septic tank or 
piped sewer, and residence in settlements rather than residential housing or villages (OR 1.6, 
95% CI 1.0 to 2.7). Increasing seropositivity with age is suggestive of low-level endemic 
transmission in Fiji. Improved sanitation where pit latrines are used and addressing potential 
transmission routes in settlements may reduce exposure to S. Typhi. Widespread unreported 
infection suggests there may be a role for typhoid vaccination in Fiji, in addition to public 
health management of cases and outbreaks.  
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Author summary 
Fiji has experienced a decade-long increase in typhoid fever cases, a potentially life-
threatening systemic bacterial disease caused by Salmonella Typhi.  We undertook a 
representative blood-serum community survey to measure antibodies (IgG) against the Vi 
antigen of Salmonella Typhi using a rigorous survey design. We found one in three residents 
of mainland, unvaccinated Fiji had detectable antibody against Vi in comparison to antibody 
levels in recovered typhoid fever cases. This was higher than would be expected from 
confirmed case notifications received by the national surveillance system. Additionally, 
similar antibody responses were detected in Fijians of all ethnicities, which contrast to 
surveillance cases in which indigenous iTaukei Fijians were disproportionately affected. 
Serology on a Fijian island in which a significant proportion of the population has been 
vaccinated found that three-quarters of residents were seropositive three years after 
vaccination with a Vi-antigen typhoid vaccine. Importantly, in mainland participants, 
seroprevalence increased with age, suggesting long-standing, low-level, endemic 
transmission. Pit latrines were associated with seropositivity when compared with septic 
tanks, and settlements compared with residential housing. Very high antibody titres in a small 
percentage of participants may suggest carriage of Salmonella Typhi. The seroprevalence 
findings suggest eliminating typhoid from Fiji by focussing on cases and outbreaks alone will 
be challenging. Our results support typhoid vaccination and further development of water, 
sanitation and hygiene infrastructure in Fiji. 
Keywords: typhoid fever, Salmonella Typhi, Vi antibody, risk factors, vaccine, Fiji, serological 
survey, immunoepidemiology, serum bank 
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3.2 Introduction 
Typhoid fever is a systemic disease resulting from infection by the bacterium Salmonella 
enterica subspecies enterica serovar Typhi (S. Typhi). S. Typhi is restricted to humans and 
transmitted in the faeces of infected individuals, which can contaminate water and food or 
spread by contact and fomites. [1,2] Infection with S. Typhi can present as a range of 
syndromes, from asymptomatic (including carriage) to a disease with life-threatening 
complications, including intestinal perforation, encephalopathy, and haemodynamic shock 
[3,4]. The majority of typhoid fever cases present as non-specific acute febrile illnesses that 
may be difficult to differentiate from other common tropical infectious diseases such as 
dengue and leptospirosis. There were an estimated 11.9 million (9.9 to 14.7) cases of typhoid 
fever in low and middle income countries in 2010, resulting in 129,000 (75,000 to 208,000) 
deaths [5]. 
The Republic of Fiji is an upper middle income country, which had  an estimated population 
of 892,000 in 2015 [6]. Fiji is comprised of approximately 300 islands (100 inhabited) in the 
Pacific Ocean of which the largest and most populous are Viti Levu and Vanua Levu [7].  Viti 
Levu is administratively separated into the Central Division, containing the capital Suva and 
its suburbs, and the Western Division. The Northern Division comprises of Vanua Levu and 
Taveuni island, whilst the Eastern Division comprises of smaller islands including the Lomaiviti 
and Lau groups (figure 3.7).  
 
Figure 3.7. Administrative Divisions and Cluster sites on mainland Fiji (Viti 
Levu and Vanua Levu) and Taveuni islands  
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Phylogenetic evidence from genome sequencing suggests that S. Typhi has existed as a 
distinct clade in the Fiji Islands for some time, though notified blood-culture confirmed cases 
numbered fewer than 30 per annum for the decade up to 2004 [8,9]. From 2005, Fiji has 
experienced a substantial increase in blood-culture confirmed cases of typhoid fever notified 
through Divisional hospitals to the national surveillance centre [9,10], rising from 4.4 cases 
per 100,000 population in 2004 to 45 cases per 100,000 population per year during 2008-
2011 [11]. Highest incidence was in the Northern Division; 121 cases per 100,000 in 2009 vs 
28 per 100,000 in the Western Division and 19 per 100,000 in the Central Division [11]. A 
proportionate increase in clinically diagnosed typhoid fever was reported over the same 
period  [12]. 
Notably, >90% of blood-culture confirmed cases are amongst indigenous Fijians (iTaukei), 
who make up approximately 57% of the population, with relatively few cases reported in 
Fijians of Indian descent (Indo-Fijians, 38% of the population) or Fijians of Asian or European 
descent[12]. The causes of this disparity are unknown [12]; health seeking behaviours would 
be expected to lead to higher relative ascertainment in Indo-Fijians than iTaukei [13].  
The peak incidence of typhoid fever in Fiji occurs around the wet season (November to April) 
[14], with a  lag of approximately two months (January to June) [15]. Outbreaks of 
waterborne and water-washed diseases also arise following cyclones in Fiji, although the 
causal association between cyclones and typhoid is unclear [12,16,17]. Inadequate access to 
effective sanitation or treated water supplies alongside low uptake of hand washing with 
soap may predispose individuals to S. Typhi infection [12,18].  It was estimated that sewage 
disposal in Fiji in 2005 occurred via reticulated systems for 23% of the population, 40% by 
septic tank, and 37% by pit latrine or other direct disposal [19]. Access to internationally 
defined “improved water sources” is near universal,[20] however, this definition includes 
untreated  piped surface water in rural areas, which may be a conduit for several enteric 
pathogens[11,20,21]. While historically the majority of the population lived a rural 
subsistence lifestyle, based on fishing and small-scale agriculture, more than half the 
population now reside in urban areas, notably the capital Suva and its suburbs; these areas 
include informal settlements close to riverbanks and other flood-prone areas with limited 
access to water and sanitation infrastructure [22].  
The Vi-polysaccharide (Vi-PS) vaccine is considered to offer partial direct protection against 
typhoid fever for two to three years [23]. Typhoid vaccine is not routinely used in Fiji; 
however, in 2010, following cyclone Tomas, a Vi-PS vaccination campaign was conducted in 
the highest incidence areas of Fiji. This campaign was conducted predominantly in the 
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Northern Division, with high coverage on Taveuni island in the Cakaudrove subdivision on 
Vanua Levu. Targeted geographical vaccination was conducted within subdivisions in other 
parts of Fiji, including Ra, Nadrogo and Ba in the Western Division, Suva in the Central 
Division, and Lomaiviti in the Eastern Division [11]. The campaign immunised 64,000 people, 
representing 8% of the total national population. A reduction in disease incidence rates was 
observed in the targeted areas whilst rates increased or were unchanged in other areas[11]. 
Given the ongoing transmission of typhoid in Fiji and the short duration of Vi-PS protection, 
an expert meeting was convened in 2012 by the Fijian Ministry of Health, with support from 
Australian Aid, to “develop, prioritise and implement a comprehensive control and 
prevention strategy” [12]. Analysis of knowledge gaps identified that a serological survey 
across multiple demographic groups could inform vaccination policy [12].  
Seroepidemiological surveys can be used to determine population immunity, pathogen 
exposure and disease susceptibility, as well as determining disease and exposure related risk 
factors [24]. Conducted alongside clinical and/or laboratory surveillance, seroepidemiology 
can help quantify surveillance under- or over-ascertainment, including for enteric diseases 
[25–28]. Setting-specific immunity and carriage are important in determining typhoid 
transmission dynamics [29–31]; however, the seroepidemiological methods to attain this are 
underexploited [25]. This may be in part due to concerns about the sensitivity and specificity 
of serology for typhoid, which historically has not demonstrated sufficient discriminatory 
power for individual-level clinical diagnosis [32], (though recent methods may offer promise 
[33]) as well as concerns about the specificity of assays for carriage detection [34–36] and the 
existence of multiple immunological pathways to immunity against typhoid fever [37]. 
Seroepidemiological surveys utilising assays based on purified, pharmaceutical-grade Vi 
polysaccharide, the “virulence” factor expressed by S. Typhi [35], for detection of anti-Vi IgG 
antibody may offer a more reliable approach by avoiding cross-reactivity that arises when Vi 
antigen preparations contain other bacterial antigens [38,39]. Furthermore, high anti-Vi titres 
may indicate chronic carriage in response to prolonged immune stimulus [38,40–42].  
To characterize and better define the immunoepidemiology of typhoid infection in Fiji, with 
the aim of informing effective and efficient control measures, we surveyed three groups of 
people in Fiji: group 1) a representative, multi-stage, clustered, cross-sectional 
seroepidemiological survey of the Fijian mainland for S. Typhi, including demographic data 
and data on potential risk factors for typhoid [18,43–56]; group 2) residents of Taveuni island, 
where 92% of the population was vaccinated in 2010, surveyed by the same methods [11]; 
and group 3) a cohort of culture-confirmed typhoid fever cases, to enable estimation of a 
threshold for seropositivity.    
121 
 
3.3 Methods 
3.3.1 Ethics 
The study was approved by the Fiji National Research Ethics Review Committee (2013-03) 
and the London School of Hygiene & Tropical Medicine observational study research ethics 
committee (6344). 
3.3.2 Study design 
Three groups of participants were recruited for the study: Group 1, Mainland: Sixty-four 
communities were randomly selected by multi-stage sampling on the two most populous 
Fijian islands, Viti Levu and Vanua Levu. These were visited for serological sampling and 
questionnaire interviews from September to December 2013. Vaccinated areas on these two 
islands were excluded to avoid confounding of interpretation of serological responses to 
natural exposure. Eastern Division, with a population of under 40,000 spread across multiple 
small islands [13],  was not visited for logistical reasons. Group 2, Taveuni: A vaccination 
campaign had been conducted on Taveuni Island in 2010; 11 communities from this location 
were randomly selected by multi-stage sampling as vaccinated comparators and surveyed in 
September 2013. Group 3, Convalescent cases: Sequential recently blood-culture confirmed 
typhoid fever cases in the Central Division were identified in October 2013 from national 
surveillance and hospital records and approached to seek informed consent for blood 
sampling. Further blood-culture confirmed cases diagnosed previously were identified during 
visits by the field team to the convalescent cases’ villages or residences and invited to 
participate after validation with national surveillance records. Between November 2013 to 
April 2014 up to three blood samples were collected from cases at a minimum of one-month 
intervals. 
Headmen, health workers and other community leaders were visited in advance to seek 
agreement to participate in the study and make arrangements to visit with the full study 
team. No communities declined participation in the study.  A team of experienced, 
multilingual Fijian field workers was trained and questionnaires piloted prior to the survey.  
Interviews were conducted in iTaukei, English or Hindi at the preference of the interviewee. 
Trained phlebotomists collected venous blood samples. 
For group 1 (mainland) and group 2 (Taveuni), a multi-stage cluster-sample survey was 
conducted [57]. For group 1, cluster numbers per geographical Division (Northern, Central, 
Western) were proportional to the resident typhoid non-immunised population. Within 
subdivisions, nursing zones are contiguous health administrative areas, each serving a 
population of approximately 1,000 to 10,000 people. For the groups 1 and 2, nursing zones 
were selected with probability proportional to population size [57] by random number 
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generation in Microsoft Excel 2007, using Ministry of Health administrative records. 
Communities were randomly selected from within the nursing zones from unweighted lists, in 
the absence of detailed population data.  
Households were randomly selected within each community and a single occupant aged one 
year or older per household was randomly invited to join the study (to reduce correlation 
compared with recruiting multiple residents), with selection using random number tables. 
Registries held by nurses or community health workers were used for household and 
participant sampling where available; when not available, geographical sampling was 
performed.  In rural village-like clusters, Expanded Programme on Immunization-derived 
sampling of houses was conducted in randomly selected directions (by pen-spin) from the 
community’s central point [58]. For clusters on streets, random sides of roads, starting points, 
and directions of progress were selected following a rapid appraisal of house numbers to 
enable selection of all households with equal probabilities.  
Household occupancy was on de facto residency in the household the previous night as per 
Fiji census methods. Information regarding the study was provided to the households, the 
participants and/or the parent/guardian of all child participants (under the age of 18 years 
old). All adult participants provided written informed consent. Parents/guardians provided 
written informed consent on behalf of all child participants (under the age of 18 years old). 
Written assent was also provided by children aged 12 years and above. Exclusion criteria 
were clotting disorders, medical anticoagulation or severe medical disorders that would 
preclude safe participation in the study. 
For group 1 residents in Viti Levu, age- stratified sampling (strata size proportional to national 
population) was used to ensure representation across all age groups after field data review 
identified potential age imbalances arising in some clusters on Vanua Levu and Taveuni. Once 
the required number of participants within an age-band was attained, further members of 
that age-band were ineligible for selection in subsequent households. If the selected 
participant was temporarily absent from a house e.g. for work or school, data collectors 
would revisit later in the day after their expected time of return. If a whole household was 
absent, an alternative house was randomly selected from the health registry, or the next 
nearest non-sampled dwelling in the same geographical sampling frame.  
3.3.3 Sample size 
A study sample size of 1,600 was proposed for the mainland group, as this would allow for 7% 
confidence intervals for seroprevalence for age band groups of 200, if seroprevalence was 
40%, at alpha = 0.05. If non-independence within age bands within clusters gave rise to a 
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design effect of two, then the confidence intervals would be 10%, which was deemed 
sufficient precision. Expected seroprevalence levels were informed by prior work on Taveuni 
(Eric Nilles, data on file). 
3.3.4 Laboratory methods 
Enzyme-linked immunosorbent assays (ELISAs) to detect S. Typhi Vi-polysaccharide antigen-
specific IgG in human serum samples were performed as described previously [59]  (provided 
by Sclavo Behring Vaccines Institute for Global Health, Siena, Italy). Briefly, ELISA plates were 
coated overnight with 1μg/ml of Vi polysaccharide antigen. Coated plates were washed and 
blocked with 5% fat-free milk solution. Following blocking, plates were washed and incubated 
with serum diluted at 1:200 at room temperature (RT) for 2 hours. Plates were washed and 
incubated with secondary antibody, alkaline phosphatase-conjugated anti-human IgG at RT 
for one hour. Finally, p-Nitrophenyl phosphate (SigmaFAST N1891, Sigma-Aldrich, United 
Kingdom) substrate was added for 30 minutes at RT and absorbance was read at dual 
wavelengths (405 nm and 490 nm) using an automated microplate reader (Biorad). Optical 
densities (OD) from blank control wells were subtracted from all sample absorbance values 
prior to estimation of serum titers from a standard curve. We selected 96 random Fijian 
plasma samples and subjected them to the anti-Vi ELISA . Twenty samples of these samples 
(with an OD >2.5) were pooled (standard plasma) and used to generate a standard curve. One 
ELISA Unit (EU) was defined as the reciprocal of the standard dilution (made by 10 2-fold 
dilutions of the standard plasma) that gave an absorbance value equal to 1 in this assay. All 
samples were tested at the Oxford University Clinical Research Unit in Ho Chi Minh City, 
Vietnam.  
 
3.3.5 Data analysis 
A surveillance seropositivity threshold was determined using a mixed-effects model of serial 
titres in the convalescent cases group. A log-normal mixture model approach to the data as 
per del Fava et al [60] had been examined previously but was considered non-informative. 
Mixed-effect models were fitted by maximum likelihood estimation (ML), using a random-
intercept fixed-slope above a putative threshold value and random intercept time-invariant 
model below, signifying antibody returning to a baseline level, with each convalescent case’s 
data assigned to either the fixed slope component or the time invariant component. Data 
from two patients with titres at the upper limit of detection (25,000 EU) were excluded 
leaving 70 titres from 28 patients. Model fit was examined at a range of threshold values with 
Akaike’s information criterion (AIC) used for threshold comparison, summing the AIC from 
the fixed-slope and time-invariant models.   
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Data were entered in EpiData 3.1 [61] and analysed in R 3.3 [62]. Seroprevalences were 
calculated using intra-cluster correlation coefficients (ICCs) and design effects determined on 
log titres with clustering at the primary sample unit. Putative risk factors for seropositivity 
were estimated with Huber-White robust standard errors, clustered on the same, using the 
“rms” package[63]. A multivariable model was developed from univariable risk factors with p-
values of less than 0.25, after-regrouping sparse cells for numerical stability, using a 
backward stepwise approach fitted by AIC, with deletion of observations with missing data. 
Potential collinearity was assessed by linear-adjusted generalized variance inflation factors in 
the “CAR” package [64,65], and variables were removed if GVIF^(1/(2*Df)) was over 2 and 
not considered epidemiologically important to retain. Data were considered insufficient to 
examine possible risk factors associated with titres that may indicate typhoid carriage. Self-
reported vaccination was assessed as non-informative and participants analysed on vaccine 
status of their residential geography (see supplementary information, section 3.7.1). For 
comparison to age-based seroprevalence, typhoid fever cumulative incidence expected 
across the life-course was estimated with binomial confidence intervals from confirmed cases 
notified in 2008-2014 to the national surveillance system at the Fiji Centre for Communicable 
Disease Control, Mataika House, Suva.   
125 
 
3.4 Results 
Group 1: Sixty-four mainland clusters in unvaccinated areas of Viti Levu and Vanua Levu were 
visited for this sero-survey (Figure 3.7). Of 1,565 people approached, five declined and 1,560 
were enrolled. There were no exclusions on medical grounds. A serum IgG titre against Vi 
polysaccharide (anti-Vi IgG) could not be attained for 29 participants (median age 23, IQR 6 to 
34; 19/29 female; 25/29 iTaukei) but was determined in 1,531 individuals (98%). The age of 
the sampled population ranged from one to 85 years (median 29; IQR 16 to 48, Table 3.1). Of 
these, 820/1,530 (54%) were female and 76% (1,164/1,530) were iTaukei (non-responses 
excluded).  
For Group 2, on Taveuni Island, the location for a vaccination campaign, 277 people were 
approached and 256 participants (127 (49.6%) female) in 11 clusters enrolled, with nil 
excluded, and all providing samples that were successfully assayed for anti-Vi IgG (Table 3.2 
and Figure 3.7).   
Group 3: Thirty-seven patients with blood-culture confirmed typhoid fever provided one or 
more samples that were assayed for anti-Vi IgG (19 (51.4%) female, median age 30, IQR 14 to 
42) (Table 3.3); thirty provided two or more blood samples (15 (50%) female, median age 30, 
IQR 15.5 to 44.5); and 19 provided three samples (10 female, median age 32, IQR 17 to 46.5). 
The median duration from reported fever onset to first sample collection was 187 days (IQR 
132 to 272 days). 
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Table 3.1. Group 1. Demographics of mainland Viti Levu and Vanua Levu (unvaccinated areas) 
survey participants  
Variable Value 
Number of participants assayed 1531 
Age (median, IQR) 29 (16 to 48) 
1 to 14 343 (22·4%) 
15-34 554 (36·2%) 
35-54 384 (25·1%) 
55+ 250 (22·9%) 
  
Female 820 (53·6%) 
  
Clusters 64 
Central Division 28 
Northern Division 11 
Western Division 25 
Participants per cluster (SD) 23·9 (2·5) 
  
iTaukei 1164 (76·1%) 
Indo-Fijian 338 (22·1%) 
Other 28 (1·8%) 
  
House income <100 FJD/wk  548 (36.3%) 
100-199 490 (32.5%) 
200-299 296 (19.6%) 
300-399 61 (4.0%) 
400+ 81 (5.4%) 
  
Self-report previous vaccination against typhoid 103 (6.7%) 
Self-report previous typhoid fever 20 (1.3%) 
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Table 3.2.  Group 2. Demographics of Taveuni island (Vi-polysaccharide vaccinated area) survey 
participants 
Variable Value 
Number of participants assayed 256 
Age (median, IQR) 36 (24 to 52) 
1 to 14 32 (12.5%) 
15-34 90 (35.3%) 
35-54 85 (33.3%) 
55+ 48 (18.8%) 
  
Female 127 (50%) 
  
Clusters 11 
  
Participants per cluster (SD) 23.3 (3.3) 
  
iTaukei 220 (86.3%) 
Indo-Fijian   27 (10.6%) 
Other     8 (3.1%) 
  
House income <100 FJD/wk 91 (36.5%) 
100-199 99 (39.8%) 
200-299 22 (8.8%) 
300-399 12 (4.8%) 
400+ 14 (5.6%) 
  
Self-report previous vaccination against typhoid 54 (21.1%) 
Self-report previous typhoid fever 5 (2.0%) 
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Table 3. Group 3. Demographics of convalescent confirmed typhoid fever cases 
Variable Value 
Number of participants assayed 37 
Age (median, IQR) 30, 14 to 42 
5 to 14 10 (27.0%) 
15-34 12 (32.4%) 
35-54 12 (32.4%) 
55-74   3 (8.1%) 
  
Female 19 (51.4%) 
  
iTaukei 36 (97.3%) 
Indo-Fijian 0 
Other (Pacific Islander) 1 (2.7%) 
 
Threshold estimation using a mixed model of sero-reversion amongst the Group 3 recovering 
typhoid fever cases exhibited best fit at 64EU (Supplementary Figure S3.1 and Supplementary 
Table S3.1). The ICC and design effect per Group 1 mainland cluster were 0.09 and 3.03, 
respectively. Across the five-year age bands (Supplementary Table S3.2), the Group 1 mean 
ICC and design effect were 0.13 and 1.09, respectively. 
Using the defined seropositivity cut-off (64 EU threshold), 32.3% of Group 1 mainland 
participants (95%CI 28.2 to 36.3%) were seropositive for anti-Vi IgG (Supplementary Table 
S3.3 Table), compared to 71.5% (95% CI 62.1% to 80.9%) of Group 2 (Taveuni island). As a 
sensitivity analysis, when a higher anti-Vi IgG threshold of 100 EU was used, 17·7% of the 
Group 1 mainland participants (95%CI 14·4 to 21.0%) were seropositive, compared to 58.6% 
(95% CI 48.4% to 68.8%) of Group 2 Taveuni islanders (Supplementary Table S3.3). To 
determine a rough estimate of carriage prevalence within Group 1 (mainland), we 
additionally examined those with the highest anti-Vi IgG titres; 2.8% (1·4 to 4·2%) of the 
sampled population had an antibody titre of 500 EU or above and 1.4% (0.4% to 2·4%) of the 
sampled population had an antibody titre of 1,000 EU or above (Supplementary Table S3.3).  
 
The anti-Vi IgG titre distributions are shown in Figure 3.8 for group 1, mainland unvaccinated 
areas (A); group 2, Taveuni island (B); and group 3, convalescent cases (C). The distribution of 
antibody titres in group 2 (Taveuni island) was shifted rightward relative to the Group 1 
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(mainland) titres, as would be predicted with the mass administration of Vi-PS vaccine. Thirty-
nine (15%, 11.2 to 20.4%) of the 256 Group 2 (Taveuni) participants had Vi IgG titres at the 
upper limits of detection. In the recovering typhoid fever cases the data were bimodal, with 
the higher peak above the modal titre for the mainland group.   
 
 
Figure 3.8. Distributions of log10 anti-Vi IgG antibody titres in three Fijian 
groups.  
A) Group 1: residents of Fiji mainland Viti Levu and Vanua Levu islands; B) Group 2: residents 
of Taveuni island, where a vaccination campaign with Vi-polysaccharide injection was 
conducted three years previously; and C) Group 3: recovering cases of culture-confirmed 
typhoid fever. Red vertical line denotes 64 ELISA unit seropositivity threshold determined from 
case antibody kinetic analysis; blue line denotes 100 ELISA unit threshold used in sensitivity 
analysis. Case titres are mean log titre if multiple samples collected, range 68 to 645 days 
from fever onset. 
 
In Group 1 (mainland), the age trends for unvaccinated iTaukei and non-iTaukei ethnic groups 
(Figure 3.9) both showed increasing seroprevalence with age based on the patient-fitted 
threshold. These increased from approximately 20% in the youngest age bands to 50% in the 
oldest, at threshold of 64 EU.  Age and ethnicity trends were comparable when a sensitivity 
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analysis at a higher threshold (100 EU) was performed with seroprevalence rising from <10% 
in younger groups to approximately 30% in the oldest age brackets. At both thresholds there 
was some suggestion that iTaukei seroprevalence may be higher than non-iTaukei 
seroprevalence, though differences between ethnic groups were not statistically significant at 
the 0.05 level. Notably, for both ethnic groups, seroprevalence by age band was substantially 
higher than the equivalent cumulative incidence that would arise if considering only 
confirmed cases, more than ten-fold in iTaukei Fijians and several hundred-fold in non-
iTaukei Fijians. 
 
Figure 3.9. Seroprevalence of anti -Vi IgG by age and ethnicity  
Seroprevalence in iTaukei and non-iTaukei groups at A) 64 ELISA units (case-fitted threshold) 
and B) 100 ELISA units (sensitivity analysis). Each panel also indicates confirmed case 
cumulative incidence by ethnicity. Shared areas denote 95% confidence intervals. 
 
A multivariable analysis of group 1 (mainland) indicated that several factors were significantly 
associated with seropositivity at a 64 EU anti-Vi IgG threshold after adjusting for potential 
confounders (Table 3.4).  Residents of Western Division had an odds ratio (OR) of 0.6 (95%CI 
0.4 to 0.8) for seropositivity in comparison to the Central Division. Age was associated with 
seropositivity, with an adjusted OR of 1.3 (95% CI 1.2 to 1.4) for every ten-year increase. 
Additionally, we found that individuals with pit sewage systems had an adjusted OR of 1.6 
(95% 1.1 to 2.3, p=0.01) for seropositivity in comparison to participants with septic tanks. 
Residence in a settlement rather than residential housing had an adjusted OR 1.6 (95% CI 1.0 
to 2.7) for seropositivity.  
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Table 3.4. Risk factors by adjusted odds ratios for anti-Vi IgG seropositivity 
 at 64 ELISA units for mainland Viti Levu and Vanua Levu by cluster-robust multivariable 
logistic regression. 
Variable Value OR 95% CI p-value  
Division or island Central Division Baseline    
  Western Division 0.58 0.41 to 0.83 0.0027 ** 
  Vanua Levu 0.74 0.46 to 1.17 0.19  
Age Per decade 1.31 1.23 to 1.40 <0.0001 *** 
Ethnicity Other vs iTaukei 0.79 0.54 to 1.14 0.21  
Community type Residential     
  Village 1.07 0.61 to 1.89  0.82  
  Settlement  1.63 1.00 to 2.65 0.048 * 
Rurality Urban baseline    
  Peri-urban 0.65 0.41 to 1.01 0.055  
  Rural 1.17 0.72 to 1.88 0.53  
Home sewage Septic tank Baseline    
  Piped sewer 1.07 0.77 to 1.48 0.69  
  Pit 1.62 1.12 to 2.32 0.01 * 
  Elsewhere 0.82 0.39 to 1.72 0.60  
Typhoid vaccination, self-
report 
Yes 1.34 0.91 to 1.96 0.14  
Typhoid fever diagnosed, 
self-report 
Yes 1.66 0.77 to 3.50 0.18  
* p<0.05, **p<0.01, ***p<0.001 
n=1436 complete records 
Lastly, after adjustment, no significant association with seropositivity was observed at p<0.05 
for ethnicity, community type, rural residence, self-reported typhoid vaccination, or self-
reported diagnosis of typhoid fever. “Home toilet type” was excluded from consideration for 
multivariable analysis: pour-flush (water seal) toilets were found to be associated with 
seropositivity on univariable analysis, however these are installed in response to disease 
outbreaks and so are confounded by indication (Fiji National Taskforce on Control of 
Outbreak-Prone Diseases, personal communication 2015). Other candidate risk factors 
identified on univariable screening (Supplementary table S3.4 Table) were not retained in the 
final model, including sex, drinking water sources, kava consumption, bathing or washing in 
rivers and typhoid fever cases within the household or social network.  
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3.5 Discussion 
This seroepidemiological survey of the Fijian mainland, established in response to a rise in 
confirmed typhoid fever case notifications, found seroprevalence of IgG against the Vi 
antigen of S. Typhi of 32.3% (95%CI 28.2 to 36.3%) based on an threshold of 64 IU determined 
from waning antibody in recovering patients. This seroprevalence, if indicative of past 
infection, is one to two orders of magnitude higher than would be predicted from case 
notifications. Seroprevalence increased with age, suggesting established endemic 
transmission; an alternative hypothesis may be that typhoid in Fiji is predominantly a 
childhood infection and that incidence has dropped over the decades, leaving older cohorts 
with serological signs and younger cohorts unexposed. Such an effect has been seen in 
hepatitis A in Indo-Fijians.[66,67] The serology would be consistent with typhoid primarily 
infecting older adults in a recent upturn, though this seems unlikely. Both iTaukei and non-
iTaukei ethnic groups exhibit similar typhoid seroprevalences across age groups, in contrast 
to typhoid fever, the disease, which is disproportionately reported from iTaukei Fijians. A 
small number of very high titres suggests that carriage occurs. Multivariable logistic 
regression found seropositivity was associated with pit latrines compared with other sewage 
systems, and living in a settlement compared with residential housing or a village. Central 
Division and Vanua Levu island had higher seroprevalences than Western Division. 
 Our investigation used a population-representative survey design rather than a convenience 
sample such as blood donors or hospital patients, or recent outbreak areas. This strengthens 
external validity of seroprevalence estimates, particularly for age-based inference, as children 
are rarely blood donors or inpatients.  A limitation of the study is the use of a single antigen 
due to resource availability, though mitigated by the use of antibody-waning data from 
recovering patients to determine a surveillance threshold. Serum-banking enables future 
investigation of other S. Typhi immune biomarkers.  
The proportion of the survey participants that was non-iTaukei (24%, specifically Indo-Fijian 
(22%)), was lower than expected from the last census [13]. This may be due to a greater 
proportion of Indo- Fijians residing in larger communities within nursing zones than 
documented in the sampling frame, due to migration from rural to urban area, or in areas 
that had been vaccinated; secular trends of a higher emigration rate and lower fertility rate 
for Indo-Fijians than iTaukei may also be have contributed [13]. Post-stratification weighting 
was not considered appropriate given uncertainties in demographic changes since the 2007 
census and sparse population records within nursing zones which could result in 
inappropriate adjustment. Representativeness was addressed through the design of the 
survey, and clustering through use of design-effects (which were modest) and cluster-robust 
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regression. The slight excess of females in the survey may be due to different residency 
patterns, such as male overnight residency in agricultural shelters, as encountered by the 
survey team. 
 
The serological results from the mainland survey, using highly purified Vi, were strengthened 
by benchmarking against serum from two other Fijian groups. Alongside threshold-estimation 
using a mixed model of antibody waning in convalescent cases, the higher anti-Vi 
seroprevalence from Vi-PS vaccinated residents of Taveuni island also informs the use of anti-
Vi IgG as a surveillance marker in the unvaccinated mainland population. Typhoid serology 
remains relatively understudied and further work could be done to strengthen comparability 
between settings and to inform thresholds used for seroprevalence surveys. Hospital-based 
serology studies of fever patients in acute illness and convalescence would be valuable in 
assessing the specificity of Vi antibody response to typhoid against patients with other 
laboratory confirmed diagnoses (notably Enterobacteriaceae family bacteraemias) and 
without specific clinical signs of concurrent typhoid fever or positive S. Typhi culture. 
Despite incomplete international standardisation of Vi assays [68], the distribution of IgG 
titres can be compared across studies. The Fiji results contrast to those from two Vi ELISA 
serosurveys done in Kathmandu, Nepal. The first compared Vi to serum bactericidal activity 
(SBA) found rising SBA with age, suggesting a similar acquisition of exposure with age, but 
found no age trend in anti-Vi IgG. [69] The second, using an assay similar to that applied in 
Fiji, reported high anti-Vi IgG in all age groups, suggesting hyperendemicity [70]. In a study in 
Cape Town, South Africa, where typhoid was considered endemic, 40% of unvaccinated 9 
year olds were found to have anti-Vi IgG titres believed to be protective [71]. In contrast, we 
found in Fiji mean seroprevalence for children of similar age (5 to 9 and 10 to 14 years) was 
not more than 20% (Figure 3.9) suggesting lower force of infection than Cape Town, if these 
antibody thresholds are comparable. This lower serological force of infection would also be 
consistent with lower confirmed case incidence [12,71]. 
The large difference in AIC between the best-fit convalescent titre threshold and higher or 
lower thresholds provide good support the choice of threshold statistically,[72] but needs 
considered in the biological context. Determining and making inference from the IgG waning 
rate is challenging due to statistical uncertainty in the fixed effect slope estimate which allow 
a wide range of biologically plausible scenarios. Incomplete seroconversion (as seen in other 
settings[73]) and waning anti-Vi IgG titres observed amongst convalescent cases in our study 
gives rise to the possibility that the seroprevalence estimates in this survey are under-
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estimates and thus conservative with respect to sero-incidence. Multiple infections, 
symptomatic or otherwise, may be required for the establishment of sustained immunity to 
typhoid fever;[74,75] such a mechanism may explain non-response in patients and be 
consistent with   experimental study of booster vaccination with killed Salmonella Typhi [76] 
as well as recent  models used to estimate vaccine impact in India [29] and elucidate 
transmission determinants in Malawi [31]. In Fiji, model-fitting using age-structured contact 
patterns could shed light on whether the age-dependent increase observed in seropositivity 
is more likely due to long-term endemic transmission or a more recent outbreak with higher 
propensity to affect older age groups. A similar upturn in typhoid fever notifications occurred 
in Papua New Guinea in the 1980-90s, also from a low-level, sporadic baseline [77]. A rise in 
population O antigen was observed [78], suggesting an overall increase in transmission; 
longitudinal serological investigations may likewise be informative to current transmission in 
Fiji. 
There are a number of epidemiologically-plausible, model-testable hypotheses for the 
differences between our seroepidemiological findings and the epidemiology of notified cases 
in Fiji, in which peak incidence is observed in adolescents and young adults of iTaukei 
ethnicity. Ingestion of a large dose of S. Typhi can overwhelm naturally-acquired immunity (as 
well as that from vaccination) [74,76,79,80], and so age- and ethnically-differential exposure 
to high and low dose inocula is one mechanism by which these data may be explained, if for 
example, iTaukei adolescents and young adults ingest larger inocula through exposure to 
particular foods.  Such patterns might also be compatible with genetic differences in typhoid 
susceptibility, potentially mediated by HLA-type [81], with reduced susceptibility in Fijians of 
Indian descent, whose South-Asian ancestors may have experienced many millennia longer 
exposure to S. Typhi than iTaukei Fijians have historically had [82–84].  
Findings from our multivariable analysis suggest that living in a settlement and the use of pit 
latrines may be risk factors for S. Typhi infection. Whilst there are likely to be public health 
benefits from improving conditions in settlements and upgrading sewage systems, specific 
interventions for typhoid prevention should be planned with consideration for findings 
emerging from case-control and environmental health research [48,85]. Widespread 
subclinical infection, both transient and chronic, such as may be inferred from these 
serological findings, suggests that whilst systematic public health management of cases and 
outbreaks and early diagnosis and treatment of patients remain of vital importance to reduce 
morbidity and mortality from typhoid fever in Fiji, a focus on these alone may be insufficient 
to eliminate transmission. Alongside continued socio-economic development and expanded 
access to infrastructure for sanitation, water supplies and handwashing with soap, 
135 
 
programmatic vaccination may be amongst interventions necessary to bring about effective 
typhoid control in Fiji. 
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3.7 Supporting Information 
Supplementary Figure S3.1. Serial anti-Vi IgG titres from convalescent 
confirmed typhoid cases  
 
Supplementary Table S3.1. AIC by maximum likelihood for anti-Vi IgG antibody waning fixed 
effect model thresholds in culture-confirmed typhoid cases 
Titre threshold (ELISA units) AIC Δ AIC from best fit 
16 -24.48 29.95 
32 -46.29 8.13 
64 -54.43 0.00 
100 -45.07 9.36 
150 -44.59 9.84 
200 -34.22 20.20 
250 -21.07 33.36 
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Supplementary Table S3.2. Design effects and ICC by 5-year age band, mainland Viti Levu and 
Vanua Levu 
Age band Design effect ICC 
01-04  1.07 0.30 
05-09  1.15 0.14 
10-14  1.11 0.10 
15-19  1.09 0.08 
20-24  1.06 0.05 
25-29  1.06 0.06 
30-34  1.40 0.39 
35-39  1.08 0.11 
40-44  1.07 0.24 
45-49  1.24 0.46 
50-54  1.06 0.13 
55-59  0.97 -0.10 
60-64  1.00 -0.02 
65-69  1.03 -0.30 
70+    0.94 0.45 
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S3 Table. Seroprevalence for anti-Vi IgG at different ELISA unit thresholds  
Amongst Group 1 mainland residents (by self-reported vaccine status),  
Group 2 Taveuni island residents and Group 3 convalescent cases. 
Group Number (proportion, 95% confidence interval)  
(by design effect for mainland and Taveuni) 
1) All mainland survey participants 1531 
Titre ≥ 64 494 (32.3%, 28.2 to 36.3%) 
Titre ≥ 100 271 (17.7%, 14.4 to 21.0%) 
Titre ≥ 500   43   (2.8%,   1.4 to   4.2%) 
Titre ≥ 1000   21   (1.4%,   0.4 to 2.4%) 
  
1a) Mainland unvaccinated (self-
report) 
1304 (excludes don’t know) 
Titre ≥ 64 410 (31.4%, 27.0 to 35.8%) 
Titre ≥ 100 223 (17.1%, 13.5 to 20.7%) 
Titre ≥ 500   37   (2.8%, 1.4 to 4.4%) 
Titre ≥ 1000   18   (1.4%, 0.3 to 2.5%) 
  
1b) Mainland vaccinated (self-
report) 
103 
Titre ≥ 64 42 (40.8%, 31.0 to 50.5%) 
Titre ≥ 100 25 (24.3%, 15.7 to 32.8%) 
Titre ≥ 500   5 (4.9%, 0.6 to 9.1%) 
Titre ≥ 1000   3 (2.9%, 0 to 6.3%) 
  
2) Taveuni island 256 
Titre ≥ 64 183 (71.5%, 62.1 to 80.9%) 
Titre ≥ 100 150 (58.6%, 48.4 to 68.8%) 
Titre ≥ 500   72 (28.1%, 18.8 to 37.5%) 
Titre ≥ 1000   57 (22.3%, 13.6 to 30.9%) 
  
3) Convalescent typhoid cases  37 
Mean titre ≥ 64 21 (56.8%, 39.6% to 72.5%) 
Mean titre ≥ 100 17 (45.9%, 29.8% to 62.9%) 
Mean titre ≥ 500   4 (10.8%, 3.5% to 26.3%) 
Mean titre ≥ 1000   3   (8.1%, 2.1% to 23.0%) 
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Supplementary Table S3.4. Univariable risk factors for seropositivity  
with anti-Vi IgG on mainland Viti Levu & Vanua Levu at 64 ELISA unit threshold 
Variable Value Count OR 95% CI P-value  
Division or island Central Division 667 Baseline    
 Western Division 607 0.68 0.48 to 0.97 0.035 * 
 Vanua Levu 257 1.24 0.85 to 1.81 0.26  
Ethnicity iTaukei 1164 Baseline    
 Other 366 0.91 0.64 to 1.29 0.58  
Age Per decade 1530 1.28 1.21 to 1.36 <0.0001 *** 
Sex Male 710 Baseline    
 Female 820 0.95 0.75 to 1.20  0.67  
Household size Unit increase 1499 0.93 0.88 to 0.98 0.0078 ** 
Community type Residential 430 Baseline    
 Village                 656 1.24   0.86 to  1.79 0.26  
 Settlement  444 1.41 0.99  to 2.02 0.06 ^ 
Rurality Urban 500 Baseline    
 Periurban 262 0.62   0.44  to 0.88 0.0067 ** 
 Rural 763 1.30   0.90  to 1.88 0.16 ^ 
Income  
(FJD household-1 
week-1) 
0-99 548 baseline    
100-199 490 0.98 0.31 to 1.64 0.91  
200-299 296 0.96 0.72 to 1.35 0.77  
 300-399 61 0.78 0.48 to 1.27 0.32  
 400+ 81 0.91 0.49 to 1.67 0.75  
Drink tap water at 
home 
4+d/wk 1427 baseline    
Never 87 1.68 1.15 to 2.47 0.0075 ** 
 Monthly 3 1.09 0.10 to 12.17 0.95  
 1-3d/wk 8 1.3 0.32 to 5.33 0.71  
Drink river water Never 1451 Baseline    
 < monthly 12 0.72 0.24 to 2.13 0.55  
 Monthly 11 1.23 0.45 to 3.31 0.69  
 1-3d/wk 9 2.68 0.73 to 9.93 0.14 ^ 
 4+d/wk 36 1.92 1.04 to 3.55 0.037 * 
Drink kava Any vs never 608:913 1.43 1.12 to 1.84 0.0048 ** 
 At least monthly vs 
less than monthly 
1018:50
3 
1.28 1.02 to 1.61 0.037 * 
Kava shared with 
how many people 
at last 
consumption? 
Not applicable 895 Baseline    
Zero to nine 387 1.28 (1.02 to 1.62) 0.0367 * 
Ten or more 235 1.79 (1.24 to 2.58) 0.0018 ** 
Bath or swim in 
rivers 
Never 1065 Baseline    
< monthly 187 0.89   0.59 to 1.34 0.57   
Monthly 99 0.82   0.52 to 1.29 0.39    
 1-3d/wk 83 0.90   0.51 to 1.56 0.70   
 4+/wk 92 1.40 0.81 to 2.41 0.23 ^ 
Home toilet Flush 1174 Baseline    
 Water seal (pour 
flush) 
244 1.52 1.03 to 2.25 0.035 * 
 Pit or bucket 106 1.38 0.98 to 1.93 0.62  
Sewage Piped sewer 285 Baseline    
 Septic tank 991 1.21   0.90  1.62 0.20 ^ 
 Pit 138 2.07   1.31  3.26 0.0019 * 
 Elsewhere 42 1.17   0.62  2.22 0.63  
Toilet location Indoor 913 Baseline    
 Detached  610 1.22 0.94 to 1.58 0.13 ^ 
Shared toilet Private 1379 Baseline    
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Variable Value Count OR 95% CI P-value  
 Shared 106 0.86 0.59 to 1.26 0.44  
Soap available 
after household 
toilet use 
No 133 baseline    
Yes, reported 1199 0.84 0.52 to 1.35 0.47  
 Yes, seen 189 0.78 0.45 to 1.35 0.38  
 Yes, seen/reported 1388 0.83 0.52 to 1.33 0.44  
Self-reported 
soap use 
No 414 Baseline    
Yes 1091 1.00 0.77 to 1.29 0.99  
Household tap No 102 Baseline    
 Yes 1422 0.72 0.46 to 1.12 0.15 ^ 
Typhoid 
vaccination self-
report 
No + Don’t know 1304+1
12 
Baseline    
Yes 103 1.51 1.07 to 2.12 0.019 * 
Typhoid diagnosis 
self-report 
No 1453 Baseline    
Yes 20 2.15 0.96 to 4.82 0.062 ^ 
Typhoid in the 
household, self-
report 
No + Don’t know 1447+6 Baseline    
Yes 20 0.63 0.19 to 2.12 0.46  
Know at least one 
person who has 
had typhoid 
No + Don’t know 1341+ 
36 
    
Yes 93 1.51 1.01 to 2.25 0.042 * 
 
 
3.7.1 Supporting information on self-reported vaccination.  
Self-reported typhoid immunisation history was considered to be non-informative, as 
only 21% of Taveuni islanders reported vaccination against an expected coverage of 
over 90%.[11] Furthermore, 100 (6.7%) mainland residents reported receiving a 
typhoid vaccine, in locations where coverage was predicted to be zero with only five 
of these participants having possibly previously resided in areas covered by the 2010 
vaccination campaign. A subgroup sensitivity analysis was conducted in the 1,428 
mainland participants who reported no history of typhoid immunisation. 
Seropositivity for anti-Vi IgG in this group was observed at thresholds of 1:64, 1:100, 
1:500 and 1:1,000 for 31.4% (27.0 to 35.8%), 17.7% (13.5% to 20.7%), 2.8% (1.4 to 
4.4%) and 1.4% (0.3 to 2.5%) respectively, indicating no difference from the full 
mainland survey group.  
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Chapter 4. Environmental factors drive the spatial distribution of Salmonella 
Typhi in Fiji: a Vi-antigen seroprevalence study. de Alwis R, Watson CH, 
Nikolay B, et al. Emerging Infectious Diseases. Under Rev. 2017. 
 
4.1 Bridging section 
 
In parallel to the main typhoid serological survey analysis, the data was provided to Rukie de 
Alwis, a postdoctoral laboratory scientist retraining in public health through an MSc at 
LSHTM, to undertake an analysis of geospatial risk factors for anti-Vi seropositivity as her MSc 
project. This was done recognising that there would not be scope within the PhD for me to 
undertake a geospatial element to the typhoid sero-epidemiological analysis, particularly 
given unfolding Ebola response activities, but that there might be epidemiological and public 
health utility in Fiji to also considering findings from such an analysis. The data was made 
available for analysis in academic year 2014-2015 on the understanding of the primacy of the 
main serosurvey paper. The geospatial analysis continued to be developed through to 2017. 
Analysis was led by Rukie de Alwis under the supervision of Jorge Cano and Birgit Nikolay of 
LSHTM.  
The serosurvey was designed from the outset to include collection of coordinates of 
participants’ residential location by handheld GPS devices, enabling geospatial analysis to be 
included. This was a particular consideration for serum banking, and for the ecological-
epidemiological approaches that were to be applied to leptospirosis when this component 
was brought into the serosurvey.  
Two GPS devices were brought to Fiji from London, and two loaned by John Lowry, a GIS 
specialist at the School of Geography, University of the South Pacific, Suva. Teams were 
trained in their use, including need to be outside, and leaving sufficient time to allow satellite 
detection and position lock. Coordinates were entered as Degrees-Hours-Minutes-Seconds to 
reduce transcription errors compared with a degree decimal system when recording onto 
survey questionnaires. Coordinates were converted to degree decimal during data cleaning. 
Geographical data are displayed at a level that avoids individual participant identification. 
John Lowry had painstakingly assembled rich geospatial data of Fiji including data on 
agriculture, rainfall, fluvial systems and soil types, and provided technical input, both of which 
were critical to the analysis. My main contributions were in identifying the scope for 
geospatial analysis, designing and delivering a field survey that could be analysed in such a 
manner. I also contributed to the interpretation of the analysed data, particularly towards 
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caution in interpreting and reporting observed findings, given uncertainties in serology, and 
multiple testing, particularly with respect to clustering.  
This chapter is the only research paper in the thesis on which I am not lead author. It sits 
between a thesis chapter and an appendix. It is closer to an appendix paper in ownership, 
and may be read as such. But because it contributes to the narrative of understanding of 
typhoid in Fiji, it is placed in the main body of the thesis. 
There was a further consideration in collecting the coordinates of study participants. In a 
country without a comprehensive address system, this was an important contributor in being 
able to follow-up study participants. This has been utilised in the arbovirus serological cohort 
study that has continued for two follow-up rounds in the Central Division.  
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Abstract  
Fiji recently experienced a sharp increase in reported typhoid fever cases. To investigate the 
geographical distribution and environmental risk factors associated with Salmonella enterica 
serovar Typhi (S.Typhi) infection, we conducted a cross-sectional cluster survey with 
associated serological testing for Vi-specific antibodies (a marker of S.Typhi exposure) in Fiji in 
2013. High Vi-specific seroprevalence “hotspots” were identified in northeast of mainland Fiji. 
Risk of Vi-seropositivity increased with increasing annual rainfall (Odds Ratio, OR: 1.26 per 
quintile increase, 95% CI: 1.12-1.42), and decreased with increasing distance to major rivers 
and major creeks (OR: 0.89 per km increase, 95% CI: 0.80-0.99) and distance to modeled 
flood-risk areas (OR: 0.80 per quintile increase, 95% CI: 0.69-0.92), after being adjusted for 
age, typhoid vaccination and home toilet type. Risk of S.Typhi exposure and its spatial 
distribution in Fiji are strongly driven by environmental factors. This study’s findings can 
directly impact typhoid-control efforts in Fiji.  
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4.2 Introduction 
 
With an estimated disease burden of 20.6 million cases in low and middle-income countries 
(LMICs) in 2010, typhoid fever remains an enteric disease of public health importance (1, 2). 
Typhoid cases largely arise in LMICs, as marked improvements in water, sanitation and 
sewage are considered to have helped reduce typhoid incidence in most developed countries 
(3-6). Salmonella enterica subspecies Typhi (S. Typhi) is the causative agent of typhoid fever. 
S. Typhi is specific to the human host and is typically transmitted faecal-orally between 
humans through the ingestion of contaminated food and water (3, 7). Typhoid infections are 
usually acute, although in around 3-5% of cases S. Typhi establishes an asymptomatic and 
persistent (chronic) infection. These individuals are commonly referred to as typhoid carriers, 
and are capable of shedding bacteria and sustaining transmission within the community (3, 
8).  
Pathogenicity of S.Typhi is conferred by virulence factors such as Vi-polysaccharide. The Vi-
polysaccharide is an outer capsular antigen that enables greater human infectivity than those 
S.Typhi strains not expressing the antigen (9). Due to the highly antigenic nature of Vi, 
infection with Vi-positive S.Typhi strains elicits Vi-specific antibodies in humans (10). 
Therefore, detection of Vi-specific IgG antibodies can be used to measure S. Typhi exposure, 
either past infection(s) or chronic infection (11). Furthermore, the current human-approved 
typhoid vaccines are primarily Vi antigen-based (such as Vi polysaccharide and Vi conjugate 
vaccines) (12). Despite antigenicity of the Vi-polysaccharide, antibodies and immunity 
conferred by the Vi-vaccine is short lived (13). 
Fiji is an archipelago of over 300 islands situated in the Pacific Ocean, with a majority of its 
population living on the two islands of Viti Levu and Vanua Levu. Between 1991 and 2000, 
less than 5 typhoid cases/100,000 people were reported per year, and mostly in Vanua Levu 
(14, 15). However, since 2005, the number of typhoid fever cases have been rising (16) and 
reached a peak of over 50 cases/100,000 inhabitants per year following the widespread 
destruction and flooding caused by Cyclone Tomas in 2010. As a result, the Fiji Ministry of 
Health increased surveillance and implemented additional prevention strategies, such as 
vaccination against typhoid fever in the worst affected regions (17, 18).  
The risk factors for typhoid transmission in Fiji are only partially understood. Inadequate 
hand-washing practices, poor sanitation, lack of access to safe water, dumping of untreated 
waste/sewage are thought to contribute to typhoid transmission in Fiji (17, 19). In addition, 
every year between November and April Fiji experiences powerful cyclones, which have led 
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to destruction of homes and contamination of water sources by extensive rainfall and 
flooding, followed by a rise in diarrheal diseases (20, 21). Although flooding has been shown 
to lead to outbreaks of other food and waterborne diseases (22-24), a direct link between 
flooding and increased typhoid fever incidence has not been confirmed in Fiji.  
Public health efforts to control typhoid have been hampered by the lack of information 
regarding the epidemiology, spatial distribution and risk factors of typhoid exposure in Fiji. 
Therefore, we used the presence of Vi-specific antibodies as a biomarker for typhoid 
exposure, and combined both geospatial and statistical approaches to identify environment-
associated risk factors in the general population of Fiji. Due to the yearly occurrence of 
cyclones in Fiji, we gave special attention to the potential contribution of flooding (and flood-
promoting factors) to S. Typhi Vi-seropositivity.  
 
4.3 Methods 
 
4.3.1 Study design   
This study was a cross-sectional cluster survey with an associated serological analysis, which 
was conducted across three Fijian divisions, i.e. Northern, Central and Western divisions. 
Administrative areas where the 2010 typhoid vaccination campaign (18) had been 
implemented were excluded. Nursing zones were selected using probability-proportional-to-
size (PPS) random sampling based on census data. Cluster sites (“communities”) within 
nursing zones were selected using random list sampling, followed by random sampling of 
households within community cluster sites using community health worker censuses or 
modified World Health Organization’s Expanded Program on Immunization sampling (25), 
and then random sampling of an individual per household. Children under 1 year of age were 
excluded from the study. Community visits and data collection took place during September-
December 2013, and entailed questionnaire administration, blood sample collection and 
geolocation of surveyed households. Geographical coordinates were collected using 
handheld geographical positioning system (GPS) devices at the participant’s house or the 
nearest community center. Sample size was calculated at alpha=0.05 using expected 
seroprevalence informed from prior studies (26). Further details on study design and 
sampling are described in chapter 3 (26).    
Informed consent was obtained in writing or thumb-print from all adult participants and 
parents or guardians of participating children, with written assent from children aged 12 and 
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over. This study was approved by the Fiji National Research Ethics Review Committee 
(#201303) and the London School of Hygiene and Tropical Medicine’s ethics committees 
(#6344 and #9187). 
4.3.2 Survey data  
The cross-sectional survey collected information on forty-four variables, as previously 
described (26). Thirteen survey variables were chosen for the present typhoid risk factor 
analysis based on potential environmental risk factors of interest and potential confounding 
covariates (26). These variables included age, education, self-reported typhoid vaccination 
status, type of toilet at home, type of sewage, work location, urbanization and several 
flooding-related variables (Figure 4.1 and Technical Appendix Table TA4.2).  
 
Figure 4.1. Geographical distribution of anti -Typhoid Vi seroprevalence in 2013 
in Fiji.  
Location of Fiji islands in the Pacific and Vi-seroprevalence in sampled communities in 2013 (A 
and B). Details of typhoid seroprevalence in large Fijian cities (i.e. Labasa, Suva, Nadi and Ba) 
(C). Typhoid seroprevalence estimated for Fijian subdivisions (D).  
 
 
4.3.3 Vi-specific serology 
Vi-specific antibody levels were determined using an enzyme-linked immunosorbent assay 
(ELISA) (methods adapted from Rondini et al 2011) (27). Briefly, ELISA plates were coated 
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with Vi-polysaccharide antigen, blocked with non-fat milk buffer, followed by incubation with 
participant sera (dilution 1:200), proceeded by alkaline phosphatase-conjugated anti-human 
IgG. Antibody binding was detected using p-Nitrophenyl phosphate substrate (Sigma-Aldrich) 
and absorbance measured at 405nm. As previously established in Watson, C et al (2017) (26, 
28), we used a cut-off of ≥64 ELISA units (EU) to classify as Vi-seropositive.  
4.3.4 Geospatial mapping and clustering  
The geographical centroid of each community was estimated by averaging latitude and 
longitudinal coordinates of households sampled within each community. Typhoid 
seroprevalence for each geo-referenced community was computed using the Vi-seroimmune 
status of participating individuals who resided in each community. Confirmed-typhoid case 
incidence data was obtained from the Fijian Ministry of Health and mapped per subdivision. 
All geographical coordinates of communities were presented in the local projected 
coordinate system, Fiji Map Grid 1986. 
Global and Anselin local Moran’s I tests were used to identify statistically significant spatial 
clusters and conducted using GeoDa v1.6.7 (Technical Appendix text TA4.2) (29, 30). Vi-
seroprevalence was log-transformed, separate row-standardized spatial weight matrices 
were calculated based on an inverse-distance relationship, and global and local spatial 
associations were analyzed within each division.  
4.3.5 Environmental variables 
Fijian administrative boundaries were downloaded from Global Administrative Divisions Map 
(GADM) (31). The largest administrative boundaries are known as Divisions (i.e. Central, 
Western, Northern and Eastern), and the island of Viti Levu is made up of Central and 
Western Divisions, while the island Vanua Levu is the Northern Division. Smaller island groups 
make up the administrative Eastern Division (where the present study did not collect 
samples). The Divisions are further broken down into 14 subdivisions.  
Geospatial environmental data were provided by the University of South Pacific (Suva, Fiji): 
topography data (elevation and slope), climate data (annual rainfall, rainfall of the wettest 
month, total rainfall for cyclone season), hydrology data (rivers and creeks) and soil data (soil 
type according to composition and drainage quality) (32, 33). Euclidean distance maps of 
straight-line distance to major rivers and creeks, and poorly drained soils were generated 
from hydrology and soils maps, respectively. Further details of spatial data used in the study 
are provided in Technical Appendix Table TA4.3. 
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A deterministic flood-risk model was generated based on the principle that depressions and 
poorly drained soils are more likely to collect rainwater and be flooded (34). Further details 
on the development of this flood-risk map are provided in Technical Appendix text TA4.1 and 
Technical Appendix Figure TA4.1.  
Except for the rainfall variables that were extracted at the community level, the remaining 
environmental data were extracted at the individual geo-spatially coded household level 
using bilinear interpolation. All geospatial processing and mapping was done using ArcGIS 
v10.2 (Redlands CA, USA). 
4.3.6 Multilevel mixed-effect logistic regression 
Risk factors for typhoid Vi-seropositive status were identified using multilevel mixed-effects 
logistic regression (also known as a generalized linear mixed-effect model, GLMM) by 
including environmental and individual-related covariates as fixed-effect and a random 
intercept. First, a null multilevel mixed-effects logistic model was run with the typhoid sero-
immune status (binary variable) as the dependent variable. The variance partition coefficient 
(VPC) and a caterpillar plot (Technical Appendix Figure 2) were generated using community 
residuals.  
Sixteen environmental covariates (Table 4.1) were tested in the univariable analysis. 
Regarding continuous independent variables, if analysis showed at least moderate evidence 
of an association with seropositivity (p<0.05), then the variable was used in the multivariable 
analysis as a continuous variable. However, if analysis showed weak or no evidence of an 
association with typhoid seropositivity (p>0.05), then the continuous variable was divided 
into quintiles (Technical Appendix Table 4.4) and re-tested in the univariable model 
separately as categorical or ordered-categorical variables. All continuous variables associated 
with Vi-seropositivity with a p<0.10 were tested for collinearity. Variables with high 
collinearity (correlation coefficient>0.8) were grouped, and the variable with the smallest p-
value from each group was included in the multivariable analysis. 
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Table 4.1. Association between environmental factors and typhoid seropositivity using 
univariable multilevel mixed-effects logistic analysis 
 
Environmental Variable n 
Variable 
Type 
Odds Ratio  
(95% CI) 
P value 
Survey Data     
 Is there a stream nearby? (0=No, 1=Yes) 1,508 Binary 1.09 (0.82-1.46) 0.528 
  No 616    
  Yes 892    
 No. of times house has flooded in the past 3 
years 1,483 Categorical 
  
  0 1,380  1.00 (reference) - 
  1 to 2 97  0.87 (0.52-1.47) 0.604 
  3 to 5 6  0.89 (0.15-5.13) 0.897 
 
No. of times land has flooded in the past 3 years 1,496 Categorical 
  
  0 1,264  1.00 (reference) - 
  1 to 2 174  1.13 (0.77-1.66) 0.534 
  3 to 5 58  1.21 (0.66-2.22) 0.542 
 Work Location* 1,359 Categorical   
  Indoors 636  1.00 (reference) - 
  Outdoors 267  1.59 (1.15-2.19) 0.005† 
  Both indoor and outdoor 456  1.22 (0.93-1.60) 0.160 
 Urbanization* 1,510 Categorical   
  Urban 500  1.00 (reference) - 
  Periurban 247  0.61 (0.37-1.01) 0.054 
  Rural 763  1.27 (0.89-1.81) 0.185 
Geospatial Data     
 Elevation (by quintiles) 1462 Ordered 
Categorical 
1.02 (0.90-1.15) 0.793 
 Slope (by quintiles) 1462 Ordered 
Categorical 
1.04 (0.93-1.15) 0.519 
 Temperature (by quintiles) 1462 Ordered 
Categorical 
0.95 (0.84-1.07)  0.398 
 Annual Rainfall (by quintiles)* 1462 Ordered 
Categorical 
1.13 (1.01-1.28) 0.039† 
 Rainfall in wettest month (by quintiles) 1462 Ordered 
Categorical 
1.15 (1.02-1.30) 0.020† 
 Rainfall during cyclone season (by quintiles) 1462 Ordered 
Categorical 
1.14 (1.01-1.29) 0.029† 
 Distance to major rivers (by quintiles) 1462 Ordered 
Categorical 
1.07 (0.95-1.20) 0.255 
 Distance to major rivers and major creeks 
(Km)* 
1462 Continuous 0.99 (0.99-1.00) 0.081 
 Distance to major rivers, major and minor 
creeks (by quintiles) 
1462 Ordered 
Categorical 
0.96 (0.86-1.07) 0.439 
 Distance to poorly drained soils - major & 
secondary flood plains (by quintiles) 
1462 Ordered 
Categorical 
0.92 (0.80-1.06) 0.275 
 Distance to poorly drained soils - major flood 
plains only (by quintiles) 
1462 Ordered 
Categorical 
1.00 (0.87-1.17) 0.949 
 Distance from modelled flood-risk area (by 
quintiles)* 
1462 Ordered 
Categorical 
0.90 (0.78-1.03) 0.134 
*Variables included in the multivariable multilevel analysis. †Variables that quite strongly associated with typhoid 
sero-immune status in the univariable analysis (i.e. p<0.05). 
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In addition to five environmental variables (as indicated in Table 4.1), several non-
environmental risk factors (i.e. age, education, self-reported typhoid vaccine status, type of 
home toilet, type of sewage, and know people who have had typhoid) of S. Typhi Vi-
seropositivity were confirmed as significant risk factors by univariable analysis (Technical 
Appendix Table TA4.2) and included in the multivariable analysis. Parsimonious regression 
models were developed using a backward stepwise variable selection approach, eliminating 
one variable at a time based on the highest p-value in a likelihood ratio test and retaining 
only variables with p≤0.05. The final fitted multivariable statistical model was validated using 
the Hosmer-Lemeshow test and by generating predicted typhoid seroprevalence values for 
sampled communities (Technical Appendix Figure TA4.2). Data were analyzed using Stata v14 
(Statacorp, College Station). 
4.3.7 Boosted regression trees (BRT) modeling  
A base model was developed using the location of communities (longitude and latitude) and 
those variables that were found to be associated with Vi-seropositivity in the univariable 
analysis. A simplification of the base model was conducted by removing redundant or non-
informative variables. An ensemble of 50 BRT models with 11 of the most influential 
predictors and random sampling from a total of 1,305 samples (a minimum of 750 sampled at 
one time) was conducted to estimate relative contributions and marginal effect plots of the 
most influential variables. Further details on the BRT model are given in Technical Appendix 
Text TA4.3. BRT modeling was conducted in R (v3.2.2, www.R-project.org) using the ‘gbm’ 
library (35). 
 
4.4 Results 
 
4.4.1 Detection of typhoid hotspot communities in Fiji 
Approximately one-third of the serum samples (485/1,516) were sero-positive for Vi-specific 
antibodies (Technical Appendix Table TA4.1). Vi-seroprevalence among sampled communities 
in Fiji ranged from 8% to 65%, with 35% and 24% estimated for Central and Western 
divisions, respectively (Figure TA4.1). Furthermore, although northern division (Vanua Levu) 
has a smaller population, it had almost 40% Vi-seroprevalence.  
Global Moran’s I analysis showed strong evidence of geographical clustering of Vi-
seroprevalence among sampled communities in the Western division (I=0.49, p=0.002), and 
weak evidence for Central and Northern divisions (I=0.08 and -0.42, p=0.08 and 0.10, 
respectively). Anselin Local Moran’s I test showed that although Vanua Levu had high typhoid 
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seroprevalence, there was no apparent typhoid hot-spot clustering among communities in 
this island (Figure 4.2A). However, four high-high (hot-spot) seroprevalence cluster 
communities were detected in the north and northeast of Western and Central divisions, 
respectively (Figure 4.2B and 4.2C), while cold-spots were primarily detected in the Western 
division (Figure 4.2B).    
 
Figure 2. Local clustering of typhoid seroprevalence within divi sions in Fiji.  
Local Anselin Moran's I analysis conducted for each division separately using an inverse-
distance weighting for the communities within the three divisions, north (A), western (B) and 
central (C). High-high clusters (also known as hotspots) are high Vi-seroprevalence 
communities that are close to other high Vi-seroprevalence communities. Similarly, low-low 
clusters (also known as coldspots) are low Vi-seroprevalence communities that are in close 
proximity to other low Vi-seroprevalence communities.   
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4.4.2 Multilevel univariable and multivariable analysis 
Univariable analysis identified four environmental variables (i.e. work location, annual 
rainfall, rainfall in the wettest month and rainfall in the cyclone season) and four non-
environmental variables (i.e. age, education, sewage disposal, typhoid vaccination status) 
with significant association with Vi-seropositivity (p<0.05) (Table 4.1 and Technical Appendix 
Table TA4.2). Furthermore, there was suggestive evidence of an association with Vi-
seropositivity (i.e. 0.1>p>0.05) for several other environmental and non-environmental 
variables (i.e. urbanization, distance to major rivers and major creeks, toilet type, knowing 
people who has had typhoid) (Table 4.1 and Technical Appendix Table TA4.2).  
One rainfall variable and all other environmental and non-environmental factors with at least 
a suggestive association (i.e. p<0.01) were included in the multivariable multilevel logistic 
regression analysis (indicated in Table 4.1 and Technical Appendix Table TA4.2). Proximity to 
modelled flood-risk areas was included as a fixed-term in the final fitted multivariate model 
regardless of its evidence of association on the univariable analysis, since other 
environmental factors (such as rainfall and proximity to rivers) maybe confounding the 
univariable analysis. The final multivariable statistical model contained six variables that 
significantly explained the variation in Vi-seropositivity for sampled individuals and 
communities. After adjusting for potential confounders (i.e. age, typhoid vaccination and 
flush toilets), annual rainfall showed positive association (OR=1.26 per quintile increase, 
p<0.001, respectively), while distance to major rivers and major creeks and to modeled flood-
risk areas showed negative associations with Vi-seropositivity (OR: 0.89 per km increase 
p=0.031 and OR 0.80 per quintile increase p=0.002, respectively) (Table 4.2).  
Table 4.2. Association between social and environmental factors with Typhoid sero-immune 
status using a multivariable multilevel model 
Variable 
Odds Ratio (95% 
CI)* 
P value 
Annual Rainfall (by quintiles) 1.26 (1.12-1.42) <0.001 
Distance to major rivers and major creeks 
(km) 0.89 (0.80-0.99) 0.031 
Distance to modelled flood-risk areas (by 
quintiles) 0.80 (0.69-0.92) 0.002 
Age of participant (yr) 1.03 (1.02-1.03) <0.001 
Vaccination status (0=Not vaccinated, 
1=Vaccinated) 1.62 (1.02-2.57) 0.041 
Type of toilet at home   
 Flush -  
 Water seal/ pour-flush 1.66 (1.16-2.38) 0.006 
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 Pit (with/without slab) & bucket 1.51 (0.91-2.52) 0.110 
*The multivariable model was run using 1,338 observations in 61 communities. 
The fitted model not only explained fixed-effect variation across individuals, but also some of 
the variation across sampled communities. Comparison of the null and final models showed a 
reduction in VPC from 7.6% (p<0.0001) to 2.1% (p<0.0001), which means that the final 
statistical model explained 72% of the variation in seropositivity between communities. The 
final multivariable model fitted was validated using the Hosmer-Lemeshow test, where the 
predicted proportions computed at the individual level were not significantly different from 
the observed proportions (p=0.558) (Technical Appendix Figure TA4.2).  
4.4.3 Boosted Regression Tree modelling 
Age, GPS location and the three environmental factors, i.e. distance to major rivers and major 
creeks, distance to flood-risk areas and annual rainfall were estimated to be the major 
predictors of Vi-seropositivity in Fiji (Table 4.3). These six covariates accounted for almost 
90% of the estimated relative contribution to S.Typhi Vi-seropositivity.  
Table 4.3. Relative contributions (%) of predictor variables from an ensemble of 50 boosted 
regression tree models for typhoid seropositivity developed with cross-validation on data from 
1,305 samples and 11 variables 
Variable Data type 
Relative Contribution  
(95% CI) 
Age (yr) Continuous 33.0   (31.1 – 34.8) 
Longitude (Degrees) Continuous 15.5 (14.7 – 16.0) 
Distance from major rivers & 
creeks (m) 
Continuous 14.5 (13.6 – 15.3) 
Annual rainfall (mm) Continuous 9.3 (8.5 – 10.0) 
Distance from flood-risk areas (m) Continuous 7.7 (6.8 – 8.4) 
Latitude (Degrees) Continuous 6.9 (5.6 – 7.9) 
Education Categorical 4.2 (3.8 – 4.6) 
Urbanization Categorical 3.3 (2.9 – 3.8) 
Typhoid vaccination Binary 2.3 (2.1 – 2.5) 
Sewage disposal Categorical 1.8 (1.5 - 2.2) 
Toilet type at home Categorical 0.8 (0.6 – 1.2)  
 
The marginal effect plot for age showed that a majority of initial exposure to S.Typhi occurs 
before 40 years of age and plateaus above 60 yrs (Figure 4.3A). Distances of less than ~1,300 
m to major rivers and major creeks were predicted to increase Vi-seropositivity, with 
distances less than ~200 m having the largest effect (Figure 4.3B). Annual rainfall had minimal 
effect on Vi-seropositivity until around 1,700 mm, above which the risk increased 
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dramatically (Figure 4.3C). Furthermore, shorter distances to modeled flood-risk areas 
showed some contribution to typhoid seropositivity (Figure 4.3D).  
 
Figure 4.3. Partial dependence plots for the four most influential variables in 
the BRT model for typhoid seropositivity.  
The partial dependence plots of age (A), Distance to major rivers and creeks (B), Annual 
rainfall (C) and Distance to flood-risk areas (D). The final ensemble BRT was built upon 50 BRT 
models, 11 environmental and social covariates, using data from 1,305 samples. The grey 
area depicts the 95% confidence intervals of the plots. 
 
4.5 Discussion 
In the past two decades Fiji has observed a steady rise in confirmed typhoid fever cases (16-
18). However, little is known about the geospatial distribution and underlying risk factors of 
typhoid fever in Fiji. Our study demonstrated a spatially heterogeneous exposure to typhoid 
fever across Fiji, with Vanua Levu island having the highest seroprevalence. High-
seroprevalence communities (hotspots) were only detected in Viti Levu whilst typhoid fever 
appeared to be more homogeneously distributed in Vanua Levu, suggesting a different 
transmission pattern in the two islands. Annual rainfall, and proximity to major rivers, creeks 
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and potentially floodable areas were found to be important environmental risk factors of 
serological evidence of exposure to S.Typhi in Fiji.  
The Vi-seroprevalence distribution closely resembled the typhoid case incidence pattern 
reported by the Fijian Ministry of Health for the period 2008-2013 (Technical Appendix Figure 
4.3), with Vanua Levu and the northeast of Viti Levu having the largest typhoid burden. 
Interestingly, in April 2016 following the wake of cyclone Winston hitting Fiji, there was a 
sudden outbreak of typhoid fever in the villages of Qelekuro and Nabulini (36), which were 
both located in northeastern Viti Levu. This latest typhoid outbreak in Fiji supports our 
findings of high-risk areas for S.Typhi exposure particularly in the northeastern region of Viti 
Levu island (Figure 4.2A) and reinforces the hypothesis of increased exposure to typhoid due 
to environmental anomalies in the aftermath of a cyclone.  
Similar to our findings, other studies have found positive associations between faecal-orally 
transmitted diseases (such as cholera and typhoid) and waterborne diseases (such as 
leptospirosis) with heavy rainfall and proximity to major rivers (37-41). Heavy rains in Fiji, 
particularly during the cyclone season (November-April) (21), may lead to the overflowing of 
septic tanks and contamination of the local environment and drinking water sources. 
Furthermore, our study indicated proximity to major rivers and creeks as a risk factor for 
acquiring S.Typhi probably due to major rivers and creeks being used in Fiji (similar to many 
other middle-income countries) as places for washing clothes, taking baths and swimming 
(42). In addition, streams near populated areas can become contaminated as a result of 
cyclones or heavy rains causing overflow of sewage and waste systems. Therefore, future 
studies investigating environmental risk factors should sample surrounding water sources for 
water quality assessment.   
Many food and waterborne diseases have been shown to increase soon after heavy flooding 
(22-24, 43). Fiji experiences typhoid fever and leptospirosis outbreaks following devastation 
and flooding by cyclones (16, 18, 41, 44). Our multivariate model demonstrated an increased 
risk for S.Typhi infection for those individuals living closer to the modeled flooding areas. 
Annual cyclone season and heavy rainfall combined with a majority of the Fijian population 
living in low-lying coastal areas make exposure to flooding a very common phenomenon in 
Fiji and a potential conduit of S.Typhi transmission.  
A major strength of this study is the unbiased, individual-level assessment of environmental 
factors specific to each participant based on their residential GPS coordinates. Furthermore, 
the large sample number analyzed enabled inclusion of a large number of independent 
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variables (consisting both major non-environmental risk factors and environmental variables) 
in the statistical modeling. Despite many strengths, the present study also has several 
limitations. Although Vi-specific antibodies were measured as a proxy for S.Typhi infection, 
the role and dynamics of Vi-specific antibodies following S.Typhi infection is unclear. For 
example, anti-Vi antibodies have been found to numtyphoid vaccination. Furthermore, 
geospatial cluster analysis was partially hampered by an uneven distribution of surveyed 
communities. To mitigate this potential spatial bias, we conducted spatial clustering analysis 
separately for each division.  
The present study is an in-depth study of the spatial epidemiology of typhoid in Fiji. It also 
investigates flooding as a risk factor for typhoid transmission. Findings of this study can be 
used to inform future typhoid control programs. Recent outbreak detection in high 
seropositivity areas (36) suggests that anti-Vi IgG sero-surveillance offers potential for 
identification of areas and communities at higher risk of typhoid fever. This spatial 
epidemiology analysis suggests flood-prone areas and other communities lying close to major 
rivers and creeks or in high-rainfall areas could be prioritized for stricter flood-control and 
typhoid-preventative measures, such as improved sanitation, provision of secure water 
sources, and typhoid vaccination campaigns. 
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4.7 Technical Appendix 
 
 
Technical Appendix Figure TA4.1.  Development of a flood-risk model.  
Detailed methods are described in Technical Appendix text TA4.1 
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Technical Appendix Figure TA4.2. Validation of the fitted multilevel mixed -effect 
logistic regression model.  
Distribution of community random effect residuals with 95% CI to justify the use of a 
multilevel model (A). Validation of the final multilevel regression model to explain variation in 
sero-immune status to typhoid Vi antigen using the Hosmer-Lemeshow test (p-value= 0.558) 
(B). Assessing the final statistical model by comparing the predicted and observed typhoid 
sero-prevalence at the community level (C). 
 
 
169 
 
 
Technical Appendix Figure TA4.3. Confirmed typhoid fever case incidence per 
100,000 inhabitants reported for each subdivision during 2008 -2013 and 2014. 
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Technical Appendix Table TA4.1. Characteristics of samples collected by the survey and those 
included in the statistical analysis  
 Variable n 
Survey Samples  
 Individuals 1,560 
 Communities 65 
 Anti-Typhoid IgG 1,531 
 
Individuals per community, mean 
(range) 
24 (15-28) 
Samples included in analysis† 
 Individuals 1,516 
 Communities 63 
 Anti-S. Typhi Vi IgG‡ 1,516 
  Sero-negative (<64 EU) 1,031 
  Sero-positive (≥64 EU) 485 
 GPS coordinates 1,463 
 Community cluster area, km2  (IQR)* 
0.04 (0.02-
0.13) 
*Cluster area of each community was assessed using the sampled household 
locations of each community. 
†Samples from pilot study were not included in present analysis. 
‡Samples with missing Anti-S. Typhi Vi IgG titres were excluded from analysis. 
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Technical Appendix Table TA4.2. Univariable analysis of non-environmental risk factors of S. 
Typhi Vi-seropositivity used in the present study  
 Variable 
Variable 
Type 
Odds Ratio  
(95% CI) 
P-
value 
Age (yr) Continuous 1.03 (1.02-1.03) <0.001* 
Education Categorical   
 No Schooling  1.00 (reference)  
 Primary  1.47 (0.94-2.30) 0.091 
 Secondary  1.71 (1.11-2.64) 0.015* 
 Vocation & University  1.17 (0.71-1.93) 0.546 
     
Toilet at home Categorical   
 Flush  1.00 (reference) - 
 Water seal/pour-flush  1.40 (1.00-1.95) 0.051* 
 Pit (with/without slab) & 
bucket 
 1.22 (0.75-1.99) 0.425 
     
Sewage disposal at home Categorical   
 Piped sewer system  1.00 (reference) - 
 Septic tank  0.59 (0.35-0.99) 0.048* 
 Pit latrine  0.65 (0.43-0.99) 0.043* 
 elsewhere  0.61 (0.28-1.33) 0.215 
     
Typhoid vaccination status 
(0=No, 1=Yes) 
Binary 1.67 (1.07-2.59) 0.023* 
Do you know people who have 
had typhoid?  (0=No, 1=Yes) 
Binary 1.56 (0.96-2.54) 0.073* 
*These non-environmental variables were included in the multivariable analysis. 
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Technical Appendix Table TA4.3. Characteristics of the topographical and environmental data 
variables used 
Variable 
Resolution 
(meters) 
Mean  
(Std Err.) 
Range 
Geospatial data    
 Elevation (m) 25 41.1(±89.3)  0-761 m 
 Slope (degree) 25 3.02(±3.81)  0-25.0  
 Mean Temperature (°C) 100 25.1(±27.5)  0-26.1  
 Annual Rainfall (mm) 100 2490(±660)  0-4040  
 Rainfall in wettest month (mm) 100 372(±76)  0-789  
 Rainfall during cyclone season (mm) 100 1032 (±195)  0-2055  
 Distance to major rivers (km) 25 1.21(±1.74)  0-9.8  
 Distance to major rivers and major 
creeks (km) 
25 0.360(±0.343)  0-2.250  
 Distance to major rivers, major and 
minor creeks (km) 
25 0.148(±0.177)  0-1.280  
 Distance to poorly drained soils - 
major & secondary floodplains (km) 
25 0.722(±1.710)  0-11.250  
 Distance to poorly drained soils -
major floodplains only (km) 
25 2.370(±3.670)  0-17.410  
 Distance from modelled flood-risk 
area (km) 
25 1.890(±4.260)  0-25.540  
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Technical Appendix Table TA4.4. The range of each category for the continuous variables that 
were broken into quintiles 
Variables Range 
Elevation Q1 0-7 m 
Q2 8-15 m 
Q3 16-19 m 
Q4 20-39 m 
Q5 ≥40 m 
Slope Q1 0.00 deg 
Q2 0.40-1.21 deg 
Q3 1.28-2.29 deg 
Q4 2.36-4.45 deg 
Q5 ≥4.46 deg 
Temperature Q1 0-25.19°C 
Q2 25.20-25.37°C 
Q3 25.38-25.64°C 
Q4 25.65-25.81°C 
Q5 ≥25.82°C 
Annual Rainfall Q1 0-1909 mm 
Q2 1910-2265 mm 
Q3 2266-2582 mm 
Q4 2583-3104 mm 
Q5 ≥3105 mm 
Rainfall in wettest month Q1 0-338 mm 
Q2 339-360 mm 
Q3 361-379 mm 
Q4 380-408 mm 
Q5 ≥409 mm 
Rainfall during cyclone season Q1 0-943 mm 
Q2 944-1001 mm 
Q3 1002-1053 mm 
Q4 1054-1125 mm 
Q5 ≥1126 mm 
Distance to major rivers Q1 0-0.150 km 
Q2 0.151- 0.459 km 
Q3 0.460-0.908 km 
Q4 0.909-1.726 km 
Q5 ≥1.727 km 
Distance to major rivers and major creeks 
 
 
 
 
 
Q1 0-0.090 km 
Q2 0.091-0.195 km 
Q3 0.196-0.320 km 
Q4 0.321-0.506 km 
Q5 ≥0.507 km 
Distance to major rivers, major and minor creeks Q1 0-0.025 km 
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Variables Range 
Q2 0.026-0.075 km 
Q3 0.076-0.111 km 
Q4 0.112-0.200 km 
Q5 ≥0.201 km 
Distance to poorly drained soils (major & secondary 
floodplains) 
Q1 - 
Q2 0-0.044 km 
Q3 0.045-0.152 km 
Q4 0.153-0.776 km 
 Q5 ≥0.777 km 
Distance to poorly drained soils (major floodplains only) Q1 - 
Q2 0-0.276 km 
Q3 0.277-1.521 km 
Q4 1.522-4.310 km 
Q5 ≥4.311 km 
Distance from modelled flood-risk area (km) 
  
Q1 - 
Q2 0-0.127 km 
Q3 0.128-0.576 km 
Q4 0.577-1.681 km 
Q5 ≥1.682 km 
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4.7.1 Technical appendix text 
 
Technical Appendix Text TA4.1. Building of a flood-risk model. 
The flood-risk model was created in four main steps as described below:  
1. A map depicting depression sites (or sink areas) was created using the DEM raster. A 
convex or depression surface was obtained with the formula; original DEM – mean DEM, 
where values < 0 were identified as convex zones. First, a mean DEM raster was created 
by averaging the elevation of 10x10 neighbouring (i.e. a 250x250m area). Then, the 
depression map was obtained by subtracting the mean DEM raster from the original DEM 
map, and selecting only the regions with negative pixel values.  
2. Areas selected as potential flooding areas where those that were convex and fall within 
an elevation range between 0-40 m, which is approximately the elevation range 
corresponding to the lower alluvial plains, which is generally affected during severe 
flooding (Townsend PA, Walsh SJ: Modeling floodplain inundation using an integrated GIS 
with radar and optical remote sensing. Geomorphology 1998, 21:295-312.).  
3. Then a raster map with poorly drained soils was created using the polygon features 
ranging from imperfectly to very poorly drained soils.  
4. A new raster flood-risk map was created using only the overlapping regions of the 
depressions map and the poorly drained soils map. These overlapping regions were 
marked as regions at high-risk of flooding. Finally, a surface map estimating Euclidean 
distances to these high-risk flooding regions was created. 
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Technical Appendix Text TA4.2. Implementation of the spatial autocorrelation analysis 
Global Moran’s I statistic (Moran PAP: Notes on continuous stochastic phenomena. 
Biometrika 1950, 37:17-23) was used to account for the global spatial autocorrelation of 
typhoid fever sero-prevalence. For the Moran’s I statistic, the sum of covariations between 
the sites for the distance d(i,j) was divided by the overall number of sites W(di,j) within the 
distance class d(i,j). Thus, the spatial autocorrelation coefficient for a distance class d(i,j) was 
the average value of spatial autocorrelation at that distance. 
𝐼 =  
n
S𝑝
 
∑ ∑ 𝑊𝑖𝑗(𝛾𝑖−?̅?)(𝛾𝑗−?̅?)
𝑛
𝑗=1
𝑛
𝑖=1
∑ (𝛾𝑖−?̅?)2
𝑛
𝑖=1
, where 
n = the sample size; 
𝑊𝑖𝑗 =  {
1 if sites i, j are neighbours
0 otherwise
= row-standardized spatial weights matrix of sites i and j; 
S𝑝 =  ∑ ∑ 𝑊𝑖.𝑗 
𝑛
𝑗=1 = sum of the number of sampling locations per distance class
𝑛
𝑖=1 ;  
 𝛾𝑖 = the value at community 𝑖; and ?̅? = global mean value 
The actual value for Moran’s I was then compared with the expected value under the 
assumption of complete randomisation.  
𝐸(𝐼) =  −
1
𝑛 − 1
 
Moran’s I values may range from -1 (disperse) to +1 (clustered). A Moran’s I value of 0 
suggests complete spatial randomness. To verify that the value of Moran’s I was significantly 
different from the expected value, a Monte Carlo randomisation test was applied with 9,999 
permutations to achieve highly significant values. This statistic is a global statistic in that it 
averages all cross outcomes over the entire domain.  
A local version, called Local Indicator of Spatial Association (LISA) or Anselin Local Moran’s I 
statistic (Anselin L: Local Indicators of Spatial Association—LISA. Geographical Analysis 
1995, 27:93-115) allows us to test for statistically significant local spatial clusters, including 
the type and location of these clusters. It is calculated as follows: 
𝐼𝑖(𝑑) =  
(𝛾𝑖−?̅?)
1
𝑛
∑ (𝛾𝑖−?̅?)
𝑛
𝑖=1
 ∑ 𝑊𝑖𝑗(𝑑)(𝛾𝑖 − ?̅?)
𝑛
𝑖=1 , where 
𝑊𝑖𝑗(𝑑) is the row-standardized weights matrix given a local neighbourhood search radius d. 
The conceptualization of spatial relationship (i.e. neighbourhood definition) was the same as 
the global statistics were applied. Unlike the global Moran’s I, which has the same expected 
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value for the entire study area, the expected value of local Moran’s I varies for each sampling 
location because it is calculated in relation to its particular set of neighbours.  
𝐸(𝐼𝑖) =  −
1
𝑛 − 1
 ∑ 𝑊𝑖,𝑗
𝑛
𝑗=1
 
 
The significance of the local Moran’s I was calculated using a randomization test on the Z–
score with 9,999 permutations to achieve highly significant values. Positive spatial 
autocorrelation occurs when, a community with a specific typhoid sero-prevalence is 
surrounded by neighbouring communities with similar outcome value (low-low, high-high), 
thus forming a spatial cluster.   
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Technical Appendix Text TA4.3. Implementation of BRT modelling approach on typhoid sero-
positivity data. 
First, a single BRT model was constructed with the individual typhoid sero-immune status 
binary data, cross-validation optimization and accounting for multi-way interactions. As per 
guidelines (Elith J, Leathwick JR and Hastie T. A working guide to boosted regression trees. J 
Anim Ecol 2008, 77:802-813) the learning rate (lr) and tree complexity (tc) were set according 
to the number of observations and testing different values on a subset of samples (75%), 
using deviance reduction as the measure of success. After several test, lr of 0.0025 and tc of 5 
were identified as optimal parameters, thereby enabling the model to account for up to 5 
potential interactions and slowing it down enough to get the model converged without over-
fitting the data. The base model was constructed including location of communities 
(longitude and latitude) and the eleven variables that were found to be associated with 
typhoid sero-positivity in the univariable logistic regression analysis (Technical Appendix 
Table TA4.2).  
A simplification of the base model was conducted by removing redundant or non-
informative variables without compromising the predictive performance of the model. This 
simplification process (implemented using the function gbm.simplify) was run within a 10-
fold cross-validation (CV) procedure, progressively simplifying the model fitted to each fold, 
and using the average CV error to decide how many variables could be removed from original 
model without affecting predictive performance. Then an ensemble BRT (i.e. 50 BRT models) 
was run with the simplified model using five parallel CPUs to attain 95% confidence intervals 
in both the relative contributions of the variables and the marginal effect plots. Relative 
contributions of variables to typhoid sero-positivity were estimated using the ensemble BRT 
model. Fitted functions of the ensemble BRT model was visualized by graphing the marginal 
effect curves or partial dependence plots, which demonstrate the effect of each independent 
variable on the typhoid sero-positive outcome while all other variables in the model are held 
constant at its average.   
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Chapter 5. Social mixing in Fiji: who-eats-with-whom contact 
patterns and the implications of age and ethnic heterogeneity for 
disease dynamics in the Pacific Islands. Watson CH, Coriakula J, 
Dung TTN, et al  
 
5.1 Bridging section 
 
Social contact data has a well-established role in improving mathematical model predictions 
on transmission of spread of “close-contact” infections, such as measles, tuberculosis and 
meningococcus, where such data was previously estimated [1–3].  The introductory chapter 
of this thesis reviewed the historical and contemporary literature on transmission of 
Salmonella Typhi infection  as a necessary prerequisite for the development of typhoid fever. 
Some of the challenge of typhoid epidemiology and control comes from its potential for 
multi-modal transmission. Faecal contamination of drinking water has contributed to high 
incidence in many settings.[4–6] Typhoid fever is recognised as a disease of “contagion” [6], 
“contact”[7], and “prosodemic” (person-to-person) transmission[8], which might be further 
separated into direct transmission, without intermediaries, and indirect transmission, such as 
through food prepared by a typhoid carrier [9]. A World Health Organization expert elicitation 
exercise found a diverse range of estimates of the contemporary contribution of water, 
foodborne and “person-to-person” disease across WHO regions [10].  
Social mixing data does not directly disentangle of the important modes of transmission in 
any given setting. It cannot say if any association between social contact rates and incidence 
is attributable to direct transmission, or reflects, for example, common exposure of a 
particular social group to contaminated food or surface water. Melegaro and colleagues have 
noted the utility of social contact data in describing the strength of social relations, finding 
more intimate connections to be better predictors than more causal forms of social contact in 
influenza. As such, this data on social structure is potentially an informative proxy for 
transmission risks. The role of social mixing data in typhoid may be in examining whether 
socially structured contact patterns better predict infection than less structured transmission 
matrices that may reflect ubiquitous exposures.  
This chapter describes the social mixing data used in the chapter 6, which examines models 
of transmission in Fiji. The social mixing survey was embedded in the seroepidemiological 
survey, obtaining data from the same participants. The preparatory work and field operations 
are described in the bridging section for the serosurvey paper (3.1). I conceived the idea of 
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using mealtime mixing as an appropriate contact matrix for enteric infection following the 
preliminary visit to Fiji in November-December 2012. Whilst it was potentially critically 
important to determine the ethnicity of participants’ contacts for epidemiological 
understanding, I recognised this to be a potentially highly sensitive question and sought input 
from local partners. With the field team, I developed a suitable approach to this line of 
enquiry, with this typically asked as “all [self-reported ethnicity of participant]?” after 
completing the participant’s report for each meal’s co-diners. This gave the participant a 
simple yes/no answer with a natural route to correct the interviewer with which contacts 
were of a different ethnicity if this was the case. This was piloted successfully and 
implemented uncontroversially.  
For analyse of the data, I was fortunate to have advice and some relevant pieces of R code 
from Stefan Flasche and Olivier Le Polain, who had recently completed social mixing analysis 
for pneumococcal disease (manuscript in preparation). I adapted this code to provide mixing 
pattern estimates for the survey mixing groups and population of Fiji, and undertook logistic 
regression analysis with the serological data to examine association with contact rates to 
examine whether serology supported the use of social mixing patterns for typhoid modelling.  
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Abstract 
Empirical data on contact patterns can inform dynamic models of infectious disease 
transmission. Such information has not been widely reported from Pacific islands, nor 
strongly multi-ethnic settings, and few attempts have been made to quantify contact 
patterns relevant for the spread of gastrointestinal infections. As part of enteric fever 
investigations, we conducted a cross-sectional survey of the general public in Fiji, finding that 
within the 9,650 mealtime contacts reported by 1,814 participants, there was strong like-
with-like mixing by age and ethnicity, with higher contact rates amongst iTaukei than non-
iTaukei Fijians. Extra-domiciliary lunchtime contacts follow these mixing patterns, indicating 
the overall data do not simply reflect household structures. Inter-ethnic mixing was most 
common amongst school-age children. Serological responses indicative of recent Salmonella 
Typhi infection were found to be associated, after adjusting for age, with increased contact 
rates between meal-sharing iTaukei, with no association observed for other contact groups. 
Animal ownership and travel within the geographical division were common. These are novel 
data that identify ethnicity as an important social mixing variable, and use retrospective 
mealtime contacts as a socially acceptable metric of relevance to enteric, contact and 
respiratory diseases that can be collected in a single visit to participants. Application of these 
data to other island settings will enable communicable disease models to incorporate locally 
relevant mixing patterns in parameterisation. 
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5.2 Introduction 
Infectious disease models synthesise epidemiological data and germ theory to understand 
and predict disease transmission. Non-homogeneous contact patterns are widely used in 
estimating the spread of an infection within a population (Hethcote and Yorke, 1984; Bansal, 
Grenfell and Meyers, 2007). For public health policy making, the prior practise of inferring 
social contact patterns as part of the model fitting has increasingly been replaced with data 
collection on social contact patterns (Edmunds, O’Callaghan and Nokes, 1997; Hens et al., 
2012). This can strengthen model validity when assessing the potential impact of 
interventions such as school closures or vaccination (Baguelin et al., 2013). 
Whilst social mixing has been studied in Europe (Mossong et al., 2008); Africa, including 
South Africa (Johnstone-Robertson et al., 2011; Dodd et al., 2016), Kenya (Kiti et al., 2014), 
Zambia (Dodd et al., 2016) and Zimbabwe (Melegaro et al., 2017); Asia, including Vietnam 
(Horby et al., 2011), Taiwan (Fu, Wang and Chuang, 2012), southern China (Read et al., 2014) 
and Japan (Ibuka et al., 2015); and Australia (Rolls et al., 2015), there is a paucity of social 
contact data for Pacific island states. This lack of data is despite the enormous historical 
mortality impact of diseases such as measles and bacillary dysentery in Pacific populations 
(Schmitt and Nordyke, 2001; Shanks, 2016), and contemporary burdens such as streptococcal 
diseases (Steer et al., 2008; Temple et al., 2012) and scabies (Romani et al., 2015). Such data 
could also inform ongoing programmes such as trachoma elimination (Marks et al., 2015), 
emerging infection preparedness (Moss et al., 2016) and surveillance-response system 
strengthening (Craig, Kool and Nilles, 2013), and insights from island outbreaks of pathogens 
such as Zika (Duffy et al., 2009; Cao-Lormeau et al., 2016; Kucharski et al., 2016). A sustained 
upturn in notified enteric fever cases caused by Salmonella Typhi in Fiji (Thompson et al., 
2014), prompted this investigation of social-mixing patterns. 
Social mixing epidemiological research has predominantly considered conversational contact 
relevant to respiratory diseases such as influenza, or sexual contacts for infections such as 
HIV. Faecal-orally transmitted diseases such as typhoid are not transmitted by droplet or 
aerosol routes, (Cvjetanovic, Grab and Uemura, 1978; Feachem, Mara and Bradley, 1983) 
making conversation less relevant to transmission than mechanisms that involve food, 
fomites, direct contact or waterborne transmission (Bakach et al., 2015). Sexual transmission 
of typhoid is rare, and associated with penile-anal or penile-oral rather than vaginal sex 
(Reller et al., 2003). Methods for social contact patterns estimation of relevance to enteric 
pathogens are required. Quantifying food-sharing contacts may be one approach (Bates et 
al., 2007; Phimpraphai et al., 2017). 
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Furthermore, whilst rarely a reported feature of social contact surveys, ethnicity – which 
encompasses perception of common ancestry or homeland, kinship, language, culture, 
physical characteristics, religion and history (Cornell and Hartmann, 2007)– may also be 
critical to understanding disease dynamics in specific epidemiological circumstances, though 
requires sensitive consideration in biomedical research (Osborne and Feit, 1992; McKenzie 
and Crowcroft, 1996). 
The contribution of different modes of transmission to typhoid fever incidence has been 
reviewed in the historical literature. Rosenau uses “contact infection” as a “convenient term” 
spanning direct and indirect spread from close association in time and place between the 
infectious and the susceptible, whether through physical contact, contaminated linen, 
medical equipment, shared food, drink, cutlery and crockery or other household 
transmission.(Rosenau MJ et al., 1913)  
Budd demonstrated the potential for typhoid person-to-person transmission along social 
networks through his detailed description of an outbreak in rural England, reported alongside 
other outbreaks involving water contaminated by faeces from typhoid fever cases (Budd, 
1873). Sedgwick and Winslow (1902) showed that once piped water had been cleaned in New 
England towns, the residual or prosodemic (person-to-person) transmission of typhoid had a 
mortality rate of around 25 per 100,000 person years; adjusting for historical death-to-
clinical-disease ratios puts these settings into the very high incidence range by today’s 
standards, suggesting waterborne disease is not the only mechanism by which sustained high 
incidence can be attained. 
The contribution of typhoid transmission by direct or indirect person-to-person in the Pacific 
islands is highly uncertain, with a World Health Organization expert elicitation exercise 
deriving a median estimate of 13% and a 95% uncertainty interval of 0% to 51% with similar 
variability in estimates of transmission from food and water. (Hald et al., 2016). Social mixing 
surveys may not directly address this but may inform another form of conceptualisation in 
typhoid epidemiology: short- and long cycle transmission. Though the exact definition is not 
agreed,(González-Guzmán, 1989; Pitzer et al., 2013; The SAGE Working Group on Typhoid 
Vaccines & the WHO Secretariat, 2017) “short cycle” transmission is typically through 
contamination of the immediate environs, which is more likely to be socially-structured, and 
“long-cycle” through the broader environment, which is typically not related to social contact 
patterns. 
Additional to day-to-day contacts, diseases with person-to-person communicability may be 
spread by population movement within a country, if infection does not entirely impede 
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mobility. A further public health threat is the spillover of disease from livestock or wildlife to 
humans, such as leptospirosis (Lau et al., 2012). Zoonotic diseases may give the impression of 
sustained human-to-human transmission when in fact there are multiple spillover events 
from an epizootic (Bausch et al., 2006). Knowledge of human-animal contact patterns may 
inform zoonotic transmission models. 
This social-mixing survey, conducted as part of a seroepidemiological survey, sought to 
determine 1) the distribution of social contacts by age and ethnicity 2) travel and internal 
migration patterns and 3) animal ownership and contact as relevant to the spread of 
communicable diseases in Fiji and other Pacific island settings. 
 
5.3 Methods 
5.3.1 Ethics approval 
The study was approved by the Fiji National Research Ethics Review Committee (2013-03) 
and the London School of Hygiene & Tropical Medicine observational study research ethics 
committee (6344). 
 
5.3.2 Setting 
Fiji is an upper-middle income state of 837,000 people in the South Pacific Ocean (Fiji Bureau 
of Statistics, 2012). Administratively, Viti Levu, the largest island, is divided into Central 
Division (population 342,000 including the capital, Suva) and the Western Division 
(population 320,000). The northern Division (population 136,000) comprises the next largest 
two islands, Vanua Levu and Taveuni. Eastern Division (population 39,000) comprises of many 
smaller island groups.  
An international expert meeting was convened in 2012 by the Fijian Ministry of Health and 
Australian Aid to investigate an upturn in typhoid fever cases from the mid-2000s. Over 90% 
of typhoid cases are reported in indigenous iTaukei Fijians who comprise 57% of the 
population,(Thompson et al., 2014) giving an odds ratio >6 relative to other ethnic groups, 
which include Fijians of Indian descent (Indo-Fijians, 38%) and Fijians of Chinese or European 
descent, thus suggesting ethnicity is important in understanding transmission. Communal 
eating, beyond the immediate family, was commonly observed in iTaukei villages and 
amongst paid workers and students of both major ethnicities in Fiji. Co-dining and food-
sharing was thus identified as a means of recording epidemiologically-relevant mixing 
patterns for enteric infections.  
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5.3.3 Survey methods 
A multistage, clustered, cross-sectional survey was done in the Central, Northern and 
Western Divisions of Fiji between September and December 2013 as a joint serological, risk-
factor and social mixing investigation. The Eastern Division, was excluded for logistical 
reasons, and we did not attempt to assess seasonal variation in contact patterns. 
The community clusters were randomly-selected from Ministry of Health and Medical 
Services administrative lists for nursing zones, a contiguous health geography, with the zones 
selected randomly with probability proportional to population size. Within each cluster, 25 
households were randomly selected. If registers were held by community health workers or 
nurses, these were preferentially used. Otherwise, in street-based settings, rapid 
enumeration of households was done with random start points and set sampling intervals. In 
rural villages/settlements extended program on immunization (EPI)-derived methods were 
used, enumerating households in random (pen-spin) directions from community centroids. 
One participant was randomly selected from each household. Fieldwork was done from 
Monday to Saturday, thereby recording social mixing for Sunday to Friday. Days for visits 
were determined by operational feasibility, not by randomisation and results are not 
reported by day. If a randomly selected household member was temporarily absent from the 
household at the time of the visit due to e.g. work or school, the survey team revisited later 
in the day after their expected return. The full survey methods have been described 
elsewhere (Lau et al., 2016; Watson et al., 2017) Sample size was calculated based on 
expected typhoid seroprevalence in 10 year age bands, the linked serosurvey’s primary 
endpoint.  Whilst a sample size was not calculated for the social mixing survey aspect and 
would be inappropriate to do post-hoc, the study size is consistent with or larger than other 
social mixing surveys (Mossong et al., 2008; Horby et al., 2011; Fu, Wang and Chuang, 2012; 
Read et al., 2014). Where others report individual year contact rates we used broader age 
bands in the survey’s implementation and analysis to provide appropriate precision in ethnic 
and age strata.  
The purpose of the survey was explained to community leaders if applicable, to the head of 
the household and the selected participant, and their permissions sought for inclusion in the 
survey. Written informed consent was sought and obtained from adult participants and 
parents of child (under 18 years) participants. Children aged 12-17 years provided written 
informed assent.  
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Interviews were done face-to-face by a trained, multilingual Fijian fieldworker in iTaukei, 
Hindi or English at the preference of the participant, at the participant’s home or in a 
community centre. Venous blood was collected by a trained phlebotomist or physician. 
Participants provided demographic details, including their age, sex and self-reported 
ethnicity. They were first asked to recall where they had lunch and dinner the previous day, 
to enable recording of both close extra-household and household contact rates. We then 
asked how many people of each age group (defined below) they ate each meal with and 
asked how many of the lunch and dinner contacts were the same individuals (to enable 
calculation of unique daily meal contacts), and asked to give their assessment of the ethnicity 
of co-diners. Ages of contacts were categorised into 0 to 4 years (preschool children), 5 to 14 
years (school-age children), 15 to 34 years (young adults), 35 to 54 (older working-age adults) 
and 55+ (retirement-age adults). If more than fifteen contacts were reported in an age group, 
then ranges 16 to 24, 25 to 49 and 50 to 99 were recorded and midpoints of these bands 
used in analysis. Parents answered on behalf of young children. Infants under one were 
omitted from participation our study, as ineligible for the serological aspect of the field 
survey, though were included in the under 5s as contacts in participant responses. Participant 
ages were categorised as above, with the youngest band 1 to 4 years accordingly. In domestic 
eating settings, including villages, participants were asked to report the details of people with 
whom they actually shared food i.e. cooking pots or buffet meals. For those eating in settings 
where cooking pot sharing would be impossible to estimate and not an appropriate measure 
of social contact (such as at a restaurant or canteen), they were asked to report with whom 
they shared a table or shared a table-like setting. See thesis Appendix A1 for the mealtime 
social contact questionnaire tool. 
 
Participants were further asked about travel outside of their neighbourhood (including 
villages or settlements) in the past week, ever having lived in a different neighbourhood, and 
about animal ownership or physical (touch) contact with select wild animals. 
We also sought information on physical contacts of participants. During survey piloting, 
candidate questions about skin-to-skin human physical contact were often met with 
embarrassment, and often received reports of zero contact with anyone other than between 
parents and infant offspring, despite observance of frequent social contact such as 
handshaking or arm-touching in villages and settlements. This line of enquiry was dropped to 
reduce participant survey fatigue and risk of social response biases in other part of the 
survey. Similarly, breakfast contacts were not sought due to expected overlap with dinner 
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contacts. Fomite contacts are hard to quantify (Read et al., 2012)  and were not sought. 
Water-related exposures are described elsewhere  (Watson et al., 2017). 
 
5.3.4 Data analysis 
Data were entered in EpiData (Lauritsen and Bruus, 2005) and analysed in R version 3.3.2 (R 
Core Team, 2017). Bootstrap 95% confidence intervals (CI) were estimated for mean contact 
rates. Total daily contacts between age and ethnicity subgroups were estimated based on 
census populations and participant-reported rates and used to construct a reciprocal-contact 
adjusted, symmetrical mixing matrix (Wallinga, Teunis and Kretzschmar, 2006). Binomial 95% 
confidence intervals were estimated for travel and animal ownership as prior analysis had 
found minimal influence of clustering on variances for age-structured data on similar 
exposures (Watson et al., 2017).  
To assess possible association between mealtime contacts and biological markers of enteric 
infection transmission, for participants resident in unvaccinated areas, we estimated by 
logistic regression the age-adjusted odds ratios for iTaukei and non-iTaukei contacts and S. 
Typhi seropositivity using anti-Vi IgG titres from a linked serosurvey at thresholds 64 ELISA 
units (EU) and 100 EU alongside examining potential confounders. Previous research in Fiji 
(Watson et al., 2017) established 64 EU as the threshold towards which case titres decay; 
≥100 EU is used to indicate a recent (months to a few years) infection such as may be 
influenced by the reported social mixing patterns. 
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5.4 Results 
 
5.4.1 Study population 
We received 1,814 analysable responses from 1,816 interviewees (two withdrew before 
contributing sufficient data, 1,842 were documented as having been approached, response 
rate = 98.6%). Of these, 1,409 (78%) were iTaukei ethnicity and 53.3% were female (Table 
5.1).  The median age was 30 years (IQR 17 to 48 years), with a median age of 29 years (IQR 
26 to 47 years) in iTaukei and 35 years (IQR 21 to 52 years) in non-iTaukei. In comparison to 
the 2007 census, the non-iTaukei Fijians were under-represented amongst survey 
participants (Supplementary Figure S5.1). Over half of participants resided in rural areas, with 
rural living more common for the iTaukei population (60%), typically living in formal village 
settings (47%), than non-iTaukei (42%) who resided almost exclusively in settlements (59%) 
or residential housing (37%).   
Table 5.1. Participant demographics  
 All participants iTaukei Non-iTaukei 
1,814 1,409 (78) 405 (22) 
Sex (%) Female 966 (53.3) 744 (53.3) 222 (54.8) 
Age (%) 1 to 4    87  (4.8)   74   (5.3)   13  (3.2) 
5-14 299 (16.5) 246 (17.5)    53  (13.1) 
15-34 654 (36.1) 523 (37.1) 131 (32.3) 
35-54 473 (26.1) 347 (24.6) 126 (31.1) 
55+ 301 (16.6) 219 (15.5)   82 (20.2) 
Setting (%) Urban        505 (27.8) 386 (27.4) 119 (29.4) 
Peri-urban       289 (15.9) 175 (12.4) 114 (28.1) 
Rural       1,020 (56.2) 848 (60.2) 172 (42.5) 
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5.4.2 Contact patterns 
The 1,814 participants reported a total of 9,650 mealtime contacts. The distribution of daily 
mealtime contacts reported by participants was right-skewed (Figure 5.1A). Whilst both the 
iTaukei and non-iTaukei modal value was two (Figure 5.1B and C), the iTaukei participant’s 
contacts distribution had higher median (4 vs. 3) than the non-iTaukei participants and a 
higher interquartile range (2-7 vs. 2-5, respectively). After stratification by age and ethnicity 
(Figure 5.1D), heavy-tailed distributions were apparent for the iTaukei in comparison with 
equivalent-age non-iTaukei. The iTaukei aged 5 to 14 years and 15 to 34 years were the most 
likely to report between 5 and 10 mealtime contacts. Few respondents of any age or ethnicity 
reported more than ten such contacts.  
 
Figure 5.1. Distribution of daily contacts   
Reported by A) all participants, B) iTaukei participants, C) non-iTaukei participants and D) 
participants stratified by age and ethnicity.  Fig 1 A to C panels truncated at 50 contacts and D 
panels at 25 contacts for clarity as there were few reports of contact numbers in higher 
bands; densities are for the full range of reported value. 
 
 
Residents of Fiji exhibited strong assortative mixing by age within the two ethnicity categories 
(Table 5.2). The highest mean reported contact rate was for iTaukei participants aged 
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between 5 to 14 years who shared a meal with people of the same age and ethnicity (3.2 
contacts per day; 95% CI 2.67 to 3.98). Few contacts were reported with people of different 
ethnic groups to the respondents; all iTaukei participant age groups had confidence intervals 
that included zero for contacts of different ethnicity. The highest mean reported heteroethnic 
contact rates were reported by Non-iTaukei participants aged between 5 and 14 years with 
their iTaukei counterparts of the same age at 0.61 contacts per day (95% CI 0.25 to 1.14). 
 
Table 5.2. Unweighted mean number of daily contacts by age and ethnicity and 95% bootstrap 
confidence interval 
 
 
 
Contacts 
iTaukei Non-iTaukei 
Age 0 to 4 5 to 14 15 to 34 35 to 54 55+ 0 to 4 5 to 14 15 to 34 35 to 54 55+ 
P
ar
ti
ci
p
an
ts
 
N
o
n
-i
Ta
u
ke
i 
1 to 
4 
0 0.07  
(0 to 
0.23) 
0 0.29  
(0 to 
0.73) 
0.2  
(0 to 
0.62) 
0.13  
(0 to 
0.5) 
0.29  
(0 to 
0.67) 
0.77  
(0.26 to 
1.3) 
0.54  
(0.2 to 1) 
0.45 
(0.09 to 
0.93) 
5 to 
14 
0.09 
(0.02 to 
0.2) 
0.61 
(0.25 to 
1.14) 
0.18 
(0.06 to 
0.34) 
0.31 
(0.06 to 
0.8) 
0.02  
(0 to 
0.07) 
0.17 
(0.07 to 
0.27) 
1.56 
(1.09 to 
2.15) 
0.75  
(0.42 to 
1.31) 
0.93  
(0.68 to 
1.19) 
0.33 
(0.18 to 
0.53) 
15 
to 
34 
0.16 
(0.06 to 
0.31) 
0.13 
(0.04 to 
0.25) 
0.28 
(0.16 to 
0.43) 
0.1  
(0.02 to 
0.23) 
0.14  
(0.05 to 
0.28) 
0.36 
(0.25 to 
0.51) 
0.48 
(0.32 to 
0.67) 
1.18  
(0.91 to 
1.5) 
1.02  
(0.8 to 
1.27) 
0.41 
(0.24 to 
0.63) 
35 
to 
54 
0.04  
(0 to 
0.09) 
0.08 
(0.02 to 
0.16) 
0.17 
(0.07 to 
0.3) 
0.11 
(0.05 to 
0.18) 
0.02  
(0 to 
0.06) 
0.35 
(0.18 to 
0.57) 
0.56  
(0.4 to 
0.77) 
1.07  
(0.81 to 
1.36) 
1.27  
(0.9 to 
1.76) 
0.57  
(0.3 to 
1.03) 
55+ 
0.01  
(0 to 
0.04) 
0.03  
(0 to 
0.13) 
0.08 
(0.01 to 
0.17) 
0.07 
(0.01 to 
0.16) 
0.07  
(0.01 to 
0.15) 
0.1  
(0.03 to 
0.18) 
0.19 
(0.07 to 
0.35) 
0.82  
(0.55 to 
1.14) 
0.57  
(0.39 to 
0.76) 
0.59 
(0.43 to 
0.79) 
iT
au
ke
i 
1 to 
4 
1.15 
(0.84 to 
1.49) 
1.05 
(0.63 to 
1.62) 
1.66 
(1.32 to 
2.09) 
0.85 
(0.61 to 
1.1) 
0.51  
(0.33 to 
0.72) 
0.01  
(0 to 
0.05) 
0 0 0.03  
(0 to 0.1) 
0 
5 to 
14 
0.63 
(0.47 to 
0.81) 
3.2  
(2.67 to 
3.98) 
1.25 
(1.09 to 
1.4) 
1.28 
(1.16 to 
1.4) 
0.33  
(0.24 to 
0.45) 
0.01  
(0 to 
0.02) 
0.03  
(0 to 
0.07) 
0  
(0 to 
0.02) 
0.01  
(0 to 0.03) 
0  
(0 to 
0.01) 
15 
to 
34 
0.75 
(0.64 to 
0.87) 
0.99 
(0.86 to 
1.13) 
2.31 
(2.05 to 
2.58) 
1.34 
(1.14 to 
1.56) 
0.67  
(0.54 to 
0.83) 
0  
(0 to 
0.01) 
0.01  
(0 to 
0.01) 
0.01  
(0 to 
0.02) 
0.01  
(0 to 0.03) 
0 
35 
to 
54 
0.47 
(0.37 to 
0.58) 
1.19 
(1.02 to 
1.36) 
1.42 
(1.18 to 
1.69) 
1.54 
(1.28 to 
1.84) 
0.59  
(0.45 to 
0.75) 
0 0  
(0 to 
0.01) 
0.02  
(0 to 
0.04) 
0.01  
(0 to 0.04) 
0.01  
(0 to 
0.02) 
55+ 
0.48 
(0.36 to 
0.61) 
0.84 
(0.67 to 
1.04) 
1.08 
(0.89 to 
1.32) 
0.92 
(0.71 to 
1.19) 
0.91  
(0.74 to 
1.1) 
0 0 0.01  
(0 to 
0.02) 
0  
(0 to 0.02) 
0.01  
(0 to 
0.02) 
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iTaukei household sizes had a median of 5 residents and mean of 4.9 residents compared 
with a median of 4 residents and mean of 4.0 residents for non-iTaukei households. Data 
from lunchtime contacts indicated that contact rates did not only reflect household structure. 
Whilst eating dinner at home was almost universal (95%), 22% of iTaukei respondents had 
lunch contacts away from home, as did 21% of non-iTaukei. Those reporting lunch away from 
home also reported more contacts than those lunching at home (mean, median and IQR 8.0, 
6, 3 to 9 and 4.5, 4, 2 to 6 contacts, respectively, p<0.0001). Participants eating lunch away 
from home (Table 5.3) had contact patterns indicating similar age and ethnically assortative 
mixing as seen in the overall contact pattern. 
 
Table 5.3. Unweighted mean number of non-household lunch contact by age and ethnicity 
(bootstrap 95% confidence intervals) 
 
 
 
Contacts 
iTaukei Non-iTaukei 
Age 0 to 4 5 to 14 15 to 34 35 to 54 55+ 0 to 4 5 to 14 15 to 34 35 to 54 55+ 
P
ar
ti
ci
p
an
ts
 
N
o
n
-i
Ta
u
ke
i 
1 to 
4 NA NA NA NA NA NA NA NA NA NA 
5 to 
14 
0.08  
(0 to 
0.18) 
0.7  
(0.19 to 
1.34) 
0.19 
(0.03 to 
0.36) 
0.43 
(0.05 to 
1.14) 0 
0.14 
(0.03 to 
0.26) 
1.78 
(1.21 to 
2.45) 
0.78  
(0.3 to 
1.48) 
0.84  
(0.54 to 
1.12) 
0.38 
(0.17 to 
0.64) 
15 
to 
34 
0.19  
(0 to 
0.67) 
0.22  
(0 to 
0.69) 
0.25  
(0 to 
0.67) 
0.22  
(0 to 
0.78) 
0.19  
(0 to 0.67) 
0.56 
(0.24 to 
1) 
0.5  
(0.09 to 
1.06) 
2.38  
(1.68 to 
3.21) 
1.69  
(1.08 to 
2.46) 
0.72 
(0.22 to 
1.5) 
35 
to 
54 0 0 0 
0.05  
(0 to 
0.15) 0 
1  
(0.06 to 
2.14) 
1  
(0.33 to 
1.83) 
1.95  
(0.92 to 
3.18) 
3.3  
(1.28 to 6) 
2.1  
(0.35 to 
4.4) 
55+ 0 0 0 0 0 0 
0.5  
(0 to 2) 
0.75  
(0 to 3) 
1.25  
(0 to 4) 
0.25  
(0 to 1) 
iT
au
ke
i 
1 to 
4 
2  
(0.33 to 
4) 
2.67  
(0 to 
8.59) 
0.83  
(0 to 
1.67) 
1.33 
(0.33 to 
2.33) 
0.33  
(0 to 0.8) 0 0 0 0 0 
5 to 
14 
0.65 
(0.42 to 
0.93) 
4.86 
(3.72 to 
6.51) 
1.3 (1.07 
to 1.56) 
1.27 
(1.08 to 
1.45) 
0.38  
(0.23 to 
0.57) 
0.01  
(0 to 
0.03) 
0.04  
(0 to 
0.12) 
0  
(0 to 0) 
0.01  
(0 to 0.03) 
0.01  
(0 to 
0.03) 
15 
to 
34 
0.86 
(0.54 to 
1.24) 
1.28 
(0.96 to 
1.68) 
3.42 
(2.79 to 
4.11) 
2.15 
(1.56 to 
2.95) 
0.86  
(0.45 to 
1.48) 0 0 
0.03  
(0 to 0.07) 
0.03  
(0 to 0.06) 0 
35 
to 
54 
0.54 
(0.17 to 
1) 
1.37 
(0.82 to 
2.08) 
2.44 
(1.48 to 
3.59) 
2.76 
(1.77 to 
3.94) 
0.93  
(0.41 to 
1.56) 0 0 
0.05  
(0 to 0.17) 
0.05  
(0 to 0.17) 0 
55+ 
1  
(0.48 to 
1.62) 
1.39 
(0.76 to 
2.11) 
1.93 
(1.17 to 
2.9) 
1.79 
(0.91 to 
2.87) 
1.32  
(0.75 to 2) 0 0 0 0 0 
 
After adjusting for reciprocity of contacts (census population and survey participant pyramids 
are shown in Supplementary Figure S5.1), total daily contact data indicated sparse mixing 
between iTaukei and non-iTaukei ethnicity categories in all but school-age children (Figure 
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5.2). Age-assortative mixing was apparent within the two ethnicity categories, along with off-
diagonal mixing, indicative of parent-child contact.  In both ethnic categories, school-age 
children had the highest mean contact rates, followed by working-age adults. In contrast to 
the iTaukei pre-school children, the non-iTaukei children aged 1 to 4 years exhibited 
disassortative mixing, with more contacts reported within the working age adults than 
children of the same age. 
 
Figure 5.2. Age and ethnicity structured mixing matrices of reciprocity-weighted 
unique mealtime contacts per day.  
 
We next examined the influence of unit increases in number of contacts on seropositivity for 
anti-Vi IgG S. Typhi amongst 1,559 participants (1,530 with complete data) from unvaccinated 
areas of Fiji. Age-adjusted seropositivity showed no correlation at threshold 64 EU used as a 
marker of any previous or current infection (odds ratio (OR) 1.01; 95% CI 0.99 to 1.02; p=0.3) 
but some evidence of association at 100 EU, posited as indicative of recent infection (OR 
1.02; 95% CI 1.00 to 1.03; p=0.002) (supplementary text S5.1). 
We performed further age-adjusted analyses to identify potential confounding variables and 
ascertain drivers for any such observed effect (supplementary text S5.1). Examination by 
197 
 
ethnicity of contacts across both participant ethnic categories combined identified elevated 
odds ratios for association between unit increase in number of iTaukei contacts and the 100 
EU recent infection serological threshold. No association was found for number of non-
iTaukei contacts and seropositivity. The iTaukei contact rate association was not influenced 
by adjustment for participant ethnicity, the number of non-iTaukei contacts, or eating lunch 
outside the home when examined by multivariable regression (supplementary text 5.1). 
Analysis stratified by participant ethnicity found an effect of increasing contact rates in 
increasing seroprevalence amongst iTaukei participants but not non-iTaukei participants.  
A parsimonious epidemiological model was constructed for serological association of recent 
infection with age-adjusted iTaukei contact rates in the unvaccinated iTaukei group, with 
non-iTaukei excluded from the model due to the absence of observed association between 
any contact rates and seropositivity, finding evidence of association at the 100 EU threshold 
(“recent infection”) for a per contact increase in odds of seropositivity, after adjusting for age   
A final model for recent was developed adjusting for epidemiological risk factors found 
previously to be associated with seropositivity at 64 EU: after adjusting for these, iTaukei 
contact remained associated with seropositivity, with adjusted odds of 1.027 (1.008 to 1.045) 
(table 5.4). 
 
Table 5.4. Logistic regression model of association between contact rates and seropositivity 
For anti-Vi IgG seropositivity (100 EU), iTaukei daily contact number and participant age in 
1,189 iTaukei participants from areas of Fiji never vaccinated against typhoid, adjusted for co-
variables found significant in the seroepidemiology survey (chapter 3). 
    
    
 
Variable Adjusted odds ratio (95%CI) p-value 
iTaukei contact (per) 1.027 (1.008 to 1.045) 0.003 
Age (per year) 1.025 (1.018 to 1.032) <0.001 
Sewage – septic tank Reference   
Sewage – piped sewer 1.05 (0.69 to 1.60) 0.8 
Sewage – pit latrine 1.10 (0.67 to 1.73) 0.7 
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Sewage – elsewhere 0.97 (0.42 to 2.03) 0.9 
Community - Residential Reference   
Community - Village 1.07 (0.72 to 1.63) 0.7 
Community - Settlement 1.35 (0.91 to 2.01) 0.14 
 
 
5.4.3 Travel and internal migration patterns 
Local travel was common amongst the survey participants, with over half reporting travel 
outside of their residential community in the past week for all but the youngest and oldest 
age groups (figure 5.3). Similar proportions of iTaukei and non-iTaukei reported travel in the 
past week. Recent travel was similar for urban, rural, and peri-urban residents (data not 
shown). Most travel was within the geographical administrative division (i.e. Central, Eastern, 
Northern, or Western Division of Fiji); of 974 participants reporting travel, 43 (4.2%, 95%CI 
3.2% to 5.6%) reported travel to another Division in the past week. 
 
Figure 5.3. Travel outside of the community in the past week  
 
Overall 37.2% (670/1803, 95% CI 35.0 to 39.4%) reported having moved residential 
community in their lifetimes. Participants aged 40 to 44 were most likely to have moved from 
a different place (Supplement Fig S5.2A) to their current community of residence.  Those 
aged 20 to 24 years were most likely to report having moved in the past 5 years, regardless of 
ethnicity category (Supplement Figs S5.2B and S5.2C). Non-iTaukei children were more likely 
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to have moved than iTaukei children, while adult iTaukei were more likely to have moved 
recently than non-iTaukei. 
 
5.4.4 Animal ownership and contact 
Animal ownership was common in both ethnicity categories and across urban/peri-urban and 
rural households (Supplementary Tables S5.1A and S5.1B). Pigs were the most commonly 
owned animal (28% of households (95% CI22 to 26%) despite being infrequently kept by non-
iTaukei Fijians (5.7%, 95% CI 3.8 to 8.4%).  Chickens were also widely kept, particularly by 
non-iTaukei (36%, 95% CI 31.5 to 40.8%). In rural communities, 20.8% (95% CI 18.4 to 23.4%) 
owned horses, with comparable ownership in both ethnic groups. This association contrasted 
with goat ownership, which was predominantly amongst rural non-iTaukei (30.8, 95%CI 24.4 
to 38.1%, compared with mean prevalences <10% amongst other groups). Few Fijians 
reported keeping sheep (1.2% 95% CI 0.8 to 1.8%).  Physical contact with wild rats or 
mongooses was reported infrequently (Supplement Table S5.1C) despite sightings of these by 
90% and 75% of participants, respectively.  
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5.5 Discussion 
Empirical research on contact patterns for infectious disease modelling has to date primarily 
considered epidemiological contacts for transmission of sexual or respiratory diseases. Social 
mixing patterns of direct relevance to enteric infections, or patterns of animal contact 
relevant to zoonotic spillover are less studied.  
Using unique daily mealtime contacts, our social contact survey of Fiji found that within 
iTaukei and non-iTaukei ethnic groups there is age-assortative mixing, even within broad age 
categories, similar to contact patterns studied in the transmission of respiratory diseases 
seen in Asian or European settings (Mossong et al., 2008; Horby et al., 2011; Fu, Wang and 
Chuang, 2012; Read et al., 2014). We found minimal social mixing between people of the two 
ethnic categories, with inter-ethnic mixing most common amongst school-age children. 
iTaukei participants had higher mean daily contact rates than non-iTaukei participants. 
Examination of extra-domestic lunchtime contacts indicates that these patterns are 
replicated outside the home, showing that data do not simply reflect household structure. 
High levels of mobility in the population for all ages from 5 years upwards (overall >50% 
travelling in the previous week) suggest that communities on these larger Fijian islands are 
not isolated and transmission between urban and rural populations is readily feasible. 
These data suggest it is plausible that effectively independent epidemics could occur in 
iTaukei and non-iTaukei residents of Fiji, for pathogens whose transmission can be 
approximated by mealtime contacts, given the low rates of substantive hetero-ethnic 
contact. The higher contact rates amongst iTaukei Fijians would more readily sustain short-
cycle transmission than the rates in non-iTaukei Fijians. Analysis of age-adjusted contact rates 
and anti-Vi IgG to Salmonella Typhi found association with inter-iTaukei contacts and titres 
above a threshold that may be indicative of recent past infection but no association for 
contact rates involving non-iTaukei, further supporting use of these ethnically-structured 
social contact data in infectious disease modelling. This association remained after adjusting 
for covariables found to be significant in prior work, (Watson et al., 2017) suggesting social 
structure to be important.  Our recording of animal ownership by ethnicity enables 
estimation of the impact of differential seeding of zoonotic diseases such as avian influenza 
were they to first arrive in the Pacific as an epizootic. 
The absolute contact rates obtained in this study cannot readily be compared with those 
from Mossong and others which are primarily conversational in nature and not restricted to 
mealtimes. Nor do we attempt to document changing social contact patterns during acute 
illness (Eames et al., 2010; Van Kerckhove et al., 2013). However, their origins in mealtime 
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contact do not limit these data to application in enteric disease only. As Goeyvaerts  and 
colleagues (2010) note, the importance of empirically-obtained social mixing rates is that 
they represent relative mixing patterns between population subgroups as proxies for the 
distribution of mechanisms of disease transmission. This study does not attempt to elucidate 
the relative contributions these components of the potential chain of typhoid transmission 
from portal of entry to exit but suggests these distributions may be reflected in social contact 
patterns. Similarly, Melegaro and colleagues’ 2011 study of airborne viral pathogens found 
“that intimate types of contacts explain the pattern of acquisition of serological markers by 
age better than other types of social contacts”.  
In the absence of setting-specific data, these data might be very cautiously applied to use in 
other Pacific Island countries and territories, though more applicable to larger states than to 
low-lying small islands given that data collection excluded Fiji’s Eastern Division. Unadjusted 
iTaukei contact rates could be applied in many settings; unadjusted inter-ethnicity contact 
patterns could have potential application in settings such as French Polynesia where the 
estimated ethnically non-Polynesian population is relatively large at 22% (Anon, 2016), 
though do not account for the different social and cultural norms of such settings.  
Our survey demonstrates that it is feasible and socially acceptable to gather data on social 
mixing not only by age but by ethnicity, in settings where heterogeneity may be of relevance 
to transmission networks and dynamics. Interestingly, we found non-iTaukei pre-school 
children had non-assortative mixing, in that they had greater contact with older age groups 
rather than with children of the same age, suggesting mealtime contact within a small family 
structure. Similar findings were reported in a UK study of under-ones (van Hoek et al., 2013). 
This contrasts to assortative mixing in iTaukei pre-schoolers, consistent with sustained high 
birth rates/large extended families in iTaukei Fijians (Fiji Bureau of Statistics, 2012) and the 
divergent demographic trends in iTaukei and non-iTaukei Fijians (Supplementary Fig S5.1).  
Compared with social contact survey settings overseas, low relative contact rates in older 
adult Fijians may reflect both lower adult life expectancy (Taylor et al., 2013) as well as 
different social mixing patterns. 
We found that non-iTaukei participants, predominantly comprising Indo-Fijians, were under-
represented in the survey relative to census estimates, despite use of a structured sampling 
method. This may to some extent reflect continued outmigration and potentially within-
country rural-to-urban migration differentially increasing nursing zones populations in 
majority Indo-Fijian areas above the numbers used in the sampling frames. Boosted surveys 
of non-iTaukei residents could address this, though value of the expected potential gains in 
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precision would need consideration. The high reported enrolment rate likely reflects 
incomplete documentation of candidate participants approached who declined involvement. 
Theoretical mixing structures that are not informed by data are largely being replaced in 
infectious disease modelling by contact patterns derived from data. Traditional, line-listing, 
prospective, paper-based, contact diaries can be demanding for participants and in data 
entry/analysis. Methods of measuring contact utilising portable electronic devices, such as 
mobile phone tracing (Wesolowski et al., 2012; Bengtsson et al., 2015) and RFID tagging 
(Cattuto et al., 2010; Stehlé et al., 2011) increasingly offer methods for collecting rich data on 
contact patterns but can involve substantive cost and/or complexity. There can be an 
advantageous degree of simplicity in asking people with whom they ate yesterday and where 
they travelled in the last week.  Data for model parameterisation can be collected in a single-
contact survey potentially alongside serology and behavioural or environmental risk data. 
Although retrospective survey responses may risk recall bias, we found that the previous 
day’s lunch and dinner partners were readily recallable by participants. This also reduces 
respondent fatigue and avoids potential for behaviour modifications that a prospective diary 
might trigger. Social response bias is reduced by reassurance that individual responses are 
kept confidential, and the socially-acceptable nature of enquiry, including careful structuring 
of ethnicity questions. 
 
Whilst eating patterns themselves are an important public health topic with regards to the 
enormous impact of the epidemic of non-communicable disease in the Pacific and worldwide 
(Taylor, 1983; Ng et al., 2017) they also offer insights for infectious disease epidemiologists 
and modellers. “Who-eats-with-whom” reflects social intimacy as well as specific food-borne 
and fomitic transmission risks and can effectively document ethnic- as well as age-assortative 
mixing. The universality of food-sharing as a human experience lends this approach, 
developed for enteric infectious diseases in Pacific Islands, to a range of settings where 
people interact and infections may transmit. 
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5.7 Supplementary material 
 
 
Supplementary Fig S5.1. Age distribution (count) of iTaukei and non -iTaukei in 
Fiji in A) 2007 census and B) 2013 social contact survey.  
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Supplementary Fig S5.2. Lifetime prevalence of having moved community and 
moved in the last five years  
for A) all participants, B) iTaukei participants, C) non-iTaukei participants, by five-year age 
bands. Hollow points denote 95% confidence intervals. 
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Supplement Table S1. Animal contact by ethnicity and geography  
(A: owned livestock, B: other owned domesticated animals, C: physical contact with wild 
rodents) 
A 
Geography 
Overall  
n            % (95% CI) 
iTaukei  
n    % (95% CI) 
Non-iTaukei  
n  % (95% CI) 
Chicken All 441 24.3 (22.4 to 26.3) 295 20.9 (18.9 to 23.1) 146 36 (31.5 to 40.8) 
Urban 23 4.6 (3.1 to 6.7)  16 4.1 (2.6 to 6.6)  7 5.9 (2.9 to 11.6)  
Peri-urban 55 19 (14.9 to 24)  24 13.7 (9.4 to 19.6)  31 27.2 (19.9 to 36)  
Rural 
363 35.6 (32.7 to 38.6)  255 30.1 (27.1 to 33.2)  108 
62.8 (55.4 to 
69.7)  
Cows All 388 
21.4 (19.6 to 23.3) 
316 22.4 (20.3 to 24.7) 72 17.8 (14.4 to 
21.8) 
Urban 44 8.7 (6.6 to 11.5)  42 10.9 (8.2 to 14.4)  2 1.7 (0.5 to 5.9)  
Peri-urban 41 14.2 (10.6 to 18.7)  27 15.4 (10.8 to 21.5)  14 12.3 (7.5 to 19.6)  
Rural 303 29.7 (27 to 32.6)  247 29.1 (26.2 to 32.3)  56 32.6 (26 to 39.9)  
Goats All 155 8.5 (7.3 to 9.9) 91 6.5 (5.3 to 7.9) 64 15.8 (12.6 to 
19.7) 
Urban 29 5.7 (4 to 8.1)  27 7 (4.9 to 10)  2 1.7 (0.5 to 5.9)  
Peri-urban 26 9 (6.2 to 12.9)  17 9.7 (6.2 to 15)  9 7.9 (4.2 to 14.3)  
Rural 
100 9.8 (8.1 to 11.8)  47 5.5 (4.2 to 7.3)  53 
30.8 (24.4 to 
38.1)  
Pigs 
 
All 508 28 (26 to 30.1) 485 34.4 (32 to 36.9) 23 5.7 (3.8 to 8.4) 
Urban 64 12.7 (10.1 to 15.9)  62 16.1 (12.7 to 20.1)  2 1.7 (0.5 to 5.9)  
Peri-urban 57 19.7 (15.5 to 24.7)  47 26.9 (20.8 to 33.9)  10 8.8 (4.8 to 15.4)  
Rural 387 37.9 (35 to 41)  376 44.3 (41 to 47.7)  11 6.4 (3.6 to 11.1)  
Sheep All 21 1.2 (0.8 to 1.8) 14 1 (0.6 to 1.7) 7 1.7 (0.8 to 3.5) 
Urban 0 0 (0 to 0.8)  0 0 (0 to 1)  0 0 (0 to 3.1)  
Peri-urban 11 3.8 (2.1 to 6.7)  10 5.7 (3.1 to 10.2)  1 0.9 (0 to 4.8)  
Rural 10 1 (0.5 to 1.8)  4 0.5 (0.2 to 1.2)  6 3.5 (1.6 to 7.4)  
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B 
Geography 
Overall  
n            % (95% CI) 
iTaukei  
n    % (95% CI) 
Non-iTaukei  
n  % (95% CI) 
Cats 
 
All 320 17.6 (16 to 19.5) 219 15.5 (13.7 to 17.5) 101 24.9 (21 to 29.4) 
Urban 84 16.6 (13.6 to 20.1)  59 15.3 (12 to 19.2)  25 21 (14.7 to 29.2)  
Peri-urban 
63 21.8 (17.4 to 26.9)  38 21.7 (16.2 to 28.4)  25 
21.9 (15.3 to 
30.4)  
Rural 
173 17 (14.8 to 19.4)  122 14.4 (12.2 to 16.9)  51 
29.7 (23.3 to 
36.9)  
Dogs All 577 31.8 (29.7 to 34) 397 28.2 (25.9 to 30.6) 180 44.4 (39.7 to 
49.3) 
Urban 
146 28.9 (25.1 to 33)  101 26.2 (22 to 30.8)  45 
37.8 (29.6 to 
46.8)  
Peri-urban 98 33.9 (28.7 to 39.5)  48 27.4 (21.4 to 34.5)  50 43.9 (35.1 to 53)  
Rural 333 32.6 (29.8 to 35.6)  248 29.2 (26.3 to 32.4)  85 49.4 (42 to 56.8)  
Horses All 265 14.6 (13.1 to 16.3) 233 16.5 (14.7 to 18.6) 32 7.9 (5.7 to 10.9) 
Urban 35 6.9 (5 to 9.5)  33 8.5 (6.2 to 11.8)  2 1.7 (0.5 to 5.9)  
Peri-urban 18 6.2 (4 to 9.6)  18 10.3 (6.6 to 15.7)  0 0 (0 to 3.3)  
Rural 212 20.8 (18.4 to 23.4)  182 21.5 (18.8 to 24.4)  30 17.4 (12.5 to 
23.8)  
 
 
 
C 
Geography 
Overall  
n        % (95% CI) 
iTaukei  
n        % (95% CI) 
Non-iTaukei  
n        % (95% CI) 
Mongooses All 110 6.1 (5.1 to 7.3) 103 7.3 (6.1 to 8.8) 7 1.7 (0.8 to 3.5) 
Urban 19 3.8 (2.4 to 5.8)  18 4.7 (3 to 7.3)  1 0.8 (0 to 4.6)  
Peri-urban 13 4.5 (2.6 to 7.5)  9 5.1 (2.7 to 9.5)  4 3.5 (1.4 to 8.7)  
Rural 78 7.6 (6.2 to 9.4)  76 9 (7.2 to 11.1)  2 1.2 (0.3 to 4.1)  
Rats 
 
All 247 13.6 (12.1 to 
15.3) 
220 15.6 (13.8 to 17.6) 27 6.7 (4.6 to 9.5) 
Urban 56 11.1 (8.6 to 14.1)  50 13 (10 to 16.7)  6 5 (2.3 to 10.6)  
Peri-urban 
38 13.1 (9.7 to 17.5)  26 14.9 (10.3 to 20.9)  12 
10.5 (6.1 to 
17.5)  
Rural 153 15 (12.9 to 17.3)  144 17 (14.6 to 19.7)  9 5.2 (2.8 to 9.6)  
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5.7.1 Supplementary text. 
 
Supplementary text S5.1. Seropositivity and social contact regression analysis 
This supplementary text describes logistic regression analyses that were undertaken to 
develop understanding of association between mealtime social contact rates and 
seroprevalence in Fiji when taking into account potential confounding variables and ethnicity-
based contact rates. These analyses follow an initial strong signal for association between 
total contact rates and seropositivity in the total survey group. These analyses are of 
residents of unvaccinated areas of mainland Fiji only, to reduce noise from vaccine-associated 
seropositivity on Taveuni island. 
Figure ST5.1 Fig 1 shows participants’ contact rates, by participant ethnicity and proportion of 
contacts that were of iTaukei ethnicity. These data show that most participants have contact 
with only one ethnicity category of contact, which is usually the same category as the 
participant. There are a number of participants with mealtime contacts from the other ethnic 
category only, and relatively few with mealtime contacts across both ethnic categories. 
 
ST5.1 Fig 1. Number of contacts per iTaukei and non -iTaukei participant, by 
proportion of contacts that were iTaukei.  
 
We first examined odds ratios for association between anti-Vi IgG seropositivity and total 
number of contacts, adjusting for participant age, without ethnicity adjustment for contacts 
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or participants. This association was examined at both a seropositivity threshold of 64 EU, 
determined in prior research to be suggestive of previous or current infection, and 100 EU, 
more suggestive of recent or current infection. The recent infection 100 EU marker was 
considered to be more likely to be influenced by the participants’ reported contact rates, as 
contact rates may have changed over time, particularly given the variation in contact rates 
demonstrated across age groups in the social mixing survey. Data for 64 EU are reported here 
for completeness. Data were available for 1559 participants from unvaccinated areas of Fiji 
mainland. 
Evidence of association between seropositivity and total contact rates (contacts of any ethnic 
category) was observed at 100 EU, with an effect size of approximately* 2% additional 
likelihood of seropositivity per additional contact. No association was demonstrated at 64 EU 
(ST5.1 Tables 1 and 2). 
* Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438-445. 
The data were then analysed by ethnicity of contacts (ST5.1 Table 1 and 2). Some evidence 
was observed for association with iTaukei contacts at 64 EU, with stronger evidence of 
association at 100 EU, where data showed a similar effect size per contact to the above total 
contact rates analyses and greater strength of association. Weak association between 
increasing non-iTaukei contact rates and seronegativity was observed at 64 EU but not 
supported by examination at 100 EU. This suggested there was no association between non-
iTaukei contact rates and seropositivity but that these data might contribute to non-
differential misclassification when included in analysis of total contact rates. 
ST5.1 Table 1. 100 EU Vi IgG threshold, participants from unvaccinated areas, all ethnicities. 
Model Variable Odds ratio  p-value AIC 
1. Any contact 
Age  
1.02 (1.00 to 1.04)  
1.025 (1.019 to 1.032) 
0.02 
<0.0001 
1376 
2. iTaukei contact 
Age 
1.025 (1.007 to 1.042)  
1.026 (1.019 to1.033) 
0.005 
<0.0001 
1373.5 
3. Non-iTaukei contact 
Age 
0.96 (0.89 to 1.02)  
1.025 (1.018 to 1.031) 
0.2 
<0.0001 
1378.9 
 
ST5.1 Table 2.  64 EU Vi IgG threshold, participants from unvaccinated areas, all ethnicities. 
Model Variable Odds ratio  p-value AIC 
4. Any contact  
Age 
1.01 (0.99 to 1.02) 
1.026 (1.020 to 1.032) 
0.33 
<0.0001 
1854.1 
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5. iTaukei contact 
Age 
1.01 (1.00 to 1.03)  
1.026 (1.020 to 1.032) 
0.08 
<0.0001 
1852.1 
6. Non-iTaukei contact 
Age 
0.96 (0.91 to 1.00) 
1.026 (1.020 to 1.031) 
0.1 
<0.0001 
1851.7 
 
Analyses were next undertaken to determine whether an effect remained when data were 
stratified by the ethnicity of the survey participant. Amongst the 1,189 iTaukei participants, 
strong association with 100 EU seropositivity was observed for increasing total or iTaukei 
contact rates (ST5.1 Table 3). This is consistent with the ST5.1 Table 1 models and ST5.1 Fig 1, 
as iTaukei participants comprise the large majority of respondents and primarily report 
iTaukei contacts. At 64 EU, models of iTaukei participants including total contacts or iTaukei 
contacts showed some association (ST5.1 Table 4). Non-iTaukei contact rates in iTaukei 
participants showed weak evidence of association for 64 EU seropositivity and this 
association further weakened at 100 EU.  
Amongst the 370 non-iTaukei participants, no association between seropositivity and 
contacts of any or either ethnic category was observed at 100 EU or 64 EU thresholds (ST5.1 
Tables 5 and 6). 
 
ST5.1 Table 3. 100 EU Vi IgG threshold, participants of iTaukei ethnicity from unvaccinated 
areas. 
Model Variable Odds ratio (95% CI) P value AIC 
7. Any contact, age 
adjusted 
Any contact 
Age (year) 
1.026 (1.007 to 1.045) 
1.023 (1.015 to 1.030) 
0.005 
<0.0001 
1046 
8. Ethnically-stratified 
contact, age adjusted 
iTaukei contact 
non-iTaukei contact 
Age (year) 
1.026 (1.007 to 1.044) 
1.24 (0.84 to 1.77) 
1.023 (1.015 to 1.031) 
0.005 
0.2 
<0.0001 
1047 
 
ST5.1 Table 4. 64 EU Vi IgG threshold, participants of iTaukei ethnicity from unvaccinated 
areas. 
Model Variable Odds ratio (95% CI) P value AIC 
9. Any contact, age 
adjusted 
Any contact 
Age (year) 
1.01 (1.00 to 1.03) 
1.026 (1.019 to 1.032) 
0.1 
<0.0001 
1416.7 
10. Ethnically-stratified 
contact, age adjusted 
iTaukei contact 
non-iTaukei contact 
1.01 (1.00 to 1.03) 
1.40 (1.00 to 2.04) 
0.1 
0.06 
1415.1 
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Age (year) 1.026 (1.019 to 1.033) <0.0001 
 
ST5.1 Table 5. 100 EU Vi IgG threshold, participants of non-iTaukei ethnicity from unvaccinated 
areas. 
Model Variable Odds ratio (95% CI) P value AIC 
11. Any contact, age 
adjusted 
Any contact 
Age (year) 
0.95 (0.86 to 1.02) 
1.035 (1.020 to 1.052) 
0.3 
<0.0001 
328.42 
12. Ethnically-stratified 
contact, age adjusted 
iTaukei contact 
non-iTaukei contact 
Age (year) 
0.98 (0.80 to 1.10) 
0.95 (0.85 to 1.02) 
1.035 (1.020 to 1.052) 
0.8 
0.2 
<0.0001 
330.28 
 
ST5.1 Table 6. 64 EU Vi IgG threshold, participants of non-iTaukei ethnicity from unvaccinated 
areas. 
Model Variable Odds ratio (95% CI) P value AIC 
13. Any contact, age 
adjusted 
Any contact 
Age (year) 
0.95 (0.88 to 1.01) 
1.027 (1.015 to 1.041) 
0.1 
<0.0001 
436.05 
14. Ethnically-stratified 
contact, age adjusted 
iTaukei contact 
non-iTaukei contact 
Age (year) 
0.92 (0.75 to 1.04) 
0.95 (0.88 to 1.01) 
1.027 (1.015 to 1.040) 
0.3 
0.2 
<0.0001 
437.83 
 
Having observed an age-adjusted association between increasing daily number of iTaukei 
contacts and recent Salmonella Typhi infection, driven by contacts made by iTaukei 
participants, we examined the full participant dataset for the influence of covariates such as 
lunching away from home on this association (S3 Tables 7 and 8). As these covariates did not 
substantially influence the effect size or evidence of association, the model presented in the 
main paper is the parsimonious model accounting for iTaukei contacts and participant age 
only. As non-iTaukei participants showed no association between contact rates and 
seropositivity, the model shown in the main paper is that applying to iTaukei only. 
 
ST5.1 Table 7. 100 EU Vi IgG threshold multivariable regression models, unvaccinated areas, 
participants of all ethnicities 
Model Variable Odds ratio (95% CI) P value AIC 
15.  iTaukei contact 
non-iTaukei contact 
Age (year) 
1.023 (1.005 to 1.041) 
0.98 (0.91 to 1.03) 
1.026 (1.019 to 1.033) 
0.01 
0.4 
<0.0001 
1374.8 
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16. iTaukei contact 
non-iTaukei contact 
Age (year) 
Non-iTaukei ethnicity 
1.025 (1.006 to 1.044) 
0.96 (0.87 to 1.02) 
1.025 (1.018 to 1.032) 
1.2 (0.8 to 1.8) 
0.007 
0.3 
<0.0001 
0.4 
1376 
17. iTaukei contact 
non-iTaukei contact 
Age (year) 
Lunch away from home 
1.01 (1.00 to 1.04) 
0.97 (0.91 to 1.02) 
1.026 (1.019 to 1.034) 
1.2 (0.8 to 1.6) 
0.022 
0.4 
<0.0001 
0.3 
1375.4 
18. iTaukei contact 
non-iTaukei contact 
Age (year) 
Non-iTaukei ethnicity  
Lunch away from home 
1.023 (1.004 to 1.042) 
0.95 (0.87 to 1.02) 
1.026 (1.019 to 1.033) 
1.2 (0.8 to 1.8) 
1.2 (0.8 to 1.7) 
0.015 
0.3 
<0.0001 
0.4 
0.3 
1376.5 
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ST5.1 Table 8. 64 EU Vi IgG threshold multivariable regression models, unvaccinated areas, 
participants of all ethnicities 
Model Variable Odds ratio (95% CI) P value AIC 
19. iTaukei contact 
non-iTaukei contact 
Age (year) 
 
1.01 (0.99 to 1.03) 
0.97 (0.91 to 1.01) 
1.026 (1.020 to 1.032) 
0.17 
0.17 
<0.0001 
1851.8 
20. iTaukei contact 
non-iTaukei contact 
Age (year) 
Non-iTaukei ethnicity 
1.01 (0.99 to 1.03) 
0.97 (0.91 to 1.02) 
1.026 (1.020 to 1.032) 
0.92 (0.69 to 1.29) 
0.2 
0.3 
<0.0001 
0.6 
1853.6 
21. iTaukei contact 
non-iTaukei contact 
Age (year) 
Non-iTaukei ethnicity  
Lunch away from home 
1.01 (1.00 to 1.03) 
0.97 (0.91 to 1.02) 
1.026 (1.021 to 1.033) 
0.93 (0.67 to 1.3) 
1.04 (0.78 to 1.37) 
0.2 
0.3 
<0.0001 
0.7 
0.8 
1852.5 
22. iTaukei contact 
non-iTaukei contact 
Age (year) 
Non-iTaukei ethnicity  
Lunch away from home 
Interaction for contacts  
1.02 (0.99 to 1.03) 
0.97 (0.91 to 1.02) 
1.026 (1.021 to 1.033) 
0.93 (0.67 to 1.3) 
1.04 (0.78 to 1.37) 
1.03 1.00 (0.94 to 1.05) 
0.2 
0.3 
<0.0001 
0.7 
0.8 
1 
1854.4 
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Chapter 6. Transmission dynamics of typhoid fever in Fiji: a model 
of vaccination and WASH. CH Watson, AJ Kucharski, WJ Edmunds 
London School of Hygiene & Tropical Medicine. 
 
6.1 Bridging section 
 
This final research paper chapter describes the fitting of, and findings from, a transmission 
dynamic model. The model was conceptualised by me in late 2016 in terms of a 
compartmental structure that could synthesis case and serological data by means of dose-
dependency of pathogenicity, with input from the co-authors. It was developed by me in 
summer 2017 after a break to return to professional duties at Public Health England. I have 
been able to estimate model parameters by maximum likelihood estimation, and produce a 
number of informative intervention impact scenarios and sensitivity analyses. The 
interpretation of findings is intended to be appropriately cautious, particularly with regard to 
precision, but the results are indicative of relative importance of parameters and may be 
indicative of impacts of putative interventions. The development of the model framework 
opens the prospect for further analysis of the situation in Fiji and to further explore the 
transmission drivers, uncertainties in parameterising the model and plausible programme 
impacts. 
Conceptualisation and coding of the model was done by me in the R statistical environment. I 
had used the analysis of the serological survey and the social mixing data to improve my R 
literacy, rather than opting for quicker and easier Stata or Excel based analyses and this 
proved extremely useful in coding up the model. Under the tutelage of Adam Kucharski and 
supervision of John Edmunds, the model was substantially extended by me from an SI 
example model, to one with six compartments (SIRCAV), 80 ages and two ethnicities.  Adam 
coded the aging process to reflect the demographic structure, which was our joint 
conceptualisation but beyond my numeracy, and checked the compartment-transition 
differential equations. I parameterised the aging process model to visual fit with census data.  
I developed the likelihood function with input from Adam Kucharski and John Edmunds, 
adapting a log likelihood function originally developed for the Fiji dengue fever model of 
adult and child dengue case data and arbovirus immunity data from the serosurvey and 2015 
follow-up. The modelled typhoid incidence case count was initially to be fitted to case data 
through a negative binomial function. However, the negative binomial overdispersion 
parameter was found to be intractable and the function unsuitable and so a Poisson 
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distribution was utilised. An important step was identifying means of reducing model run 
times from over an hour to seconds, by taking advantage of time step handling properties in 
the ODE45 implementation of the Runge Kutta differential equation solver. This opened up 
scope to run maximum likelihood estimation using the bbmle package rather than through a 
low-resolution grid search. My analysis, sensitivity analysis, interpretation and drafting of the 
manuscript was done with review by John Edmunds.  
Preliminary findings have been discussed with the Ministry of Health and research partners in 
October 2017 in support of typhoid control. 
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Transmission dynamics of typhoid fever in Fiji:  
a model of vaccination and WASH.  
 
CH Watson, AJ Kucharski, WJ Edmunds 
London School of Hygiene & Tropical Medicine. 
 
6.2 Introduction 
Typhoid fever is a systemic human bacterial disease, caused by Salmonella enterica serovar 
Typhi (S. Typhi), spread through the faecal-oral route. Initial symptoms of fever and malaise 
can be followed by debilitating abdominal pain, headache, cough, anorexia, nausea, myalgia 
and confusion, with life-threatening complications in prolonged illness including intestinal 
perforation, gastrointestinal haemorrhage and encephalopathy.1 As in many parts of Asia-
Pacific,2,3 typhoid fever is a pressing public health concern in Fiji.  An emergency typhoid Vi-
polysaccharide (ViPS) mass vaccination campaign was implemented in the highest-risk areas 
of Fiji (7% by population) following Cyclone Tomas in 2010, demonstrating effectiveness 
consistent with vaccine efficacy and coverage.4  Ministry of Health and public health partners 
have sought to understand and control the disease, convening an expert meeting to assess 
long-term strategies for control, and knowledge gaps that would support this. Serologically-
informed modelling was proposed to inform vaccination programme considerations.5  
Typhoid has an incidence of approximately 380 blood-culture confirmed cases per annum in 
Fiji, or 45 per 100,000 person-years.5 Over 90% of reported culture-confirmed cases are of 
the indigenous iTaukei community (57% of the census population), predominantly affecting 
young adults, with few cases reported in Fijians of Indian descent (Indo-Fijians) or other non-
iTaukei ethnicities.5,6 This contrasts to findings of our serological survey, which identified 
similar seroprevalences in both iTaukei and non-iTaukei ethnic groupings of anti-Vi IgG, a 
putative marker of current or past S. Typhi exposure, based on a case cohort-fitted 
threshold.7 The survey indicated seroprevalence of approximately 1 in 3, though there remain 
considerable uncertainties as to the sensitivity and specificity of such thresholds, and found 
increasing seroprevalence by age and a non-significantly higher seroprevalence in iTaukei 
than non-iTaukei. 
Different conceptual frameworks exist for typhoid transmission models,8,9 with different 
analytical intent, described previously.10 One conceptualisation of typhoid immunogenicity 
and pathogenicity is that the occurrence and presentation of typhoid fever is dependent on 
the inoculating dose of S. Typhi. A simplified schematic for the role of dose-dependency in 
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the “clinical iceberg” of typhoid fever is shown in figure 6.1. With known surveillance case 
numbers and sero-survey data supporting estimates for the total size of ever-infected 
population in Fiji, a transmission dynamic approach offers potential insight into the relative 
size of the infectious case population that would drive disease dynamics, and the impact of 
underlying natural immunity on interventions such as vaccination. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.  Clinical iceberg conceptual schematic for acute typhoid fever.  
The dose response gradient for typhoid infection is dichotomised into high and low doses 
exposures from S. Typhi shedding in a primary case. These result in infectious (grey triangle) 
or non-infectious (white triangle section) secondary cases depending on the ingested dose. Of 
infectious cases, a proportion are unwell enough to seek medical care, and of these some 
have blood taken, test positive and are notified to public health surveillance (black triangle).  
 
As outlined in the introduction to this thesis, high inoculating doses were established in the 
Maryland typhoid human challenge studies as more likely to result in symptomatic disease, as 
assessed by various diagnostic approaches, with earlier onset compared to low-dose 
challenge.11,12 In community settings, high inoculating doses may be derived from prepared-
food faecal contamination; direct person-to-person and fomite transmission in the absence of 
adequate infection control and hygiene practices; or consumption of drinking water with high 
volumes of faeces containing S. Typhi, most typically stored or surface water in the 
immediate environment around a case.  Symptomatic cases from such events are very likely 
to shed S. Typhi in faeces.11 Immunity occurs following recovery, with infectious 
asymptomatic carriage established in a small proportion of cases.1  
Low-dose inoculation, such as may be derived from contamination of the environment, water 
contaminated with lower volumes of faeces (such as that further away from cases) and 
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unprepared foods, or other similar distal, non-direct transmission, may give rise to 
asymptomatic infection and natural immunity without observed or surveillance-notified 
development of systematic disease. The Maryland challenge studies found an inoculating 
threshold below which clinical disease did not develop. Low dose exposure may act as an 
immunising force, creating immunity without faecal shedding. Mild or asymptomatic typhoid 
infection in childhood can preclude severe disease later in life,13 consistent with classical 
models of tropical infection.14  
Both typhoid immunisation and other interventions to reduce transmission offer potential to 
reduce the burden of typhoid in Fiji; though relative impact may depend on both intervention 
efficacy and the underlying immuno-epidemiological landscape. 
 
6.2.1 Aims 
We developed a deterministic, compartmental, dynamical model of typhoid fever in Fiji 
utilising field data on social mixing patterns and seropositivity, alongside national surveillance 
data. This study aimed to describe the observed serological and case data for Fiji and examine 
a range of model structures reflecting different epidemiological conceptual constructs of 
typhoid transmission in Fiji, and the goodness-of-fit of these to the data. We sought to 
estimate the potential impact on typhoid fever incidence of immunisation programmes and 
other programmes to reduce transmission, such as adequate water, sanitation and (hand & 
food) hygiene (collectively: WASH).15,16 We considered different vaccination strategies such as 
school-entry vaccination programmes and one-time school-age campaigns, which were 
examined with and without WASH interventions. 
 
 
6.3 Methods 
6.3.1 Ethics approval 
This study was approved by the Fiji National Research Ethics Review Committee (2013-03) 
and the London School of Hygiene and Tropical Medicine’s ethics committees (6344). 
 
6.3.2 Data sources 
Anonymised, blood-cultured confirmed, national surveillance case data were provided by the 
Fiji National Centre for Communicable Disease Control for the years 2008 to 2014, the 
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complete range of cleaned, disaggregated data available for analysis.  There were mean 363 
(range 285 to 425) cases annually, which were relatively stable with an average decline of 11 
cases per year (r2 = 0.15). Ninety-seven percent of cases were iTaukei. 
Serological data was obtained through a field survey, described previously, of 1,531 residents 
aged 1year and over in unvaccinated areas of the two main Fijian islands (Viti Levu and Vanua 
Levu) conducted between September and December 2013. An anti-Vi IgG ELISA titre 
threshold of 64 was considered indicative of natural immunity, based on a mixed model of 
antibody decay in recovering confirmed cases.7  
 
6.3.3 Model structure 
The full model structure comprises of six compartments representing five disease states plus 
vaccination (figure 6.2). Each compartment is age- and ethnicity- structured (0 to 79 years; 
iTaukei and non-iTaukei). Daily movements between compartments are specified by a system 
of ordinary differential equations (equations 1 to 6). Simpler model structures can be created 
by setting relevant parameters to zero. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Model structure 
 
Susceptible (S) non-immune individuals can move into the Infectious (I) compartment at a 
rate λhi following inoculation from a high dose of S. Typhi from a case (I) or long-term 
infectious carrier (C), due to proximal or short-cycle transmission including direct contact and 
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localised transmission from locally-contaminated water, food, fomites and environment with 
force of infection determined by social contact patterns. They can be joined in I by S 
compartment individuals arriving at a rate λlowpd, indicating a proportion of individuals 
receiving a low inoculating dose (generalised force of infection independent of contact 
patterns) that results in becoming infectious (with or without symptoms).  
 
 
𝑑𝑆𝑖,𝑗
𝑑𝑡
= 𝑏𝑖,𝑗 + 𝜙𝑖−1,𝑗𝜁𝑖,𝑗  𝑆𝑖−1,𝑗 + 𝜔𝑛𝑅𝑖,𝑗 + 𝜔𝑣𝑉𝑖,𝑗 − 𝜆ℎ𝑖𝑔ℎ,𝑖,𝑗(1 − 𝑝𝑛,𝑗)𝑆𝑖,𝑗
− 𝜆𝑙𝑜𝑤𝑆𝑖,𝑗 − 𝜈𝑖,𝑗𝑆𝑖,𝑗 − 𝜙𝑖,𝑗𝑆𝑖,𝑗 
 
(1) 
𝑑𝐼𝑖,𝑗
𝑑𝑡
= 𝜙𝑖−1,𝑗𝜁𝑖,𝑗  𝐼𝑖−1,𝑗 + 𝜆ℎ𝑖𝑔ℎ,𝑖,𝑗(1 − 𝑝𝑛,𝑗)𝑆𝑖,𝑗 +  𝜆𝑙𝑜𝑤 𝑝𝑑 𝑆𝑖,𝑗
+  𝜆ℎ𝑖𝑔ℎ,𝑖,𝑗(1 −  𝑝𝑣)(1 − 𝑝𝑛)𝑉𝑖,𝑗 − 𝛾𝑑𝐼𝑖,𝑗 − 𝜙𝑖,𝑗𝐼𝑖,𝑗 
 
(2) 
𝑑𝑅𝑖,𝑗
𝑑𝑡
= 𝜙𝑖−1,𝑗𝜁𝑖,𝑗  𝑅𝑖−1,𝑗 + 𝛾𝑑(1 − 𝑝𝑐) 𝐼𝑖,𝑗 + 𝛾𝑐𝐶𝑖,𝑗 + 𝛾𝑑𝐴𝑖,𝑗  − 𝜔𝑛𝑅𝑖,𝑗
− 𝜙𝑖,𝑗𝑅𝑖,𝑗 
 
(3) 
𝑑𝐶𝑖,𝑗
𝑑𝑡
= 𝜙𝑖−1,𝑗𝜁𝑖,𝑗  𝐶𝑖−1,𝑗 + 𝛾𝑑𝑝𝑐 𝐼𝑖,𝑗 −  𝛾𝑐𝐶𝑖,𝑗  − 𝜙𝑖,𝑗𝐶𝑖,𝑗 
 
(4) 
𝑑𝐴𝑖,𝑗
𝑑𝑡
= 𝜙𝑖−1,𝑗𝜁𝑖,𝑗 𝐴𝑖−1,𝑗 + 𝜆𝑙𝑜𝑤(1 − 𝑝𝑑) 𝑆𝑖,𝑗 −  𝛾𝑑𝐴𝑖,𝑗 − 𝜙𝑖,𝑗𝐴𝑖,𝑗 
 
(5) 
𝑑𝑉𝑖,𝑗
𝑑𝑡
= 𝜙𝑖−1,𝑗𝜁𝑖,𝑗 𝑉𝑖−1,𝑗 + 𝜈𝑖,𝑗𝑆𝑖,𝑗 −  𝜆ℎ𝑖𝑔ℎ,𝑖,𝑗(1 − 𝑝𝑣)(1 − 𝑝𝑛)𝑉𝑖,𝑗 −  𝜔𝑣𝑉𝑖,𝑗
− 𝜙𝑖,𝑗𝑉𝑖,𝑗 
 
(6) 
𝑑𝐹𝑖,𝑗
𝑑𝑡
=  𝜆ℎ𝑖𝑔ℎ,𝑖,𝑗(1 − 𝑝𝑛)𝑆𝑖,𝑗 +  𝜆𝑙𝑜𝑤 𝑝𝑑 𝑆𝑖,𝑗
+  𝜆ℎ𝑖𝑔ℎ,𝑖,𝑗(1 −  𝑝𝑣)(1 − 𝑝𝑛)𝑉𝑖,𝑗 
(7) 
 
Where:  
Si,j, Ii,j, Ri,j, Ci,j, Ai,j and Vi,j are the number of susceptible, acute infectious, recovered (naturally 
immune), chronic infectious carrier, asymptomatically infected non-infectious  and 
vaccinated individuals respectively in the population, by year of age and  ethnicity.  
Fi,j records incident acute infectious typhoid cases, by year of age and  ethnicity. 
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i denotes year of age (0 to 79) 
j denotes ethnicity (iTaukei or non-iTaukei) 
bi,j is ethnicity-specific daily births into for i=0 (0 for i>0) 
γc  is the daily recovery rate from carriage C class infection 
γd  is the daily recovery rate from infectious I and asymptomatic A class infection 
φi,j is daily aging rate, by year of age and  ethnicity (φi-1,j = 0 if i=0) 
ζi,j is survival proportion following aging, by year of age and  ethnicity 
νi,j is the daily rate of vaccination to achieve a specified vaccine coverage over the course of a 
year in a specified year of age and ethnic group  
pc is the proportion of cases that become carriers 
pd is the proportion of low dose infections that lead to the infectious I class 
pn,j is the proportionate reduction in high-dose force of infection for non-iTaukei relative to 
iTaukei (pn=0 if j = iTaukei) 
pv is the vaccine efficacy 
ωn is daily waning rate of natural immunity 
ωv is daily waning rate of vaccine immunity 
λhigh, i,j is the daily high-dose force of infection and λlow is the low-dose force of infection 
 
 
An age and ethnic group structured F compartment records incident I-compartment cases 
(equation 7). A subset of F-compartment cases is reported in culture-confirmed national 
surveillance at a reporting rate p1 which is further modified by p2, the reduction in reporting 
rate in children. See “surveillance reporting” section for details.  
S compartment individuals transition to an asymptomatic, non-infectious (A) compartment at 
rate λlow(1-pd) indicating receipt of a low inoculating dose without becoming infectious. 
Individuals exit A and enter a recovered (R), naturally immune compartment at a rate γd. The 
same exit rate applies to the I class, with a proportion pc entering the C compartment and the 
remainder entering R. Carriers leave C and enter R at a rate γc. The transition rate for R to S 
(loss of natural immunity) is ωn. The model does not include a latent period. Force of 
infection is described by equations 8 and 9.  
Force of infection (high-dose) is  
𝝀𝒉𝒊𝒈𝒉,𝒊,𝒋 =  𝜷 ∑ ∑ 𝑴𝒊𝒋 𝒌𝒍
𝟐
𝒏=𝟏
(
𝑰𝒌,𝒍 + 𝑪𝒌,𝒍
𝑵𝒌,𝒍
)
𝟓
𝒎=𝟏
 
(8) 
And force of infection (low-dose) is 
𝝀𝒍𝒐𝒘 =  
𝜶𝜷 ∑ ∑ (𝑰𝒌,𝒍 + 𝑪𝒌,𝒍)
𝟐
𝒍=𝟏
𝟓
𝒌=𝟏
∑ ∑ 𝑵𝒌,𝒍
𝟐
𝒍=𝟏
𝟓
𝒌=𝟏
 
(9) 
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Where:  
i is year of age and j is ethnic group of susceptible and vaccinated individuals  
k is age band (0-4, 5-14,15-34, 35-54 and 55-79 years) and l is ethnic group of infectious and 
carrier individuals 
Mij kl is the contact matrix by year of age (i) and age band (k) and ethnic group (j and l), 
weighted for reciprocal contact, for transmission from kl to ij  
β is the effective contact rate for high-dose transmission 
α is the low-dose β ratio 
Nk,l is the population size by age band and ethnic group. 
 
Vaccination transition S to V occurs at a rate ν with V to S loss of vaccine immunity at rate ωv. 
V compartment individuals enter I with 𝜆ℎ𝑖𝑔ℎ modified by 1-pv where pv is vaccine efficacy, 
but do not transition to A as vaccine is assumed to fully protect against low dose typhoid 
infection.   
 
6.3.3.1 Structural sensitivity analysis 
Alternative epidemiological models were examined as follows: 
 With high-dose social mixing homogeneous within iTaukei and non-iTaukei groups 
 With high-dose social mixing homogenous across age band and ethnic groups 
 Without low-dose force of infection and thus no asymptomatic non-infectious 
compartment; and high dose force of infection social mixing: 
o heterogeneous by age and ethnic group  
o homogeneous within iTaukei and non-iTaukei ethnic groups. 
o homogeneous across age band and ethnic groups 
 
6.3.3.2 Waning force of infection sensitivity analysis 
In chapter 3, the possibility was raised that the observed seroepidemiological age patterns 
could be explained by endemic transmission, or decreasing force of infection across several 
decades, potentially with transmission concentrated in childhood. Using an approach 
adapted from Gay for hepatitis A,17 a five-fold higher baseline equilibrium was fitted and 
models of decreasing force of infection were run as a sensitivity analysis using a monotonic 
decline function (equation 10).  
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𝜓 =  3 − 2 tanh (
2(𝑡 − 𝑚𝑒𝑑 (𝑡))
𝑇
) 
(10) 
Where: 
Ψ is the Beta scaling factor 
t is the time period of analysis in years 
T is the time period over which force of infection predominantly declines in years. 
 
In the sensitivity analyses t is 100 years and T is 50 years.  
 
 
6.3.4 Software 
Analysis was conducted in R version 3.4.1.18 The model was established as a series of ordinary 
differential equations which were solved using the ODE45 adaptive time step Runge-Kutta 
method in package deSolve.19  
 
6.3.5 Demographics 
A demographic process operates across each model compartment to approximate the 2007 
census population structure for each ethnicity category.20 Individuals are born into the 
iTaukei or non-iTaukei age zero strata of the susceptible compartment, with daily births equal 
to the sum of the ethnicity-specific all-age deaths. Individuals exit each age stratum with a 
daily aging rate and a number enter the next age stratum proportional to an age- and 
ethnicity- specific survival probability.   This survival proportion is less than one for all ages of 
iTaukei and one for non-iTaukei to the age of 39, after which it declines. Comparison between 
the census population and the equilibrium synthetic population are shown in figure 6.3 
below.  
The demographic process is identical across each compartment; there is no adjustment to 
death rates for disease states. The model population structures are attributable only to 
constant rates of births and deaths with no adjustment for migration or historical trends in 
birth and death rates.  
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6.3.6 Social contact 
A reciprocity-weighted contact matrix of mealtime social contacts, determined by a field 
survey and described previously (chapter 5),21 was used for daily contact rates for high-dose 
transmission events. Age groups were 0-4, 5-14,15-34, 35-54 and 55+ years and ethnic 
categories were iTaukei and non-iTaukei. In the analysis of association between social mixing 
and seropositivity for anti-Vi IgG, we found that an increase in number of age-adjusted 
contacts was associated with increased odds of seropositivity, driven by inter-iTaukei contact. 
This supports the utilisation of the field-sourced mealtime contact rate matrix in this 
modelling analysis. 
 
 
Figure 6.3. Model demographic structure and census population (2007) by age 
and ethnicity and after 100-year equilibration.  
Panels denote iTaukei (top row) and non-iTaukei (bottom row) demographics. Starting 
parameters (left panel dots and right panel dashed lines) indicate census population relative 
to the model equilibrium demographic state (right panels’ solid lines).  
 
231 
 
6.3.7 Model fitting 
Three transmission parameters and two reporting parameters were fitted by maximum 
likelihood estimation (MLE) using the mle2 function in the package bbmle.22  Parameter space 
exploration was first undertaken with visual fitting to surveillance data and serology. MLE was 
performed using Nelder-Mead optimisation.  
The model was fitted to case and serology data. Simulation surveillance-reported cases were 
compared to data for annual (2008-2014) national surveillance blood culture confirmed case 
reporting, disaggregated by age group (as per the social mixing matrix) and ethnic category. 
Simulated R compartment proportion by year of age and ethnic category was compared to 
IgG Vi seropositivity from the 2013 serological survey. Fixed parameters are shown in table 
6.1. 
Model 
Parameter 
Description Value Source 
γd Recovery rate from acute 
infection (14 days) 
1/14 per day CCDM23 
γc Recovery rate from 
carriage (10 years) 
1/(365*10) 
per day 
Assumed from 24,25 
pc Proportion of infectious 
cases becoming carriers 
1% Adapted from 26 
pn Proportion of low-dose 
inoculation recipients 
developing infectious 
illness 
1% Assumed 
ωn Loss of natural immunity 
(40 years) 
1/(365*40) Inferred from 27 
and examined by 
sensitivity analysis 
Table 6.1. Fixed parameter values 
 
The log likelihood function is given in equation 10 below. 
𝐿(𝜃|𝑋, 𝑍) =  ∑ ∑  
2
𝑒=1
5
𝑏=1
((∑  𝑥𝑦𝑙𝑜𝑔𝑝1 𝑝2,𝑏Λ𝑏,𝑒
7
𝑦=1
) − 7Λ𝑏,𝑒)  
+ ∑ ∑(𝑧𝑎,𝑒 log 𝑝𝑎,𝑒 + (𝑛𝑎,𝑒 − 𝑧𝑎,𝑒)log (1 − 𝑝𝑎,𝑒))
2
𝑒=1
80
𝑎=1
 
(11) 
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Where:  
x are national surveillance case data across five age groups (b), (0-4, 5-14,15-34, 35-54 and 
55+ years) two ethnic groups (e) (iTaukei and non-iTaukei) and seven surveillance years from 
2008 to 2014 (y); 
Λ is the simulation equilibrium annual case count by age and ethnic group;  
p1 is the surveillance reporting fraction and p2 is the reporting fraction modifier for children 
(b≤2; 0 to 14 years, 1 for b>2) 
z is the observed seropositive count from n serosurvey participants in each of 80 one-year 
ages (a) and two ethnic groups (e); and pa,e is the simulation equilibrium R compartment 
prevalence by year of age and ethnic group.  
 
6.3.8 Surveillance reporting 
Propensity to seek care, propensity to obtain blood for culture, poor blood culture sensitivity 
and incomplete notification to national authorities leads to under-ascertainment of cases in 
national culture-confirmed surveillance.3,28  There is no known differential care-seeking 
behaviour (including antimicrobial utilisation, which may avert seroconversion arising in 
prolonged infection)29 in different ethnic groups in Fiji and so we do not modify reporting by 
ethnicity.20,30 Data we collected in 2015 for a dengue fever serosurvey found no difference in 
health-seeking behaviour between iTaukei and non-iTaukei Fijians who had had recent fever 
(34 of 43 and 17 of 20 respectively; odds ratio for non-iTaukei 1.5; 95% confidence interval 
0.4 to 9.7; p-value = 0.6). Under-ascertainment in children relative to adults is well 
established internationally3,31 and so we include both a surveillance reporting fraction p1 for 
adults (age 15+) and a further modifier to this for children (p2). 
 
6.3.9 Carriage 
Typhoid is noted for its asymptomatic carriage, which contributes to sustained transmission 
in low endemicity settings.32 Anderson and May33 posit that typhoid carriers should not have 
the same β as acute cases, as this gives them a contribution in excess of ten times that of 
acute cases after taking into account duration of infection.  Feachem and colleagues14 note 
that typhoid carriers shed very high concentrations of bacteria in faeces, of the same orders 
of magnitude as cases. Shedding events may be intermittent, making detection challenging,34 
and making it challenging to estimate the infectiousness of a carrier relative to an acute case 
(notwithstanding the depletion of susceptibles socially-connected to a carrier, which may 
become saturated during their infectious period).  
Recent data on the proportion of cases who become carriers is sparse, particularly for low 
and middle income countries.25,35 Surveillance data from Baltimore, USA, found 0 carriers 
from 55 child typhoid cases while in Scotland 32 carriers were identified relative to 267 acute 
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cases though potential differential ascertainment precludes assuming this to be a ratio.36 US 
data from the pre-antibiotic era found 2.9% of cases became carriers with increasing risk with 
age26 – approximating for the Fijian population distribution, we modelled 1% of acute 
infectious cases becoming carriers, but do not vary this proportion by age.37 
Carriage duration varies from months to years with the longest known carriage 41 years.24,25 
We model recovery from carriage as an exponentially waning rate with mean duration 10 
years rather than assuming lifelong carriage.37 
 
6.3.9.1 Carriage sensitivity analysis 
Sensitivity analysis of the full model were undertaken with carrier β set as one-tenth and one-
hundredth of case β. 
 
6.3.10 Natural immunity 
Typhoid immunity is generally considered partial in that it can be overwhelmed by a large 
inoculum.38 However, data on second attacks suggests this is infrequent, and most likely to 
occur 10 years or more after the first attack.27 We reflect this by modelling natural immunity 
as initially complete but waning over a long time period. Sensitivity analysis of duration of 
natural immunity was done. We do not include acute relapse in the model.39 
 
 
6.3.11 Control scenarios 
Two Vi-containing vaccines were modelled based on parameters from a systematic review.40 
The characteristics of these vaccines in the baseline analyses are: 
1) Licensed Vi-polysaccharide (ViPS) of 70% (leaky) initial efficacy, 3 year mean duration 
2) A typhoid Vi-conjugate (TCV) of 95% (leaky) initial efficacy, 15 year mean duration. 
The following scenarios were modelled for each vaccine. 
1) Baseline scenario (no vaccination) 
2) Routine vaccination at school entry (6 years old) 
3) Routine vaccination at school exit (15 years old) 
4) Routine vaccination at school entry and exit 
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5) Routine vaccination at school entry and exit with a one-time school catch up 
campaign (ages 7 to 14 year). 
6) A one-time school catch-up campaign (age 6 to 15 years).  
A sensitivity analysis was done on the most impactful single-dose routine vaccination 
scenario to examine the impact of different vaccine efficacies and durations of immunity. 
These allow for impact assessment for vaccines such as different regimen and formulations of 
the Ty21a live oral typhoid vaccine, which might otherwise be considered comparable to 
ViPS,40–42 and for vaccines in clinical trials.43,44 
A further scenario was modelled for TCV only, reflecting efficacy data,40 and the current WHO 
position paper which recommends TCV vaccination in endemic areas at  age six months, or 
nine months or in the second year of life (to align with measles-containing vaccination and 
other vaccinations that may be given at the same time.45 
7) Vaccination at 12-23 months of age. 
Vaccination coverage was set at 95% per school year (modelled as a rate applied to the S 
compartment over 365 days) and per campaign, consistent with the UNICEF estimate (94%) 
and 2016 official figures for measles-rubella vaccine first dose and school entry dose.46 
 
The above were run with WASH scenarios: 
1) Baseline transmission 
2) 10% reduction in transmission parameter β 
3) 25% reduction in transmission parameter β 
4) 50% reduction in transmission parameter β. 
These are consistent with previous typhoid modelling studies.8,37 WASH programmes were 
not disaggregated by component elements (nor readily can be) but treated as a single 
intervention in the model. While not directly applicable to S. Typhi and typhoid fever, 
systematic reviews of the available, limited, data on WASH for diarrhoeal disease control 
suggest risk reduction for handwashing with soap (HWWS), improved water quality and 
excreta disposal as 48%, 17% and 36% respectively,15 suggesting these are a plausible range 
of modelled scenarios for effectively implemented programmes.  
A further set of sensitivity analysis was done examining the impact of a hypothetical WASH 
intervention reducing the low-dose transmission scaling factor α by the above proportions 
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with no change to β. Equivalent changes to the surveillance reporting fraction p1 were also 
examined graphically.  
 
 
6.4 Results 
6.4.1 Model fit 
The full model was able to reproduce the seroprevalence patterns and case-surveillance data 
for typhoid in Fiji. Figure 6.4 shows the model output for the best fit parameters attained 
through MLE. Convergence occurred from a range of starting parameters, suggesting no local 
minima were found. The step-changes observed in figure 6.4 in simulation case data indicate 
transition across age-boundaries of the social contact matrix. 
There are two particularly notable findings in the fitted parameters (Table 6.2). The first is 
that α, the low-dose force of infection scaling parameter was clearly non-zero, indicating that 
the movement of susceptible individuals into the asymptomatic non-infectious compartment 
was an important contributor to the model fit. The second is that due to the low incidence of 
non-iTaukei cases in surveillance data, model best fit arose when pn, the reduction in force of 
infection from high dose exposures acting on susceptible non-iTaukei relative to iTaukei 
counterparts, was 99%. This suggests high-dose exposures almost never occur to non-iTaukei, 
or that if they do, these exposures do not lead to surveillance-detectable disease.   The 
surveillance reporting fractions for acute infectious cases were 20% in adults and 8% (overall) 
in children. Sensitivity analysis of duration of natural immunity found no statistically 
significant difference between 40 year and 50 year immunity, which were better fits than 
other durations of natural protection (table 6.3) and returned the same fitted parameter 
values. We used 40 year natural immunity for scenario projections.  
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Figure 6.4. MLE-fitted age- and ethnicity-specific model equilibrium outputs 
with anti-Vi serological and confirmed case data.  
A: iTaukei serology (anti-Vi IgG>=64 ELISA units) and immunity at model equilibrium.    
B iTaukei modelled cases (solid line) and modelled cases scaled for reporting (dashed line). 
Dots represent cases data by age with each colour representing a different year. 
C: Non-iTaukei serology (anti-Vi IgG>=64 ELISA units) and model output line for immunity.    
D: Non-iTaukei modelled cases (solid line) and modelled cases scaled for reporting (dashed 
line). Dots represent cases data by age with each colour representing a different year. 
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Model Parameter Description Fitted Value 
β (Beta) Per contact daily effective transmission risk for “high-
dose” exposure from I and C individuals 
0.00558 
α (Alpha)  Ratio parameter for the low dose force of infection 
relative to the high dose force of infection.  
The fitted value indicates that for each symptomatic 
secondary case generated, approximately five 
asymptomatic infections would occur in a susceptible 
population, all else being equal. 
 
5.42 
pn Proportion reduction in high-dose Beta in non-iTaukei 
relative to non-iTaukei 
 
99.1% 
p1 Reporting fraction 1.  
 
Proportion of adult (15+) I-compartment 
symptomatic infectious cases that appear in national 
surveillance confirmed-case surveillance. 
19.6% 
p2 Reporting fraction 2.  
 
Further reduction in the proportion of child (0-14) I-
compartment symptomatic infectious cases that 
appear in national confirmed-case surveillance. 
 
This gives I-compartment children a 19.6% x 40.1% = 
7.9% probability of appearing in national surveillance. 
40.1% 
Table 6.2. Fitted parameter values 
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Mean duration of 
natural immunity 
Negative log 
likelihood 
20 years 512 
30 years 500 
40 years 498 
50 years 497 
Lifelong 617 
Table 6.3. Sensitivity analysis of duration of natural immunity   
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6.4.1.1 Sensitivity analysis of model structure 
 
Model fit was examined under different mixing matrices and in the absence of low-dose 
infection giving rise to a non-infectious asymptomatic compartment (table 6.4). As would be 
anticipated from the best-fit value of α, models without low-dose force of infection had 
significantly worse fit than those with this. For models with or without a low-dose force of 
infection and non-infectious asymptomatic compartment, examining mixing patterns for high 
dose force of infection found that a matrix with age-ethnic heterogeneity fitted the data 
significantly better than homogenous or ethnically heterogeneous matrices.  Interestingly, 
models with ethnically heterogeneous mixing did not have improved fit over those with 
homogeneous mixing. 
 
Model Asymptomatic 
non-infectious 
component 
Mixing pattern in high-
dose force of infection 
Negative log likelihood 
1 No Homogeneous 784.4 
2 No Ethnic only 784.6 
3 No Age-ethnic 713.6 
4 Yes Homogeneous 576.0 
5 Yes Ethnic only 594.5 
6 (full) Yes Age-ethnic 498.1 
Table 6.4. Model fit under different epidemiological assumptions 
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6.4.1.2 Sensitivity analysis of declining force of infection 
For models without low dose force of infection, fit was improved by including historically 
higher incidence through a time-dependent scaling parameter (table 6.5, models 7 and 9 vs 
table 6.4, models 1 and 3).  However, these were still significantly poorer fit than models with 
an asymptomatic component. In a variant (model 8) of the homogenous mixing model (model 
7), allowing transmission to be predominantly in childhood did not improve fit. Against the 
best-fit model of stable transmission (model 6), inclusion of historically high transmission did 
not fit as strongly (model 10).  
 
Model 
With 
declining 
force of 
infection 
Asymptomatic 
non-infectious 
component 
Mixing pattern in high-
dose force of infection 
Negative log likelihood 
7 No Homogeneous 740.3 
8 No Homogeneous with adult 
beta one-tenth of child 
beta 
795.2 
9 No Age-ethnic 688.3 
10 Yes Age-ethnic 508.7 
Table 6.5 Model fit under declining force of infection 
 
 
6.4.1.2 Sensitivity analysis of carriage 
In sensitivity analysis of carrier infectiousness, the fit of models with carriers' infectiousness 
reduced by 90% or 99% relative to acute cases was very close to that of the best fit model 
(table 6.6, models 11 and 12 vs table 6.4, model 6). Scenario projections were therefore 
taken forward of interventions under reduced carrier contribution to transmission. 
 
Model Carrier beta relative to acute infectious case beta Negative log likelihood 
11 10% 499.0 
12 1% 499.1 
Table 6.6 Model fit under reduced carriage beta 
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6.4.2 Interventions 
With peak surveillance incidence in young adults, we first examined the projected impact of a 
school-leavers ViPS vaccination programme, which cut cases by an estimated 8% (notified 
cases by 9%) (figure 6.5 and table 6.5). A school-entry vaccination programme was more 
effective, reducing cases by 16% (notified: 13%) indicating the role of school-aged mixing in 
contributing to the high-dose force of infection in the model suggesting this is a preferable 
timing if the model assumptions are valid.  Combined school entry and leaver vaccination 
resulted in 24% (notified: 22%) reduction in projected cases. The projected gain for a one-
time catch-up campaign of other school years was modest, an additional 2% over 50 years, 
with benefits largely accruing in the first decade and incidence returning to baseline after two 
decades. This was the same case reduction seen for a one-off school-age ViPS campaign, with 
incidence returning to baseline after two decades. 
 
Figure 6.5. Projected total (A) and notified (B) typhoid fever cases over 50 years 
by ViPS vaccination scenario.  
 
A WASH intervention that reduced transmission per case by 10% would be estimated to 
result in a 25% reduction in annual cases (notified: 24%) (table 6.4 and figure 6.6); equivalent 
to the most effective ViPS programmes.  
A                                                                                 B 
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Figure 6.6. Projected total (A) and notified (B) typhoid fever cases over 50 years 
by ViPS vaccination scenario with 10% transmission reduction through WA SH. 
 
Vaccine Intervention scenario Total 
annual 
cases 
 
Averted 
total 
annual 
cases % 
Notified 
annual 
cases 
 
Averted 
notified 
annual 
cases % 
None Baseline 2579 0 0 384 0 0 
None WASH 10% risk reduction 1929 650 25 290 94 24 
None WASH 25% risk reduction 1072 1506 58 163 221 58 
None WASH 50% risk reduction 350 2229 86 54 330 86 
Table 6.7. Projected impacts of transmission reduction through WASH  
 
Adding the above ViPS programmes to a 10% WASH programme brings projected incremental 
benefits approximately equivalent to the arithmetic sum of the WASH and vaccine 
programme (table 6.5, figure 6.6).   
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Vaccine Intervention scenario Total 
annual 
cases 
 
Averted 
total 
annual 
cases % 
Notified 
annual 
cases 
 
Averted 
notified 
annual 
cases % 
None Baseline 2579 0 0 384 0 0 
ViPS School entry  2172 407 16 335 49 13 
ViPS School leaver  2360 219 8 348 36 9 
ViPS Entry and Leaver  1957 622 24 299 85 22 
ViPS Entry & Leaver + campaign 1911 668 26 293 91 24 
ViPS Campaign 2515 64 2 376 8 2 
ViPS WASH 10% + School entry 1591 988 38 247 137 36 
ViPS WASH 10% + School leaver 1733 846 33 258 126 33 
ViPS WASH 10% + Entry &Leaver 1414 1165 45 218 166 43 
ViPS WASH 10% + Entry & Leaver + 
campaign 
1374 1205 47 213 171 45 
ViPS WASH 10% + Campaign 1868 711 28 282 102 27 
ViPS WASH 25% + School entry 890 1689 65 140 244 64 
ViPS WASH 25% + School leaver 955 1624 63 144 240 62 
ViPS WASH 25% + Entry & Leaver 793 1786 69 123 261 68 
ViPS WASH 25% + Entry & Leaver + 
campaign 
765 1814 70 119 265 69 
ViPS WASH 25% + Campaign 1025 1554 60 157 227 59 
ViPS WASH 50% + School entry 313 2266 88 49 335 87 
ViPS WASH 50% + School leaver 323 2256 87 49 335 87 
ViPS WASH 50% + Entry &Leaver 290 2289 89 45 339 88 
ViPS WASH 50% + Entry & Leaver + 
campaign 
279 2300 89 44 340 89 
ViPS WASH 50% + Campaign 332 2247 87 51 333 87 
Table 6.8. Projected impacts of ViPS vaccination programmes with transmission reduction 
through WASH  
 
 
If WASH resulted in 25% or 50% reduction in the per-case transmission parameter (figure 6.7 
and figure 6.8, table 6.4), the model suggests this would reduce cases by 58% and 86% 
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respectively, down to tens of notified cases for a 50% WASH intervention. Projections suggest 
adding vaccination programmes to a 25% WASH programme has further benefits, for a total 
case reduction of 65% with school-entry vaccination and marginal gain for more intensive 
programmes. The projected incremental gains of ViPS vaccination programmes on 50% WASH 
were very modest compared with use in other modelled WASH scenarios (table 6.5).  
 
Figure 6.7. Projected total (A) and notified (B) typhoid fever cases over 50 years 
by ViPS vaccination scenario with 25% transmission reduction thro ugh WASH. 
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Figure 6.8. Projected total (A) and notified (B) typhoid fever cases over 50 years 
by ViPS vaccination scenario with 50% transmission reduction through WASH.  
 
If a TCV vaccine was available with the efficacy and durable immunity utilised in our model, it 
could have substantial impact (table 6.6, figures 6.9 to 6.12).  
Vaccine Intervention scenario Total 
annual 
cases 
 
Averted 
total 
annual 
cases % 
Notified 
annual 
cases 
 
Averted 
notified 
annual 
cases % 
None Baseline 2579 0 0 384 0 0 
TCV Infant 1311 1268 49 214 170 44 
TCV School entry 1348 1231 48 216 168 44 
TCV School leaver 1771 808 31 252 132 34 
TCV Entry and Leaver 961 1618 63 149 235 61 
TCV Entry & Leaver +campaign 837 1742 68 132 252 66 
TCV Campaign 2252 327 13 337 47 12 
TCV WASH 10% + Infant 977 1602 62 159 225 59 
TCV WASH 10% + School entry 992 1587 62 159 225 59 
TCV WASH 10% + School leaver 1268 1311 51 182 202 53 
TCV WASH 10% + Entry &Leaver 720 1859 72 112 272 71 
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TCV WASH 10% + Entry & Leaver + 
campaign 
626 1953 76 99 285 74 
TCV WASH 10% + Campaign 1627 952 37 246 138 36 
TCV WASH 25% + Infant 603 1976 77 98 286 74 
TCV WASH 25% + School entry 603 1976 77 97 287 75 
TCV WASH 25% + School leaver 718 1861 72 104 280 73 
TCV WASH 25% + Entry & Leaver 461 2118 82 72 312 81 
TCV WASH 25% + Entry &Leaver + 
campaign 
402 2177 84 64 320 83 
TCV WASH 25% + Campaign 867 1712 66 133 251 65 
TCV WASH 50% + Infant 256 2323 90 42 342 89 
TCV WASH 50% + School entry 253 2326 90 41 343 89 
TCV WASH 50% + School leaver 273 2306 89 40 344 90 
TCV WASH 50% + Entry & Leaver 210 2369 92 33 351 91 
TCV WASH 50% + Entry & Leaver + 
campaign 
186 2393 93 30 354 92 
TCV WASH 50% + Campaign 285 2294 89 44 340 89 
Table 6.9. Projected impacts of TCV vaccination programmes with transmission reduction 
through WASH  
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Figure 6.9. Projected total (A) and notified (B) typhoid fever cases over  50 years 
by TCV vaccination scenario.  
 
Figure 6.10. Projected total (A) and notified (B) typhoid fever cases over 50 
years by TCV vaccination scenario with 10% transmission reduction through 
WASH. 
A                                                                                 B 
A                                                                                 B 
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Figure 6.11. Projected total (A) and notified (B) typhoid fever cases over 50 
years by TCV vaccination scenario with 25% transmission red uction through 
WASH. 
 
 
 
Figure 6.12. Projected total (A) and notified (B) typhoid fever cases over 50 
years by TCV vaccination scenario with 50% transmission reduction through  
WASH. 
  
A                                                                          B 
A                                                                          B 
249 
 
The optimal single-dose programme of those modelled would be vaccination in the second 
year of life rather than school age, reducing cases by an estimated 31% (notified 34%) in the 
absence of WASH intervention. A two dose school programme could cut incidence by an 
estimated 63% with the possibility of greater gain from an infant plus school leaver 
programme given the projected effect of the single dose infant programme and durability of 
vaccine immunity. Combining TCV annual programmes with WASH interventions suggests 
incidence reduction of over 60% over a 50-year horizon, with TCV programmes projected to 
be more effective than ViPS in reducing incidence over the gains accrued from major WASH 
interventions.  
A sensitivity analysis of vaccine efficacies and durability of vaccine immunity modelled 
incidence reduction in a school-entry routine immunisation programme (figure 6.13) and 
allows comparison across combinations of effects. For example, a 95% initial efficacy 3-year 
vaccine offers similar incidence reduction to a 70% initial efficacy 5-year vaccine.  
 
Figure 6.13. Impact of vaccine efficacy and duration of vaccine immunity.  
Percentage reduction in cases over 50 years for a school entry vaccination programme. 
  
250 
 
Projections were done for scenarios in which carriers’ infectiousness per contact per day 
(beta) was 90% less than acute cases. To achieve the same reported case incidence requires a 
higher annual incidence of total acute infections than the baseline model: 3768 vs 2579. 
Examining TCV vaccination and 10% WASH improvements, without the “damping” effect of 
so many carriers, interventions resulted in more rapid drop in incidence, but also “rebound” 
effects following one off-campaigns (figure 6.14). 
 
Figure 6.14. Projected total (A) and notified (B) typhoid fever cases over 50 
years in scenarios with carrier beta at 10% of acute case beta . 
 
Over the 50 year projected time horizon, a greater reduction in incidence would be observed 
than under equivalent scenarios with carrier beta equal to acute case beta. For example, 
infant TCV vaccination with 10% WASH improvement results in 87% reduction in notified 
cases (table 6.10) versus 59% reduction (table 6.9), with the gain from vaccination 
proportionately greater than the gain from WASH (30% vs 24% effectiveness for 10% WASH 
improvement), as a result of indirect protection. Carriage contribution therefore represents a 
considerable degree of uncertainty in projected impacts, particularly for vaccination, and 
could affect the balance of prioritisation within WASH versus vaccination. There is no change 
to order of effectiveness in terms of vaccination strategies. 
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Intervention scenario Notified 
annual 
cases 
 
Averted notified 
annual cases % 
Baseline 385 0 0 
WASH 10% 269 116 30 
WASH + Vi-conjugate infancy 51 334 87 
WASH + School entry 66 319 83 
WASH + School leaver 119 266 69 
WASH + Entry and Leaver 40 344 89 
WASH + Entry and Leaver with campaign 23 362 94 
WASH + Campaign 231 154 40 
Table 6.10 projected reduction in annual notified cases of typhoid fever over 50 years in 
scenarios with carrier beta at 10% of acute case beta. 
 
Whilst this paper is directed towards interventions from Fiji’s current situation, the 
mechanism by which the current epidemiological situation arose bears consideration in 
assessing assumptions implicit in the model. There has been a notable upturn in confirmed 
case incidence from pre-2004 when incidence was <5 per 100,000 person-years47 to the 
approximately 45 per 100,000 levels seen in 2008 onwards.5 These analyses offer some 
possible insight into the observed epidemic dynamics. These projections start from the 
current modelled equilibrium rather than projecting forward to the present day from 
unknown historical immunological situation. We examined a scenario set in which the low-
dose per-case α transmission parameter was reduced while keeping constant the β 
parameter that determines high-dose transmission (figure 6.15 and table 6.11). These 
scenarios suggest that the resultant increase in number of susceptibles would be projected to 
increase case numbers by 5% in a 10% α-reduction scenario over 50 years, and 31% if α was 
reduced by 50%. Loss of immunity through a reduced α parameter and declining 
asymptomatic infection leads to a build-up of susceptible individuals and subsequent increase 
in cases. Such scenarios are plausible in settings in which infectious disease is in decline. The 
modelled timeline over which this takes place and scale – approximately three to four 
decades for a 40% increase in cases at a halved α is not consistent with the observed 
252 
 
epidemic increase of typhoid in Fiji.  In an illustrative set of models, increasing the reporting 
fraction p1 scaled notified cases linearly (figure 6.16) suggesting this is a feasible mechanism 
to explain the observed increase in notifications. 
 
Figure 6.15. Projected total (A) and notified (B) typhoid fever cases over 50 
years in scenarios reducing low-dose force of infection only.  
 
Reduction in low 
dose force of 
infection only 
Total 
annual 
cases 
Additional 
annual cases 
% 
Reported 
annual 
cases 
Additional 
annual reported 
cases 
% 
Baseline 2579 0 0 384 0 0 
10% α reduction 2699 120 5 402 18 5 
25% α reduction 2910 331 13 435 51 13 
50% α reduction 3381 802 31 506 122 32 
Table 6.11. Projected impact of reduction in low dose force of infection 
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Figure 6.16. Projected total  (A) and notified (B) typhoid fever cases under 
different reporting scenarios.  
  
A final scenario set projection of an increase in the β per-case transmission parameter was 
undertaken for consideration alongside the sensitivity analyses of the α parameter and 
reporting fraction (figure 6.17). An increase in the effective β per-case transmission 
parameter may be suggested as associated with increased inter-person contact rates with 
travel, housing and work pattern changes, changes to transmission mechanisms such as 
sanitation breakdown or increases in the pathogen’s innate biological transmissibility. An 
increase in β appears more consistent with the observed trend in notified cases than changes 
to α, with a slight decline in cases following the sharp epidemic upturn that may or may not 
reflect such a change in transmissibility.  
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Figure 6.17. Projected total (A) and notified (B) typhoid fever cases under 
different increases to β transmission parameter.  
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6.5 Discussion 
This study examines models of the epidemiology of typhoid fever in Fiji and explores the 
potential impact of control measures in age- and ethnicity-structured transmission dynamic 
model projections. The findings are strengthened by model-fitting under a range of 
epidemiological constructs, which found that generation of asymptomatic, non-infectious 
cases, and assortative mixing for case generation were important in reproducing the field 
serology and surveillance data. The study combines a conceptual framework incorporating a 
literature-grounded assessment of typhoid dose-dependence of infection with Fijian national 
surveillance data and a nationally-representative field survey for serology and social contact 
patterns.  
Projecting over a fifty-year time horizon, we found that ViPS vaccination programmes offered 
modest reduction in incidence when implemented as school-age programmes. The largest 
incidence reduction, of around 25%, was seen with a programme utilising school entry and 
school leaver vaccination, with equivalent reduction in incidence from a 10% reduction in 
per-case transmission parameters, such as through effective enhancement of WASH 
infrastructure and norms. School vaccination campaigns and catch-ups offered some short-
term additional benefits to programmatic use without long-term impact. A high efficacy TCV 
programme could substantially reduce incidence, including through implementation 
alongside measles-rubella vaccination at 12 months of age and in parallel to WASH 
strengthening. Notably, vaccination at 12 months, as recommended by WHO, was projected 
to have less impact than a schedule with two doses (one in early childhood and a second dose 
at school-exit age); though this is based on speculative duration of vaccine effect, which 
remains an important area for research. There is important uncertainty in the model 
projections due to the role of carriers in transmission. If carriers are substantially less 
infectious per day than cases, then the impacts projected in this paper may underestimate 
the impact of vaccination and improvements to WASH, and the balance of these, with lower 
carriage contribution enhancing the impact of vaccination. 
The finding of best fit at a 99% reduction in high dose inoculation in non-iTaukei Fijians was 
unexpected in its magnitude. Descriptive data collected during the linked serosurvey on 
putative risk factors such as HWWS, socio-economic status, piped water and sanitation 
systems would not seem to account for such a scale of difference in risk between iTaukei and 
non-iTaukei Fijians, though social response bias is a consideration. Differences in health-
seeking behaviour of this scale did not seem borne out in public sector hospital attendances 
observed during fieldwork, nor in responses to a dengue fever survey. This model finding 
adds weight to the hypothesis that the notified disease difference may be in part due to 
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reduced susceptibility in Indo-Fijians. There is a known protective HLA type,48 and the  
ancestral exposure of Fijians of Indian descent to S. Typhi through millennia of double-digit 
typhoid case fatality rates would be a potent driver of selection for immunity. This contrasts 
to the known vulnerability of iTaukei and other Melanesians to dysenteric infections.49 Budd 
reports the population of Tahiti, a Polynesian island, being “swept off” by typhoid imported 
from Europe 150 years ago.50 
Our approach is similar to but conceptually distinct from short-cycle (direct) and long-cycle 
(environmental, indirect) transmission modelling.37,51 Our model explicitly includes the 
different pathogenic outcomes following low or high dose inoculation, building on the 
Maryland challenge studies,11,12 focussing on the inoculating infectious event and its 
consequences rather than the source of the inoculum.  Long-cycle may be more likely to 
typically convey low-dose inoculum with low probability of pathogenesis and short cycle to 
convey high dose, though this is not an explicit component of this model. The high dose 
contact patterns and transmission events in the model do not preclude an element of long-
cycle transmission and vice versa, given known localised environmental bacterial detection 
around cases,52 and serological association with wetter areas described previously53 as well as 
reports of river-borne transmission between iTaukei villages.  
We examine WASH as a reduction in the β per contact transmission parameter, without 
prescribing components for intervention, which are be better determined by case-control 
studies, such as a recent paper by Prasad and colleagues.54 Prasad’s study found risk factors 
to be (by decreasing population attributable risk (PAR)) unimproved sanitation (72%), non-
washing for produce before consumption, intermittent water supplies, and consumption of 
surface water as a secondary water source. Protective factors were HWWS and high 
handwashing frequency after defecation. All of these are compatible with the findings of this 
modelling study – the two studies together suggest substantial impact would be possible by 
addressing safe sanitation systems as a priority. 
 
The balance of infectious and immunising forces in the model was examined by a sensitivity 
analysis of the α scaling parameter for low-dose transmission. Reducing this increases the 
susceptible population and caused a rise in cases, though not on a timescale that explains the 
upturn in cases seen in the last decade. It is unlikely that interventions for WASH might 
independently act to reduce α without impacting primarily on β: follow up serosurveys and 
national typhoid fever surveillance would be important means of observing changes to 
population immunity and any association with case incidence.  
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A number of mechanism may explain the rise in cases in Fiji in the 2000s. In Malawi, the 
arrival of the globally-expanding virulent multidrug resistant H58 subclade of S. Typhi has 
been suggested as increasing transmission.55 The absence of emerging antimicrobial 
resistance5 or of persistence of H58 isolated in Fiji in the early 1990s56,57 against the endemic 
Oceanian S. Typhi clade suggests transmission has not risen as a result of H58 expansion. Loss 
of population immunity is not consistent with the timescale and extent of increase in notified 
cases. Of scenarios we tentatively examine with this model, socio-epidemiological changes 
increasing transmission could fit with the timescale as could changes in disease reporting. 
Dunn and colleagues suggest that the increase in notification was a result in the change in 
laboratory detection following a scale-up in hospitals’ use of blood culture diagnostics in the 
2000s.47 This modelling analysis, in assuming a stable long-term disease equilibrium, implicitly 
accepts Dunn’s assessment, supported by serology consistent with an endemic transmission 
pattern.7 When fitted to declining transmission parameters from a historically higher baseline, 
examined models were less able to reproduce the data than under equilibrium assumptions. Pre-
2004 serum samples could be strongly informative to further analysis. The modelling 
framework we have developed may offer a mechanism for further investigation of these 
events. 
There are a number of limitations to our study. Limitations on the interpretation of serology 
are a key consideration, and are reviewed in more detail elsewhere in this thesis, centring on 
sensitivity and specificity of anti-Vi IgG and the fitted threshold for seropositivity used as an 
indicator of past infection and subsequent immunity.  Parameter estimates are best fit values 
but could have uncertainty quantified by likelihood profiling. Bayesian methods could 
alternatively be applied to parameter estimation. Our model considers typhoid transmission 
to occur as single time point events. This simplification does not exclude the possibility or 
probability that exposure to Typhi can occur over a prolonged period, with such occurrences 
plausibly associated with raising anti-Vi titres to observed levels. The carriage risk following 
an acute infectious episode was fixed across age groups; this could be varied, though would 
be expected to have only modest impact on dynamics. The reporting fraction adjustment for 
children could be varied further by age in line with a recent meta-regression analysis.3,31  
A further model extension would be to include seasonality through a varying β parameter. 
Typhoid incidence tracks rainfall in Fiji by approximately a two month lag,58 though the 
relative contribution to this of environmental factors or seasonally varying social mixing 
patterns and other seasonal factors is unclear, and is likely to have modest impact in long-run 
projections.  
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Much remains to be determined in the pathogenicity and immunogenicity of natural typhoid 
infection in informing its control; the interplay of human challenge studies, field 
epidemiology and modelling offer potential insights alongside new developments in 
surveillance, laboratory research and vaccine trials.44,59 Stool shedding of Typhi can occur in 
those who ingest Typhi but do not develop overt disease, though may not arise in the 
majority of such cases. Hornick and colleagues note this was seen at the ID50 of 107 bacilli, 
whilst low dose exposure in community settings might be considered in the range 103 to 105. 
Recent blood culture-PCR in the Oxford typhoid human challenge study tested positive for 6 
of 17 culture negative participants who were not diagnosed with typhoid, further indicating 
asymptomatic bloodstream infection occurs, as might lead to raised plasma anti-Vi IgG. Five 
of the six Oxford asymptomatic DNAaemic participants did not have S. Typhi detected in 
stool: this broadly supports our handling of an asymptomatic case compartment as non-
infectious whilst also have infectious cases potentially subclinical in their presentation. 
In efforts to understand the transmission of typhoid in Fiji, we have developed a 
parsimonious age structured model that incorporates ethnicity and inoculation dose-
dependency in its structure, reflecting some of the complexity of Fijian society and the 
pathology of Salmonella Typhi. Our modelling study, grounded in a sero-epidemiological and 
social contact survey, suggests the potential role of established and recently-recommended 
vaccines, whilst further supporting the use of effective WASH interventions in control of the 
persistent scourge of typhoid fever. 
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Chapter 7. Discussion 
 
The aim of this thesis has been to examine the seroepidemiology of human Salmonella Typhi 
infection in Fiji and potential impacts of vaccination programmes or other public health 
interventions to reduce typhoid transmission and typhoid fever cases.  
This discussion chapter seeks to: 
 briefly restate the principal findings of this research project;  
 review strengths and limitations; 
 compare findings to the state of knowledge prior to the work; 
 to suggest implications of the research; and  
 to indicate possible research future directions. 
At the commencement of these studies, surveillance data indicated the overwhelming 
majority of cases were in iTaukei Fijians, most commonly those aged 15-34 years.1 There was 
limited data by which the extent of under-reporting could readily be assessed.2 Alongside 
universal demographic factors such as age and sex, a particular consideration for Fiji is the 
role of ethnicity in the epidemiology of health and disease,3 including for typhoid fever and 
other communicable diseases.  
The thesis papers are approximately sequential in development with prior papers informing 
the more recent. The following summarises the key findings of the papers, with those for the 
serosurvey, contact study and model described in relation to the aims presented in the 
introduction to the thesis. 
In chapter 2, the literature review,4 I identified that transmission models are relatively under-
utilised in typhoid control, particularly in economic evaluation, with little guide to relative 
cost-effectiveness of vaccination in place of or alongside with WASH. The particular relevance 
of the review to Fiji was in identifying model conceptualisations and the need for setting 
specific parameterisation. 
Chapter 3 covered the serological survey.5  This has the principal field research finding, which 
is that iTaukei and non-iTaukei Fijians have similar risk of developing raised IgG antibodies to 
the Vi antigen expressed by S. Typhi, and that seroprevalence increases with age. This is 
suggestive of endemic transmission, though also compatible with historically higher incidence 
in childhood cohorts.  
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Antibody decline towards baseline was determined in a patient cohort examined alongside 
the cross-sectional survey. Risk factor analysis suggests there may be possible roles for 
unimproved sanitation and settlement residency in antibody acquisition, whilst the study did 
not indicate different risks by sex, ethnicity, rurality or water sources. The implications of the 
serosurvey for the epidemiological model of Fiji is that there appears to be substantial un-
reported typhoid transmission in Fiji, affecting both major ethnic groups, which requires a 
mechanistic explanation. 
The geospatial paper6 in chapter 4 identifies rainfall, proximity to major rivers and creeks, and 
proximity to flood-prone areas as environmental risk factors for acquisition of anti-Vi IgG 
antibodies, after adjusting for age, self-reported vaccination status and home toilet type.   
In the social contact survey (chapter 5),7 I found that social mixing is assortative by ethnicity 
and age when assessed by mealtime contacts. These are not unexpected findings but provide 
quantitative estimates of daily contact rates. Similar to conversation-based contact studies in 
other countries, these were found to be highest in school-age children. Increasing number of 
age-adjusted contacts increases the odds ratio for being seropositive, driven by number of 
iTaukei contacts of iTaukei participants, with no evidence from other ethnicity-based 
contacts, after adjusting for age, sanitation and settlement residency.  
The transmission dynamic model (chapter 6) was designed to synthesise the findings from the 
prior studies. The model fitted the serology and case data well when fitted parameters 
included a substantially reduced force of infection for high-dose infection being passed to 
non-iTaukei Fijians, and there was high generation of homogeneously-distributed 
asymptomatic non-infectious cases per new infectious case. Surveillance reporting of 
infectious cases was estimated as one in five infectious adult cases and one in twelve 
infectious child cases. Vaccine scenarios suggested that of single dose routine programmes, 
school entry could be more effective than school leaver vaccination, reflecting age-contact 
transmission probabilities in the model. Modest reduction (10%) in per-case infectious 
transmission through effective WASH programmes offered substantial incidence reductions 
of around 25%, comparable to two-dose (school entry and exit) ViPS vaccination 
programmes. Potential benefits of conjugate vaccines were projected to be similar to more 
effective WASH programmes, with administration alongside other vaccines in the second year 
of life projected to offer approximately 50% incidence reduction, the most benefit of any 
single dose regimen.  
A strength of the research programme is the collection of field data specifically for the 
purpose of informing epidemiological understanding, to support modelled assessments of 
265 
 
vaccine impact.  Epidemiological fieldwork without a theoretical framework and data-free 
theoretical models are increasingly recognised as less productive than approaches utilising 
both.8,9 The absence of serology, imperfect is it might be, would have left parameter space 
much freer and greatly increased the difficulties in attempting to assess the extent of under-
reporting in Fiji, particularly given the important differences observed in case ethnicity. Social 
mixing data further strengthens the model in this regard. 
The research findings may be informative to local communicable disease control policy, 
though require caution in interpretation, not least for serology in this study, including the 
fitted threshold. This study represents an early endeavour in the use of anti-Vi IgG as a 
typhoid serosurveillance tool. The surveillance threshold fitted from convalescent case data is 
used as indicative of exposure and immunity but requires further development in assessing 
sensitivity and specificity, and thus the degree to which the derived threshold may under- or 
over-ascertain past infection. The decision to pursue an anti-Vi serosurvey was supported by 
a relatively modest body of research including immunological analysis,10 field research,11 and 
vaccine trials.12,13 Since the start of the study, there has been increased immunological 
support for Vi as a marker of natural protection14 including supportive finding on the role of 
modest Vi titres in protection from human challenge studies.15,16  The use in the serosurvey of 
purified pharmaceutical grade Vi for ELISA may contribute to reduced cross-reactivity and 
strengthen test validity relative to less refined Vi preparations.17 Recent findings from the 
Oxford human challenge studies suggest serum bactericidal activity (SBA) protects against 
severe disease but not infection18 – this  is not field data but nonetheless supports the use of 
Vi ELISA as a more suitable current tool for typhoid seroepidemiology.  
Further comparison with d-flagellin assays would have been welcome in triangulating 
findings. Re-examination with recently developed reference serum, even in the absence of 
agreed correlates of protection,19–21 and for typhoid toxin22 or other novel biomarkers are 
potential extensions to such seroepidemiological work.  We reached a limit in the number of 
confirmed typhoid patients from Colonial War Memorial, the national teaching hospital, that 
could feasibly be traced and recruited but a larger Fijian patient cohort prospectively 
identified and with longer follow-up could potentially inform population serology.  
An important consideration in seroepidemiology is that serology is not necessarily a marker 
of past or current disease. As suggested in the serology study and modelling study, a large 
proportion of typhoid cases are mild or asymptomatic. Those enrolled as patients may be a 
frailer subset (in the statistical hazard sense) of the general population and not 
representative of population immunity. There are potential differences in kinetics between 
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patients and those whose typhoid (mild or otherwise) goes untreated in the community. 
Clinical serology from Vietnam23 (with supporting evidence from the Oxford challenge 
study)24 suggest infection longer than two weeks may be necessary for sustained Vi response; 
in the Fijian patients, no antibody differences was seen when grouped by self-reported 
clinical duration. The antibody kinetics in seroconverted patients suggests a more rapid 
decline towards baseline than durations fitted in the model. Modelling typhoid in Fiji with 
short natural immunity resulted in very poor serological fit relative to multi-decade or lifelong 
immunity. It is possible that decline becomes asymptotic towards the threshold but a further 
explanation is asymptomatic boosting or prolonged exposure: unlike the Yale Asia model,25 
the Fiji model simplification does not capture boosting processes. As noted in the 
introduction, two further rounds of serum collection have been undertaken with Central 
Division participants for arboviral disease investigation. These additional survey rounds offer 
the possibility of examining true population typhoid antibody kinetics such as wane and 
boosting, by paired or cohort analysis of anti-Vi titres.  
International comparison with representative population serology from high and low 
incidence settings may offer the most informative means to examine typhoid natural 
immunity distributions. This work uses a dichotomised immunity state, in a conventional 
medico-epidemiological approach to simplification of biological processes for analytical 
purposes. What is suggested from synthesis of the literature on dose dependency in 
infection, inconclusive thresholds for correlates of immunity, and the serological study’s 
population distributions of antibody titre, is that typhoid immunity could or should be treated 
as a distribution accounting for protection to different inoculating doses. As noted in the 
model chapter, multiple dose-pathology responses could be developed; sensitivity analysis of 
thresholds and allocation to compartments could also be done. Some approaches to 
modelling vaccine immunity distributions alongside inoculation distributions have been 
suggested in recent analysis of simulated susceptible-infectious data by Gomes and 
colleagues.26 To really begin to examine immunological thresholds and distributions of 
natural anti-Vi protection, adaptations of the human challenge study could be done based on 
known baseline antibody titres of participants. Challenge studies in endemic areas would be a 
major undertaking and likely require sustained engagement with local research ethics 
committees.  
In terms of within-population risk factors, the mechanisms for the transmission of 
seropositivity are not necessarily the mechanisms by which disease is transmitted. This may 
particularly be the case if high dose and low dose are transmitted separately – for example, if 
municipal waterborne typhoid transmission is more likely to be of a low inoculum, as noted in 
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Glynn and Bradley’s study of historical outbreaks.27   Thus it is important to be very cautious 
in interpretation of findings from the serosurvey (including geospatial component) as to how 
these might apply to typhoid fever, the disease. A further consideration in this domain is that 
the mechanism by which the geospatially-determined water-based exposures might give rise 
to seropositivity is not necessarily ingestion of water. No variables for river exposure 
(bathing/swimming, walking through, cleaning clothes, cleaning pots) or drinking water 
sources were identified as associated with seropositivity in the main serosurvey paper. This 
may point towards the saturated physical environment as a conduit, consistent with other 
research in Fiji.28  
In the social mixing study, the association of seropositivity with age-adjusted inter-iTaukei 
contact rates is supportive of a hypothesis of socially-structured transmission being 
important to the spread of typhoid in Fiji, which is not synonymous with direct person-to-
person transmission but potentially reflects common exposure to indirect transmission within 
a social context, which may include contamination of food or surface water supplies, and 
contaminated fomites, in line with contemporaneous studies and historical reports of typhoid 
transmission. The age-assortative social contact data has highest rates in the school-aged, 
which steers our model towards accepting childhood transmission as important in typhoid, 
consistent with established theories of transmission in developing countries  of typhoid and 
non-typhoidal enteric bacterial infections.29,30 Other mixing matrices’ fit to data were less 
good when examined in the model.  
The last full year of available national surveillance data was 2014. Analysis with more recent 
data could also be informative. There was suggestion in simple linear regression of case data 
of a trend of an 11-cases per year decline from 2008 to 2014. This would be consistent both 
with an increased transmission coefficient () as a driver of the epidemic, and consistent with 
improved WASH interventions reducing  as part of outbreak response. These were premised 
on endemicity – models of declining transmission rates across decades from historical highs 
did not fit the data as well. Access to historical serum sets would support assessment of the 
mechanisms underpinning the rise in cases. 
The findings from this project have implications for public health practice, even with these 
limitations.  Whilst economic evaluation was left beyond the scope of the doctoral project, 
the model findings are informative to the relative potential contribution of vaccines and 
sanitation, and their sensitivity to factors such as the relative infectiousness of carriers. 
Whilst some policymakers may use these to signify the necessity of vaccination, the model is 
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intended to give an appreciation of levels of effective intervention necessary for disease 
control of different degrees though both vaccination and WASH.  
Of possible risk factors generated in the analysis of the serosurvey, unimproved sanitation 
systems are consistent with findings of disease association from recently completed case-
control and case-environmental analyses of Fiji’s Central Division, primarily implicating 
unimproved or damaged sewage systems, with attributable risk also from unwashed 
produce, intermittent water, surface water as a secondary drinking water source and the 
absence of handwashing with soap.31,32 Interestingly, these typhoid fever findings are 
consistent with systematic reviews33 on diarrhoeal disease (which, as a classification, excludes 
typhoid fever), rather than suggesting different predominant modes of transmission for 
Salmonella Typhi compared with enteric bacterial pathogens considered to have lower 
inoculating doses  such as Shigella spp. Collectively, the transmission model and these studies 
create a consistent picture of the importance of addressing sanitation and hygiene to reduce 
Salmonella Typhi transmission from infectious cases and carriers to protect those around 
them, water courses and food produce, in line with the F-diagram approach to sanitary 
engineering outlined in the introduction to this thesis, the historical literature,34–36 and Asia-
Pacific case control studies.37–40  
A policy consideration should be the cost and opportunity cost of establishing a long-term 
typhoid vaccination programme versus other interventions, particularly if baseline typhoid 
fever incidence may be falling. Unlike a vertical vaccination programme, WASH strengthening 
also contributes to control of other communicable diseases. Were vaccine campaigns to be 
considered for short term control, potentially as a stop-gap to improvements in WASH, our 
modelling suggests effective school based campaigns can result in substantial incidence 
reductions without the potential health service disruption of all-age vaccination drives. 
Consistent with the national narrative on citizenship and identity, the modelled analyses do 
not examine the impact of immunisation or targeted WASH interventions based on ethnic 
group.  
The age- and ethnic- structured modelling framework could be adapted for other public 
health threats in Fiji. A recent outbreak of the faecal-orally transmitted hepatitis A virus 
primarily affected Indo-Fijians in Western Division.41 Serological studies have shown markedly 
different viral hepatitis seroprevalences by ethnicity in Fiji42,43 and could be integrated into a 
dynamic, socially-structured model, potentially with serological testing of the 2013 samples.   
Direct application of the modelled vaccine effectiveness results to other settings, or specific 
comparison to results from other models,25,44 is limited by setting-specific epidemiology and 
model parameterisation other than in general terms described above, such as the likely 
relative effect of different vaccine characteristics and the interplay of WASH and vaccination. 
The project demonstrates that it is feasible to undertake serological data collection and use 
this to inform model projections that account for otherwise unobserved transmission and 
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immunity. Serologically informed typhoid modelling could readily be applied in other settings 
for vaccine impact estimation, such as those included in international typhoid surveillance 
programmes.45,46 The major Wellcome- and Gates- funded STRATAA study uses anti-Vi IgG 
ELISA for detection of seroconversion in household contacts of cases to determine secondary 
attack rates.47   
In terms of research unknowns, long-term carriage remains one of the most interesting 
characteristics of typhoid transmission. Carriage supports persistence of S. Typhi in low 
transmission settings and may make elimination more challenging.4 The literature review 
found that carriage prevalence or risk of carriage following acute illness was an important 
determinant of indirect vaccine protection in models combining lifelong carriage with or 
without a β modifier. A similar finding was observed in the Fiji model, with the β of carriers 
relative to cases having important influence on vaccine effectiveness, and no difference in fit 
observable across two orders of magnitude variation in carrier β. Despite the concept that Vi 
carriage can be determined by Vi serosurveillance, there was insufficient data in the field 
survey (and no known Fijian carriers from which to have a positive control set) to begin to 
determine a serological threshold suggestive of carriage, beyond the speculative observations 
in the field survey paper.  As noted in the introduction, historical efforts to use Vi serology for 
carrier detection have not been universally successful as a convenient alternative to repeat 
stool culture. 
A number of programmes could support the identification of carriers and the development of 
carriage serological thresholds, some of which were proposed for Fiji but not yet taken 
forward from the 2012 expert meeting. An anti-Vi screening programme for carriage was 
proposed to replace stool screening, on the grounds that case and peri-case stool screening is 
wasteful, though this would be inconsistent with recent UK guidelines which still give primacy 
to stool culture over serological methods.48 Undertaking these developments as research 
rather than a programme would seem appropriate. Serological testing of cholecystectomy 
patients alongside suitable gallbladder or gallstone culture could identify carriers and possible 
thresholds for screening and inform carrier seroprevalence from the national serosurvey. 
The social mixing survey develops this field of research in two dimensions – the use of meal-
based contact for enteric infectious disease modelling (rather than conversational contacts 
for respiratory diseases), and in enquiry about ethnicity. By quantifying mealtime social 
contacts, this study is one of the first social mixing studies specifically designed to inform 
transmission of faecal-orally transmitted pathogens, though it is important to note the intent 
of such data is to inform intensity of social contact as a proxy for risk rather than being 
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prescriptive about the mechanism.49 On this basis, the mixing matrices could readily have 
wider application in Fiji for addressing data gaps in epidemiological modelling of diseases 
such as scabies (personal communication, David Regan), again utilising the social intimacy of 
eating as a proxy for transmission risk.7,49 The contact survey has potential utility beyond Fiji, 
both as Pacific island mixing data, and in methodological development.  The study warrants 
further investigation and validation against a range of markers of infection for a range of 
enteric diseases and in other settings.  
Consistent with a broader health utility perspective, the serosurvey was designed for 
application across multiple diseases. Since undertaking this study, there has been a call for 
increased use of such serum banking for infectious disease investigation, endorsed by leading 
Anglo-American public health institutes.50 Establishing the Fiji serum bank has opened up a 
multiplicity of uses and contribution to communicable disease research beyond typhoid 
fever, most notably to date through the leptospirosis investigation led by Colleen Lau,51,52 but 
also arboviral disease, including dengue outbreaks and the emerging threat of Zika virus.  
A final point I had been pondering during my doctoral research was where the intersection 
might lie of these typhoid control investigations and my parallel research in Ebola vaccine 
field trials and novel trial designs for control of diseases of epidemic potential.53,54 A 
reanalysis by Mohammad Ali and colleagues of a cholera vaccine cluster randomised trial as a 
ring vaccination trial showed one possible approach.55 Another answer came from Kim 
Mullholland (personal communication): ring vaccination trials against typhoid, with the 
possibility of demonstration projects in Fiji or other Oceanian island states. Such studies, 
whether individually- or cluster-randomised, would be compatible with current WHO 
recommendations on typhoid vaccination in outbreak control,56 internationally declining 
typhoid incidence trends,57 and case response by environmental health teams in some low to 
moderate incidence settings.  The serial interval between cases makes this a plausible, if 
enormously challenging, means of examining vaccine efficacy and effectiveness and an 
intriguing parallel approach to ongoing large-scale cluster randomised trials of typhoid 
conjugate vaccines in Asia and Africa.58 The prospects for scientifically-informed typhoid fever 
control look increasingly promising. 
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Appendix A1. Informed consent and questionnaire 
 
Typhoid and leptospirosis in Fiji 
Research Consent form for adult and child participants 
Participant ID Number: FJT 
 
I/we have read and understood the information sheet. I/we understand that participation 
is voluntary and I/we can withdraw assent/consent at any point without giving a reason. 
I consent to the following:  (please tick yes or no to each question) Yes No 
1. 
A sample of my/my child's blood may be taken and used for typhoid 
and leptospirosis research. 
  
2. 
The answers I/we give to questions can be used for public health 
research, including typhoid and leptospirosis. 
  
3. 
The Ministry of Health, or researchers working with the Ministry, can 
contact me/us again about typhoid and leptospirosis research. 
  
4. My/my child's blood sample can be used for other health research. 
  
5. 
The Ministry of Health, or researchers working with the Ministry, can 
contact me/us about other health research. 
  
 
 
Name of participant: 
(please print) 
Age in years: 
 
Signed by participant if age 12+: Date (dd/mm/yyyy) 
Name of PARENT or CARER for child participants (age 17 or less):  
(please print) 
Signed by parent/carer: Date (dd/mm/yyyy) 
letter site person 
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If the participant/parent/carer does not speak English: 
Witnessed by:  
(please print name) 
Signed by witness: 
 
Date (dd/mm/yyyy) 
 
Participant ID FJT  Data entered  Re-entered  
checked 
Date today:  __ __ / __ __ / 20__ __ (dd/mm/yyyy) 
Day of the week (circle number): 1=Mon 2=Tue 3=Wed 4=Thu 5=Fri 6=Sat
 7=Sun 
Interviewer (circle) :  JC  IK  MT  LV    SR  AS     KR  CW 
 Other:_____________________  
How many homes did you have to visit before this one? ____ empty 
_____did not want to take part. 
Location 
Q1a. Location name (Village, Settlement, or Street): 
_________________________________________ 
Q1b. Community type:  1= Village (registered), 2= Village (unregistered Fijian 
settlement),   
3= Settlement (Indo-Fijian),  4= Settlement (Mixed) 5= Squatter, 
 6=Residential (private housing/flats),   
7=Residential (government/social housing) 8 = other: ___________  
Q1c. Geography:  1=urban,  2=peri-urban,  3=rural 
Q1d. Nursing Zone: ___________________________ Q1e. Medical Area:  
____________________________  
Q1f. Division (circle):  1= Northern,   2= Central,   3= Western,   4=Eastern  
Q1g. GPS coordinates of (circle):  1= front door of house,   2= community 
centroid, if not possible to visit house   
Q1h. South 0°.’ (circle) West / East 
°.’   
Q1i. GPS elevation: ________metres Q1j. Garmin  1 or 2 (circle)  & Waymark no 
 
Household occupants 
Q2. Please tell me the age and gender of each person who stayed in the household last night. 
(circle sex) 
No Age  Sex  No Age Sex  No Age Sex  No Age  Sex 
1  M F  6  M F  11  M F  16  M F 
Consent taken by research staff member: 
 (please print name) 
 
Signed by research staff member: 
 
Date (dd/mm/yyyy) 
letter site      person 
277 
 
2  M F  7  M F  12  M F  17  M F 
3  M F  8  M F  13  M F  18  M F 
4  M F  9  M F  14  M F  19  M F 
5  M F  10  M F  15  M F  20  M F 
Q2a. Random number from tables to select the participant (reselect if <1year old):  
Q2b. Record any participant number(s) selected but who could not be contacted: 
_______________ 
The selected participant  
Q3a. First name:_________________ Q3b.Family Name : _____________________ 
 Ask for initials if this is declined, or record “-2” if refused. 
Q4a. Age (from above) years Q4b. Date of birth :  __ __ / __ __ / __ __ 
__ __  (dd/mm/yyyy) 
Q5. Sex: (from above) 1= Male,   2= Female,   -2= refused. 
Q6. Were you born in Fiji?  1=yes (skip to Q7a), 0=no, -1=don’t know, -2=refused  
If no, don’t know, refused:  Q6a. Roughly how long have you lived in Fiji? 
____________years 
    Q6b. Where did you live before that: _________________ 
Q7a. How long have you lived in this village/settlement/town? _________years   
-3= all my life (skip to Q8) -1 =don’t know, -2=refused 
Q7b. What was the last place you lived before here? 
 Name of place: ___________________________________-1 d/k   -2=refused 
Q7c. Province/area/town ________________________________________________ -1 
d/k   -2refused 
Q7d. Division (circle): 1= Northern,   2= Central,   3= 
Western ,   4=Eastern,  5=outside Fiji: ________ 
Q7e. Which of the following best describes that place: 1=urban, 2=peri-
urban,  3=rural,  4=remote island 
Q7f. Community type: 1= Village (registered), 2= Fijian settlement 
(e.g. unregistered village),  
3= Settlement (Indo-Fijian),  4= Settlement (Mixed) 5= Squatter, 
 6=Residential (private housing/flats),  
6=Residential (government social housing) 7 = other__________ -1=don’t know,  -
2=refused 
Q8. What is your ethnicity?  
1 = Fijian / iTaukei / indigenous Fijian 2 = Indo-Fijian / Fijian of Indian Descent / 
Indian  
3 = European / Fijian of European Descent  4 = Chinese / Fijian of Chinese Descent  
5 = Melanesian/Polynesian/Micronesian/other Pacific island  
6 = Mixed 7=other  -1 = don’t know -2 = refused 
Q9. What is your 
religion?  
1 = Christian - Methodist 
5 = Christian - Anglican 8 = Muslim 0 = none 
2 = Christian - Catholic  6 = Christian - Other  9 = Sikh -1 = don’t 
know 
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3 = Christian - Assembly of 
God 
7 = Hindu 10 = other -2 = refused 
4 = Christian - 7th Day 
Adventist 
   
 
Q10. What is the highest level of school you have completed?  Either Class _____ or Form 
______ or:  
0= No formal schooling 1= Primary 2= Secondary 3= Technical / Vocational 
School 4=University/tertiary -1= don’t know -2= refused 
Work and Farming 
Q11a. What is your job title or job description, if any? 
_______________________________________  
Q11b. Do you mostly work:  1=indoors,  2=outdoors, or  3=a mix of both?   
 -1 = don’t know,  -2 = refused  -3 not applicable 
Q11c. Which of the following best describes your main job? (Suggest one based on above 
description) 
(The occupation that the participant spends the most time on. Circle one number only):
  
1 = pre-school child; 6 = manual labourer; 11= retired; 
2 = pupil/student; 7 = skilled manual worker; 12 = unemployed; 
3 = professional/office 
worker; 
8 = farming; 13 = other; 
4 = shop worker; 9 = fishing; -1 = don’t know; 
5 = Market/outdoor trader; 10 = housewife/househusband; -2 = refused. 
Q12. What is the total household income each week? (combined total of everyone who lives 
there)  
0= less than FJD100, 1=100 to 199, 2=200 to 299, 3=300 to 399,  
4 = 400 to 499, 5=500 to 999, 6=1000 or more.  -1 = don’t know,  -2 = 
refused 
Q13. If the main job is not farming: Have you done any part-time/casual farming in the last 
12 months? (not just growing vegetables in the yard or keeping a few animals) 1=yes, 
 0=no, (go to Q16)  -1=don’t 
know -2=refused 
Q14. If a farmer (main job or part-time/casual), which of the following do you farm? (tick all 
that apply) 
Q15. If farming: To go from home to where you mostly farm, is it:  1=uphill, 2= 
downhill, 3=up+down  or 0=on the same level?  
  
a Chickens  d Goats  g Vegetables/root crop  
b Pigs  e Cows  h Fruit  
c Sheep  f Sugar 
Cane 
 i Other:_______________  
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Travel and meeting people 
Q16. How often do you visit places outside your village/settlement/town? (not just for 
farming/fishing) 
Every 
day 
4 to 6 days 
per week 
1 to 3 days per 
week 
One a month or 
more, (but not once 
a week) 
Less than once a 
month, but not 
never 
Never 
(go to 
Q18) 
Don't 
know 
Refused 
5= 4= 3= 2= 1= 0= -1= -2= 
Q17a. Could you please name all the villages, settlements or towns you have visited in the 
last 7 days?  
(either for work or visiting friends and relative)  0= 
Visited no village, settlement or town.  -1= don’t know 
  
Name 
Division 
(circle) 
Community type Tick 
furthest 
away 
iTaukei 
Village 
Indo-
Fijian 
Settlement 
Town Other:  
1  N C W E      
2  N C W E      
3  N C W E      
4  N C W E      
5  N C W E      
6  N C W E      
7  N C W E      
8  N C W E      
9  N C W E      
10  N C W E      
If more than ten, please give ten examples, including the furthest away, and typical places 
visited. 
Q17b. If more than ten, roughly how many? ___________  
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I’d like to ask you about who you had meals with yesterday. If asked, this is because typhoid 
may be spread on food. 
Q18a. First, where did you eat lunch yesterday? 
Q18b. And where did you eat dinner yesterday? 
Lunch 
(X one 
answer 
only) 
 Dinner 
(X one 
answer only) 
Q19 
1 Home   
Ask: “how 
many people 
of each age 
also ate the 
same food?”  
2 Somebody else’s home   
3 
Buffet / lovo at church, village social 
gathering or similar 
  
4 
Workplace/school  – brought food from 
home/from somebody else’s home 
  
5 Workplace/school – cafeteria food   Ask: “how 
many friends, 
family or 
colleagues of 
different 
ages did you 
share a table 
with?”   
6 
Restaurant/cafe/food court/takeaway 
(takeaway or ate there, includes hotel 
restaurants) 
  
7 Outdoor food stall (takeaway or ate there).   
8 Bought from a walking food seller   
9 Didn’t eat lunch/dinner    
10 Other:________________________    
-1 Don’t know     
-2 Refuse to say    
 
Q19. I’d like you to think about how many people of different ages you shared food with, 
first at lunch, then at dinner. (The participant should not include him or herself.) 
 
(1) For people who ate at home, somebody else’s home, at a buffet, or brought food to work,  
ask “how many people of each age also ate the same food?”  
(food made in the same kitchen, shared at the meal, or from the same buffet) 
 
(2) For people who ate at a work cafeteria, from a roadside stall/street seller or  
a restaurant/food court, ask “how many friends, family or colleagues of different ages did 
you share a table with?”   
(or equivalent to a table if ate outdoors) 
 
Q19a. First lunch, starting with children under 5:  
- of these people, how many were iTaukei Fijian, Indo-Fijian, or other? 
 
Q19b. Then dinner, starting with children under 5:  
- of these people, how many were iTaukei Fijian, Indo-Fijian, or other? 
 
Q19c. And finally, how many of these people were the same at both lunch and dinner? 
- of these people, how many were iTaukei Fijian, Indo-Fijian, or other? 
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Go through each age group. Record exact numbers for numbers 0 through to 15. If the 
participant is concerned about getting it exactly right, tell them it is ok if they are a little bit 
out or can’t remember exactly.  
If more than 15, use these bands: 16-24, 25-49, 50-99, 100+.  Use also:-1=don’t know, -2 
= refused, -3 not applicable. 
Age: 0 to 4 5 to 14 15 to 34 35 to 54 55+ 
19a. 
Lunch 
 
 
Fjn 
 
Fjn 
 
Fjn 
 
Fjn 
 
Fjn 
Indo Indo Indo Indo Indo 
Othr Othr Othr Othr Othr 
19b. 
Dinner 
 
 
Fjn 
 
Fjn 
 
Fjn 
 
Fjn 
 
Fjn 
Indo Indo Indo Indo Indo 
Othr Othr Othr Othr Othr 
19c. 
Same 
people 
 
Fjn 
 
Fjn 
 
Fjn 
 
Fjn 
 
Fjn 
Indo Indo Indo Indo Indo 
Othr Othr Othr Othr Othr 
 
Contact with people 
Q20. No longer being asked 
 
Water and Sanitation 
Q21. How often do you drink 
the following? (circle 
number) 
Every 
day 
4 to 6 
days per 
week 
1 to 3 
days per 
week 
One a month or 
more, but not 
once a week 
Less than once a 
month, but not 
never 
Never Don't 
know 
Refused 
Water 
from 
a... 
a. Tap at home 5 4 3 2 1 0 -1 -2 
b. Tap somewhere 
else (e.g. village 
standpipe, cafe) 
5 4 3 2 1 0 -1 -2 
c. Well, pump or 
borehole 
5 4 3 2 1 0 -1 -2 
d. Rainwater 
container 
5 4 3 2 1 0 -1 -2 
e. River, stream, 
pond or lake 
5 4 3 2 1 0 -1 -2 
f. Juice made by a cafe or 
street stall (not carton juice) 
5 4 3 2 1 0 -1 -2 
g. Grog/Kava 5 4 3 2 1 0 -1 -2 
 
Q22. Do you treat your water in any way to make it safer to drink? (i.e. does anyone in the 
household treat the water, we are not asking if the water supplied to the 
household/participant is already treated) 
3=Yes - 
always 
2=Yes - usually 1=Yes, sometimes 0= no, never -1= don’t 
know 
-2 = 
refused 
(at least 95% 
of the time) 
(50% or more of 
the time but not 
95%), 
(less than 50% of 
the time but not 
5%) 
(5% or less of 
the time) (go to 
Q24) 
 
Q23. If yes, what do you usually do to the water to make it safer to drink? 
282 
 
Prompt “Anything else?”  (Record all that are mentioned, do not prompt specific 
methods) 
Boiling Use a water filter Other 
____________________ 
Add bleach/chlorine Solar disinfection Don't know 
Strain it through a cloth Let it stand Refused 
 
Q24, If the participant drinks grog/kava: The last time you had grog/kava, how many people 
did you drink it with? 
 (circle the number, do not include the participant in the total) 
Not 
app. 
no one 
else 
1 to 
4, 
5 to 9, 10 to 
14, 
15 to 
19, 
20 to 
24, 
25 to 
49, 
50+ Don’t 
know 
refused 
-3= 0=  1=  2=  3=  4=  5=  6 =  7= -1 =  -2 =  
 
Q25. Thinking about lunch and dinner yesterday, was soap and water available, if you had 
wanted to wash your hands before eating?  
Did you wash your hands with soap and water before eating? 
 
a. Lunch: soap & water available:   1=yes 0=no  -1= don’t know -2 = refused -
3=not applicable 
b. Lunch: washed hands with soap & water:   1=yes 0=no  -1= don’t 
know -2 = refused -3=not applicable 
 
c. Dinner: soap & water available:   1=yes 0=no  -1= don’t know -2 = refused -
3=not applicable 
d. Dinner: washed hands with soap & water:   1=yes 0=no  -1= don’t 
know -2 = refused -3=not applicable 
 
Q26. What sort of toilet do you have at home? (circle) 
 
not 
applicable 
Flush 
toilet 
Water 
seal/pour 
flush 
Pit 
with 
slab 
Pit 
without 
slab 
Compost 
toilet 
Bucket 
latrine 
Hanging 
latrine 
Field/ 
bush 
River / 
stream 
Sea 
don’t 
know 
refused 
Home -3 1* 2* 3 4 5 6 7 8 9 10 -1 -2 
 
*Q26a.  If flush/water seal/pour flush, where does it go to? 1=piped sewer system, 2=septic 
tank, 3=pit latrine, 4=elsewhere (street, yard. plot, open sewer, ditch, drainage way).  
-1= don’t know, -2=refused,  -3=not applicable 
 
Q27. Where is your home toilet located: 1=indoor, 2=detached, -1= don’t know, -2=refused, 
-3= not applicable. 
Q27a. Is it shared with any other households?  1=yes,  2=no, -1= don’t know, -2 refused, 
 
Q27b. Is there soap and water available to wash hands after going to the home toilet?  
 2=Yes, visually confirmed; 1=yes, but unable to check; 0=No,  -1= don’t know,
 -2=refused. 
Q27c. The last time you used your home toilet, did you wash your hands with soap and 
water afterwards? 
 1=yes,  2=no  -1= don’t know, -2 refused 
 
 
 
 
 
Q28. When you are at work/school, what sort of toilet do you have access to? 
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not 
applicable 
Flush 
toilet 
Water 
seal/ pour 
flush 
Pit 
with 
slab 
Pit 
without 
slab 
Bucket 
latrine 
Hanging 
latrine 
Field/ 
bush 
River / 
stream 
Sea 
don’t 
know 
refused 
a. Work 
Defecate (poo) 
-3 1 2 3 4 5 6 7 8 9 -1 -2 
b. Work 
Urinate (pee) 
-3 1 2 3 4 5 6 7 8 9 -1 -2 
Q28c. When at work/school, are there facilities for washing hands with soap and water after 
going to the toilet? 
 1=yes,  2=no -1= don’t know, -2 refused  -3= not applicable. 
Q28d. Last time you went to the toilet at work/school, did you wash your hands with soap 
and water afterwards? 
 1=yes,  2=no -1= don’t know, -2 refused  -3= not applicable. 
The house 
Q29. What is the house made of? 1=concrete/brick, 2=wood, 3=corrugated iron, 4=bure, 
5=bamboo, -1=don’t know,  
-2=refused. If it is made of more than one, record the main material (e.g. concrete 
with metal roof =1).  
Q30. What is the floor mostly made of? 1= earth/sand, 2=palm/bamboo, 3= wooden planks, 
4= polished wooden floor, 5=vinyl, 6=ceramic tile, 
7=cement, 8=carpet 
Q31. Is the floor raised at least one foot (30cm) from the ground?  
1=yes, 0=no, -1= don’t know, -2= refused 
If the home is on stilts on a hillside, decide based on the edge nearest the hillside. Answer 
yes only if all edges are at least one foot from the ground. An A4 piece of paper is one foot 
long. 
Q32, In your home, how many living rooms and bed rooms are there? _______ 
Do not count bathrooms, landings, porches, kitchens, storage rooms ; record -1 for don’t 
know, and -2 for refused. 
Q33. Does your home have tap water?  1=yes, 0=no,  -1= don’t know,  -2= refused 
Q33a. If yes, is the tap water treated by the government?  1=yes, 0=no,  -1= don’t 
know,  -2= refused 
Q34. Does your home have a working indoor shower, or a tap to wash yourself under?
 1=yes, 0=no,  -1= don’t know,  -2= refused 
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Waste disposal 
Q35. How is garbage / rubbish mainly disposed of from the house?  
Dumped:  1= roadside / field / bush 2 = river/stream/lake 3= sea 
Burnt:  4= incinerator,  5=bonfire 
Buried: 6 = Household pit with raised mounting and tight cover,  
7=household pit without these, 8 = communal pit,   9= Communal skip  
Collection service:  10= bin with tight lid 11= bin without tight lid  
 12= bags on roadside  13= bags on raised rack 
Other: 14=Composting 15=Recycling 16=Reuse  
 17= other _______________ 
 -1= don’t know,  -2= refused 
Exposure to water 
Q36. Is there a stream or river near your home?  1=yes, 0=no,  -1= don’t know, 
 -2= refused 
Near is within the village/settlement for residents of these, or 100m (a rugby/football 
pitch) for other households 
Q37a. Has your house been flooded in the last three years? By inland water such as river or 
stream, not by seawater. 
 1=yes, 0=no (skip to Q38),  -1= don’t know,  -2= refused 
Q37b. If yes, how many times?  1= One or two, 2= three to five, 3=more than five,
  
 -1= don’t know,  -2= refused 
Q38a. Has the land around your house been flooded in the last 3 years?   
 1=yes, 0=no,  -1= don’t know,  -2= refused 
Q38b. If yes, how many times?  1= One or two, 2= three to five, 3=more than five,
  -1= don’t know,  -2= refused 
Q39a. Have you ever been swimming, playing, or bathing in flood water?  
1=yes,  0=no,  -1= don’t know,  -2= refused 
Q39b. Or walking in flood water?  1=yes,  0=no,  -1= don’t know,  -2= refused 
 
Q40. How often do you do the following?  
 Every 
day 
4-6 days a 
week 
1-3 days a 
week 
One a month or 
more, but not once 
a week 
Less than once 
a month, but 
not never 
Never Don't 
know 
Refused 
a. Swim, play, bath in a river, 
stream, waterfall or lake? 
(not flood water, not the sea). 
5 4 3 2 1 0 -1 -2 
b. Walk through a river, stream, 
waterfall or lake? 
5 4 3 2 1 0 -1 -2 
c. Use river, stream, waterfall 
or lake water for washing 
clothes 
5 4 3 2 1 0 -1 -2 
d. Use river, stream, waterfall 
or lake water for washing 
dishes 
5 4 3 2 1 0 -1 -2 
e. Bath using an indoor 
shower/under an indoor tap? 
5 4 3 2 1 0 -1 -2 
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Typhoid and leptospirosis 
Q41. Had you heard of typhoid before this study?  1=yes, 0=no (ask Q42 
then skip to Q46), -1=d/k, -2=refused 
Q42. Have you ever been vaccinated against typhoid? It is NOT usually given in 
childhood. (Some people were vaccinated in 2010 after the cyclone.) 
 1=yes, 0=no, -1=don’t know, -2=refused. 42a. If yes, which year? 
_____________ 
Q43. Have you ever been diagnosed with typhoid by a doctor?   
1=yes, 0=no (skip to Q44) -1=don’t know (skip to Q44) -2=refused 
(skip to Q44) 
Q43a. If yes, roughly when did you get ill? Month (-1 don’t know) _________Year (-1 
don’t know) ________ 
Q43b. How or why do you think you got ill? (-1=don’t know);  
____________________________________________________________________ 
Q44. Has anyone in your household been diagnosed with typhoid?   
 1=yes, 0=no, (skip to Q45) -1=don’t know, (skip to Q45) -2=refused 
(skip to Q45) 
Q44a. If yes, roughly when did they become ill?   
(If more than one person, give the dates of illness of the first person to get ill, and the 
most recent)  
a. First/ only ill person Month (-1 don’t know) _________Year (-1 don’t know) 
___________ 
b. Most recent ill person -3= not applicable Month (-1 don’t know) ________ Year (-1 don’t 
know) __________ 
Q45. Thinking about friends, neighbours, colleagues and extended family in Fiji, how 
many people do you know who have had typhoid? 0= none, 1=one or two,  
2 = three to five, 3=six to ten,  4= eleven+, -1=don’t know, -2=refused 
 
Q46. Had you heard of leptospirosis (lepto) before this study?  1=yes,  
0=no (skip to Q49),  -1=don’t know,  -2=refused 
Q46a. If yes, Have you ever been diagnosed with leptospirosis by a doctor? 1=yes,  
0=no (skip to Q47),  -1=don’t know, -2=refused 
Q46b. If yes, roughly when did you get ill?   Month (-1 don’t know) _______Year (-1 
don’t know) _________ 
Q46c. how/why do you think you became ill? (-1=don’t know): 
_____________________________________________________________ 
Q47. Has anyone in your household been diagnosed with leptospirosis?  
1=yes, 0=no (skip to Q48) -1=don’t know(skip to Q48), 
 -2=refused(skip to Q48) 
Q47a. If yes, roughly when did they become ill?    
(If more than one person, give the dates of illness of the first person to get ill, and the 
most recent)  
a. First/ only ill person Month (-1 don’t know) ______Year (-1 don’t know)_______ 
b. Most recent ill person  -3= not applicable Month (-1 don’t know) ______ Year (-1 don’t 
know) _______ 
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Q48. Thinking about friends, neighbours, colleagues and extended family in Fiji, how 
many people do you know who have had leptospirosis? 0= none, 1=one or two,  
2 = three to five, 3=six to ten,  4=eleven+,   -1=don’t know, -2=refused 
Contact with animals 
Q49. Over the past three years, have you seen rats or mice… 
a. At or around your home?  1=yes, 0=no, -1=don’t know, -2=refused 
b. At or around your work/school?  -3=not applicable  1=yes, 0=no,  
-1=don’t know, -2=refused 
c. Have you been in physical contact with rats or mice in that time?  1=yes, 0=no, -
1=d/k -2=refused 
Q50. Over the past three years, have you seen mongooses… 
a. At or around your home?  1=yes, 0=no, -1=don’t know, -2=refused 
b. At or around your work/school?  -3=not applicable 1=yes, 0=no, -1=don’t 
know, -2=refused 
c. Have you been in physical contact with mongooses in that time?  1=yes, 0=no, -
1=d/k -2=refused 
Q51. Over the past three years, have you been bitten by ticks or fleas?  
1=yes, 0=no, -1=don’t know, -2=refused 
(not bed bugs, which usually bite in a line of small dots at night, or mosquitoes. Ticks or fleas are often carried by 
furry mammals) 
Local animals and vegetables 
Q52. Please tell me which of the following animals or vegetables, are found locally, if any?  
Select all that apply (mark with a cross). We are not asking about other types. 
  
In garden / at 
home? 
(If applicable) 
In village/ 
settlement/ slum? 
(if applicable) 
Animals kept 
in a pen / 
tied up? 
Direction from house to the nearest 
penned/tied-up animals or to the 
fruit/vegetables 
Uphill  Level Downhill  
a Chickens       
b Pigs       
c Sheep       
d Goats       
e Cows       
f Horses       
g Dogs       
h Cats       
i Sugar Cane       
j Vegetables/ 
root crop 
      
k Fruit       
 
Vinaka vaka levu!       Thanks for taking part in this study. 
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Q53. Could we please take a phone number in case we have further questions? 
__________________________ 
 
Q54. Do you have any other comments? 
 
Remember to get GPS coordinates. Can soap be checked easily? Record any other important 
notes overleaf. 
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Appendix A2. Evaluating Typhoid Vaccine Effectiveness in 
Travelers' Vaccination. CH Watson. J Travel Med. 2015;22:76-77 
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A2.1 Editorial 
Evaluating typhoid vaccine effectiveness in travelers 
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Conall H. Watson, MRPharmS MFPH 
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical 
Medicine, London, United Kingdom 
conall.watson@lshtm.ac.uk 
 
Typhoid fever exists somewhere in the borderlands of the neglected tropical diseases. Its 
history in Europe and North America, and market for vaccination of travelers means typhoid 
is not entirely in the pharmaceutical public health wilderness. Travel immunisation 
recommendations however are based on results of efficacy trials performed in typhoid-prone 
areas, rather than on evidence of direct effectiveness in those journeying from low-risk 
settings. Two recent epidemiological studies address the efficacy in travelers,1,2 one of which 
is in  this edition of JTM. Here, Karen Wagner and colleagues used the detailed enteric fever 
surveillance records of the English public health services to compare typhoid Vi-
polysaccharide (ViPS) vaccine history amongst typhoid and paratyphoid cases. They 
estimated that vaccine effectiveness against typhoid was 65% over three years in travelers, 
after multivariable adjustment, consistent with efficacy trials.  
Their approach, using the indirect cohort design or ‘Broome method’, first developed to 
examine pneumococcal vaccine efficacy across different serotypes,3 is well-suited to the 
question. Paratyphoid cases are suitable controls for typhoid because the geographies in 
which they arise and routes of acquisition are similar. 
Crucially, ViPS vaccine does not protect against paratyphoid: for unbiased estimates of 
typhoid vaccine effectiveness it is necessary to have equal probability of paratyphoid fever 
notification in ViPS-vaccinated and unvaccinated groups.5 There is as yet no licensed vaccine 
against S. Paratyphi, though a number are in development,6 while Ty21a oral typhoid 
vaccines, which have possible cross-protection with Salmonella Paratyphi A and B,7  are 
uncommonly prescribed in the UK and do not feature in the analysis. Similar indirect cohort 
studies of forthcoming typhoid Vi-conjugate vaccines may be possible if there is an interval 
between widespread adoption of these and paratyphoid vaccines, or with detailed vaccine 
history-taking. 
The suitability of paratyphoid controls bears further consideration: if the likelihood of pre-
travel vaccination was different between the cohorts who ultimately end up as paratyphoid 
and typhoid cases then this could also bias estimates.8  For example, travelers visiting friends 
and relatives may be less likely to seek advice or be vaccinated against typhoid than 
holidaymakers,9 and they may also have different Salmonella enterica serovar exposure.  
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Case-control studies in urban Asian settings have suggested different risk factors for the two 
pathogens. In Jakarta, Indonesia, typhoid risk factors were characterised as “within the 
household”: recent typhoid cases, shared plates, and the absence of soap or toilets.10 
Paratyphoid was associated with extra-household factors:  eating street food or recent 
flooding. In Kathmandu, Nepal, a similar categorisation might be inferred:  street-food 
consumption and migration were associated with paratyphoid fever, in contrast with typhoid 
for which risk factors were poor water and low income.11  
So there might be some differences in enteric fever case cohorts in terms of backpackers and 
sunseekers eating out, and travelers staying with family and friends. This seems borne out to 
a modest extent in this study, with tourists making a slightly higher proportion of the 
paratyphoid group, which also has a higher mean age, though there was minimal difference 
in effect size after adjustment for age group, sex, country of birth and ethnicity. 
Particular strengths of Wagner’s paper are the comprehensive breakdown by traveler 
subgroup and by time, and the validation of vaccine histories by cross-checking a subset of 
enteric fever notifications with the patients’ primary care records. One subgroup finding of 
interest is the possibility that vaccine efficacy may be reduced for travelers of white ethnicity, 
though low numbers make estimates imprecise and no significant difference was described. 
While genetic differences in typhoid susceptibility have been demonstrated elsewhere,12 it 
would be premature to suggest this arises in UK travelers. Given the comprehensiveness of 
enteric fever surveillance in England, confirmation or refutation may be possible as more 
data accumulate. Further years’ data could also determine if reduced-antigen Typhim ViPS 
batches, withdrawn by Sanofi Pasteur MSD from the UK, show impaired efficacy with time. It 
is reassuring that the first year of protection shows no difference from full-potency batches. 
A similar indirect cohort study using paratyphoid controls was also completed recently by the 
US Centers for Disease Control and Prevention. Due to missing data, this assessed efficacy 
across both ViPS and Ty21a vaccines, and had less complete vaccine history ascertainment 
than in England. CDC found 80% vaccine effectiveness, higher than that in trials, which they 
ascribe to less intense exposure amongst American travelers compared with residents 
endemic-area studies, both in ingested dose and time at risk.1 High infectious doses of S. 
Typhi can overcome vaccine-derived immunity13  (S. Paratyphi is thought to require higher 
infectious doses than S. Typhi, with food a multiplier, contributing to the differential 
epidemiology10,11), while in one Australian study, all enteric fever cases had been abroad for 
at least three weeks.14 
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As well as measuring vaccine effectiveness within their own travelers, the two effectiveness 
studies provide ecological indicators of the effect of vaccine coverage on typhoid cases 
averted, adding to previous reports.15  In the US, where just 8% of the notional cohort was 
vaccinated, this ratio was around four typhoid cases to each paratyphoid case, while in 
England, where 29% of studied enteric fever cases had been vaccinated, the case ratio was 
closer to 1:1.   
Some of the difference in uptake may be due to typhoid vaccination being offered free-of-
charge to travelers on the English National Health Service, as a public health measure 
intended to provide indirect protection to the families and communities of travelers, as well 
as direct protection to the vaccinees. The limited vaccine uptake amongst English travelers at 
risk of typhoid suggests that, on its own, removing financial barriers to access is not sufficient 
for all such voyagers to receive pre-departure vaccination, with opportunistic pre-travel 
advice from family physicians being one option suggested for improving uptake amongst 
travelers of south Asian ethnicity.9  It also serves to remind us that while we await the arrival 
of paratyphoid vaccines and Vi-conjugate vaccines, the success of these interventions 
depends not just on their efficacy, but on the ability of public health systems to deliver 
vaccines to people who need them, whether residents of endemic areas or their visitors. 
 
 
Acknowledgment 
CHW is supported by the UK Medical Research Council, grant MR/J003999/1. 
 
A2.1.1 References 
 
1  Mahon BE, Newton AE, Mintz ED. Effectiveness 
of typhoid vaccination in US travelers. Vaccine 
2014;32:3577–9. 
2  Wagner K, Freedman J, Andrews N, et al. 
Effectiveness of the typhoid Vi vaccine in 
overseas travellers from England. J Travel Med 
2014;22:  87-93. 
3  Broome C V, Facklam RR, Fraser DW. 
Pneumococcal disease after pneumococcal 
vaccination. N Engl J Med 1980;303:549–52. 
4  Fangtham M, Wilde H. Emergence of Salmonella 
paratyphi A as a major cause of enteric fever: 
need for early detection, preventive measures, 
and effective vaccines. J Travel Med 
2008;15:344–50. 
5  Andrews N, Waight PA, Borrow R, et al. Using 
the indirect cohort design to estimate the 
effectiveness of the seven valent pneumococcal 
conjugate vaccine in England and Wales. PLoS 
One 2011;6:e28435. 
6  Martin LB. Vaccines for typhoid fever and other 
salmonelloses. Curr Opin Infect Dis 
2012;25:489–99. 
7  Pakkanen SH, Kantele JM, Kantele A. Cross-
reactive gut-directed immune response against 
Salmonella enterica serovar Paratyphi A and B in 
typhoid fever and after oral Ty21a typhoid 
vaccination. Vaccine 2012;30:6047–53. 
293 
 
8  Rodrigues LC, Smith PG. Use of the case-control 
approach in vaccine evaluation: efficacy and 
adverse effects. Epidemiol Rev 1999;21:56–72. 
9  Baggett HC, Graham S, Kozarsky PE, et al. 
Pretravel health preparation among US 
residents traveling to India to VFRs: importance 
of ethnicity in defining VFRs. J Travel Med 
2009;16:112–8. 
10  Vollaard AM, Ali S, van Asten H a GH, et al. Risk 
factors for typhoid and paratyphoid fever in 
Jakarta, Indonesia. JAMA 2004;291:2607–15. 
11  Karkey A, Thompson CN, Tran N, et al. 
Differential Epidemiology of Salmonella Typhi 
and Paratyphi A in Kathmandu , Nepal: A 
Matched Case Control Investigation in a Highly 
Endemic Enteric Fever Setting. PLoS Negl Trop 
Dis 2013;7.  
12  Dunstan SJ, Hue NT, Han B, et al. Variation at 
HLA-DRB1 is associated with resistance to 
enteric fever. Nat Genet Published Online First: 
10 November 2014.  
13  Waddington CS, Darton TC, Woodward WE, et 
al. Advancing the management and control of 
typhoid fever: A review of the historical role of 
human challenge studies. J Infect 2014;68:405–
18. 
14  Blackstock SJ, Sheppeard VK, Paterson JM, et al. 
Typhoid and paratyphoid fever in Western 
Sydney Local Health District, NSW, January-June 
2011. N S W Public Health Bull 2013;23:148–52. 
15  Connor BA, Schwartz E. Typhoid and 
paratyphoid fever in travellers. Lancet Infect Dis 
2005;5:623–8.  
 
 
 294 
 
 
Appendix A3. Human Leptospirosis Infection in Fiji: An Eco-
epidemiological Approach to Identifying Risk Factors and 
Environmental Drivers for Transmission. Lau CL, Watson CH, 
Lowry JH, et al.   PLoS Negl Trop Dis. 2016;10(1):e0004405. 
 
 
 
Indicator of Open Access 
 
 
Author Contributions 
Conceived and designed the experiments: CLL CHW SBC MK EJN. Performed the experiments: 
CLL CHW SBC SJW. Analyzed the data: CLL CHW JHL MCD. Contributed 
reagents/materials/analysis tools: SBC SJW. Wrote the paper: CLL CHW JHL MCD EJN. 
 
 
 
 
 295 
 
 
 
 
 296 
 
An Eco-epidemiological Approach to Identifying the Main 
Determinants of Human Leptospirosis Infection in Fiji 
 
Authors: 
Colleen L Lau1, 2, *, Conall H Watson3, John H Lowry4, Michael C David1, Scott B Craig5, Sarah J 
Wynwood5, Mike Kama6, Eric J Nilles7 
 
Affiliations: 
1 Queensland Children’s Medical Research Institute, Brisbane, Australia 
2 Children’s Health and Environment Program, Centre for Child Health Research, The 
University of Queensland, Brisbane, Australia 
3 Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & 
Tropical Medicine, London, United Kingdom 
4 School of Geography, Earth Science and Environment, University of the South Pacific, Suva, 
Fiji 
5 WHO/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis, Forensic 
and Scientific Services, Health Support Queensland, Department of Health, Brisbane, 
Australia 
6 Fiji Centre for Communicable Disease Control, Ministry of Health, Suva, Fiji 
7 Division of Pacific Technical Support, World Health Organization, Suva, Fiji  
 
* Corresponding author: colleen.lau@uq.edu.au 
 
 297 
 
Abstract 
Leptospirosis is an important zoonotic disease in the Pacific Islands. In Fiji, two successive 
cyclones and severe flooding in 2012 resulted in outbreaks with 525 reported cases and 10% 
case-fatality. We conducted a cross-sectional seroprevalence study and used an eco-
epidemiological approach to characterize the risk factors and drivers for human leptospirosis 
infection in Fiji, and aimed to provide an evidence base for improving the effectiveness of 
public health mitigation and intervention strategies. Antibodies indicative of previous or 
recent infection were found in 19.4% of 2152 participants (82 communities on the 3 main 
islands). Questionnaires and geographic information systems data were used to assess 
variables related to demographics, individual behaviour, contact with animals, 
socioeconomics, living conditions, land use, and the natural environment. On multivariable 
logistic regression analysis, variables associated with the presence of Leptospira antibodies 
included male gender (OR 1.55), iTaukei ethnicity (OR 3.51), living in villages (OR 1.64), lack of 
treated water at home (OR 1.52), working outdoors (1.64), rural areas (OR 1.43), high poverty 
rate (OR 1.74), living <100m from a major river (OR 1.41), pigs in the community (OR 1.54), 
cattle density in the district (OR 1.04 per head/sqkm), and maximum rainfall in the wettest 
month (OR 1.003 per mm). Risk factors and drivers for human leptospirosis infection in Fiji 
are complex and multifactorial, with environmental factors playing crucial roles. With global 
climate change, severe weather and flooding are expected to intensify in the South Pacific. 
Population growth invariably leads to more intensive livestock farming; and urbanization in 
developing countries is often associated with urban and peri-urban slums where diseases of 
poverty proliferate. Climate change, flooding, population growth, urbanization, poverty and 
agricultural intensification are important drivers of zoonotic disease transmission; these 
factors may independently, or potentially synergistically, lead to enhanced leptospirosis 
transmission in Fiji and other similar settings.  
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Author summary 
Leptospirosis is a bacterial infection transmitted from animals to humans, and many 
outbreaks are associated with flooding. Globally, leptospirosis is responsible for at least 
500,000 cases of severe illness each year, and many deaths.  The bacteria are excreted in the 
urine of infected animals; humans can become infected through direct contact with animals 
or through contaminated water and soil. In Fiji, two successive cyclones and severe flooding 
in 2012 resulted in 525 cases and 52 deaths. We conducted this study to improve our 
understanding of the factors that increase the risk of leptospirosis transmission, so that 
public health control measures can be improved.  Our study found that infection risk is 
related to many factors including individual demographics and behaviour, contact with 
animals, living conditions, poverty, and flooding risk. With global climate change, flooding is 
expected to become a bigger problem in the South Pacific. Population growth invariably leads 
to more intensive livestock farming; and urbanization in developing countries is often 
associated with slums with high risk of infectious diseases. Climate change, flooding, 
population growth, urbanization, poverty and livestock farming are important factors for 
leptospirosis transmission; these factors may combine to increase the risk of leptospirosis in 
Fiji in the future.  
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A3.1 Introduction  
 
Leptospirosis is an emerging infectious disease worldwide, with particularly high incidence 
reported in the Pacific Islands [1,2]. Humans are infected through direct contact with infected 
animals, or through contact with water or soil that has been contaminated by urine of 
infected animals. Disease transmission is strongly driven by environmental factors including 
high rainfall, flooding, natural disasters, population growth, urbanisation, and poor sanitation 
and hygiene [2-4]. In addition, infection risk depends on individual behaviour (e.g. swimming 
in fresh water, working outdoors), and contact with animals including livestock, rodents, pets, 
& wildlife [2,4]. Risk factors for infections and drivers of outbreaks depend on interactions 
between humans, animals, and the environment, and vary significantly between locations 
based on environmental, cultural, and socio-demographic factors [4].  Transmission dynamics 
are therefore highly complex variable, and likely to evolve with global environmental change 
of both natural and anthropogenic environments [2,3]. 
In Pacific island nations, important risk factors for human leptospirosis include outdoor 
activities, tropical climate, flooding secondary to extreme weather events, and exposure to 
livestock [5-8]. Subsistence livestock are commonly kept in backyards, and veterinary 
expertise is generally limited. In some Pacific Islands, rapid population growth and 
urbanization exacerbate problems with sanitation, access to clean water, and waste 
management. Most islands have limited human or financial resources for the management 
and mitigation of the health impacts of natural disasters and climate change [9,10]. In Fiji, 
leptospirosis was identified as one of the four priority climate-sensitive diseases of major 
public health concern [11]. A recent systematic review of the global morbidity and mortality 
of leptospirosis identified tropical islands as particularly high-risk settings [2]. Apart from the 
tropical climate and high frequency of extreme weather events [3], factors that could 
contribute to the high risk of leptospirosis on tropical islands include the low biodiversity and 
delicate ecosystems that make islands vulnerable to invasive species such as rodents [12]; the 
outdoor lifestyle and associated intense exposure to the environment; and close contact with 
subsistence livestock animals [2,4].  
Climate change is projected to increase the severity of extreme weather events including 
increased precipitation and flooding in the Pacific Islands [10], and such events have been 
associated with increased leptospirosis transmission and outbreaks around the world [3,7,13-
16].  In 2012, two successive tropical depressions caused severe flooding and resulted in two 
outbreaks of leptospirosis in Fiji, with 525 reported cases and 52 deaths (10% case-fatality) 
(Fiji Ministry of Health and Medical Services [MHMS]). Cases were defined as positive 
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reactions to Leptospira ELISA IgM (Panbio, Brisbane, Australia); this laboratory test was only 
available at the national reference laboratory, and it was likely that reported cases were an 
underestimate of the true scale of the outbreaks.  In comparison, previous studies reported a 
total of 576 cases during an 8-year period from 2000-2007 [17], and 487 cases during a 13-
year period from 1969-1981 [18].  These studies identified a higher risk of infection in males, 
indigenous Fijians (iTaukei), young adults (aged 15 to 45 years), rural dwellers and abattoir 
workers; increase in reported cases in the rainy months and after a cyclone in 2001; and 
geographic variation in incidence.  
Following the outbreaks in 2012, the Fiji MHMS and the World Health Organization convened 
a leptospirosis expert consultation to review the epidemiology of leptospirosis in Fiji and 
recommend priorities for control of endemic and epidemic disease. A key conclusion of the 
expert consultation was that significant knowledge gaps in the current epidemiology of 
leptospirosis in Fiji limited effective prevention and control. The study described in this paper 
was identified as one of several important steps to address the knowledge gaps. This study 
uses an eco-epidemiological approach and framework [19] to characterize the epidemiology 
and risk factors for human leptospirosis infection in Fiji, and aimed to provide an evidence 
base for improving the effectiveness and efficiency of public health mitigation and 
intervention strategies. Our findings would also be relevant to other countries with similar 
environments, particularly in the South Pacific. 
 
A3.2 Methods 
 
A3.2.1 Study location and population  
The Republic of the Fiji Islands is an archipelago of 322 islands with a population of 837,217 in 
2007; indigenous Fijians (iTaukei) and Indo-Fijians (Fijians of Indian descent) account for 57% 
and 35% [20] of the population respectively. Fiji is considered a ‘small island developing state’ 
by the United Nations [21] with a per capita GDP of US$4,712 [22].  The main island of Viti 
Levu has a landmass of 10,349 square kilometers and is home to >70% of the population.  
Vanua Levu is the second largest island in both population and land area, followed by 
Taveuni. The largest urban centre is the Greater Suva Area (population ~ 180,000) on the 
southeast coast of Viti Levu. The largest administrative units in geographical size are the 
Divisions (Central, Western, Northern, and Eastern) followed by Provinces (14 in total), 
Tikinas (86 in total), and Enumeration Areas (smallest unit for population census that typically 
include 80 to 120 households).  Nursing zones are the smallest administrative unit of the 
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MHMS; they are under the care of a single nursing station and form a contiguous network 
across the Fijian Islands. Communities are residential clusters defined by MHMS and used for 
administrative purposes. The four main community types in Fiji are urban residential areas, 
villages, Indo-Fijian settlements, and mixed Indo-Fijian/iTaukei settlements. 
A3.2.2. Seroprevalence study and sampling design 
Field data were collected from September to December 2013 (January to March being the 
wettest months), and included the Central Division (on the eastern side of Viti Levu), the 
Western Division (on the western side of Viti Levu), and the Northern Division (the islands of 
Vanua Levu and Taveuni).  The Eastern Division, with a population of ~40,000 spread across 
multiple small islands groups, was not included in the study because of logistical reasons.  
Field data were collected for a sero-epidemiological study of typhoid as well as the 
leptospirosis study described here. 
We conducted a cross-sectional seroprevalence study, with a four-stage sampling design. An 
overview of the sampling plan is shown in Figure A3.1. In the first stage, both population-
proportionate sampling and purposeful sampling approaches were used. The former was 
used to select 28 nursing zones from the Central Division, 21 from the Western Division, 12 
from the Northern Division and 4 from the Ba Province which lies within the Western 
Division. Due to high incidence of reported leptospirosis and post-flood outbreaks in 2012, 
the latter sampling approach was used to select 6 more nursing zones from the Ba Province. 
Similar to Ba Province, Taveuni Island (part of the Northern Division) was oversampled 
because of a high incidence of typhoid in 2008-2009. Consequently, 11 additional nursing 
zones were selected from this region, resulting in 82 zones in total being selected from the 
five regions in the first stage of sampling.  At the second stage of sampling, one community 
was randomly selected from each of the 82 nursing zones. Headmen, health workers and 
other community leaders were consulted to seek agreement to participate in the study; no 
community leaders declined participation. At the third stage of sampling, 25 households were 
randomly selected from each community using health census records, if available, or using 
the World Health Organization’s Expanded Programme on Immunization (EPI) sampling 
method. For the fourth and final stage of sampling, household members (defined as a person 
who stayed at the house the previous night) were enumerated and one selected at random 
for inclusion, except in Ba subdivision where up to three randomly selected household 
members were included. If a selected household member was absent but returning later that 
day, the survey team would await their return or made a repeat visit.  Wholly absent 
household members were substituted from within the household.  Empty households were 
substituted by selecting the nearest house to the right of the front door.  The above sampling 
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strategy aimed to include 25 households in each of 82 communities, with up to three 
participants per household in Ba, and one participant per households in other areas. We 
therefore aimed to recruit a total of 2050 to 2250 participants.   
 
Figure A3.1.  Overview of sampling strategy used in 2015 field study  
 
Participants were eligible for inclusion if they were aged 12 months or older. Exclusion 
criteria included clotting disorders or medical anticoagulation, severe underlying medical 
conditions, significant acute illness, and fear of needles. 
The communities included in the study represented the general population and different 
environments in Fiji (urban, peri-urban, rural), with higher sampling density in Ba and 
Taveuni. The study included a total of 82 clusters, with 28 in Central Division, 10 in Ba, 21 in 
other parts of the Western Division, 12 in Taveuni, and 11 in Vanua Levu.  These areas will be 
referred to as the five ‘regions’ in this paper. 
An overview of data sources and statistical methods is shown in figure A3.2. 
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. Figure A3.2.  Overview of data sources and statistical methods  
 
A3.2.3 Informed consent and ethics approvals  
Ethics approvals were granted by the Fiji National Research Ethics Review Committee (2013 
03), the Human Research Ethics Committee of The University of Queensland (2014000008) 
and the London School of Hygiene & Tropical Medicine (6344). Support was sought and 
obtained from divisional and sub-divisional Ministry of Health officers for community visits. 
To ensure that research activities were culturally acceptable and local customs respected, 
community visits were conducted with field teams that included multilingual local Fijians. The 
study was explained to the heads of each of the randomly selected households, or another 
competent adult, and permission sought to include the household in the study. Written or 
thumb-printed informed consent was obtained from adult participants. The ethics 
committees specifically approved the use of thumbprint informed consent in illiterate 
participants. Parental/guardian consent and informed assent was obtained for child 
participants. 
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A3.2.4 Data collection during field study 
The following were collected from each participant: 
1. Venous blood samples, collected by trained phlebotomists under sterile conditions 
(5-8mL depending on the age of the participant).  
2. Questionnaire data, using standard questionnaires administered by field research 
assistants, and conducted in English or other local languages depending on each 
participant’s preference.  Questions related to demographics, income, occupation, 
recreational activities, household environment, contact with animals, and other 
potential risk factors for leptospirosis.  
3. Geographic Positioning System (GPS) coordinates of the place of residence, using 
handheld GPS devices.  
A3.2.5 Environmental, census, socio-demographic and livestock data 
Environmental data on hydrology and roads were obtained from the Fiji Ministry of Lands and 
Mineral Resources [23]; and soils and land use/cover data from Fiji Ministry of Agriculture 
[24].  Climate (temperature and rainfall) and elevation data were obtained from the Landcare 
Research Institute [25].  Data on educational attainment, household construction, 
employment, ethnicity, and other socio-demographic variables were obtained from the 2007 
Fiji National Census [20], and data on poverty rates from the 2011 World Bank Report [26]. 
Livestock data were provided by the Fiji Ministry of Agriculture’s 2009 National Agricultural 
Census (unpublished data).  All geospatial data were georeferenced to the Fiji Map Grid 1986 
coordinate system.  Table A3.1 provides a summary of the environmental, census, socio-
demographic and livestock data used in the study.  The five geographic regions used in this 
study and examples of the geo-referenced data are shown in Figure A3.3.  
Household GPS coordinates from the study were projected on to the Fiji Map Grid 1986 
coordinate system.  Attributes from the geospatial predictor layers were linked to each 
household location by intersecting points through polygons for vector GIS data, and sampling 
the raster GIS data in a similar fashion. As a result, GIS attributes for each predictor layer 
were obtained for each household location.  Attributes for a community were obtained by 
first calculating the location of the median centre of sampled households, followed by an 
approach similar to that which was carried out for individual households.  All GIS data 
preparation and analysis was performed using ArcGIS v10.1 (Environmental Systems Research 
Institute, Redlands, CA). 
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Maps were drawn to present seroprevalence at each community; household-level results 
were not mapped in order to protect the identity of participants. Locations of communities 
were mapped to their median centre, calculated as the location nearest to all sampled 
households in the community while minimizing the effects of outliers.  
All GIS data preparation and analysis was performed using ArcGIS v10.1 (Environmental 
Systems Research Institute, Redlands, CA).  
 
Figure A3.3. Fiji geography, and examples of environmental and census data  
 a) Divisions and ‘regions’ included in the study, major rivers; b) altitude; c) rainfall; d) total 
cattle density; e) poverty rate; f) proportion of households with metered (treated) water at 
home. See Table A3.1 for data sources. 
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Table A3.1. Summary of environmental, census, socio-demograhpic and livestock data used  
Data Source Variables examined Description & Resolution 
Hydrology Fiji Ministry of Lands and 
Mineral Resources. Digital 
data from FLIS (Fiji Land 
Information System).  Original 
1:50K topographic maps [23].  
Distance to rivers, major, minor 
creeks. 
Euclidean distance to rivers, 
major, minor creeks.   
25 m raster data. 
Roads Fiji Ministry of Lands and 
Resources. Digital data from 
FLIS (Fiji Land Information 
System).  Original 1:50K 
topographic maps. 
Road density. Number of roads per sq km 
within 1 km radius.   
25 m raster data. 
Soils Fiji Ministry of Agriculture.  
1980/85 National Soil Survey 
[24].  
Soils of major and secondary 
floodplains, and depressions. 
Soil units and distance from 
soil units.   
25 m raster data. 
Land 
use/cover 
Ministry of Agriculture.  Digital 
data from Secretariat of the 
Pacific (SPC).  Circa 2010. 
Multiple land use/cover types. Visual interpretation of 
satellite imagery.  
25 m raster data. 
Climate Landcare Research Institute 
[25]. 
Annual, maximum, minimum, 
and average temperature and 
rainfall 
Spatially interpolated climate 
data meteorological station 
data from 1971-2000.  
100 m raster data. 
Elevation Landcare Research Institute 
[3]. 
Altitude and slope Elevation derived from 20 m 
contours.   
25 m raster data. 
Census Fiji National Census 2007 [20]. Multiple measures of education 
attainment, house construction, 
employment, ethnicity, and 
other sociodemographic factors. 
Census variables available at 
the Enumeration Area level 
(~80-120 households).  Vector 
count data converted to 
proportions. 
Economic 
status 
World Bank (2011) report 
[26]. 
Poverty rate (% of population 
below poverty line) and poverty 
gap (how far on average. people 
are from the poverty line) 
Poverty rates estimated using 
small area estimation method.  
Vector data at the Tikina level. 
Livestock Fiji Ministry of Agriculture. 
Unpublished data from the 
2009 Fiji Agricultural Census. 
Number of farms and farm 
animals by species: cattle, 
commercial beef, dairy, 
subsistence beef, etc. 
Density per sq km calculated by 
Tikina (not available for all 
Tikinas). 
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A3.2.6 Stratification of independent variables 
Independent variables were stratified according to the ecological level at which they could 
potentially influence the risk of leptospirosis transmission and infection.  Individual-level data 
relate to risk factors that are specific to individual demographics or behaviour.  Household-
level and community-level data include risk factors that are common to all inhabitants of a 
household and community respectively.  
 Individual-level data. Potential risk factors for leptospirosis were assessed using 
questionnaire-based interviews, including demographics, occupation, recreational 
activities, contact with animals, education, and knowledge about leptospirosis. 
 Household-level data.  Information on household income, house construction, access 
to utilities (toilets, water, sewage, electricity), and the presence of animals and crops 
around the home were obtained through questionnaires.  In addition, data on 
environmental attributes (including rainfall, temperature, elevation, land cover, soil 
type, and distance to rivers) at household locations were extracted or calculated 
using geographic information systems (GIS) as described above.   
 Community-level data. Community type, urban/rural settings, and the presence of 
animal species in each community were ascertained through questionnaires. Census 
and agricultural data were extracted or calculated using the geospatial databases 
described in Table A3.1. Data were available at the enumeration area resolution (~80-
120 households) for a variety of socioeconomic and demographic measures, including 
the proportions of households with metered water, toilets, electricity, and sewage 
services; population ethnicity, level of educational attainment, and reliance on 
subsistence farming as the main source of income. At the Tikina level, data were 
available on World Bank estimates of poverty measures, and census of animal 
populations conducted by the Fiji Ministry of Agriculture.  
 
A3.2.7 Maps 
Maps were produced to show the locations of communities that participated in the field 
study, and the observed community-level seroprevalence in 2013.  Although all household 
GPS locations were recorded, only community-level seroprevalence were depicted on maps 
to protect the identity of participants.  
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A3.2.8 Serological analysis 
Blood samples were processed in Fiji, and frozen sera transported to Australia, for serological 
analysis.  Microscopic agglutination tests (MAT) were used to detect anti-Leptospira 
antibodies, and determine the putative serogroups associated with infections. The MAT is the 
reference serological test recommended by the WHO and the International Committee on 
Systematic Bacteriology (Subcommittee on the Taxonomy of Leptospira) [27,28]. Serological 
analyses were conducted at the WHO/FAO/OIE Collaborating Centre for Reference & 
Research on Leptospirosis in Brisbane, Australia.  
Based on the laboratory’s knowledge of the epidemiology of leptospiral serovars in the South 
Pacific, 21 pathogenic serovars (see Appendix) were selected for the MAT panel for this 
study, and samples were tested at dilutions from 1:50 to 1:3200.  The 21-serovar panel was 
used to test a random selection of ~10% of total samples to determine the most common 
serogroups responsible for infections in humans. In addition, the 21-serovar panel was to test 
199 Leptospira ELISA-positive samples collected from patients with suspected clinical 
leptospirosis in Fiji in 2012 and 2013 to ensure that the most common serogroups to identify 
the most important serogroups associated with clinical infections.  Based on the MAT results 
from the two sets of sera, six serovars were chosen for the final panel used to test the 
remaining samples from this study (A3.S1 Appendix): Leptospira interrogans serovars Pohnpei 
(serogroup Australis), Australis (serogroup Australis), Canicola (serogroup Canicola), 
Copenhageni (serogroup Icterohaemorrhagiae), Hardjo (serogroup Sejroe), and and 
Leptospira borgpetersenii serovar Ballum (serogroup Ballum). 
The MATs assay is expensive and time-consuming, and the described strategy to limit the 
number of serovars included in the panel resulted in reduced project costs. Considering that 
one dominant serovar was identified in the preliminary tests, it was determined that the 
smaller MAT panel was unlikely to have significant impact on the overall epidemiological 
findings. MAT titres of ≥1:50 were considered reactive or seropositive, and indicative of 
recent or past infection.  For samples that reacted to multiple serovars within a serogroup, 
the serovar associated with the highest titre was considered to be the reacting serovar.  
Samples that reacted to serovars in more than one serogroup were recorded as reacting to 
multiple serovars. Although serogroups are no longer used in the taxonomic classification of 
serovars, they remain useful for laboratory purposes and epidemiological comparisons. 
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A3.2.9 Statistical analysis 
An overview of the statistical analyses is shown in Figure A3.2. The outcome measure used 
was seropositive reactions to any of the six serovars included in the final MAT panel. Firstly, 
crude associations between the independent variables and the outcome measure were 
obtained by univariable logistic regression. Independent variables associated with the 
outcome by a likelihood ratio test (LRT) p-value of <0.2 were then subjected to a stepwise 
backward elimination process (p<0.05) to select the final set of independent variables for the 
multivariable logistic regression models. In addition, the possible presence of effect 
modification in the multivariable modelling was investigated using the LRT. This was assessed 
using interaction terms, which consisted of all independent variables found to be significant 
in the univariable analysis. Interaction terms were added separately to the analyses to 
determine their joint effect on the outcome measure.  Multilevel hierarchical modelling was 
used to take into account the clustering of participants, and allowed for correlation of 
observations by region (n=5), community (n=82), and household (up to 3 participants per 
household in Ba) as random effects. Intra-cluster correlation coefficients (ICCs) with 
corresponding 95% confidence intervals were obtained from final multivariable models. 
Biological plausibility and collinearity between variables were taken into account when 
selecting the variables to be retained in the final models. For example, if we observed strong 
collinearity between poverty rate and absence of electricity at home, poverty rate would be 
chosen for the final model because of more direct relationship to exposure risks.  
Two multivariable models were built: 
Model A:  Used independent variables where data could be ascertained by questioning an 
individual, and included primarily individual-level variables, but also some household-level 
and community-level variables. Model A was designed to assess the risk of infection for an 
individual, e.g. for producing predictive risk charts to graphically depict the combined effects 
of variables in determining overall seroprevalence.  The charts are designed for use in clinical 
settings, and are similar to cardiovascular risk charts used to predict the risk of cardiac events 
based on combinations of risk factors such as blood pressure, diabetes, smoking, and 
cholesterol levels. 
Model B: Used independent variables derived from geospatial and other national databases 
described in Table A3.1, without using the field data collected in this study. Model B included 
household-level and community-level variables only, and was designed to assess the risk of 
infection at geographic locations, e.g. estimating community-level seroprevalence, identifying 
hotspots and producing predictive risk maps. 
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Independent variables found to be statistically significant on multivariable regression 
analyses were reported. Adjusted odds ratios (OR) with 95% confidence intervals obtained 
from regression coefficients were used to quantify associations between the independent 
and outcome variables. In addition, univariate results of variables associated with animal 
exposure and contact were reported. Statistical significance was considered at p < 0.05 and 
two-sided. Data analysis was performed using STATA 13 (StataCorp, 2013). Model fit was 
assessed using the Hosmer-Lemeshow test [29], while relative predictive performance was 
undertaken using the area under the receiver operating curve (AUC) was calculated for each 
model and compared for statistical differences. An AUC of 0.7 was deemed to indicate an 
adequate predictive ability of the model. Akaike information criterion (AIC) and Bayesian 
information criterion (BIC) were reported for the final models. 
 
A3.3 Results  
 
A3.3.1 Study population 
A total of 2152 participants from 1922 households in 82 communities on the three main 
islands of Fiji were included in the study.  The age of participants ranged from 1 to 90 years 
(mean 33.6, SD 19.8), and 985 (45.8%) were males.  The age and sex distribution of 
participants are shown in Figure A3.4.  
 
Figure A3.4. Seroprevalence by age group and gender.  
Seroprevalence was defined as the percentage of participants with reactive MAT ( ≥ 1:50) to 
at least one of the 6 serovars used in the final panel.  Blue=male. Red=female.
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The study included 662 participants from the Central Division (28 communities), 453 from Ba 
(10 communities), 520 from other parts of the Western Division (21 communities), 261 from 
Taveuni (12 communities), and 256 from Vanua Levu (12 communities) (Table A3.2). 
 
Table A3.2. Leptospira seroprevalence by age, gender, ethnicity, community types, and region 
Variables No of 
participants  
Reactive 
MATs* 
Sero-prevalence 
(%) 
 
95% CI 
Total sampled  2152 417 19.4% 17.7 – 21.1% 
Gender Male 985 234 23.8% 21.1 – 26.5% 
 Female 1160 182 15.7% 13.6 – 17.9% 
Age groups 
(years) 
0 – 9 256 21 8.2% 5.1 – 12.3% 
 10 – 19 362 69 19.1% 15.1 – 23.5% 
 20 – 29 387 101 26.1% 21.8 – 30.8% 
 30 – 39 340 61 17.9% 14.0 – 22.4% 
 40 – 49 279 63 22.6% 17.8 – 27.9% 
 50 – 59 263 50 19.0% 14.5 – 24.3% 
 ≥ 60 263 52 19.8% 15.1 – 25.1% 
Ethnicity Indo-Fijian 459 34 7.4% 5.2 – 10.2% 
 iTaukei 1651 374 22.7% 20.7 – 24.7% 
 Other 39 8 20.5% 9.3 – 36.5% 
Community type Private residential 502 44 8.8% 6.4 – 11.6% 
 Settlement  
(Indo-Fijian) 
103 18 17.5% 10.7 – 26.2% 
 Settlement  
(mixed ethnicity) 
511 91 17.8% 14.6 – 21.4% 
 Village 1036 264 25.5% 22.9 – 28.3% 
Urban/Rural Urban 579 64 11.1% 8.6 – 13.9% 
 Peri-urban 287 44 15.3% 11.4 – 20.0% 
 Rural 1286 309 24.0% 21.7 – 26.5% 
Region Central Division 662 107 16.2% 13.4 – 19.2% 
 Western Division 
– Ba  
453 82 18.1% 14.7 – 22.0% 
 Western Division – 
Other 
520 94 18.1% 14.9 – 21.7% 
 Northern Division – 
Taveuni 
261 59 22.6% 17.7 – 28.2% 
 Northern Division – 
Vanua Levu 
256 75 29.3% 23.8 – 35.3% 
*Reactive MAT defined at titre of ≥1:50 for one or more serovars used in the 6-serovar panel 
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3.3.2 Seroprevalence and serovars 
Details of the 21 serovars included in the screening panel and the seroprevalence of the 
initial 198 randomly selected samples are shown in A3.S1 Appendix, together with the six 
serovars included in the final MAT panel which accounted for 86.7% of reactive tests: 
Leptospira interrogans serovars Pohnpei, Australis, Canicola, Copenhageni, Hardjo, and and 
Leptospira borgpetersenii serovar Ballum. Using the 6-serovar panel, the overall 
seroprevalence was 19.4% (95% CI  17.7% - 21.1%), with 417 participants having reactive 
MATs to at least one serovar.  One predominant serovar, Pohnpei, accounted for 351 (84.2%; 
95% CI 80.3% - 87.5%) of reactive MATs. A total of 63 participants had MAT titres of ≥1:400 
(47 for serovar Pohnpei, and 16 for other serovars), the cutoff used by our laboratory to 
indicate an acute infection. The distribution of MAT titres for Pohnpei and other serovars is 
shown in Figure A3.5.  
 
Figure A3.5. Distribution of MAT titres for serovar Pohnpei (blue) and other 
serovars (red); using the final panel of 6 serovars.  
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Table A3.2 shows that there were significant differences in seroprevalence by age, gender, 
ethnicity, community types, and region. Community-level seroprevalence ranged from 0% to 
60%, and are shown on the maps in Figures A3.6a-d. Variations in seropositive reactions to 
each serovar by age groups and region of residence are shown in Figures A3.7a&b 
respectively.  
 
 
 
Figure A3.6. Community-level seroprevalence at the 82 communities included in 
the study 
 a) prevalence varied from 0% to 60%; b) enlargement of the Suva area in eastern Viti Levu; c) 
enlargement of Taveuni and eastern Vanua Levu; and d) enlargement of northwestern Viti 
Levu including Ba. 
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Figure A3.7. Percentage of positive MAT reactions associated with each of the 6 
serovars included in the final panel  by: a) age groups, and b) regions.  
 Positve MAT reactions defined as titre of  ≥ 1:50. 
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A3.3.3 Risk factor analysis and multivariable models 
A total of 118 independent variables were assessed on univariate analysis: 75 variables 
obtained from questionnaires, and 43 derived using GIS from the sources described in Table 
A3.1. Independent variables included 31 individual-level, 38 household-level, and 49 
community-level risk factors described above. A3.S2 Appendix provides a list of the 
independent variables assessed at the univariate level. Variables that were statistically 
significant on univariate analyses were considered for the multivariable models, and included 
19 individual-level, 21 household-level, and 25 community-level risk factors. Due to statistical 
significance not be reached, no interaction effect was included in the multivariable modelling. 
Multivariable Model A (using variables where data could be ascertained by questioning an 
individual) included five variables that were independently associated with the presence of 
Leptospira antibodies, with an AUC of 0.7 (Table A3.3) including: male gender (OR 1.55 
compared to females), iTaukei ethnicity (OR 3.51 compared to Indo-Fijians), living in 
settlements and villages (OR 2.13 and 1.64 respectively compared to urban residential areas), 
not having metered water at home (OR 1.52), and working outdoors (OR 1.64 compared to 
working indoors). Of the 434 participants who worked outdoors, 378 (87%) were full- or part-
time farmers, indicating that outdoor work in Fiji is predominantly related to farming. 
Multivariable Model B (using only variables derived from geospatial and other national 
databases) included six variables that were independently associated with the presence of 
Leptospira antibodies, with an AUC of 0.7 (Table A3.4) including: living in rural areas (OR 1.43 
compared to living in urban or peri-urban areas), poverty rate ≥ 40% (OR 1.74), living <100m 
from a river or major creek (OR 1.41), presence of pigs in the community (OR 1.54), total 
cattle density in the Tikina (OR 1.04 per head of cattle per square km), and high maximum 
rainfall in the wettest month (OR 1.003 per mm of rain). Total cattle density (includes both 
commercial and subsistence livestock) ranged from 0.11 to 31.48 head of cattle per square 
km (mean 8.96, SD 5.31), and maximum rainfall in the wettest month ranged from 275 to 
789mm (mean 375.02, SD 56.94). A similar multivariable model using total dairy farm density 
instead of total cattle density performed better than the final model (results not shown), but 
data on dairy farm density were only available for 57 of the 82 (69.5%) communities included 
in our study, and this variable was therefore not used in the final Model B. 
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Table A3.3. Variables significantly associated with positive MAT for Leptospira on univariable 
and multivariable analysis – Model A^ (individual-level variables) 
Variables No of 
subjects  
Reactive 
MAT* 
Sero-
prevalence 
(%) 
Univariable 
Odds Ratio 
(95% CI) 
Adjusted 
Odds Ratio 
(95% CI) 
p 
value# 
 
Total sampled  2152 417 19.4%    
Gender Female 1160 182 15.7% 1 1  
 Male 985 234 23.8% 1.67  
(1.35–2.08) 
1.55  
(1.16–2.08) 
0.003 
Ethnic group Indo-Fijian 459 34 7.4% 1 1  
 iTaukei 1651 374 22.7% 3.66  
(2.53–5.29) 
3.51  
(2.23–5.54) 
<0.001 
 Other 39 8 20.5% 3.23  
(1.38–7.56) 
2.32  
(0.82–6.58) 
0.114 
Community 
type 
Urban 
residential 
502 44 8.8% 1 1  
 Settlement  614 109 17.8% 2.25  
(1.55–3.26) 
2.13  
(1.41–3.21) 
<0.001 
 Village 1036 264 25.5% 3.56  
(2.54–5.00) 
1.64  
(1.08–2.51) 
0.021 
Metered water 
available at 
home 
Yes 1412 221 15.7% 1 1  
 No 720 189 26.3% 1.92  
(1.54–2.39) 
1.52  
(1.14–2.03) 
0.004 
Work location Indoors 832 106 12.7% 1 1  
 Mixed 
indoors/ 
outdoors 
639 123 19.2% 1.63  
(1.23–2.17) 
1.65  
(1.23–2.20) 
0.001 
 Outdoors 434 119 27.4% 2.59  
(1.93–3.47) 
1.64  
(1.15–2.34) 
0.006 
^ Model goodness of fit: AIC 1675.9, BIC 1731.3, df 10. 
*Reactive MAT defined at titre of ≥1:50 for one or more serovars used in the 6-serovar panel 
# p value for adjusted odds ratios, multivariable model  
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Table A3.4. Variables significantly associated with positive MAT for Leptospira on univariable 
and multivariable analyses – Model B^ (environmental and census variables) 
Variables No of 
subjects  
Reactive 
MAT* 
Sero-
prevalence 
(%) 
Univariable  
Odds Ratio 
(95% CI) 
Adjusted 
Odds Ratio 
(95% CI) 
p 
value# 
 
Urban/Rural Urban/ Peri-
urban 
866 108 12.5% 1 1  
 Rural 1286 309 24.0% 2.22  
(1.75–2.82) 
1.43  
(1.07–1.91) 
0.016 
Poverty rate < 40% 1277 187 14.6% 1 1  
 ≥ 40% 875 230 26.3% 2.08  
(1.67–2.58) 
1.74  
(1.31–2.31) 
<0.001 
Distance 
between 
home and 
river or major 
creek 
> 100m 1590 279 17.6% 1 1  
 ≤ 100m 456 115 25.2% 1.58  
(1.24 –2.03) 
1.41  
(1.09–1.83) 
0.009 
Presence of 
pigs in 
community 
No 1587 266 16.8% 1 1  
 Yes 561 150 26.7% 1.81  
(1.44–2.28) 
1.54  
(1.21–1.98) 
0.001 
  
Mean (Standard deviation) 
   
Total cattle 
density in 
Tikina§ (per 
head of cattle 
per sq km) 
Seronegative 
subjects 
8.86 (5.18)    
Seropositive 
subjects 
9.38 (5.83) 1.02  
(1.00–1.04) 
1.04  
(1.02–1.06) 
<0.001 
Maximum 
rainfall in 
wettest 
month (per 
mm) 
Seronegative 
subjects 
372.83 (50.05)    
Seropositive 
subjects 
384.18 (79.01) 1.003  
(1.001–
1.005) 
1.003  
(1.001–
1.005) 
0.002 
^Model goodness of fit: AIC 1924.3, BIC 1963.6, df 7. 
*Reactive MAT defined at titre of ≥1:50 for one or more serovars used in the 6-serovar panel 
# p value for adjusted odds ratios, multivariable model 
§ Includes both commercial and subsistence cattle  
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Collection of biological samples from animals was outside of the scope of this study, but 
study questionnaires included detailed information about contact with animals (rodents, 
mongoose, pets, and livestock) at home and the presence of animals in the community. A 
number of animal-related exposures were significantly associated with the presence of 
Leptospira antibodies on univariable analysis (Table A3.5).  The presence of rats, mice, and 
mongoose around the home was not significantly associated with seroprevalence, but higher 
infection rates were found in participants who reported physical contact with rats or mice 
(OR 1.58) and mongoose (OR 1.81).  Table A3.5 shows that many Fijians have livestock 
animals at home and in the community. The presence of each livestock species was 
associated with a higher infection rates on univariable analysis, but only the presence of pigs 
in the community was significant on multivariable analysis, and included in Model B. 
Table A3.5. Associations between positive MAT for Leptospira and animal exposure at home 
and in the community  
Questions related to animal exposure 
and contact  
Number of 
subjects who 
answered 
‘yes’ 
% of subjects 
who answered 
‘yes’ 
Univariable Odds 
Ratio  
(95% CI) 
p value 
Seen rats or mice at or around your 
home 
1844 85.9% 1.16 (0.84 –1.59) 0.371 
Been in physical contact with rats or 
mice 
323 15.3% 1.58 (1.20–2.09) 0.001 
Seen mongooses at or around your 
home 
1655 77.1% 1.08 (0.83–1.39) 0.574 
Been in physical contact with 
mongooses 
135 6.5% 1.81 (1.23–2.68) 0.003 
Pigs at your home or in your garden 230 10.7% 1.55 (1.23–2.12) 0.007 
Pigs in your community 561 26.1% 1.81 (1.44–2.28) 0.000 
Cows at your home or in your garden 284 13.2% 1.53 (1.15–2.05) 0.004 
Cows in your community 481 22.4% 1.52 (1.19–1.93) 0.001 
Horses at your home or in your garden 200 9.3% 1.53 (1.09–2.14) 0.013 
Horses in your community 377 17.6% 1.55 (1.19–2.01) 0.001 
Are there goats at your home or in your 
garden? 
107 5.0% 1.08 (0.67–1.75) 0.749 
Goats in your community 242 11.3% 1.47 (1.08–2.01) 0.015 
Chickens at your home or in your garden 431 20.1% 1.21 (0.93–1.57) 0.152 
Chickens in your community 819 38.1% 1.39 (1.12–1.72) 0.003 
Dogs at your home or in your garden 645 30.0% 1.00 (0.79–1.26) 0.992 
Dogs in your community 998 46.5% 1.25 (1.01–1.55) 0.041 
Cats at your home or in your garden 355 16.5% 0.78 (0.58–1.06) 0.115 
Cats in your community 830 38.6% 1.38 (1.11–1.72) 0.003 
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Two multilevel hierarchical models were built to take into account spatial correlation of data: 
i) defining region and community as random effects, using the entire dataset, and ii) defining 
community and household as random effects, using Ba data only. The results of multilevel 
models were not statistically different to the results of multivariable Model A (chi2 = 0.01, p = 
0.99) or multivariable Model B (chi2 = 0.02, p = 0.99), and therefore not reported here 
because coefficient estimates were very similar to the reported models. 
 
A3.3.4 Seroprevalence estimation chart using Model A 
Figure A3.8 shows a seroprevalence estimation chart that incorporates individual-level 
variables to show the combined effects of multiple independent risk factors on the 
prevalence of infection. Estimated seroprevalence were based on the five variables used in 
Model A. For example, the chart shows a range of seroprevalence from 2.0% for female Indo-
Fijians who live in urban residential areas, have metered water at home, and work indoors; to 
34.2% for male iTaukei who live in villages, do not have metered water and home, and work 
outdoors. It is uncommon for Indo-Fijians to live in villages or for iTaukei to live in Indo-Fijian 
settlements, and results were therefore not shown for these scenarios. 
 
Figure A3.8. Seroprevalence estimation chart based on Model A, a multivariable 
logistic regression model of individual -level variables for a) females and b) 
males.  
The chart shows the combined effects of independent risk on the estimated prevalence of 
leptospirosis infection. Seroprevalence was defined as as the percentage of participants with 
reactive MAT ( ≥ 1:50) to at least one of the 6 serovars in the final panel.   
 
Work	location Work	location Predicted	
Community	type Indoors Mixed Outdoors Indoors Mixed Outdoors seroprevalence
Indo-Fijian Urban	residential 2.0 3.2 3.1 2.9 4.7 4.7 0	-	4.9%
Village 5	-	9.9%
Female Mixed	Ethnic	Settlmt 3.9 6.2 6.1 5.8 9.0 9.1 10	-	19.9%
Indo-Fijian	Settlmt 8.0 12.4 12.3 11.5 17.4 17.6 20	-	29.9%
≥	30%
iTaukei Urban	residential 7.8 12.2 12.0 11.3 17.3 17.1 Unlikely	scenario
Village 12.1 18.4 18.1 17.1 25.3 25.0
Mixed	Ethnic	Settlmt 14.6 21.9 21.6 20.4 29.7 29.3
Indo-Fijian	Settlmt
Work	location Work	location
Community	type Indoors Mixed Outdoors Indoors Mixed Outdoors
Indo-Fijian Urban	residential 3.1 4.9 4.8 4.5 7.2 7.1
Village
Male Mixed	Ethnic	Settlmt 6.0 9.4 9.3 8.7 13.5 13.3
Indo-Fijian	Settlmt 11.9 18.2 17.9 16.9 25.0 24.7
iTaukei Urban	residential 11.7 17.9 17.6 16.6 24.6 24.3
Village 17.7 26.1 25.7 24.4 34.6 34.2
Mixed	Ethnic	Settlmt 21.1 30.5 30.1 28.7 39.7 39.4
Indo-Fijian	Settlmt
	Have	metered	water	at	home No	metered	water	at	home
	Have	metered	water	at	home No	metered	water	at	home
 320 
 
A3.4 Discussion  
 
Our study identified a high risk of human leptospirosis infection in Fiji, with an overall 
seroprevalence of 19.4% using a 6-serovar MAT panel. One dominant serovar, Pohnpei, was 
associated with 84.2% of reactive MATs. The serovar was originally isolated from rodents and 
pigs during an animal leptospirosis study in the island of Pohnpei in the Federated States of 
Micronesia [30], and has been found to be an important cause of human infections [31].  
Seroprevalence varied significantly between the five regions in our study, and ranged from 
16.2% in the Central Division to 29.3% in Vanua Levu in the Northern Division. Community-
level seroprevalence also varied significantly from 0% to 60% in the 82 communities included 
in our study. These findings indicate marked geographic variation in infection risk in Fiji and 
the presence of hotspots where disease transmission is more intense.   
Globally, reported leptospirosis seroprevalence vary significantly between and within 
countries, based on environmental settings, behavioural risk factors, and socio-
demographics; our results corroborate these findings. To put the Fiji results into a global 
context, examples of seroprevalence reported from known high risk settings [2,4] such as 
urban slums, tropical islands, and flood risk areas include 15.4% in an urban slum in Brazil 
[32], 37% of healthy adult males in the Seychelles [33], 18.8% in the Mekong delta in Vietnam 
[34], and 23.9% and 38.2% in flood-prone areas in Laos and Bangladesh respectively [35,36]. 
As found in Fiji, small-scale variations in seroprevalence within countries and differences 
between occupational groups have been reported. In American Samoa (a group of remote 
islands in the south Pacific), a community-based study reported an overall seroprevalence of 
15.5% [8] and significant variation between islands with different environments, and 
between areas with different population density [37]. In Peru, seroprevalence varied from 
28.0% in the Amazonian city of Iquitos and 16.5% in the surrounding villages (wet tropics), to 
0.7% in a desert shantytown near Lima [38]. In the Andaman Islands, a study of high-risk 
populations found seroprevalence of 62.5% in agricultural workers, 39.4% in sewage workers, 
37.5% in animal handlers, and 30.0% in butchers [39]. In contrast, a study of healthy blood 
donors in an area of high leptospirosis incidence in northern Queensland in Australia found a 
seroprevalence of only 1.4% [40,41].  
Our study found that individual-level factors were important predictors of leptospirosis 
infection risk in Fiji. Model A shows that gender, ethnicity, community type, availability of 
water at home, and work location were independently associated with the presence of 
Leptospira antibodies.  Higher infection rates in males corroborates findings in the majority of 
leptospirosis studies around the world, and is likely to be associated with higher frequency of 
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outdoor activities as well as higher risk occupational and recreational exposures. Reasons for 
the marked difference in seroprevalence between the two main ethnic groups in Fiji are 
unclear, but could be related to differences in genetic susceptibility or behaviours that were 
not elucidated by our questionnaire, e.g. differences in animal husbandry or slaughtering 
practices related to religion or culture. Further studies are required to explain the disparate 
risk between ethnic groups. Seroprevalence in villages was significantly higher than in urban 
residential areas or settlements, and is likely the result of more intimate contact with the 
natural environment and domestic animals. In our study, working outdoors was associated 
with a higher risk of infection, and the majority of outdoor work in Fiji involves farming. 
Agriculture is an important part of Fiji’s economy, and apart from the livestock industry, there 
is commercial farming of a range of crops include sugarcane, coconut, copra, and a wide 
variety of fruits and vegetables. Occupational exposure in the agricultural industry is 
therefore likely to be an important source of leptospirosis infection in Fiji. 
Of note, three of the predictors included in our final multivariable models were related to 
water: the availability of metered (treated) water at home (Model A), distance between the 
home and the closest river or major creek (Model B), and maximum rainfall in the wettest 
month (Model B).  Considering that Leptospira can survive for weeks to months in fresh 
water, and are efficiently carried and disseminated by water (e.g. flooding, flowing 
downstream in rivers), the findings were not unexpected. Lack of metered water at home and 
proximity to rivers are likely to be associated with higher levels of contact with untreated 
freshwater, e.g. using rivers for bathing, cleaning, swimming, and recreational activities.  
Furthermore, poor access to water at home is generally associated with poverty (discussed 
below), and also influences personal hygiene, e.g. the ability to clean and wash after working 
outdoors, or after contact with mud, contaminated water, or animals. Two of the water-
related predictors (distance to river or major creek and maximum rainfall in the wettest 
month) are also proxy measures of flooding risk. As seen with the post-flood leptospirosis 
outbreaks in 2012, flooding is an important driver of transmission in Fiji, as it is in many parts 
of the world.  
Two of the predictors in Model B relate to livestock exposure: total cattle density in the Tikina 
and presence of pigs in the community. Data on cattle density in Tikinas includes both 
commercial and subsistence farming, and varied from < 1 to over 30 heads of cattle per 
square km. Infection risk could be related to direct occupational contact with cattle, or 
through more general contamination of the environment (especially rivers) with cattle urine. 
As shown in Table A3.5, many households in Fiji keep subsistence livestock. Backyard 
piggeries are commonly found in communities in Fiji and other Pacific Islands, and are usually 
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small pens with less than 10 pigs.  The pens are often built on the edge of rivers and streams 
to allow convenient drainage of waste, but unfortunately also lead to contamination of 
freshwater at that community as well as further downstream.  In American Samoa, similar 
backyard piggeries have been associated with the risk of human leptospirosis infection [8,42]. 
Dairy farmers are known to be at high risk for leptospirosis in many parts of the world 
because of close contact with cattle, and exposure to urine during milking.  In our study, high 
density of dairy farms was strongly associated with infection risk, but was not included as a 
variable in the final model because data were only available for ~70% of the Tikinas in our 
study.  As more data on dairy farms become available, associations with leptospirosis risk 
could be further explored and model performance potentially improved. Commercial dairy 
and beef farming could potentially intensify in the future with population growth, and 
increase the risk of leptospirosis.   
Model B also shows that leptospirosis is a disease of poverty in Fiji and disproportionately 
affects the poorest.  Leptospirosis has been associated with poverty in diverse settings 
around the world, including Brazilian and Indian urban slums [32,43,44], Peruvian Amazon 
[38], and areas of poor socioeconomic status in the USA and Europe [45,46].  Furthermore, 
the combination of poverty, livestock keeping, and global climate change are important 
drivers of zoonotic diseases transmission [47]. In our study, participants living in communities 
with high poverty rates (defined as ≥40% of households in the community) had almost twice 
the infection rate compared to other communities, independent of the other predictors in 
Model B. As discussed above, poor access to metered (treated) water at home was associated 
with a higher risk of infection for many reasons, and is also a proxy measure of 
socioeconomic status.   
Although serovar Pohnpei was associated for 84.2% of reactive MATs, there were differences 
in serovar distribution by age and by region of residence, suggesting that the relative 
importance of animal species in disease transmission varies between subgroups. Variation in 
risk factors between age groups likely relates to age-specific behaviours, e.g. young children 
spend more time playing around the home, and have closer contact with pets and soil; 
teenagers have more frequent recreational freshwater contact from swimming in rivers and 
waterfalls; and adults have more intense contact with livestock through occupational 
exposure and managing animals at home. Variation in risk factors between regions likely 
relates to differences in environmental settings, with proportionately greater urbanization in 
the Central division, and more farming in the other regions. For example, rodents could be 
more important in transmission cycles in urban and peri-urban areas, and livestock more 
important in rural areas.   
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Many of the risk factors and environmental drivers identified in our study provide significant 
cause for concern about future risk of leptospirosis in Fiji, as well as other Pacific Islands with 
similar environments.  Population growth is typically associated with agricultural 
intensification, leading to increase in livestock numbers (both commercial and subsistence) 
and occupational exposure.  With global climate change, extreme weather events and 
flooding are predicted to become more frequent and intense in the Pacific Islands.  Rapid 
population growth in developing countries is often associated with urban and peri-urban 
slums where diseases of poverty proliferate.  Although our study found that leptospirosis 
seroprevalence was lower in urban areas, poverty rate was a significant risk factor 
independent of urban or rural settings.  Climate change, flooding, population growth, 
urbanization, and agricultural intensification may independently, or potentially 
synergistically, lead to enhanced leptospirosis transmission in Fiji [3].  
The findings should be considered in light of the study’s limitations.  Limitations of the MAT 
have been well documented; the test is considered to be serogroup rather than serovar 
specific, cross-reactions occur between serovars within a serogroup, and complex paradoxical 
reactions could occur in persons who have had previous infections [28].  Despite these 
limitations, the MAT is considered the gold standard test for identifying putative serogroups 
and serovars when isolates are not available [27]. Isolates of leptospires would be required to 
definitively confirm the serovars circulating in Fiji. Due to budgetary reasons, our study used a 
6- rather than 21-serovar MAT panel to test the majority of samples. If the larger panel was 
used, additional less-common serovars may have been detected.  However, the 6 serovars 
selected included the most reactive serovars when 198 randomly selected samples from this 
study were tested against the full 21- serovar panel; the 6 serovars selected accounted for 
86.7% of the reactive samples, and one dominant serovar (Pohnpei) accounted for 65.9% of 
reactive samples. The reduced MAT panel size could have underestimated the overall 
seroprevalence by a factor of 0.13 compared to a 21-serovar panel, but unlikely to have 
significantly influenced the overall epidemiological patterns reported here because one 
serovar dominated the reactive MATs, and our data analyses in this paper were not stratified 
by serovars. 
Our study measured antibodies to Leptospira to identify evidence of prior infection. However, 
many leptospirosis infections do not result in any apparent illness and are of no clinical 
significance. The severity of clinical disease depends on many factors including pathogen 
virulence and the individual’s immune status, comorbidities, and age [48].  Serovar Pohnpei, 
the serovar associated with 84.2% of MAT-reactive cases, has been reported as an important 
cause of overt clinical disease in the Federated States of Micronesia [31], suggesting the 
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findings in this study are applicable to not only infection but also clinical illness. However, 
there are currently no available data on the proportion of serovar Pohnpei infections that 
result in clinical disease or severe complications.  
Future studies could further improve our understanding of leptospirosis transmission in Fiji 
by examining serovar-specific risk factors; identifying the most important exposures in 
different subgroups such as age groups, gender, ethnic groups, and community types; 
determining the relative importance of livestock, rodents, pets and wildlife in transmitting 
leptospirosis to humans; and developing models to determine transmission (causal) pathways 
rather than just epidemiological links. For environmental and census variables, we used data 
at the place of residence, but infections could also have occurred at work or elsewhere. 
Future studies that focus specifically on work-related activities would provide more insight 
into the importance of occupational exposures in Fiji.  The performances of models were 
partly determined by the accuracy of available environmental, census, and livestock data, and 
models could be updated and improved as more data become available.  Models based on 
environmental factors, such as Model B, could be used to produce predictive risk maps for 
the whole of Fiji. 
In summary, our study found that risk factors and drivers for human leptospirosis infection in 
Fiji are complex and multifactorial, and include climate, the natural environment, livestock 
(both subsistence and commercial), living conditions, socioeconomic status, demographics 
and individual behaviour.  Some of these factors corroborate findings previously reported in 
other settings (e.g. male gender, working outdoors), but other factors appear to be specific to 
the cultural and environmental settings in Fiji, including ethnicity and presence of pigs in 
communities.  By using an integrated eco-epidemiological approach and including a wide 
range of data sources in our analyses, we were able to quantify the relative importance of 
risk factors at different ecological scales.  At the individual level, gender, ethnicity, and work 
location were strongly associated with infection risk.  At the community level, important 
predictors of risk included rural setting, community type, poor access to clean water, close 
proximity to rivers, high rainfall in the wettest month, high poverty rate, presence of pigs, 
and high cattle density. From a wider perspective, significant spatial variations in risk and the 
ability to predict risk based only on environmental and census variables indicate that 
environmental factors play a crucial role in driving leptospirosis transmission in Fiji.   
The above findings provide an important evidence base to guide the focus of public health 
and environmental health interventions at individual, community, and national levels.  Health 
promotion activities and educational materials should be designed to reach the highest risk 
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groups including males, farmers, and iTaukei. Public health and environmental health 
interventions should target the highest risk communities (villages, rural areas, those in 
hotspots and high-risk regions), and include advice on proper management of livestock, 
avoiding contact with floodwaters, and minimizing flooding risk (e.g. adequate garbage 
disposal to reduce the risk of flooding from blocked streams and drains).  At high risk times, 
e.g. post-flooding, communities should also be reminded about the risk of leptospirosis, 
protective measures, and the importance of seeking early medical care if unwell.  In smaller 
communities in Fiji, where laboratory diagnostic tests are often not available, the predictive 
risk chart shown in Figure A3.8 could assist clinicians with determining the likelihood (pre-test 
probability) of leptospirosis infection based on a combination of individual-level variables. 
Broader environmental factors (both natural and anthropogenic) play a major role in 
leptospirosis transmission in Fiji, most of which are beyond the immediate control of 
individuals or small communities. Effective environmental health management at the public 
health and national level will therefore be crucial for the sustainable control of leptospirosis 
in Fiji and other countries with similar environmental and socio-demographic settings. 
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A3.6 Supporting Information 
 
A3.S1 Appendix. Initial 21 pathogenic serovars included in the microscopic agglutination test 
(MAT) panels, and the six serovars chosen for the final MAT panel. 
Species Serogroup Serovar 
198 randomly selected 
samples from this 
study#:  
% of seropositive 
reactions associated 
with each serovar 
199 Leptospira ELISA-
positive samples*: 
% of seropositive* 
reactions associated 
with each serovar 
Used in 
final 
6-serovar 
panel 
Interrogans Australis Australis 7.3% 1.5%  
Interrogans Australis Pohnpei 65.9% 51.5%  
Interrogans Autumnalis Autumnalis    
Borgpetersenii Ballum Ballum 3.7% 6.1%  
Interrogans Bataviae Bataviae    
Interrogans Canicola Canicola 4.9% 10.6%  
Weilii Celledoni Celledoni  4.5%  
Kirshneri Cynopteri Cynopteri 1.2%   
Interrogans Djasiman Djasiman    
Interrogans Grippotyphosa Grippotyphosa    
Interrogans Hebdomadis Hebdomadis    
Interrogans Icterohaemorrhagiae Copenhageni 4.9% 21.2%  
Borgpetersenii Javanica Javanica    
Borgpetersenii Mini Mini 3.7%   
Noguchii Panama Panama 7.3%   
Interrogans Pomona Pomona    
Interrogans Pyrogenes Pyrogenes  1.5%  
Santarosai Shermani Shermani    
Weilii Sarmin Sarmin 1.2%   
Interrogans Sejroe Hardjo  3.0%  
Borgpetersenii Tarassovi Tarassovi    
TOTAL   100% 100%  
# Overall, 32.3% of samples reacted to at least one of the 21 serovars used in the MAT panel; 17.7% 
with MAT titre of 1:50, 9.1% 1:100; 9.1% 1:200; 5.1% 1:400; 0.5% 1:800.  
*Leptospira ELISA-positive samples from patients with suspected clinical leptospirosis from April 
2012 to November 2013 (spanning both epidemic and endemic periods).  Samples were 
systematically selected from a total of 570 samples collected during this period; selection process 
was designed to maximise the probability of identifying the most common serogroups from all 
Divisions (geographic spread) and over the entire time period (temporal spread).  Overall, 33.2% of 
samples reacted to at least one of the 21 serovars used in the MAT panel; 4.5% with MAT titre of 
1:50; 10.5% 1:100; 5.5% 1:200; 7.0% 1:400; 4.0% 1:800; 1.0% 1:1600; 0.5% 1:6400. 
 
  
 329 
 
A3.S2 Appendix. Independent variables stratified by data source and scale of ecological 
influence. 
 Data source 
Scale of 
ecological 
influence 
Questionnaires Derived using geographic information 
systems (GIS) 
Individual-
level 
Age 
Sex 
Country of birth 
Ethnicity 
Religion 
Highest school level completed 
Occupation 
Farming – none, part-time, full-time 
If farmer, type(s) of animal(s) 
Relative altitudes of home and farm 
Availability of soap & water at lunch 
Wash hands with soap & water after lunch 
Availability of soap & water at dinner 
Wash hands with soap & water after dinner 
Type of toilet at school or work 
Availability of soap & water at school or work 
Wash hands with soap & water after toilet at school 
or work 
Swimming, playing, or bathing in flood water 
Walking in flood water 
Contact with freshwater – recreation, walking, 
washing clothes, washing dishes 
Sighting rats or mice at home 
Physical contact with rats or mice  
Sighting mongoose at home 
Physical contact with mongoose 
Bitten by ticks or fleas 
Heard of leptospirosis before this study 
Diagnosed with leptospirosis 
Contacts (family, friends, colleagues) diagnosed 
with leptospirosis 
 
 
Household-
level 
Number of household members 
Household income 
Source(s) of drinking water 
Method(s) used to treat drinking water 
Availability of tap water in house 
Supply of government treated water to house 
Indoor shower or tap for washing 
Type of toilet at home (if any) 
Location of home toilet 
Sharing home toilet with other households 
Availability of soap & water at home toilet 
Wash hands with soap & water after using home 
toilet 
House construction material 
Floor construction material 
Floor raised at least 30cm above ground  
Number of rooms in house 
Garbage disposal method 
Stream or river near home (in community, or within 
100m) 
Flooding at home  
Flooding of land around home 
Presence of animal species at home 
Grow crops, fruits, vegetables at home 
 
Distance to rivers or major creeks 
Elevation above sea level 
Slope 
Road density 
Rainfall (multiple measures including 
maximum, minimum, average) 
Temperature (multiple measures 
including maximum, minimum, 
average) 
Land use 
Soil type 
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Community-
level 
Community type 
Urban rural classification 
Presence of animal species in community 
Grow crops, fruit, vegetables in community 
Educational attainment 
House construction 
Sources of income (subsistence, 
salaried) 
Ethnicity 
Water supply 
Electricity 
Toilets 
Population density 
Population growth 
Poverty rate 
Poverty gap 
Commercial beef – numbers of animals 
and farms 
Commercial dairy – numbers of 
animals and farms 
Subsistence beef – numbers of animals 
and farms 
Subsistence dairy – numbers of 
animals and farms 
Total cattle – numbers of animals and 
farms 
Pigs – numbers of animals and farms 
Goats – numbers of animals and farms 
Horses – numbers of animals and 
farms 
Sheep – numbers of animals and farms 
Poultry – numbers of animals and 
farms 
Duck – numbers of animals and farms 
 
 
 
 
 
 
 
 
